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Summary.
The aim of the work in this thesis was to characterise the formation of sn- 
1,2-diglyceride (DG) in the Swiss 3T3 fibroblast, a model system for mitogenic 
signalling, and to assess the source of that DG.
The generation of inositol phosphates was assessed using isotopic and mass 
assays in Swiss 3T3 cells stimulated with bombesin. The generation of [^HJInsPg 
was rapid and essentially transient, whilst the elevation of [^H]InsP2 and [^HJInsP 
was consistent with the rapid metabolism of [^HjlnsPg. In addition Ins(l,4 ,5 )P3 
mass rose to peak after 5 sec stimulation and returned to pre-stimulated levels by 30 
seconds. The accumulation of total [^Hjinositol phosphates (InsPt ) and Ins 
(1,4 ,5 )P3 mass stimulated by bombesin was dose-dependent with similar, though 
not identical, HC50 values (0.58 ± 0.34 nM and 5.88 ± 3.66 nM respectively).
The phorbol ester phorbol-12-myristate- 13-acetate (PMA) did not stimulate 
[3 H]InsPt accumulation but inhibited by 50% H]InsPt accumulation stimulated 
by bombesin, [Arg8]vasopressin ([Arg8 ]Vp) and prostaglandin F2 a  (PGF2 a ). 
Prolonged treatment of Swiss 3T3 cells with 400nM PMA to down-regulate protein 
kinase C (PKC) resulted in the potentiation of maximum [^H]InsPt accumulation 
stimulated by bombesin, [Arg8]Vp and PGF2 a ; in addition these responses were 
no longer inhibited by acute PMA pre-treatment.
The generation of DG mass in response to bombesin was biphasic; the first 
phase corresponded with the elevation of Ins(l,4 ,5 )P3 mass but the second, 
sustained elevation from 30 seconds up to 30 min was dissociated from 
Ins(l,4 ,5)P3 mass accumulation; the net generation of DG mass in the first phase 
exceeded that of Ins(l,4 ,5 )P3 by at least four-fold. Stimulation of Swiss 3T3 cells 
with PMA resulted in the accumulation of DG mass which exhibited similar kinetics 
to the second phase of bombesin-stimulated DG formation and was dose- 
dependent; the HC50 (2 nM) was similar to the IC5q for PMA-mediated inhibition 
of bombesin-stimulated [^H]InsPt accumulation (5.58 ± 3.84 nM). PMA- 
stimulated [^H]1,2-DG formation was also observed in Swiss 3T3 cells labelled 
with [3 H]palmitic acid in which the fatty acid was preferentially incorporated into
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phosphatidylcholine (PtdCho).
Stimulation of [3H] palmitate labelled Swiss 3T3 cells with bombesin or 
PMA in the presence of 0.3% (v/v) butan-l-ol resulted in the formation of 
[3H]phosphatidylbutanol ([3H]PtdBut) indicating that both agents were activating 
phospholipase D. The EC^q for [3H]PtdBut formation was essentially identical to 
that for DG formation for both bombesin and PMA. For PMA and bombesin, the 
onset of PLD activity preceded that of the sustained phase of DG formation 
suggesting that phosphatidic acid (PtdOH), the normal lipid product of PLD, might 
actually serve as a precursor of DG via a coupled PLD/PtdOH phosphohydrolase 
pathway. Use of butan-l-ol to ’trap' phosphatidate moieties as the metabolically 
stable PtdBut inhibited 75% of PMA-stimulated DG formation but only 30% of 
bombesin-stimulated DG formation indicating different roles for a PLD/PPH 
pathway in contributing to DG formation by bombesin and PMA.
Down-regulation of PKC resulted in the complete loss of bombesin- and 
PMA-stimulated PLD activity suggesting an absolute requirement for PKC. 
Studies with the PKC inhibitor Ro-31-8220 confirmed the PKC-dependency of 
PMA-stimulated PLD activity. However, Ro-31-8220 only inhibited bombesin- 
stimulated PLD activity by 45% suggesting that there might be PKC-independent 
regulation of PLD.
Chelation of extracellular [Ca^+] to approximately 150 nM with EGTA 
resulted in 50% inhibition of bombesin-stimulated PLD activity; the PMA response 
was unaffected. The combination of Ro-31-8220 and EGTA was less than additive 
in inhibiting bombesin-stimulated PLD activity; at least 30% of the response to 
bombesin remained intact in the presence of both agents. The ionophore, A23187, 
stimulated PLD activity though to a lesser extent than bombesin or PMA. This 
response was inhibited by chelation of extracellular Ca^+, though not completely, 
and also by the PKC inhibitor Ro-31-8220; combination of both treatments 
inhibited the majority of A23187-stimulated PLD activity.
A simple ion-exchange system was developed to resolve choline (Cho), 
phosphocholine (ChoP) and glycerophosphocholine (GroPCho). This technique 
was used to assay changes in the level of [3H]choline metabolites in radiolabelled
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Swiss 3T3 cells. Bombesin and PMA elicited an increase in [3 H]Cho prior to any 
significant increase in [3 H]ChoP; the kinetics and dose dependency of [3 H]Cho 
formation were the same as those for [3H]PtdBut formation indicating that PtdCho 
was a major substrate for bombesin- and PMA-stimulated PLD activity. [Arg8]Vp 
and PGF2 a  also stimulated the same apparent PtdCho-PLD activity with EC50 
values corresponding to those for accumulation of [3 H]InsPt in each case. The 
ability of PMA, bombesin, [Arg8]Vp and PGF2 a  to stimulate accumulation of 
[3 H]Cho was completely abolished in cells which had been treated with 400nM 
PMA for 48 hours to fdown-regulate' PKC.
Epidermal growth factor (EGF) stimulated an increase in DG mass which 
was sustained above control for up to 60 min but was of smaller magnitude than the 
response to bombesin or PMA. Half-maximal effects of EGF were obtained at 
doses at which EGF elicited no significant accumulation of [3 H]InsPt . EGF did 
stimulate PtdCho-PLD activity as measured by the release of [3 H]Cho and the 
formation of [3 H]PtdBut. However, butan-l-ol did not inhibit EGF-stimulated DG 
formation suggesting that it did not arise by a PLD/PPH pathway. EGF-stimulated 
PLD activity was not inhibited by the PKC inhibitor Ro-31-8220 but was inhibited 
by the EGF-receptor tyrosine kinase inhibitor, AG 18. Platelet-derived growth 
factor (PDGF) was also able to stimulate the formation of [3 H]PtdBut and the 
release of [3 H]Cho indicating that it also activates a PtdCho-PLD activity. PDGF- 
stimulated [3 H]PtdBut formation was apparent after 30 seconds and therefore 
occurred at least as quickly as increases in Ins(l,4 ,5 )P3 mass. PDGF-stimulated 
release of [3 H]Cho and [3 H]PtdBut formation were abolished in cells which had 
been depleted of cellular PKC.
The results are considered in terms of the role of inositol lipid and PtdCho 
hydrolysis in mitogen-stimulated DG formation in Swiss 3T3 cells and the role of 
sustained DG formation as an early signal in mitogenesis. In the light of potential 
messenger functions for PtdOH the regulation of PLD activity by growth factors is 
discussed.
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Chapter 1.
Introduction; growth factor signal transduction.
1.1 Regulation of the cell cycle.
Cells grow and divide by progressing through the ’cell cycle', a 
programmed series of events involving synthesis of proteins and DNA which 
culminates in mitosis and division into two daughter cells. This process is under 
rigorous control such that the majority of higher eukaryote cells exist in vivo in a 
fully viable but non-proliferating state known as quiescence. Progress through the 
cell cycle is controlled both from within and outside the cell. Within the cell, the 
products of a number of cell division cycle (CDC) genes such as CDC2HS, the 
human homologue of the yeast cdc2 gene, play vital regulatory roles in controlling 
the transition between different phases of the cell cycle (reviewed by Nurse, 1990). 
Outwith the cell, proliferation is controlled by extracellular signals, known 
collectively as growth factors, which produce chemical messages within the cell 
resulting ultimately in activation of CDC gene products and initiation of the cell 
cycle. These growth factors can include neuropeptides, polypeptides, hormones, 
prostaglandins, and immune complexes depending on the type of recipient cell.
The mechanisms by which these factors stimulate cells are one of the keys 
to our understanding the whole process of cell division in normal cells and may 
allow us to identify lesions and thus potential sites of intervention in cancer cells 
exhibiting unrestrained growth in the absence of a functional requirement for cell 
division.
The study of many of the biochemical events culminating in cell division has 
been facilitated by the use of homogenous clonal cell populations grown in vitro in 
biochemically defined growth medium i.e. the process of cell culture. Many cell 
types can be cultured in a balanced salt solution containing serum which is rich in 
growth factors. Cultured cells can be made quiescent by allowing them to reach 
confluency, thereby depleting serum growth factors and contact inhibiting growth, 
or by replacing the growth medium with serum-free or low-serum containing 
medium; by adding back whole serum or defined growth factors DNA synthesis 
can be re-initiated. Such approaches have allowed the identification of distinct 
phases of the cell cycle and the biochemical signals controlling initiation of these 
phases. The main disadvantage of using these 'immortal' cell lines in vitro is that
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cells are maintained and handled in an unnatural state and 'immortal' cell lines are 
prone to spontaneous 'transformation' to tumour-like cells during extended culture 
periods. Indeed, 'immortality' is considered one of the stages in the progression 
from a 'normal' to a 'transformed' phenotype. As such, their use in probing the 
normal processes of cell division is a necessary compromise.
A typical mammalian cell cycle can be anything from 10-30 hours long. 
G |,  represents the gap between the previous nuclear division (M for mitosis) and 
the beginning of DNA synthesis (S-phase) and is the major variable whereas G2 is 
the gap between DNA synthesis and nuclear division (M). Quiescent cells are 
generally considered to be in a distinct physiological state- Gq, though some 
consider quisecence to be an extension of Gj in slow growing cells. In this latter 
model, rapidly growing cells have a very short G j whilst terminally differentiated 
cells such as striated muscle fibres or neurones have an infinite G j.
Addition of exogenous growth factors to quiescent 3T3 fibroblasts results in 
a transition from Gq into a series of events culminating in DNA synthesis and 
mitosis. A model in which cells, given an initial stimulus, become 'competent' to 
further stimulation and enter the cell cycle, has been proposed in the Balb/c 3T3 cell 
line but is not universally applicable (Pledger et al., 1978; O'Keefe & Pledger,
1983). Quiescent Balb/c 3T3 cells, stimulated with a 'competence factor’, will 
remain 12 hours from S phase but will complete Gj transit and initiate DNA 
synthesis when stimulated by factors in platelet-poor plasma. In CCL39 cells a- 
thrombin is required to be present for the entire pre-replicative phase (8-10 hours) 
for DNA synthesis to subsequently occurr (Van Obberghen-Schilling et al.t 1982). 
What is clear is that, after a given time (between 8-12 hours), cells are said to be 
'committed' to progression through the cell cycle and traverse through this variable 
pre-synthetic phase of Gj is independent of the presence of serum or growth 
factors (Zetterberg & Larson, 1985). Whilst cells still remain responsive to various 
growth factors through the cell cycle, it seems likely that the regulation of entry into 
and exit from mitosis as well as the committment to DNA synthesis come 
increasingly under the control of CDC gene products, especially the pp34 product 
of the CDC2 gene (reviewed by Nurse, 1990).
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1.2 Early growth factor-stimulated events in the pre-replicative 
phase of the cell cycle.
Some of the early biochemical and molecular signals initiated following 
stimulation with growth factors include ion fluxes, changes in the phosphorylation 
state of key regulatory proteins and activation of the so-called 'early' CDC genes 
such as c-fos, c-myc and c-jun
1.2.1 Ion fluxes.
The addition of serum or defined growth factors to quiescent Swiss 3T3 
cells and other cells in culture leads to a rapid increase in the intracellular free Ca2+ 
concentration ([Ca2+]j) (Hesketh et al., 1985; 1988), typically from 100-200nM 
up to as much as l^iM.
Different growth factors exert different effects upon [Ca^+]j as defined by 
the kinetics of the response and its dependency upon extracellular Ca2+ ([Ca2+]0). 
In Swiss 3T3 cells, bombesin or vasopressin elicit a biphasic increase: an initial 
'spike' apparent within a few seconds and largely independent of [Ca2+]0 followed 
by a smaller, sustained rise which is dependent upon [Ca2+]0 (Hesketh et al., 
1985 & 1988; Lopez-Rivas et al., 1987; Hasegawa-Sasaki et al., 1988; Bierman 
et al., 1990). In contrast, EGF induces a slower rise in [Ca2+]j which is 
absolutely dependent upon the presence of external Ca2+ (Hesketh et al., 1985;
1988).
Mitogen-stimulation of a variety of quiescent cells, including Swiss 3T3 
cells and thymocytes (Hesketh et al., 1985) results in a gradual, sustained 
elevation of intracellular pH (pHj), the so-called 'alkalinisation' signal. This pHj 
increase can also be achieved by addition of the Ca2+ ionophore, A23187, as well 
as the tumour promoting phorbol ester phorbol-12-myristate-13-acetate (PMA), 
which act synergistically to stimulate early gene transcription prior to DNA 
synthesis (Kaibuchi et al., 1986). The cytoplasmic alkalinisation is a result of 
stimulated Na+/H+ exchange by an electroneutral, amiloride sensitive antiporter 
(reviewed by Pouyssdgur, 1985a). The resulting rise in [Na+]j may be buffered by 
a oubain sensitive Na+/K+ pump so that the early changes in monovalent ion fluxes
and pHj may be integrated into a [Na+]j equilibrium cycle (reviewed by Rozengurt,
1985).
The purpose of the [Ca2+]j and pHj changes in mitogenesis is still not fully 
understood. The transient rise in [Ca2+]i followed by the sustained alkalinisation 
of the cytosol are obligatory for progression to DNA synthesis in the fertilised sea 
urchin egg (Whitaker & Steinhardt, 1982). In Swiss 3T3 cells, addition of A23187 
to artificially elevate [Ca2+]i actually stimulates a subsequent alkalinisation 
(Hesketh et al., 1985 ) and can mimic EGF and PDGF induced c-myc expression 
(Tsuda et al., 1985). Elevation of [Ca2+]j will certainly contribute to the assembly 
of Ca2+-calmodulin (CaM) complexes and the subsequent activation of Ca2+-CaM 
dependent processes such as activation of cyclic AMP phosphodiesterases (Tanner 
et al., 1987; Whitfield et al., 1987; reviewed by Wang et al., 1990). This may 
contribute to the initial drop in [cAMP] seen in a variety of cell lines upon mitogenic 
stimulation (Pastan et al., 1975). Furthermore, [Ca2+ increases are implicated in 
various non-mitogenic responses to growth factors including cytoskeletal 
reorganisation, fluid endocytosis and chemotaxis. In sea urchin eggs, [Ca2+]j is 
clearly implicated in cortical granule secretion and the raising of a 'fertilization 
envelope' after sperm entry; indeed every parameter of normal activation by sperm 
is also observed when eggs are exposed to A23187, including the respiratory burst 
and pHj increases (Whitaker & Steinhardt, 1985). In addition to its role as an early 
signal, Ca2+ is very important at later stages in the cell cycle including S and M 
phases, particularly in construction of the mitotic spindle and the migration of 
condensed chromosomes (reviewed by Whitfield et al., 1987).
The increase in pHj associated with growth factor stimulation, typically of 
0.2 units, is thought to have a permissive rather than a triggering role. In sea 
urchin eggs, pHj must rise by 0.2 units to permit DNA synthesis to begin 
(reviewed by Whitaker & Steinhardt, 1982). By using mutant fibroblasts which 
lack a functional Na+/H+ antiporter, Pouyssdgui and colleagues have shown that 
below a threshold of pH 7.2, pHj is limiting for cell proliferation and one major pH 
dependent step is the mitogenic stimulation of protein synthesis (Pouyssdgur et al.,
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1985a & b). In this regard, it is interesting to note that the ribosomal protein S6 
kinase may be activated by increases in pHj (Pouyss6gur et al., 1982) as can 
another early mitogenic signal, protein phosphorylation (Martin-Perez et al., 
1984).
1.2.2 Protein phosphorylation.
Phosphorylation of proteins upon serine, threonine and tyrosine residues 
appears to be a common consequence of mitogenic stimulation by growth factors. 
Regulation of protein function by phosphorylation/de-phosphorylation cycles is 
recognized as a common feature of biologically responsive sytems, the 
phosphorylation state of target proteins being determined by the action of specific 
kinases and phosphatases. The enzymes responsible for regulating protein 
phosphorylation during mitogenic stimulation vary according to the signal 
transduction pathway employed by the growth factor and as such will be considered 
when the relevant pathways are discussed. However, a number of elements 
involved in controlling cell division are regulated by changes in phosphorylation 
state.
One example is the Na+/H+ antiporter which is responsible for the early 
increase in pHj. Recent studies have shown that the antiporter is phosphorylated 
upon serine residues in a variety of cells upon stimulation with serum, phorbol 
esters, thrombin and EGF with a stoichiometry of 1 mol of phosphate per mole of 
anti porter (Sardet et al., 1990).
Another common substrate for growth factor-stimulated phosphorylation is 
pp42, a mitogen activated protein kinase (MAP-2 kinase, formerly termed 
microtubule-associated protein), a mitogen-activated, serine- and threonine- directed 
kinase (Rossomand et al., 1989). It has been shown that activation of MAP-2 
kinase requires its phosphorylation upon both threonine and tyrosine residues and, 
as such, it may function as an important integrator of distinct signal transduction 
pathways (Anderson etal., 1990b).
A variety of proto-oncogene products are phosphorylated in response to
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mitogenic stimulation, though it is not clear in all cases what physiological 
relevance these events have. The c-raf proto-oncogene product, Raf-1, a serine- 
and threonine-directed kinase, is phosphorylated by activated PDGF (3 receptors in 
3T3 cells and CHO cells whilst PDGF stimulated phosphorylation of Raf-1 on 
tyrosine residues correlates with a 4-6 fold increase in activity (Morrison et al.,
1989). Oncogenic activation of Raf-1 can occur by amino-terminal truncation 
(Rapp et al., 1987a) and injection of this truncated form of Raf-1 into serum- 
starved NIH3T3 cells results in the initiation of DNA synthesis (Rapp et a l , 
1987b). Clearly, phosphorylation and activation of Raf-1 in response to defined 
growth factors may play a role in mitogenesis. In addition, the product of the c-src 
proto-oncogene, a membrane associated tyrosine kinase is also phosphorylated 
(Gould & Hunter, 1988) and activated (Kypta et al., 1990) by growth factors such 
as PDGF.
Activation of protein synthesis is an early, obligatory step in mitogenesis 
and is regulated in part by multiple phosphorylations of the 40S ribosomal protein, 
S6 (Duncan & McConkey, 1982; Martin-Perez et al., 1984). A mitogen- 
stimulated S6 kinase has been purified from Swiss 3T3 cells which catalyses an 
identical phosphorylation pattern to that obtained in vivo (Jeno et al., 1988) and is 
highly specific for S6 (Jeno et al., 1989). It is activated in vivo by serine and 
threonine phosphorylation (Ballou et al., 1988) and this may be stimulated by a 
variety of growth factors including EGF, insulin and PGF2 a  (Martin-Perez et al.,
1984) as well as a kinase closely related to MAP-2 kinase (Ahn et al., 1990).
Finally the activity of pp34cc^ c ,^ the product of the cdc2 gene, is regulated 
by the phosphorylation/de-phosphorylation of Tyr 15 which dictates, in part, the 
entry into mitosis (Gould & Nurse, 1989; reviewed by Norbury & Nurse, 1989 
and Nurse, 1990).
1.2.3 Transcription of 'immediate early' or 'competence' genes.
A common response to many growth factors is the transcription of the so- 
called 'early-response' or ’competence' genes such as the nuclear proto-oncogenes
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c-fos and c-myc.
Transient expression of c-fos and c-myc mRNA occurs in Swiss 3T3 cells 
in response to stimulation with PDGF, FGF, PMA and A23187 (Kaibuchi et al.,
1986) and bombesin (Palumbo et al., 1986; Rozengurt & Sinnett-Smith, 1987). 
Expression of c-fos mRNA typically precedes c-myc; for example, in bombesin- 
stimulated Swiss 3T3 cells c-fos mRNA is elevated after 15 minutes, maximal at 
30 minutes and declines after 60 minutes whereas c-myc mRNA is only apparent 
after 60 minutes and is maintained for upto 6 hours (Palumbo et al., 1986; 
Rozengurt & Sinnett-Smith, 1987). The product of the c-fos gene is thought to act 
as a fra/zs-acting factor, capable of stimulating gene expression by interaction with 
the transcription factor c-Jun/APl (Chiu et al., 1988) though it has no intrinsic, 
specific DNA-binding properties of its own.
Expression of c-fos and c-myc, whilst generally associated with the 
transition from Gq is not confined to quiescent cells. Thus, PDGF induced c-fos 
expression has been demonstrated in Balb/c 3T3 cells undergoing synchronous 
transit through S phase and G2 (Morgan & Pledger, 1989) and in serum-stimulated 
NIH 3T3 cells synchronized in S phase by hydroxyurea treatment (Bravo et 
al., 1986). The precise role of c-fos and c-myc in the transition from quiescence 
is still unclear, in Swiss 3T3 cells in the presence of insulin, bombesin stimulated 
DNA synthesis at sub-nanomolar concentrations which had little effect upon ’early 
gene' tr anscription. Furthermore, when PKC was depleted from the cells 
bombesin was still co-mitogenic with insulin at sub-nanomolar concentrations 
which had no effect upon ’early gene’ induction (Rozengurt & Sinnett-Smith,
1987). Despite this, c-fos is thought to act as a’third messenger’ in mitogenesis, 
involved in transmitting signals encoded by second messengers to the 
transcriptional machinery.
7
1.3 Signal transduction pathways implicated in the control of cell 
proliferation.
Like many hormones and neurotransmitters, growth factors bind to specific 
plasma membrane receptors and activate signal transduction pathways within the 
cell to exert their effect. Growth factor receptors exhibit many of the properties of 
classical hormone receptors such as saturable binding with characteristic values 
for a given growth factor and target cell, amplification of the signal by transducing 
elements and effector systems and the generation of second messengers which 
initiate a chain of events leading to the physiological response. The difficulty in 
studying growth factor action is that since the physiological response, DNA 
synthesis or cell division, occurs at least 18-20 hours after stimulation with a 
growth factor the chain of events may be very long and difficult to dissect
The majority of known growth factors can be broadly divided into three 
categories based upon cognate receptor structure and post-receptor signalling 
pathways. These are:
(i) Growth factors which bind to receptors possessing intrinsic, ligand-activated 
tyrosine kinase activity (receptor tyrosine kinase or RTK-type)
or growth factors which bind to receptors coupling to a separate effector enzyme 
such as
(ii) Adenylyl cyclase or
(iii) Polyphosphoinositide phospholipase C (or Phosphoinositidase C).
By analogy with many hormones and neurotransmitters, growth factors in 
the second and third class bind to receptors and activate an effector system through 
the mediation of a guanine nucleotide regulatory protein (G-protein) (Pouyssegur,
1990). Such growth factors (Receptor-G-protein-Effector or RGE-type) are 
exemplified by bombesin, vasopressin, a-thrombin, PGF2 a , Substance K and 
endothelin and the receptors for these mitogens typically possess seven 
transmembrane domains (Masu et al., 1987; Battey et al., 1991).
These three signal transduction pathways have been implicated in the control 
of cell proliferation and are now described in further detail with particular emphasis 
on the role of inositol lipid hydrolysis and the generation of DG in proliferation.
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However, these transduction pathways cannot be considered in isolation and so the 
role of other signalling pathways in mitogenesis is also reviewed.
1.3.1 A class of growth factors bind to receptors which possess an 
intrinsic, ligand activated, tyrosine kinase activity.
A class of growth factors, typified by EGF, PDGF and FGF, bind to 
plasma membrane spanning receptors whose intracellular domains exhibit an 
intrinsic, ligand activated, tyrosine kinase activity. The study of mutant EGF and 
PDGF receptors, constructed by site-directed deletions and insertions, has provided 
a great deal of information concerning the mechanism of action of the activated 
receptor (reviewed by Ullrich & Schlessinger, 1990).
These receptors typically possess a single external domain for ligand 
binding, a single membrane spanning domain and a cytosolic, catalytic domain. 
Growth factor receptor binding induces oligomerization either by receptor-receptor 
interactions (EGF) or by dimerization of neighbouring receptors. Oligomerization 
leads to activation of the receptors intrinsic tyrosine kinase and an enhanced ligand 
binding affinity. A common consequence of growth factor binding is receptor 
autophosphorylation catalysed by its own tyrosine kinase activity; in the case of 
EGF and insulin receptors, this takes the form of cross-phosphorylation of receptor 
dimers (Ullrich & Schlessinger, 1990). Autophosphorylation of the insulin 
receptor P subunit increases the Vmax of the kinase activity and maintains it in the 
active state (Rosen et al., 1983). In the case of the PDGF and EGF receptors, 
autophosphorylation in the kinase insert domain (Tyr 751) and on a C-terminal 
cluster of tyrosines respectively, may dictate interactions with and phosphorylation 
of substrates (Kazlauskas & Cooper, 1989).
Activation of the tyrosine kinase activity of EGF and PDGF receptors 
absolutely requires the Lys in the ATP binding site consensus sequence Gly X Gly 
X X Gly X(15-20)Lys. Furthermore, the kinase activity itself is a prerequisite for 
signal transduction and initiation of early and late mitogenic responses including
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Ca?+ influx, Na+/H + exchange, c-fos and c-myc expression, S6 kinase activity 
and DNA synthesis (Honegger et al., 1987a, b; Chen et al., 1987; Moolenaar et 
al, 1988). In the case of the PDGF and FGF receptors, the kinase domain is 
divided into two halves by a kinase insert sequence containing the 
autophosphorylation site (Tyr 751). Site directed mutagenesis studies have 
suggested that this insert region may be the site of interaction between the receptor 
and cellular substrates and effector proteins (Kazlauskas & Cooper, 1989).
Whilst it has long been assumed that growth factor receptor tyrosine kinases 
exert their effects by tyrosine phosphorylation of target proteins, the identity of 
some of these substrates is only now becoming apparent. Interestingly, many of 
them are proteins implicated in the control of cell proliferation and include proto­
oncogene products, their allosteric modulators and enzymes controlling signal 
transduction pathways known to be involved in mitogenesis. PDGF and EGF can 
induce the tyrosine phosphorylation (Meisenhelder et a l, 1989) and activation 
(Nishibe et a l ,  1990) of phospholipase C -yl, an enzyme controlling 
polyphosphoinositide hydrolysis which is also involved in mitogenesis (Ullrich & 
Schlessinger, 1990). In addition, the activated PDGF receptor is capable of 
phosphorylating and associating with a type I Ptdlns kinase the enzyme responsible 
for the synthesis of inositol lipids phosphorylated upon the 3' position of the 
inositol ring whose function in mitogenic signalling remains unclear (see section 
1.4.2). The PDGF receptor is also able to phosphorylate and activate the Raf-1 
serine/threonine kinase, (Morrison et a l,  1989) and both the PDGF and EGF 
receptors are also able to phosphorylate the p21ras GTPase activating protein 
(GAP) (Kaplan et a l, 1989; Molloy et a l,  1989; Ellis et a l,  1990) though the 
functional relevance of this event remains unclear. Finally, a recent report has 
shown that the PDGF receptor is able to associate with and activate the pp60c-,yrc, 
p 5 9 fyn and pp62c~yes proteins all of which are members of the src family of 
non-receptor tyrosine kinases (Kypta et al., 1990). In the case of pp60c_,src, 
PDGF treatment also results in tyrosine phosphorylation of the protein though this 
has not been shown to be the case for the others as yet.
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1.3.2 Growth factors which regulate adenylyl cyclase activity.
A variety of hormones and neurotransmitters bind to plasma membrane 
receptors and stimulate an elevation of adenosine 3'5'-cyclicmonophosphate 
(cAMP) by activating adenylyl cyclase (Ad.Cyc.). Transduction of the extracellular 
signal to activation of Ad.Cyc. is mediated by a specific stimulatory G-protein, Gs, 
which is a substrate for cholera toxin-catalysed ADP-ribosylation. Inhibition of 
Ad.Cyc. by activated receptors occurs via an inhibitory G-protein, Gj, which is a 
substrate for pertussis toxin-catalysed ADP-ribosylation. Cyclic AMP is a second 
messenger which binds to the regulatory subunit of protein kinase A (PKA), 
thereby relieving the inhibitory effect upon the catalytic domain which is then able 
to phosphorylate distinct substrates upon serine and, occa sionally, threonine 
residues.
Receptor coupled activation and inhibition of adenylate cyclase is the best 
understood signal transduction system and has been reviewed extensively (e.g., 
Levitski, 1990b). Perhaps the best example of the system is the action of 
adrenaline at the p-adrenergic receptor (e.g., Bahouth & Malbon, 1988). Briefly, 
the levels of cAMP are regulated by a combination of the following:-
(1) receptor and Gs mediated activation of Ad.Cyc.,
(2) receptor and Gj mediated inhibition of Ad.Cyc.,
(3) activation of cAMP specific phosphodiesterases, to remove cAMP,
(4) competition between Gs & Gj for shared Py subunits, and
(5) covalent modification of receptors, G-proteins and/or Ad.Cyc. as a means of 
desensitization/cross talk.
These facets of the adenylate cyclase system have been studied in a variety 
of model systems (reviewed by Casey & Gilman, 1988). Despite this, the role of 
cAMP as a second messenger in the regulation of cell proliferation remains unclear. 
During the 1970s, a body of evidence accumulated to suggest that cAMP was a 
negative modulator of mammalian cell proliferation: cAMP analogues or cAMP 
elevating agents inhibited growth (Johnson & Pastan, 1971; Rozengurt & Pardee, 
1972); elevation of cAMP did not correlate with proliferative status (Otten et aL, 
1972; Bannai & Sheppard, 1974); raising cAMP levels in 3T3 cells inhibited serum
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stimulated DNA synthesis (Kram et al., 1973) and cAMP levels dropped when 
growth arrested cells were stimulated with mitogenic agents (Sheppard, 1972; 
Seifert & Rudland, 1974).
This issue has been been examined extensively by Pouyss6gur and co- 
workers (reviewed by Pouyssegur, 1990) in a-thrombin-stimulated CCL39 cells. 
Chambard et al. (1987) have shown that a-thrombin-stimulated proliferation was 
entirely blocked by pretreatment of the cells with pertussis toxin and yet a -  
thrombin-stimulated inositol lipid hydrolysis is only inhibited by approximately 
50% (Paris & Pouyss6gur, 1986). Furthermore, a-thrombin induced a 30% 
reduction in PGEj- and cholera toxin-stimulated cAMP levels, an effect which was 
100% pertussis toxin sensitive (Magnaldo et al., 1988). The dose-dependency of 
the effects of pertussis toxin on cAMP levels, mitogenesis and ADP-ribosylation of 
Gj-like protein were identical. In the same cell line pertussis toxin completely 
abolished the mitogenicity of 5-HT. Using selective 5-HT antagonists Seuwen et 
a/.(1988a) showed that inositol lipid hydrolysis (via the 5-HT2 receptor) could be 
abolished without inhibiting mitogenesis, but that 5-HT1B antagonists prevented 
both inhibition of adenylate cyclase and mitogenesis. Thus a major pathway for a- 
thrombin and 5-HT mitogenicity may be via Gj mediated inhibition of Ad.Cyc. 
Similar conclusions have recently been reached for the mitogenic effects of lyso- 
phosphatidic acid (van Corven et al., 1989).
Despite this, there is some evidence of a role for cAMP in mitogenesis in 
certain cell types. Cholera toxin treatment of Swiss 3T3 cells, to raise cAMP, 
promoted serum-stimulated DNA synthesis with similar dose dependencies for both 
effects; the effects of cholera toxin being potentiated by inhibitors of cAMP-specific 
phosphodiesterases (Rozengurt et al., 1981). p-adrenergic agonists, acting 
through cAMP generation, stimulated the proliferation of rat parotid cells in vivo 
and in culture (Tsang et al., 1980) and the regenerating rat liver also employs this 
pathway (reviewed in Whitfield et al., 1987; Dumont et al., 1989). Stimulation of 
Swiss 3T3 cells with partially purified porcine PDGF and highly purified human 
PDGF resulted in an elevation of intracellular cAMP which was maintained for up 
to four hours (Rozengurt et al., 1983 ). The use of cAMP phosphodiesterase
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inhibitors resulted in a slight leftward shift in the dose response curve for PDGF 
stimulated [^H] thymidine incorporation suggesting that elevated cAMP facilitates 
the mitogenic effect of PDGF. However, the elevation of cAMP by PDGF is an 
indirect effect mediated through autocrine production of E-type prostaglandins.
The conflicting results obtained when considering a role for cAMP in 
mitogenesis may be due to the variety of tissues studied since cAMP clearly acts as 
a mitogenic signal in certain cell types (reviewed by Dumont et al., 1989). In this 
regard, a number of growth hormone-secreting pituitary tumours are associated 
with GTPase-abolishing mutations in Gs. These cell types exhibit constitutive 
activation of Gs and Ad.Cyc. as well as elevated cAMP levels (Vallar et al., 1987; 
Landis et al., 1989). Not only does this implicate cAMP in the regulation of cell 
growth and proliferation but it also confers the status of oncogene upon the mutated 
Gs gene, Gsp. Furthermore, transfection of the same Gs mutant (Glut 227->Leu 
a s) into Swiss 3T3 cells resulted in elevated basal Ad. Cyc. activity, enhanced 
cAMP accumulation and increased mitogenic responsiveness to forskolin and the 
phosphodiesterase inhibitor Ro-20-1724 (Zachary et al., 1990).
In addition to cell type variations, there may be a number of explanations for 
the opposing results obtained when studying the mitogenic effects of cAMP. One 
of these relates to temporal variations in cAMP levels during the cell cycle. In 
quiescent fibroblast cell lines, Boynton & Whitfield (1983) identified three distinct 
phases where cAMP levels decline, rise and again fall during the pre-replicative 
phase; the characteristic early drop in total cAMP content after mitogenic stimulation 
may correlate with suggestions that an early inhibition of Ad.Cyc. is required for 
mitogenesis (Pouyssegur, 1990).
A second reason for the confusion may stem from the fact that depending on 
the dose the same mitogen may inhibit or stimulate Ad.Cyc.; thus, in CCL39 
fibroblasts low concentrations of a-thrombin inhibit cholera toxin, forskolin and 
PGEj stimulated Ad.Cyc. whilst higher concentrations fully activate inositol lipid 
hydrolysis and PKC which can then stimulate Ad.Cyc activity thereby increasing 
[cAMP]j (Magnaldo et al., 1988).
A third possible explanation of the cAMP paradox is the existence of two
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distinct isozymes of cAMP dependent PKA, sharing identical catalytic subunits but 
having different regulatory subunits. It has been suggested that selective 
modulation of the two isozymes may be a function of cAMP in regulating cell 
proliferation. Use of site specific cAMP analogues has led to suggestions that Type 
II PKA may be associated with inhibition of the growth of human cancer cell lines, 
Type II levels being elevated and Type I decreased (Katsaros et al., 1987). Thus, 
some of the conflicting results obtained for cAMP as a mitogenic second messenger 
may reflect temporal variations in [cAMPJj during the cell cycle or variations in the 
target A-kinase activated by cAMP.
1.3.3 Growth factors which activate phosphoinositidase C.
A large number of growth factors, neurotransmitters and hormones bind to 
plasma membrane receptors and stimulate the hydrolysis of polyphosphoinositides, 
a process which is coupled to the subsequent increase in [Cd?+\  (Michell, 1975). 
Phosphoinositides are minor components of total cellular lipid: phosphatidylinositol 
(Ptdlns) constitutes approximately 10% of total phospholipids and is distributed 
throughout all cellular membranes whereas phosphatidylinositol-4-phosphate 
(PtdIns(4)P) and phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) make up 
only 1-2% of total inositol lipids and are confined to the plasma membrane 
(reviewed by Michell, 1975; Downes & Michell, 1985). The three lipids are 
interconverted by specific kinases and phosphatases which are active even in 
unstimulated cells. It has been estimated that the half life for metabolic renewal of 
the 4- and 5- phosphate groups in polyphosphoinositides is no more than 5 min in 
unstimulated, isolated rat hepatocytes (Palmer et al., 1986). Binding of a Ca2+- 
mobilizing ligand to its receptor (e.g. acetylcholine acting at the M j muscarinic 
receptor) results in the activation of phosphoinositidase C which catalyses the 
phosphodiesteric hydrolysis of PtdIns(4,5)P2. The products of this reaction are the 
two second messen ger molecules, inositol(l,4,5)trisphosphate (Ins(l,4,5)P3) and 
^n-l,2-diacylglycerol (DG), which mobilize Ca^+ from an intracellular store and 
activate protein kinase C (PKC) respectively.
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1.3.4 Evidence for a role for polyphosphoinositide hydrolysis in the 
control of cell proliferation.
The observation that a variety of growth factors stimulate the hydrolysis of 
PtdIns(4,5)P2 and generation of Ins(l,4,5)P3 and DG implicates stimulated 
inositol lipid hydrolysis as an early signalling pathway in mitogenesis (reviewed by 
Whitman & Cantley, 1988; see Fig. 1.1). The resulting second messengers are 
able to activate effector systems which are clearly involved in the transition from G0 
through Gj to S phase. Ins(l,4,5)p3 increases [Ca2+]j (see section 1.5.1 & 1.5.2) 
which is implicated in the control of proliferation (section 1.2) and DG activates 
PKC (see section 1.5.3-1.5.5) which regulates Na+/H+ antiporter activity, S6 
kinase activity and c-fos and c-myc expression (section 1.2). Micro-injection of 
DG stimulates Balb/c 3T3 cells to enter the cell cycle (Suzuki-Sekimori et al., 
1989), whilst micro-injection of antibodies to PtdIns(4,5)P2 abolishes PDGF- and 
bombesin-stimulated mitogenesis (Matuoka et al., 1988). Over-expression of 
PKC in 3T3 cell lines causes disordered growth patterns and increased 
tumorigenicity of cells when injected into nude mice (Persons et al., 1988; Housey 
et al., 1988) and PKC itself is now recognized as the receptor for the tumour 
promoting phorbol esters (Castagna et al., 1982) which are structural analogues of 
DG (see section 1.4). Phosphorylation of nuclear lamin B is stimulated by 
bryostatin-1 and dioctanoylglycerol, both activators of PKC, and correlates with 
translocation of PKC activity to the nuclear envelope in FDC-P1 cells and HL-60 
cells (Fields et al.t 1989; Hocevar & Fields, 1991). The eukaiyote initiation factor 
complex, eIF-4F, is phosphorylated by addition of PM A to [^2Pi]-labelled rabbit 
reticulocytes and the 2-D phosphopeptide map generated by proteolytic digestion of 
eIF-4F is the same as that obtained from the purified protein after incubation with 
PKC in vitro (Morley & Traugh, 1989), though to date it is not known what effect 
this has upon the eIF-4F activity. In addition, expression of a variety of proto­
oncogenes and oncogenes, including ras, src, ros, and abl, in fibroblasts causes 
increases in the basal rates of inositol lipid hydrolysis and levels of inositol 
phosphates and DG (reviewed by Whitman & Cantley, 1988). This may not be a 
direct effect of the oncogene products but there is certainly a strong correlation
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Figure 1.1 Schematic representation of the role inositol lipid 
hydrolysis in early mitogenic signalling events.
Binding of a growth factor of the RGE class, such as bombesin, to its 
cognate receptor results activation of phosphoinositidase C (PIC) (Heslop et al.,
1986); this appears to be mediated by a guanine nucleotide regulatory protein, Gp 
(Plevin et al., 1990). PIC-catalysed hydrolysis of PtdIns(4,5)P2 results in the 
formation of the second messengers Ins(l,4,5)P3 and ,m-1,2-DG. Ins(l,4,5)P3 
binds to a specific receptor thereby releasing stores of intracellular Ca^+, whereas 
sn- 1,2-DG binds to protein kinase C (PKC), forms a complex with PtdSer and 
Ca2+ and thereby activates the serine/threonine phosphorylation of key target 
proteins. These two signals, increased [Ca2+]i and protein phosphorylation, 
cooperate in initiating many of the early events associated with the transit from 
quiescence (Gg) into the cell cycle (Gj and ultimately DNA synthesis). PKC is the 
receptor for the tumour promoting phorbol esters (Castagna et al., 1982) and is 
involved in the regulation of a Na+/H+ antiporter and, thereby, pHj. In addition, 
PKC is implicated in the regulation of S6 kinase, MAP-2 kinase, Raf-1 kinase 
activities as well the expression of the 'competence1 proto-oncogenes such as c-fos 
and c-myc.
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between enhanced growth rates and elevated levels of Ins Ps and DG.
In contrast, there are a number of growth factors which exert their effect 
without enhancing inositol lipid hydrolysis such as EGF in Swiss 3T3 cells 
(Hesketh et al., 1985; 1988; Taylor et al.y 1988) and PDGF in IIC9 cells (Pessin 
et al., 1990). Clearly, for many growth factors, hydrolysis of inositol lipids is 
neither necessary nor sufficient for a full mitogenic signal, but it may play an 
important role in generating signals for the transition to a state analagous to 
'competence’ (Whitman & Cantley, 1988). Thus, in cooperation with other 
pathways the generation of Ins(l,4,5)P3 and DG will constitute a potent mitogenic 
signal (Fig 1.1).
1.3.5 Phosphoinositidase C (PIC).
PIC catalyses the hydrolysis of PtdIns(4,5)P2 to generate the second 
messengers Ins(l,4,5)P3 and DG (reviewed by Downes & Michell, 1985). The 
first inositol lipid specific PLC purified to homogeneity was a 68 kDa form from rat 
liver (Takenawa & Nagai, 1981), now referred to as PLC-a according to the 
nomenclature of Rhee et al. (1989). Antibodies to this protein were able to 
recognize a 62 kDa form in guinea pig uterus (Bennett & Crooke, 1987) and a 65- 
68 kDa form in sheep seminal vesicles (Hofmann & Majerus, 1982). It seems 
likely that these are isoforms or proteolytic products of PLC-a which are certainly 
immunologically distinct from the three isozymes which have been purified, cloned 
and sequenced from bovine brain: PLC-P-1 (mol.wt. 150 kDa), PLC-y (145 kDa) 
and PLC-8 (85-88)kDa. They are distinct gene products but exhibit primary 
sequence homology particularly in two regions, designated X and Y (Suh et al., 
1988 a & b), which are thought to be involved in catalytic function although these 
regions are missing from PLC-a. PLC-a is also unique in possessing a 24 amino 
acid N-terminal membrane anchoring sequence (Bennett et al., 1988) and 
exhibiting significant activity in the absence of Ca2+. In addition to the described 
classification there are reported to be three forms of PLC-p of molecular weights
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150 kDa (P-l), 140 kDa ((3-2) & 100 kDa (|3-3) (Rhee et al., 1989) though the 0-3 
form may be a proteolytic product. In addition, there are known to be two forms of 
PLC-y, (Rhee et al., 1989; Emori et al., 1989).
Unique amongst the PLC isozymes identified to date PLC-y possesses three 
regions of homology to the non-receptor tyrosine kinases, A, B & C, which divide 
the X and Y sequences. These sequences, termed SH (jrc homology) regions, are 
found in c-src and the crk oncogene product and suggest the possibility of 
interactions with various receptor and non-receptor tyrosine kinases (Mayer et al., 
1988; Suh et al., 1988 a & b ; Stahl et al., 1988; Anderson et al., 1990a). This 
is supported by the observation of tyrosine phosphorylation of PLC-yl by growth 
factor receptor tyrosine kinases (Meisenhelder et a/., 1989; discussed in 1.4.3). 
However, this is not the case with other isozymes of PLC and these may be the 
forms involved in the 'classical' coupling of receptors to PIC via G-proteins or 
other as yet unidentified regulatory mechanisms.
The PIC isozymes possess in common the ability to hydrolyse Ptdlns, 
PtdIns(4)P and PtdIns(4,5)P2 but not PtdCho or PtdEtn. Their preferred substrate 
differs as Ca^+ and pH are varied but at low Ca^+ concentrations PtdIns(4,5)P2 is 
the preferred substrate.
Phosphorylation of PLC is a candidate machanism for PKC-mediated 
feedback inhibition of PtdIns(4,5)P2 hydrolysis (Brown et al., 1987). 
Phosphorylation of PLC by PKC has been demonstrated in vivo for PLC-a 
(Bennett & Crooke, 1987) and in vitro for the a ,  (3, y and 8 isozymes (Rhee et 
a l., 1989). However, this has not been shown to affect PLC activity as yet; 
alternatively it may affect the ability of PLC to interact with positive (Gp, see 
section 1.4.1) and negative regulatory elements.
1.4 Receptor coupled PtdIns(4,5)P2 hydrolysis.
Unlike receptor tyrosine kinases where ligand binding, transducing and 
catalytic domains reside in the same molecule, receptors do not possess an intrinsic
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PIC activity. Rather, they interact with PIC directly or via transducing elements 
such as guanine nucleotide regulatory proteins. These various methods of coupling 
between receptors and PIC are reviewed.
1.4.1 A role for guanine nucleotide regulatory proteins.
Guanine-nucleotide binding proteins (G-proteins) play a central role in the 
transduction of a variety of extracellular stimuli to effector systems as diverse as 
adenylyl cyclase, guanylyl cyclase and ion channels (reviewed by Gilman, 1987; 
Birnbaumer et al., 1990). The classical, high molecular weight, G-proteins are 
heterotrimers consisting of an a-subunit of molecular weight 39-52 kDa and a py- 
subunit complex of molecular weights 35-36 kDa and 9-13 kDa respectively. They 
function in a cyclical manner with binding of an agonist to its receptor stimulating 
exchange of GTP for bound GDP on the a-subunit. In the presence of Mg^+, the 
a-GTP complex may dissociate from the Py-subunit complex and is then able to 
modulate an effector system. The signal is terminated by the intrinsic GTPase 
activity of the a-subunit and the cycle is completed by the recomplexing of the 
subunits to form the heterotrimer. Since it is the a-subunit which is the site of 
guanine nucleotide binding and interacts with both receptor and effector entities it is 
likely to confer individuality and specificity upon the G-protein.
The high molecular weight G-proteins have been classified on the basis of 
their sensitivity to pertussis (Gj) and cholera toxins (Gs). In addition there are a 
number of G-proteins which are not substrates for toxins e.g., Gz. Finally there are 
an increasing group of G-proteins, identified by PCR cloning and low stringency 
hybridization (Strathmann et al., 1989), for which there remains no known 
function.
The proposal that receptor-activated inositol lipid hydrolysis may be 
modulated by a G-protein, Gp, was first made by Cockcroft (1987). This was 
based on the observation that ligand-stimulated Ins(l,4,5)P3 or InsPt formation 
was potentiated by non-hydrolysable guanine-nucleotide analogues such as GTPyS 
or guanosine 5'-[Py-imido]triphosphate (GppNHp) and inhibited by GDPpS in
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various permeabilized cells (e.g., Geny et al., 1989; Plevin et al, 1990). In 
addition, fluoroaluminate ions (A1F4") which bind to GDP in the nucleotide binding 
site of G-proteins mimicking the terminal phosphate of GTP but are non- 
hydrolysable, can elevate inositol phosphate formation in the absence of ligand 
(Cockcroft & Taylor, 1987).
Despite the number of systems where guanine nucleotide-dependent InsPt 
formation has been identified, the molecular identity of Gp remains unresolved. 
Recent reports have described the purification of a G-protein a-subunit which is not 
a bacterial toxin substrate and appears to exhibit the properties of Gp in a 
reconstituted system (Taylor et al., 1990; Pang &Stemweiss, 1990). Other reports 
have suggested that, in some cell lines where InsP formation is inhibited to varying 
degrees by pre-treatment with pertussis toxin, Gp may actually be a member of the 
Gj family (Lad et al., 1985; Pfeilschifter et al., 1986) but again the identity of 
such a protein remains unknown.
A second and rapidly expanding family of guanine nucleotide regulatory 
proteins comprises the low or small molecular weight G-proteins (reviewed by 
Sanders, 1990) which differ markedly from the classical aPy heterotrimers. This 
group is exemplified by the members of the ras gene super family; protein products 
of the cellular ras proto-oncogene. Ras genes encode proteins of molecular 
weight 21kDa ($21ras), possessing a single subunit with an intrinsic GTPase 
activity. Like the classical G-proteins, ras undergoes a GDP/GTP exchange cycle 
but this is not modulated by interaction with a py complex. Indeed, ras proteins 
possess a much lower intrinsic GTPase activity than the classical G-proteins and in 
vivo and this is normally controlled by a cellular protein known as GTPase 
activating protein (GAP) (Trahey & McCormick, 1987) which stimulates GTP 
hydrolysis by ras. The majority of transforming mutations found in ras-induced 
tumors are due to point mutations in the GTP-binding domain or at the site at which 
GAP interacts with ras preventing GTP hydrolysis, with the result that ras 
remains permanently in the GTP-bound, active state.
It is proposed that in its constitutively active state ras generates an 
uncontrolled proliferative signal resulting in transformation; by analogy with other
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G-proteins this would suggest that normal c-ras is involved in a signal transduction 
pathway which regulates mitogenesis. Mammalian ras proteins exhibit extensive 
sequence homology with the yeast RAS genes which function in the regulation of 
the mating pathway and adenylate cyclase, but in higher eukaryotes ras genes do 
not regulate adenylate cyclase (reviewed by Hall, 1990). A number of observations 
have suggested a role for y l \ ras as Gp , the G-protein controlling inositol lipid 
hydrolysis (Fleischmann et al., 1986; Wakelam et al., 1986; Lloyd et al., 1989). 
For example, elevated InsP levels correlate with transforming mutations of ras 
which abolish GTPase activity (Hancock et al., 1988). Furthermore, in the T15+ 
clone of NIH3T3 cells, containing the p21^"ras: gene under the control of a steroid- 
inducible promoter, expression of the p21N' rfl,s gene confers responsiveness to 
bombesin resulting in the stimulated formation of Ins(l,4,5)P3 and elevation of 
[Ca^+]j which is negligible in the control cell line T15" (Lloyd et al., 1989). 
However, other studies have been unable to show similar effects (e.g., Seuwen et 
a l., 1988b), whilst elevated InsP levels have been reported in cell lines 
transformed by a variety of oncogenes and may simply reflect elevated growth rates 
and/or overexpression of growth factor receptors in transformed cells (Downward 
et al., 1988). Clearly, expression of the p21N‘ra,y gene in the T15+ cell line does 
increase bombesin receptor-PIC coupling either directly or indirectly, but it is 
unlikely that ras simply acts as Gp.
1.4.2 Activation of PtdIns-3-kinase.
Ptdlns 3-kinase was first demonstrated in immunoprecipitates from 
polyoma middle T-transformed cells (Whitman et al., 1988) and has recently been 
purified from rat liver (Carpenter et al., 1990). The enzyme consists of an 85kDa 
protein, the same as that found to associate with activated PDGF receptors and the 
middle T antigen (Kaplan et al., 1987), and a 1 lOkDa protein which form a native 
complex of 190kDa (Carpenter et al., 1990). Since the 85kDa subunit is 
phosphorylated extensively upon association with PDGF receptors (Kaplan et al.,
1987) whilst the 1 lOkDa subunit has not been shown to associate with receptors to
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date it is possible that the smaller subunit exerts a regulatory role upon the catalytic 
activity of the holoenzyme. Non-transforming mutants of Middle T antigen and 
tyrosine kinase-negative mutants of the PDGF receptor which do not transduce a 
mitogenic signal do not have an associated Ptdlns 3-kinase activity suggesting that 
this pathway does produce a signal involved in mitogenesis. However, the nature 
of this signal is unclear (Majerus et al., 1990); it is not yet known if PtdIns(3)P is 
the precursor for the two novel polyphosphoinositides, PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3 (Auger et al., 1989), but none of the 3-phosphate containing 
inositol lipids are good substrates for phosphoinositidase C from liver or brain 
(Serunian et al., 1989). Recent reports have implicated this pathway in the 
response to some extracellular ligands (Auger et al., 1989; Traynor-Kaplan et al., 
1989), but its relevance to either second messenger generation or a physiological 
response remains to be rigorously defined.
1.4.3 Phosphorylation of PLC-yl.
Immunoprecipitation of activated growth factor receptors followed by 
blotting with anti-phosphotyrosine or anti-PIC antibodies has shown that a PIC 
subtype, type II or PLC-yl, associates with and is phosphorylated upon tyrosine 
residues in a ligand-dependent manner by PDGF and EGF receptors (Meisenhelder 
et al., 1989). The receptor tyrosine kinase activity is essential for growth factor- 
induced PLC activation, and it has recently been shown directly that this tyrosine 
phosphorylation results in the activation of PLC-yl as well as its translocation to the 
plasma membrane wherein resides its substrate (Nishibe et al., 1990; Todderud et 
al., 1990). Such coupling of growth factor receptors to PLC-yl is fundamentally 
different to that for mitogenic peptides such as bombesin (Plevin et al., 1990) since 
it is not modulated by guanine nucleotide analogues. These results are consistent 
with what is known about the primary structure of PLC-yl since it contains two 
SH2 regions which are thought to play a regulatory role in directing specific 
interactions with cellular components (Anderson et al., 1990a; reviewed by Rhee 
et a l,  1989).
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This apparent diversity of coupling mechanisms for activation of PIC 
presumably reflects some evolutionary advantage in having multiple pathways for 
regulating inositol lipid hydrolysis. Such speculation will await the identification of 
Gp, if such a function can be attributed to a single molecular species. The 
physiological significance of the PLC-yl pathway remains to be fully defined since 
overexpression of PLC-yl does not result in increased PDGF-stimulated 
mitogenesis (Margolis et al., 1990). However different modes of regulation of 
PIC activity may account for the diversity of responses seen to different agents in 
the same or different cell lines such as the differing effects of bombesin and PDGF 
in Swiss 3T3 cells (Nanberg & Rozengurt, 1988; Blakeley et al., 1989).
1.5 Agonist-stimulated polyphosphoinositide hydrolysis generates 
two second messengers.
A major feature of the signal transduction pathway involving the hydrolysis 
of the polyphosphoinositides is that both the products of PIC activity are second 
messengers with distinct cellular functions. Consequently this bifurcating signal 
constitutes a flexible pathway for initiating diverse effects within the cell (reviewed 
by Downes & Michell, 1985; Berridge, 1987a) including many of the early events 
associated with proliferation (Berridge, 1987b; Whitman & Cantley, 1988). The 
major elements of the hormone sensitive inositol lipid cycle are outlined in Fig. 1.2. 
This figure does not include details of the metabolism of the 3phosphatecontaining 
inositol lipids since their physiological relevance remains unclear; however, this 
issue has recently been reviewed extensively by Majerus etal. (1990) and Cantley 
e ta l  (1991).
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Figure 1.2 The major elements of the hormone-sensitive inositol 
lipid cycle.
A summary of the major elements of the hormone-sensitive inositol lipid 
cycle is shown; details of the 3' phosphate-containing inositol lipids and the higher 
phosphorylated forms of inositol ( In sP ^ ) are not shown since their physiological 
relevance remains unclear. The enzymes are (1) Ptdlns synthetase (CMP-PtdOH; 
inositol phosphatidyltransferase); (2) PtdIns-4-kinase; (3) PtdIns(4)P 
phosphom onoesterase; (4) P tdIns(4)P-5 '-kinase; (5) P tdIns(4,5)P2 
phosphomonoesterase; (6) phosphoinositidase C; (7) DG kinase; (8) CMP-PtdOH 
synthetase; (9) Ins(l,4,5)P3-5'-phosphatase; (10) inositolpolyphosphate-1'- 
phosphatase; (11) Ins(x)P phosphatase; (12) Ins(l,4,5)P3-3'-kinase; (13) 
Ins(l,4,5)P3/Ins(l,3,4,5)P4-5'-phosphatase; (14) inositolpolyphosphate-4'- 
phosphatase; (15) Ins(l,3)P2-3'-phosphatase; (16) Ins( 1,3,4)P3-6-kinase. All 
inositol phosphates are numbered as the D-myo-inositol configurations as 
described by Berridge & Irvine, (1989).
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1.5.1 Ins(l,4,5)p3 and intracellular calcium homeostasis.
Whilst agonist-stimulated inositol lipid turnover was first documented in 
1953 (Hokin & Hokin, 1953) it was not until 1975 that Michell (1975) identified 
stimulated inositol lipid turnover as the common denominator for a variety of 
agonists which elicit a rapid increase in intracellular free calcium concentration 
([Ca2+]j). Indeed, it was 1983 before it was recognised that PtdIns(4 ,5 )P2 is the 
major precursor (Creba et al., 1983) and Ins(l,4 ,5 )P3 is the initial product 
(Berridge, 1983) of agonist-stimulated inositol lipid hydrolysis, whilst Streb et al. 
(1983) showed that Ins(l,4 ,5 )P3 was effective in releasing Ca2 + from 
permeabilized pancreatic acinar cells. Such observations have now been repeated in 
a variety of cell types including Swiss 3T3 cells, GH3 pituitary cells, hepatocytes 
and vascular smooth muscle cells (reviewed by Berridge, 1987a). To satisfy the 
role of 'Ca2+ mobilised Ins(l,4 ,5 )P3 must, and indeed is, produced very rapidly 
upon stimulation of responsive cells. Relatively few studies have looked at 
timepoints below 10 seconds but in bradykinin-stimulated NG115-401L cells 
[•^H]Ins(l,4 ,5 )P3 levels are significantly above control at two seconds (Jackson et 
a l, 1987).
In permeabilized cells, the reponse to Ins(l,4 ,5 )P3 takes the form of 
saturable release of between 30 and 70% of sequestered Ca2+ with an EC50  in the 
range of 0.1-l|iM. There is marked selectivity for inositol phosphate induced Ca2+ 
release with orders of potency of Ins(l,4 ,5 )P3 > GroPtdIns(4 ,5)P2 = Ins(2 ,4 ,5 )P3 > 
Ins(4 ,5 )P2 suggesting an absolute requiremant for vie inal 4' and 5’ phosphate 
groups with a 1' phosphate enhancing the effect. These observations of saturability 
and selectivity are consistent with Ins(l,4 ,5 )P3 exerting its effect by binding to a 
specific receptor. Consequently, it is now accepted that Ins(l,4 ,5 )P3 , released by 
hydrolysis of PtdIns(4 ,5 )P2 » binds to an intracellular receptor mediating the release 
of Ca2+ from an intracellular store into the cytosol.
The Ins(l,4 ,5 )P3 receptor has now been purified from brain homogenates 
(Supattapone et al., 1988) and cloned from cerebellar Purkinje neurons (Furuichi 
et al., 1989). The receptor is a glycoprotein with predicted molecular weight of 
313 kDa which probably exists as a tetramer in vivo and when solubilized giving a
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molecular weight of around 1000 kDa. In overall topography as well as at the C- 
terminus, the Ins(l,4,5)P3 receptor exhibits significant homology with the 
ryanodine Ca2+ channel from the sarcoplasmic reticulum of skeletal muscle 
(Takeshima et al., 1989).
The subcellular location and identity of the Ins(l,4,5)P3 sensitive Ca2+ 
store remains to be rigorously defined and indeed may be different depending on 
the nature of the cell or tissue concerned. However, it is clear that the Ins(l,4,5)P3 
sensitive store is not part of the mitochondria (Burgess et al., 1984; Volpe et al., 
1987; Ross et al., 1989) which constitutes a major store of intracellular Ca2+. 
Recent immunocytochemical data suggest that the rough E.R. and the nuclear 
envelope are principal sites of the Ins(l,4,5)P3 receptor as is peripheral smooth 
E.R., close to the plasma membrane (Ross et al., 1989). The more uniform 
labelling of the E.R. reported by Mignery et al. (1989) would seem to argue 
against a role for a specialized Ins(l,4,5)P3-responsive organelle such as the 
’calciosome’ proposed by Volpe et al. (1988).
The transient release of Ca2+ from the Ins(l,4,5)P3-sensitive store is not 
due to the desensitization of the Ins(l,4,5)P3 receptor since use of the non­
metabolised analogue inositol(l,4,5)trisphosphorothioate results in a sustained 
Ca2+ efflux from hepatocytes with no net re-sequestration suggesting that the 
Ins( 1,4,5)P3 -gated channel remains open (Taylor et al., 1990).
Phosphorylation of Ins(l,4,5)P3 by a 3' kinase (see Fig. 1.2) may serve to 
generate another second messenger molecule, Ins(l,3,4,5)p4. The sustained, 
though smaller, elevation of [Ca2+]j represents Ca2+ entry into the cell and it has 
been suggested that this may be due to a second messenger-operated Ca2+ channel 
(reviewed by Berridge & Irvine, 1989; Irvine, 1990). The precise role of 
Ins(l,3,4,5)P4 in regulating Ca2+ entry is unclear since it exerts no effect unless a 
Ca2+-mobilizing InsP3 (Ins(l,4,5)P3 or Ins(2,4,5)P3) is present (Irvine et al., 
1988). Irvine (1990) has speculated that there are three ’players’ in the regulation 
of Ca2+entry: the intraluminal [Ca2+] in the E.R., Ins(l,4 ,5)P3 and 
Ins(l,3,4,5)P4 . He argued that Ins(l,4,5)P3 binding to its receptor discharges
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Ca2+ from the E.R. lumen and this results in the dissociation of the Ins(l,4,5)P3 
receptor from an Ins(l,3,4,5)4 receptor at the plasma membrane, thus removing a 
tonic inhibition of Ca^+ entry. Ins(l,3,4,5)P4 may also contribute to this by 
binding to its receptor and promoting dissociation of the Ins(l,4,5)P3 receptor. In 
support of this Irvine cited the example of the proposed communication between the 
ryanodine receptor on the sarcoplasmic reticulum and the sarcolemma but 
confirmation of such a model must await the purification and identification of the 
Ins(l,3,4,5)P4 receptor.
1.5.2 The metabolism of Ins(l,4 ,5)P3; physiological relevance.
The transient nature of many Ca2+ responses suggests that Ins(l,4,5)P3 is 
rapidly removed and/or responses are rapidly desensitized at the receptor-Gp-PIC 
level. It is well established that, in eukaryotes, Ins(l,4,5)P3 may be removed 
rapidly by two pathways (see Fig. 1.2) and there is some evidence to suggest that a 
rise in [Ca2+]j may actually facilitate the removal of Ins(l,4,5)P3, thereby ensuring 
the transient nature of the response.
The first pathway involves the rapid dephosphorylation of Ins(l,4,5)P3 by 
a 5'-phosphatase to yield Ins(l,4)P2 (Downes et al., 1982; Storey et al., 1984) 
which, lacking the 4f and 5' vie inal phosphate groups, is unable to release Ca2+ 
from the internal store. The observation that Ca2+ activates the 5'-phosphatase in a 
variety of cells (Kikita et al., 1986; Sasaguri et al., 1985) thereby ensuring the 
removal of the second messenger is attractive but not universal (Connolly et al.,
1987). Ins(l,4)P2 then undergoes a de-phosphorylation reaction to InsP. It would 
appear that the favoured reaction is a l'-phosphatase giving Ins(4)P as the product; 
less than 5% of Ins(l,4)P2 is metabolized by the 4'-phosphatase (Morris et al.,
1988). It is known that a single enzyme de-phosphorylates Ins(l)P, Ins(3)P and 
Ins(4)P to yield myo-inositol (Gee et al., 1988). The Ins(x)P-phosphatase is 
inhibited in an uncompetitive manner by millimolar concentrations of Li+ , 
providing a useful block in the de-phosphorylation of inositol phosphates. This 
allows a convenient measure of receptor-mediated inositol lipid hydrolysis to be
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made in terms of the accumulation of total inositol phosphates (InsPt) (Berridge et 
al., 1982).
The second pathway for the removal of Ins(l,4,5)P3 is its rapid 
phosphorylation to inositol(l,3,4,5)tetrakisphosphate (Ins(l,3,4,5)P4 ) by a 3'- 
kinase. This reaction was first observed in parotid gland (Batty et al., 1985) and 
has subsequently been demonstrated in a variety of tissues. Again, in terms of 
removal of a Ca2+-mobilising second messenger, the 3* kinase is activated by 
elevation of [Ca2+]} and, in brain and neural tissues, by Ca2 +-calmodulin 
complexes (Biden et al., 1987; Morris et al., 1987), allowing fine control of 
intracellular Ca2+ elevation. Ins(l,3,4,5)P4 is rapidly de-phosphorylated by a 
Mg2+-dependent 5'-phosphatase which is probably the same enzyme which de- 
phosphorylates Ins(l,4,5)P3 (Connolly et al., 1987). Ins(l,3,4)P3 is ineffective 
at mobilizing intracellular Ca2+ and is probably de-phosphorylated by the same 1'- 
phosphatase which acts on Ins(l,4)P2 (Inhom & Majerus, 1987) The product, 
Ins(3,4)P2 may be de-phosphorylated by a Mg2+-independent 4’-phosphatase 
(Bansal et al., 1987).
The complex metabolism of inositol phosphates, including the higher 
phosphorylated forms (e.g., InsP^ and InsP^) has been reviewed by Shears (1989) 
and is not considered here but recent articles by Stephens & Downes (1990) and 
Stephens & Irvine (1990) provide new insights.
The rapid decline in Ins(l,4,5)P3 levels may not simply reflect metabolism 
but also a negative feedback. In Swiss 3T3 cells it has been proposed that DG, the 
other product of PtdIns(4,5)P2 hydrolysis may, through the activation of protein 
kinase C lead to the inhibition of further PtdIns(4,5)P2 breakdown (Brown et al.,
1987). This inhibition of responses can be mimicked by pre-treating cells with the 
phobol ester, PM A, for 10 minutes prior to stimulation with bombesin, but is 
abolished in Swiss 3T3 cells where PKC activity has been down-regulated by 
prolonged exposure to phorbol ester (Brown et al., 1987).
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1.5.3 The diglyceride/protein kinase-C arm of the signalling  
pathway.
The term sn-1,2-diradylglycerol refers to all forms of diglyceride with the 
sn-1,2- configuration and includes ester-linked diacyl species (DAG) and ether- 
linked l-O-alky-2-acyl and l-<9-alk-l'enyl-2-acyl species (AAG). Unless 
referring to a diglyceride with a particular linkage the abbreviation DG will be used 
as a general term encompassing sn-1,2-diglycerides.
DG is a neutral lipid which remains in the inner leaflet of the plasma 
membrane when formed as a result of stimulated inositol lipid hydrolysis. It is the 
endogenous activator of the Ca2+- and phospholipid-dependent serine/threonine 
directed phosphotransferase, protein kinase C (PKC), isolated in Nishizukas 
laboratory in 1977 (Inoue et al., 1977; Takai et al., 1979a & b; Kishimoto et al., 
1980; reviewed by Nishizuka, 1984). The mechanism by which DG activates PKC 
is well documented. Briefly, DG acts by lowering the enzymes' Km for Ca2+ by 
as much as one thousand-fold (Kishimoto et al., 1980; Kaibuchi et al., 1981); 
PKC may be activated by millimolar concentrations of Ca2+ in vitro, but inclusion 
of DG allows activation at [Ca2+]j in the range 0.1-l|iM . Since these Ca2+ 
concentrations are attained in cells as a consequence of Ins( 1,4,5)Pg-induced Ca2+ 
mobilisation, this represents cooperation between the two arms of what is 
essentially a bifurcating signal pathway. It is only the sn-1,2- forms of DG 
(derived from phospholipid hydrolysis) which activate PKC; neither 1,3-DG or 
rac- 1,2-DG (sn-2,3-DG) are able to support PKC activity (Rando & Young, 
1984; Boni & Rando, 1985; Nomura et al., 1986). There is some debate as to 
whether the AAG forms of DG are able to activate PKC (Ganong et al., 1986; 
Daniel et al., 1988), but a recent report shows quite clearly that naturally occurring 
plasmalogenic diglycerides do support rabbit myocardial PKC activity (Ford & 
Gross, 1990a).
It is proposed that, upon stimulation, soluble PKC translocates to the 
plasma membrane (Kraft et al., 1982; Kraft & Anderson, 1983) where it combines 
with its endogenous activator (DG) forming an active quaternary complex of PKC, 
DG, Ca2+ and PtdSer (Ganong et al., 1986). However, quite how PKC rapidly
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moves from an aqueous, hydrophilic environment to associate with the plasma 
membrane is unclear, though increased [Ca2+]j may play a role. Perhaps a more 
realistic model envisages PKC normally loosely associated with the plasma 
membrane, with this association strengthened by complexing with DG and PtdSer 
in stimulated cells. This model will still allow for the appearance of soluble PKC in 
control cells since the looser association would result in displacement from the 
membrane during subcellular fractionation.
1.5.4 Protein kinase C, an in tracellu lar receptor for the tum our- 
prom oting phorbol esters.
In 1982, Castagna et al. (1982) demonstrated a crucial link between tumour 
induction and a signal transduction pathway by showing that the phorbol ester-type 
tumour promoters could activate PKC and that this activation correlated with their 
tumour promoting ability (Castagna et al., 1982; Niedel et al., 1983). As a result 
protein kinase C is now considered to occupy a central role in the pathways 
proposed to control cell division and proliferation (reviewed by Berridge, 1987b; 
Whitfield et al., 1987; Housey et al., 1988; Persons et al., 1988; Whitman & 
Cantley, 1988).
Phorbol esters, typified by phorbol-12-myristate-13-acetate (PMA) act as 
structural homologues of the diradylglycerols; the "diradyl" portion of PMA is 
structually analagous to the s/z-l,2-DGs and studies have shown that, like DG, 
PMA activates PKC by increasing its Ca2+ sensitivity (Castagna et al., 1982). In 
addition, PMA and DG compete for binding to PKC with a stoichiometry of 1 mol 
per mol of protein (reviewed by Downes & Michell, 1985). The potent tumour 
promoting properties of PMA can be explained by the fact that unlike DG it is not 
readily metabolized within cells and so accumulates, resulting in the prolonged 
activation of PKC. This is reflected in the potentcy of the phorbol esters in 
activating PKC; PMA is active at nanomolar concentrations whereas cell permeant 
diglycerides, which are metabolized, require micromolar concentrations.
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Phorbol esters, being membrane permeable, have proved to be useful tools 
for dissecting the involvement of DG production and PKC activation in cell 
responses and, being poorly metabolized, accentuate and lengthen normal 
responses. Their use, coupled with that of membrane permeable DG analogues, 
such as l-oleoyl-2-acety 1-glycerol (OAG), has allowed the identification of PKC 
dependency in a variety of signal-response systems (reviewed by Nishizuka, 1984; 
Kikkawa etal., 1989; Parker etal., 1989).
In addition, for some cells, most notably the Swiss 3T3 fibroblast, 
prolonged exposure to super-maximal concentrations of PMA (400nM) for up to 48 
hours depletes cellular PKC as measured by binding of [^HJPDBu (Collins & 
Rozengurt, 1984), histone phosphorylation (Rodriguez-Pena & Rozengurt, 1984) 
and western blotting for the protein itself (Brown et al., 1990). This loss of PKC 
activity, known as 'down-regulation', has allowed the identification of PKC- 
dependent events in a number of hormone and growth factor-stimulated cell lines 
such as the inhibition of DNA synthesis in down-regulated Swiss 3T3 cells 
(Rozengurt & Sinnett-Smith, 1987).
1.5.5 Multiple isoforms of protein kinase C with distinct properties.
The relatively simple model of DG and Ca^+ cooperating in the activation of 
PKC is now no longer sufficient to account for the complexity revealed by the 
purification and cloning of at least seven different isozymes of protein kinase C 
(reviewed by Kikkawa et al., 1989; Parker et al., 1989). The a , pi, p n  and y 
forms exhibit the same general structural organization (Kikkawa et al., 1988; 
Parker et al., 1989) being divided into cysteine-rich regulatory and catalytic 
domains; the pi and pH subspecies are derived by alternate splicing of a single 
RNA transcript (Coussens et al., 1987; Kubo et al., 1987). In the last two years 
cDNAs for at least three further subspecies of PKC (8-, e- and £-PKC) have been 
isolated using a mixture of a -, p il and y- cDNA clones as probes under low 
stringency conditions (Ono et al., 1987; 1988). These novel forms exhibit 
extensive clusters of sequence homology to a-, P- & y- species in their catalytic
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domains and in cysteine-rich clusters in the regulatory domains, whilst their overall 
molecular weights are of a similar order. Calpain-catalysed proteolysis results in 
the cleavage of PKC into separate regulatory and catalytic domains and, under such 
conditions, the catalytic domain is fully active in a manner independent of PtdSer or 
DG, suggesting that the regulatory domain exerts a negative influence over the 
catalytic site which is overcome by complexing with DG, Ca2+ and PtdSer.
In terms of activation, a-type PKC is most sensitive to l-stearoyl-2- 
arachidonoylglycerol, derived from PtdIns(4,5)P2 hydrolysis, whilst p i and p ll 
exhibit substantial activity without raised Ca2+ levels. The y-sub species is less 
sensitive to DG but is activated by relatively low concentrations of arachidonic acid; 
indeed, activation by arachidonic acid does not appear to require Ca2+, DG or 
phospholipid (reviewed by Kikkawa et al., 1989). Recently nPKC (Ohno et al.,
1988), PKC-e (Schaap & Parker, 1990) and PKC-L (Bacher et al., 1991) have 
been characterised as Ca2+-independent, DG/PMA activated PKCs.
The various isozymes appear to have distinct substrate specificities aswell as 
distinct specific activities against well defined PKC substrates such as histone HIS 
(Schaap & Parker, 1990; Ohno et al., 1988). Furthermore, what was previously 
considered to be a homogenous PKC substrate, the 80k phosphoprotein, is now 
known to consist of at least two isoforms (Morris & Rozengurt, 1988; Hirai & 
Shimizu, 1990) phosphorylated to different extents by a-, p- & y-PKCs. Digestion 
with trypsin generated different phosphopeptide maps (Hirai & Shimizu, 1990) and 
one isoform (80K-H) was substantially phosphorylated in the absence of Ca2+.
These data suggest that different cells may possess a number of PKC 
subspecies which may be differentially activated during different phases of a 
cellular response under conditions in which DG levels or other phospholipid 
metabolites are elevated in the presence or absence of increased [Ca2+]j, such as 
stimulated hydrolysis of PtdIns(4,5)P2 or PtdCho (and other phospholipids) by 
phospholipases A2, C or D. This potentially broad repertoire of PKC activities may 
result in different substrates being phosphorylated at various stages of the response 
and may be of relevance in long term effects such as smooth muscle contraction, 
long term potentiation and cell proliferation.
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1.5.6 The removal of sn*l,2-DG; physiological relevance.
As with Ins(l,4,5)p3, the primary function of the rapid removal of DG is 
the termination of the physiological response, that is PKC activation. Two major 
pathways exist for the removal of DG, catalysed by DG kinase and DG lipase. 
However, it is becoming increasingly apparent that the products of both of these 
reactions, PtdOH and free fatty acids (particularly arachidonate), may themselves 
have potent biological effects (Putney et al., 1980; Moolenaar et al., 1986; van 
Corven et al., 1989; Tsai et al, 1989; 1990).
The phosphorylation of DG to yield sn-1,2-diradylglycerol-3-phosphate, 
i.e. phosphatidic acid (PtdOH), is probably the most quantitatively significant 
pathway for the removal of DG (Bishop et al., 1986). It is catalysed by the 
enzyme diacylglycerol kinase (ATP:l,2-diacylglycerol 3-phosphotransferase), a 
Mg2+ and ATP dependent kinase first described by Hokin & Hokin (1959). Until 
recently, there have been few detailed studies of this enzyme in higher eukaryote 
cells; the realisation of its role as a major ’switch1 which turns off protein kinase C 
activity has focussed attention on what is, by analogy with the cyclic nucleotide 
phosphodiesterases, likely to prove a major control point in PKC mediated signals 
(reviewed by Kanoh et al., 1990).
In common with PKC, there is an increase in DG kinase activity recovered 
from the plasma membrane and a loss from the cytosol when cells are stimulated 
with Ca2+-mobilizing agonists which cause hydrolysis of inositol lipids or phorbol 
esters (Ishitoya et al., 1987; Maroney & Macara, 1989). This may represent an 
important control point since DG is produced in, and confined to, the plasma 
membrane. Coupled with this, recent reports suggest that porcine DG kinase 
activity may be enhanced at the physiological [Ca2+]i attainable in stimulated cells 
(Sakane et al., 1990). Indeed, the primary sequence for the 80kDa form of DG 
kinase purified from porcine thymus cytosol and cloned from a porcine thymus 
cDNA library contains two Ca2+-binding EF hands as well as homologies to PKC, 
calmodulin and other Ca2+ regulated proteins (Sakane et al., 1990). Interestingly, 
this form of DG kinase also possesses two cysteine-rich motifs which are
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conserved in a variety of proteins which bind phorbol esters such as PKC and n- 
chimaerin (Ahmed et al., 1990); consequently this region may represent the 
DG/phorbol ester binding region. Cysteine-rich, zinc-finger-like motifs are 
implicated in DNA binding though there is no evidence of DG kinase activity in the 
nucleus to date. However, recent reports of insulin-like growth factor 1-stimulated 
phospholipid metabolism in the nucleus of Swiss 3T3 cells (Cocco et al., 1988) 
may be of relevance to reports of PKC activity in the nucleus (Fields et al., 1989; 
1990; Hocevar & Fields, 1991).
Studies of the substrate specificity of DG kinase from Swiss 3T3 
membranes (MacDonald et al., 1988) has demonstrated the presence of an isoform 
which exhibits greatest activity against the arachidonoyl containing diglycerides. In 
particular, l-stearoyl-2-arachidonoyl glycerol (SAG) is an especially good substrate 
for the DG kinase of Swiss 3T3 membranes and this specificity may provide a 
means by which inositol lipids become enriched in arachidonoyl containing 
diglycerides (MacDonald et al., 1988). Furthermore, rabbit brain microsomal DG 
kinase exhibits 30-fold greater activity against diacylglycerols (DAG) than alkyl- 
acyl (Alkyl AG) and alkenyl acyl glycerols (AAG) (Ford & Gross, 1990b). This 
may explain why increases in plasmalogenic diglycerides are more sustained than 
the increases in DAG in those cells which produce significant quantities of 
plasmalogenic DG upon stimulation e.g., neutrophils and HL60 cells (Truett et al., 
1989a; Bonser et al., 1989; Billah et al., 1989b).
These observations can be brought together in a model to explain the rapid 
removal of DG. The increase in l-stearoyl-2-arachidonoyl glycerol (SAG) 
accompanying stimulated inositol lipid hydrolysis will result in the 'translocation' 
and activation of an arachidonoyl-diglyceride specific DG kinase. This activation 
might be enhanced by the concomitant rise in [Ca^+]j as a result of Ins(l,4,5)P3 
elevation. These factors, combined with the potentsubstrate-induced activation 
reported by MacDonald et al. (1988) would result in the rapid removal of SAG. 
Until recently the accumulation of PtdOH was taken to infer this, but observations 
of agonist-stimulated phospholipase D activation may also contribute to this 
elevation of PtdOH and ultimately DG (see section 1.8).
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The second major pathway for removing diglyceride is its deacylation at 
either the wi-1, or particularly, the sn-2 position. This reaction is catalysed by 
DG lipase. Despite relatively little evidence, it is thought that DG lipase is of less 
quantitative importance in removing DG than DG kinase (Bishop et al., 1986). 
However the enzyme may be of qualitative importance in generating free 
arachidonic acid which serves as the precursor for the eicosanoids, leukotrienes, 
and thromboxanes and may well have second messenger properties of its own 
(reviewed by Kikkawa et al., 1989; Smith, 1989; Millar & Rozengurt, 1990). 
Consequently the DG lipase reaction may be of importance in generating a variety 
of other biologically active compounds such as the prostaglandins (reviewed by 
Smith, 1989).
The use of the putative inhibitors of either DG lipase (RHC 80267) or DG 
kinase (R 59022) has been reported to raise both control and stimulated levels of 
diglyceride. However the efficacy of both compounds has been questioned and the 
former is no longer commercially available. Clearly a thorough study of the 
contributions of DG lipase and DG kinase in DG and arachidonate homeostasis is 
required, especially since arachidonate has recently been reported to be an activator 
of PKC (reviewed by Kikkawa et aL, 1989). The purification, cloning and 
expression of these enzymes in a model system should go some way towards 
addressing these issues.
Following phosphorylation of DG by DG kinase the PtdOH so produced is 
combined with CTP to form CMP-PtdOH (CMP-PtdOH synthetase, Fig. 1.2) 
which serves as the immediate lipid precursor for Ptdlns by the action of Ptdlns 
synthetase (Fig. 1.2). In this way the cycle is completed and inositol moieties are 
recycled for replenishing of inositol lipids.
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1.6 Evidence for alternative sources of s/i-l,2 -D G  in stim ulated  
c e lls .
In the last three or four years, a number of observations have suggested that 
s n - \,2-diglyceride can be generated either in the absence of Ins(l,4,5)P3 
accumulation or from non-inositide sources in response to a variety of mitogenic 
and non-mitogenic stimuli (reviewed by Billah & Anthes, 1990). In particular 
some agonists which stimulate the rapid generation of Ins(l,4,5)P3 and DG also 
elicit a slower sustained elevation of DG which is not accompanied by Ins(l,4,5)P3 
formation (Wright et al., 1988; Truett et al., 1989a; Reibmann et al., 1988). 
Other agonists can apparently stimulate an increase in DG which is completely 
divorced from inositol lipid hydrolysis (e.g., Wright et al., 1990). Three major 
alternative sources of DG which have been considered and are outlined below, but 
recent attention has focussed particularly on a possible role for hydrolysis of 
phosphatidylcholine in generating diglyceride and this is therefore reviewed in 
greatest depth.
1.6.1 Hydrolysis of Ptdlns.
Agonist-stimulated formation of Ins(l)P or Ins(l,4)P2 or Ins(l,4,5)P3 
from Ptdlns, PtdIns(4)P and PtdIns(4,5)P2 respectively must be accompanied by 
DG formation since PLC-catalysed cleavage of these lipids attacks the ester bond 
between the 1' phosphate and the diglyceride moiety leaving the phosphate group 
on the inositol ring. Consequently, PLC-catalysed hydrolysis of any 
phosphoinositide, or indeed any glycerophospholipid, can conceivably give rise to 
DG formation. A number of studies have suggested a role for the hydrolysis of 
Ptdlns in signalling events. In vascular smooth muscle cells labelled with 
[^Hjinositol, Griendling et al. (1986) have argued that hydrolysis of 
Ptdlns(4,5)p2 is the primary, but transient, event which is followed by a later 
calcium-dependent hydrolysis of Ptdlns to yield InsP. PIC catalysed hydrolysis of 
Ptdlns would generate diglyceride for activation of protein kinase C, but in the 
absence of elevated [Ca2+]j since the water soluble products would not include
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Ins(l,4 ,5 )P3 . However, the results of radiochemical changes in the specific 
activity of individual [^Hjinositol lipids are difficult to interpret as hydrolytic 
events. Since PtdIns(4 ,5)P2 is such a minor component of the inositol lipid pool, 
changes in its associated radioactivity are readily seen (Creba et al., 1983; Takuwa 
et al., 1987a). In contrast, Ptdlns, the major inositol lipid, needs to undergo much 
greater changes before differences in its radioactivity can be detected.
Imai & Gershengom (1986) also suggest a similar temporal relationship 
between primary PtdIns(4,5)P2 hydrolysis and secondary, sustained Ptdlns 
hydrolysis in TRH-stimulated GH3 pituitary cells. They observed that in GH3 cells 
labelled with ^^Pi for only 1 min and then stimulated with TRH the increase in 
labelling of PtdIns(4,5)P2 was transient, lasting less than 2 min, whereas the 
increase in labelling of Ptdlns and PtdOH was sustained. Furthermore, if GH3 
cells were stimulated with TRH for 4 min and then exposed to ^ P i  there was a 
sustained increase in ^^Pi labelling of PtdOH and Ptdlns without any labelling of 
PtdIns(4,5)P2 at all suggesting that hydrolysis of PtdIns(4,5)P2 was finished but 
that Ptdlns hydrolysis was continuing.
In a variety of systems, Ins(l,4 ,5)P3 levels return rapidly towards control 
after stimulation and this has been taken as an indication that the cells are 
desensitized and PtdIns(4 ,5 )P2 is diminished. Whilst this may well be the case in 
some cells, an additional explanation is likely to be the high activity of Ins(l,4 ,5 )P3 
5'-phosphatase and 3’-kinase which quickly remove Ins(l,4 ,5 )P3 . Thus, the low 
levels of Ins(l,4 ,5 )P3 may represent a new 'steady state' where stimulated 
formation is effectively matched by rapid removal. Therefore, in the presence of 
Li+, the prolonged accumulation of InsP may reflect a simple shunting of inositol 
moieties from Ins(l,4 ,5 )P3 to InsP.
1.6.2 de novo synthesis of DG.
Relatively few reports have described de novo synthesis from glycerol as a 
pathway of stimulated DG formation. In the main these studies have looked at the 
stimulated incorporation of [^Hjglycerol mto DG and attributed this to synthesis.
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However, it seems likely that even a short labelling period, under these conditions, 
will result in significant incorporation into the major phospholipids, so that the 
appearance of [^H]DG may be potentially explained by phospholipid hydrolysis. 
Despite this caveat, Farese and co-workers have been able to demonstrate insulin- 
stimulated increases in [^H]DG in rat diaphragms (Ishizuka et al., 1990) when the 
[^H] glycerol was added at the same time as the insulin. However, the increase in 
labelling of DG was preceded by significant increases in the labelling of PtdOH at 5 
minutes therefore suggesting that the increase in DG is due to enhanced synthesis of 
PtdOH de novo followed by its conversion to DG. In BC3H-1 myocytes, the case 
is less clear (Farese et a l,  1988): whilst there is a good correlation between the 
time courses of insulin-stimulated increases in DG mass and [^Hjglycerol 
incorporation into DG, it is not clear if some of the increase in [^H]DG may reflect 
hydrolysis of pre-existing phospholipids such as PtdCho and PtdEtn which 
incorporate significant [^Hjglycerol over a 2 hour exposure.
It seems likely that in those sytems where de novo synthesis of DG may 
play a role in stimulated DG formation, the onset of the response may be slower 
than that for the classical pathway for DG formation from phospholipid hydrolysis 
which is apparent within seconds of addition of the appropriate stimulus. Thus, it 
may be that de novo synthesis may be of relevance to long term increases in DG.
1.6.3 A g o n is t-s tim u la ted  h y d ro ly sis  o f p h o sp h a tid y lch o lin e  
(PtdCho) and other phospholipids.
A role for phosphatidylcholine metabolism in signal transduction dates back 
to a number of observations made in the late 1970s and early 1980s. In cultured 
chick embryo myoblasts Grove and Schimmel showed that addition of the phorbol 
ester, PMA, stimulated the synthesis Ptdlns, PtdCho and an elevation of PtdOH 
and 1,2-DG levels (Grove & Schimmel, 1982). The fatty acid composition of this 
DG was similar to that of PtdCho. A number of studies have demonstrated 
incorporation of [^^P]Pi and [^HJcholine into PtdCho over a matter of minutes in
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response to a variety of stimuli (Grove & Schimmel, 1982; Kolesnick, 1987; Muir 
& Murray, 1987; Monaco et al., 1988). Furthermore, many hormones, growth 
factors, cell permeant DGs and phorbol esters can stimulate PtdCho synthesis 
through the activation of choline kinase (Warden & Friedkin, 1984; 1985) and 
CTP:phosphocholine cytidylyltransferase (Kolesnick, 1987; Muir & Murray,
1987). However, in considering a role for PtdCho hydrolysis in generating DG, a 
primary hydrolytic event must be identified; even then assaying the secondary event 
of PtdCho resynthesis provides little kinetic or mechanistic information.
One of the earliest reports of stimulated PtdCho hydrolysis was by Mufson 
et al. (1981) who demonstrated that addition of PMA to [^ H J c h o lin e  labelled 
C3H10T1/2 mouse embryo fibroblasts resulted in the release of choline and 
phosphocholine. Similar effects of PMA have subsequently been identified in a 
variety of cell types in the last few years including cultured human epidermal 
keratinocytes (DeLeo et al., 1986), NG108-15 neuroblastoma x glioma hybridoma 
cells (Liscovitch et al., 1987), Swiss 3T3 fibroblasts (Muir & Murray, 1987; Price 
et al., 1989) and REF52 fibroblasts (Welsh et al., 1988; Cabot et al., 1989). 
Furthemore, agonist-stimulated hydrolysis of PtdCho and generation of choline and 
phosphocholine has been demonstrated in reponse to a variety of agonists which 
bind to plasma membrane receptors including bradykinin (Martin & Michaelis,
1988), bombesin (Muir & Murray, 1987; Price et al., 1989), PDGF (Besterman 
et al., 1986b; Price e ta l ,  1989) and carbachol (Martinson eta l., 1989). Perhaps 
the most convincing evidence for PtdCho hydrolysis serving as a source of DG 
has come from the studies of Raben and co-workers (Pessin & Raben, 1989; 
Pessin et al., 1990). By comparing the fatty acid composition of DG derived from 
stimulated cells with that of the individual cellular phospholipids, they showed that 
only at early time points (15 seconds) were inositol lipids making a significant 
contribution to DG in a-thrombin-stimulated IIC9 cells. At later times (5 and 60 
min), the DG has a fatty acid profile similar to that of PtdCho. These results 
correlate well with the biphasic increase in DG mass seen in these cells when 
stimulated with a-thrombin (Wright et al., 1988); the early phase parallelled 
increases in InsPj whereas the later phase was divorced from InsP3 formation.
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Hydrolysis of PtdCho to generate DG could occur by two distinct 
mechanisms: activation of a PtdCho specific phospholipase C activity to yield DG 
and phosphocholine (ChoP) (Fig. 1.3) or activation of a PtdCho specific 
phospholipase D to generate PtdOH and choline (Cho) (Fig. 1.3) followed by de­
phosphorylation of PtdOH to DG by 3-s/z-phosphatidate phosphohydrolase (PPH) 
(a PLD/PPH pathway, Fig. 1.4). It is certainly necessary to define which of these 
two pathways is activated since, whilst both can provide DG, PPH may de- 
phosphorylate the PtdOH produced by DG kinase: thus, activation of both enzymes 
could constitute a futile cycle wasting ATP. As such, the PLD/PPH coupled 
pathway might have major ramifications not only for lipid metabolism but also for 
cell function and cellular ATP conservation.
With this in mind, it is interesting to note that, to date, the majority of 
reports of stimulated PtdCho breakdown have identified the PLD-catalysed route 
(discussed in section 1.7 & 1.8). There are relatively few accounts which provide 
strong evidence for stimulated PtdCho hydrolysis occurring by a PLC pathway. 
Thus, Besterman et al.{ 1986b) in 3T3-L1 cells and Larrodera et al. (1990) in 
Swiss 3T3 cells reported that PDGF stimulated an increase in DG which was 
accompanied by release of phosphocholine but not choline. However, in the latter 
case, the earliest timepoint at which the increase in ChoP was observed was 4 hours 
after addition of PDGF. Since, in Swiss 3T3 cells, Price et al. (1989) have shown 
that PDGF can stimulate increases in Cho within 20 minutes, the later elevation of 
ChoP may be explained by phosphorylation of liberated Cho by Cho kinase 
(Warden & Friedkin, 1984; 1985). There are a number of instances where DG 
formation is accompanied by the release of both Cho and ChoP and, in these cases, 
it is not clear which is the pathway responsible for the DG generation (Martinson et 
al., 1989; Price et al., 1989; Wright et al., 1990).
In addition to the hydrolysis of PtdCho there is also some evidence that 
phorbol esters can stimulate the hydrolysis of phosphatidylethanolamine (PtdEtn) in 
NIH3T3 fibroblasts and HL-60 granulocytes (Kiss & Anderson, 1989). This may 
represent another potential source of lipid-derived second messengers and future 
studies are likely to make a more thorough analysis of this phenomenon.
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Figure 1.3 Sites of action of phospholipases A, C & D on 
phosphatidylcholine.
A simplified structure of PtdCho is shown in which the ester linked fatty 
acid groups are represented by Rj and R2 . Phospholipase Aj hydrolyses the ester 
linkage at the sn-l position to produce free fatty acid and l-lyso-2-acyl-PtdCho; 
there is no evidence, to date, of a hormone-sensitive or receptor-activated PLAj 
activity. Phospholipase A2 hydrolyses the ester linkage at the sn-2 position to 
produce free fatty acid and l-acyl-2-lyso-PtdCho; there is increasing evidence for a 
hormone-sensitive PtdCho-PLA2 activity which may serve as a major source for 
free arachidonic acid. Phospholipase C, by analogy with PIC, hydrolyses the 
phospho-ester bond linking the DG moiety to the phosphocholine (ChoP) group; 
the products are sn-l,2-DG and ChoP. Phospholipase D catalyses the release the 
choline head group by attacking the phospho-ester bond between the head group 
and the phosphatidate moiety; the products are phosphatidic acid (PtdOH) and 
choline (Cho). There is now significant evidence, discussed in the text, to suggest 
that PtdCho-PLC and PLD activity may be regulated by hormones and growth 
factors as well as phorbol esters (reviewed by Billah & Anthes, 1990).
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1.7 Phospholipase D (PLD).
Phospholipase D (PLD) catalyses the cleavage of the terminal 
phosphodiester bond of phospholipids, according to the following general reaction 
scheme
Phosphatidyl-X + X'-OH --------------- > Phosphatidyl-X' + X-OH.
The enzyme catalyses a transphosphatidylation reaction (Fig. 1.4) in which the 
phosphatidyl moiety liberated by choline release is transferred on to an accepting 
nucleophile, X'-OH. The so-called hydrolytic activity is the normal reaction in 
vivo but can be considered a specific example of transphosphatidylation where the 
acceptor is water (i.e. when X' = H); the products are phosphatidic acid (PtdOH) 
and the free, polar head group (i.e. choline, ethanolamine). However, in the 
presence of relatively low concentrations of primary, short chain, aliphatic alcohols 
(0.1-1%, v/v) the enzyme catalyses a so-called transferase reaction in which the 
phosphatidyl moiety is transferred on to the alcohol to form the corresponding 
phosphatidylalcohol (e.g., PtdEthanol (PtdEth), PtdButanol (PtdBut), etc.).
Originally studied extensively in plant and bacterial systems (e.g., Dawson, 
1967) PLD activity has been reported in a variety of mammalian tissues since its 
first description in a 'solubilized' rat brain preparation (Saito & Kanfer, 1973). The 
transferase activity of PLD was discovered fortuitously by Dawson & Hemington 
(1967) by the inclusion of glycerol in an incubation containing cabbage PLD and 
PtdCho. In addition, phosphatidylethanol formation has been reported in a variety 
of rat organs after ethanol intoxication (Ailing et al., 1984). More recently, both 
the hydrolytic and transferase activities have been demonstrated in rat brain 
microsomes (Witter & Kanfer, 1985) and rat brain synaptosomes (Kobayashi & 
Kanfer, 1987) and the rat brain enzyme has been partially purified (Taki & Kanfer, 
1979). The precise reaction mechanism is unclear but Saito & Kanfer (1975) have 
shown that PLD activity from a rat brain particulate fraction is inhibited by p- 
chloromercuriophenyl sulphonate and this is in turn relieved by dithiothreitol 
suggesting a role for a sulphydryl group in formation of an enzyme-substrate
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Figure 1.4 The hydrolytic and transferase activities of PLD.
The precise mechanism of action of phospholipase D (PLD) remains 
unknown but the evidence to date is consistent with the scheme shown opposite. 
Transphosphatidylation can be considered as the general reaction with hydrolysis 
being a specific case in which the acceptor for the phosphatidate moiety is water. 
However, because the phosphatidyl alcohols are unique to PLD activity but distinct 
from PtdOH in terms of subsequent metabolism, the two are often considered as 
products of different activities of the same enzyme. It is thought that the first step 
in the reaction is the PLD-catalysed head goup release and the formation of a 
phosphatidyl-PLD intermediate. This species is then the target for nucleophilic 
attack by water (the hydrolytic function) giving rise to the normal product 
phosphatidic acid (PtdOH). PtdOH may then be de-phosphorylated by the enzyme 
phosphatidate phosphohydrolase (PPH) to yield DG (Billah et al., 1989b; the left 
hand scheme) and this represents the coupled PLD/PPH pathway of DG formation. 
In the transphosphatidylation reaction short chain primary alcohols (e.g., ethanol, 
butan-l-ol) are stronger nucleophiles and compete with water to accept the 
phosphatidyl moiety (i.e., a phosphatidyltransferase activity) giving rise to the 
phosphatidylalcohol (Pai et al., 1988a & b; the right hand scheme). The formation 
of phosphatidylalcohols serves as a useful diagnostic tool in whole cells since they 
are not formed by other metabolic pathways and require only low concentrations of 
alcohol (0.1-0.3%, v/v) which are not cytotoxic. Furthermore, they allow 
intervention in a PLD/PPH pathway of DG formation since the 
phosphatidylalcohols are poor substrates for PPH (Metz & Dunlop, 1991; right 
hand scheme).
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complex. This complex is then presumably the target for the attacking nucleophile, 
water or a primary alcohol (Fig. 1.4).
Phospholipase D activity in rat brain microsomes exhibits a pH optimum of 
6.5 (Witter & Kanfer, 1985) whereas that from post-nuclear frations of human 
neutrophils possesses a major pH optimum of 7.5 and a minor activity at pH 5 
(Balsinde et al., 1989). In neutrophils, the 'neutral' PLD requires millimolar 
concentrations of Ca2+ for maximal activity and is cytosolic in location whereas the 
'acid' PLD is Ca2+-independent and associated with the lysosomes (Balsinde et 
al., 1989). Furthermore, addition of A23187 to human neutrophils is reported to 
activate PLD suggesting a role for Ca2+ in its activation (Billah et al., 1989a). 
However, lOmM Ca2+ had no effect upon PLD activity in rat brain microsomes 
whilst A23187 caused a slight inhibition (Witter & Kanfer, 1985). These 
contrasting observations suggest that a number of isoforms of PLD may exist with 
distinct sensitivities to Ca2+ and perhaps organelle, tissue and species specific 
distribution. Monosaturated fatty acids, particularly sodium oleate, acting as 
detergents, are very potent activators of PLD in rat brain microsomes and 
synaptosomes (Witter & Kanfer, 1985; Kobayashi & Kanfer, 1987). Finally, 
recent evidence suggests that PLD may be regulated by activated cell surface 
receptors, second messengers and protein kinases involved in signal transduction 
(reviewed by Billah & Anthes, 1990).
Until recently, the importance of PLD was considered to be confined to 
phospholipid re-modelling events associated with head group exchange in 
membranes, supplying PtdOH for triglyceride biosynthesis and choline for 
acetylcholine biosynthesis (reviewed by Loffelholz, 1989). However, there is now 
an increasing body of evidence, reviewed in section 1.8, to support a role for PLD 
activation in the signal transduction pathways of a variety of hormones and 
neurotransmitters.
1.7.1 A distinction between PLD and the base-exchange enzymes ?
Assaying the release of head group bases from phospholipids is not
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unequivocal evidence for activation of PLD. The Ca2+-dependent, ATP 
independent, base exchange reactions replace the head group moieties on 
phospholipids with free bases (serine, choline & ethanolamine) without a net 
generation of PtdOH, according to the following scheme
Phosphatidyl base A + base B --------—> Phosphatidyl base B + base A.
As such, the release of choline, serine or ethanolamine from phospholipids is only 
indicative of a 'PLD-like activity' including base exchange reactions. However, it 
seems likely, from a variety of studies in rat brain, that the two activities can be 
resolved. Thus, a purified base exchange enzyme from rat brain did not exhibit 
PLD activity (Taki & Kanfer,1978; Suzuki & Kanfer, 1985) whilst a partially 
purified PLD from rat brain showed no ability to incorporate bases into 
phospholipids (Taki & Kanfer, 1979). Furthermore, in rat brain, under conditions 
supporting Ca2+- dependent base exchange, Gustavsson & Ailing (1987) were 
unable to demonstrate Ca2+-stimulated PtdEt formation which could still be formed 
by the brain, oleate activated, Ca2+- independent PLD.
Despite this, a recent report by Mori et al. (1989) has demonstrated a 
Ca2+-dependent PLD activity in bovine retinal microsomes which is accompanied 
by base liberation and generation of PtdOH. When excess exogenous base was 
added, the PtdOH accumulation was decreased and the base was incorporated into 
phospholipids. However, the total amount of bases released far exceeded PtdOH 
formation suggesting that base release activity could not be explained by the PLD 
activity alone. In addition, the PLD activity in bovine retinal microsomes differed 
markedly from that in rat brain, having a much higher pH optima (8-8.5) and an 
absolute requirement for Ca2+.
Clearly, these conflicting observations provide further evidence for 
isoforms of PLD which may differ markedly in their biochemical properties, both in 
terms of activation and in terms of their ability to catalyse base exchange reactions. 
Whilst the final proof of whether PLD possesses base exchange/incorporation
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properties awaits purification of what may be a multi-enzyme family, the majority 
of evidence suggests that the two activities reside in distinct molecules.
1.8 A role for PLD activity in signal transduction ?
1.8.1 Agonist-stimulated PLD activation.
The first unequivocal demonstration of agonist-stimulated PLD activation 
came from the work of Billah and co-workers (Pai et al., 1988a & b; Billah et al., 
1989a & b) in neutrophils and HL-60 granulocytes stimulated with either fMLP or 
PMA. Using l-0-[^H]alkyl-lyso[^2P]PtdCho to specifically label the PtdCho 
pool with [22P] they were able to demonstrate formation of l-0-[^H]alkyl- 
lyso[^2P]PtdOH. Since, under these conditions, the cellular ATP pool was not 
labelled with ^2P, the [^2P] PtdOH could not have been formed by the action of DG 
kinase and must have been due to PLD catalysed hydrolysis of l-0-[^H]alkyl- 
lyso[^2P]PtdCho (Pai et al., 1988b; Billah et al., 1989b). In hindsight, this 
phenomenon was probably first documented by Cockcroft (1984) who showed that 
in 32P i- la b e lle d  neutrophils stimulated with fMet-Leu-Phe the specific activity of the 
[32pjptdOH actually decreased markedly within 5-10 seconds; an observation 
inconsistent with the incorporation of ^ 2Pi from the cellular ATP pool via the DG 
kinase route which would increase the specific activity of the [^2P]PtdOH. 
Cockcroft (1984) concluded that the mass of PtdOH was increasing by activation of 
a PLD activity, though at the time Ptdlns was proposed as the substrate.
In addition, the ability of primary alcohols to substitute for water in the PLD 
catalysed-transphosphatidylation reaction (Pai et al., 1988a; Fig. 1.4) has been 
used as a definitive marker for PLD activity in a number of cells including bovine 
pulmonary artery endothelial cells (Martin et al., 1989; 1990; Martin & Michaelis, 
1989), adrenal glomerulosa cells (Liscovitch & Amsterdam, 1989), 1321N1 
astrocytoma cells (Martinson et al., 1989), NIH3T3 fibroblasts (Ben-Av & 
Liscovitch, 1989), He-La cells (Hii et al., 1989) and spermatozoa stimulated to
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undergo the acrosome reaction by a fucose sulphate glycoconjugate (Domino et al.,
1989).
There are also a number of reports which provide strong evidence for 
activation of PLD in response to extracellular stimuli (reviewed by Exton, 1990; 
Billah & Anthes, 1990). The release of choline prior to, or in the absence of, 
phosphocholine strongly suggests that activation of PLD occurs in NG108-15 cells 
(Liscovitch et al., 1987), bovine pulmonary endothelial cells (Martin & Michaelis, 
1988) and 1321N1 astrocytoma cells (Martinson etal., 1989). In all these cases 
the kinetics of this Cho release are similar to either Ptdalcohol and/or PtdOH 
formation suggesting activation of a PtdCho-PLD activity.
1.8.2 The product of PLD, PtdOH, is a phospholipid with diverse 
biological functions.
One function of PtdOH produced by PLD activity, to serve as a precursor 
for DG via the action of PPH, is reviewed below (see section 1.8.3). However, a 
PLD/PPH pathway of DG presents the cell with significant regulatory problems 
because of the possibility of a futile cycle of DGK and PPH activities wasting ATP 
and, for this reason alone, a much simpler pathway would involve activation of a 
PtdCho-PLC. It therefore seems pertinent to ask what other purpose PLD 
activation may serve ?
It seems likely that a major function for PLD is to produce PtdOH which 
may function as a second messenger. PtdOH has had various functions ascribed to 
it in the past including that of a Ca^+ ionophore (Putney et al., 1980), a growth 
factor acting via activation of inositol lipid hydrolysis and inhibition of adenylyl 
cyclase (Moolenaar et al., 1986; van Corven et al., 1989) and activator of PKC 
(Epand & Stafford, 1990). PtdOH and PtdSer have been reported to stimulate PIC 
activity (Jackowski & Rock, 1989): thus, PtdOH produced in the plasma membrane 
may have receptor independent effects upon PIC activity. The formation of PtdOH 
correlates with the release of secretory granules in fMet-Leu-Phe-stimulated 
neutrophils (Cockcroft, 1984) which have been shown to produce PtdOH by
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stimulated PLD activity (Pai et al., 1988 a & b; Billah et al., 1989a & b). It seems 
likely that the formation of PtdOH will be a common result of PtdIns(4,5)P2 
hydrolysis (via DG kinase) and PtdCho hydrolysis (via PLD) and so future studies 
may be directed towards potential biological functions for this molecule in stimulus- 
response systems. This issue is discussed in more detail in Chapter 7.
1.8.3 PtdOH as a precursor of DG.
The human neutrophil, primed with cytochalasin B, has proved a useful 
model for demonstrating a coupled PLD/PPH pathway of DG formation (Fig 1.4) 
in response to fMet-Leu-Phe and phorbol esters (Billah et al., 1989b; Bonser et 
al., 1989). In cells labelled with l-0-[^H]alkyl-lyso-PtdCho, fMet-Leu-Phe- 
stimulated [^H] alkyl PtdOH formation clearly precedes [^H]DG formation 
suggesting that PtdOH is the precursor for DG, rather than the product of DG 
kinase activity. Furthermore, in cells labelled with l-O-f^HJalkyl-lyso- 
[32p]ptdCho, [^P ]C hoP  is not formed; rather, the release of [^ ^P ]P 0 4 
accompanies the rise in [^H]DG indicating dephosphorylation of the 
[^H]alkyl[^^P]PtdOH by PPH. The use of the PPH inhibitor propranolol results in 
the complete inhibition of fMet-Leu-Phe-stimulated [^H]DG formation but actually 
potentiates Hjalkyl [^^P] PtdOH.
The transferase activity of PLD gives rise to phosphatidylalcohols which are 
poor substrates for PPH; it has been estimated that the half-life of PtdOH is less 
than 15 min in intact pancreatic islets whilst that of PtdEth is greater than 2 hours 
(Metz & Dunlop, 1991). The presence of butan-l-ol, and the consequent formation 
of PtdBut, inhibit both DG generation and the respiratory burst in fMet-Leu-Phe- 
stimulated neutrophils by directing phosphatidyl moieties away from PtdOH and 
towards PtdBut (Bonser et al., 1989; Fig. 1.4). This provides strong evidence for 
the PLD/PPH pathway of DG formation in neutrophils and suggests that this 
pathway is necessary for the functional response. Similar inhibition of DG 
formation using primary alcohols has now been documented in a other cell types
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including MDCK epithelial cells and bovine pulmonary endothelial cells (Huang & 
Cabot, 1990a). As such it seems likely that in a variety of cell types the coupled 
pathway of PLD and PPH will serve as a route for the stimulated formation of DG.
In addition to these studies, when cells are isotopically labelled with [^H] or 
[14C] labelled fatty acids the stimulated formation of PtdOH prior to, or 
commensurate with DG has also been reported in a variety of cell types (Domino et 
al., 1989; Martinson et al., 1989; Huang & Cabot, 1990a & b; Martin et al.,
1990) and is suggestive of a sequential PLD-PPH pathway. Furthermore, when a 
fatty acid is used to label PtdCho preferentially over Ptdlns, for example oleic, 
myristic or palmitic, the formation of labelled DG has provided further evidence for 
DG being derived from a non-inositide source (Martinson et al., 1989; Huang & 
Cabot, 1990a & b).
However, whilst there are now a number of documented examples of 
agonist-stimulated PLD activation, not all of these studies have been able to 
demonstrate that the resulting PtdOH is de-phosphorylated to DG to provide 
sustained increases in cellular DG (Huang & Cabot, 1990a). Thus DG formation 
may occur by an additional pathway and the prime purpose of PLD may be to form 
PtdOH, a candidate second messenger.
1.8.4 Is PLD regulated directly by receptors or is it dependent upon 
prior inositol lipid hydrolysis ?
For those agonists which couple to activation of PIC via Gp the formation 
of Ins(l,4,5)P3 is very rapid being maximally elevated within 5 or 10 seconds of 
addition of the agonist and without a measurable lag time (e.g., Wright et al., 
1988; Truett et al., 1989a). The generation of DG is equally rapid, but unlike the 
transient Ins(l,4,5)P3 response, rises in a second phase. In all the reports of 
agonist-stimulated PLD activity to date the kinetics of PtdOH or Ptdalcohol 
formation are clearly slower than those for Ins(l,4,5)p3 (e.g., Domino et al., 
1989; Martin & Michaelis, 1988,1989; Agwu et al., 1989) with lag times of 5-15 
sec before elevation is apparent, whilst maximal responses are not attained until
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after 1-2 min. This raises the question of whether receptors couple directly to PLD 
or whether this response is downstream of some other early event. Candidates for 
such early modulatory events are the rapid increase in [Ca^+]j and PKC activity due 
to PtdIns(4,5)P2 hydrolysis.
A number of studies have shown that phorbol esters and cell permeant DG 
analogues are able to activate PLD and/or PtdCho hydrolysis (Agwu et al., 1989; 
Price et al., 1989; Martin et al., 1990) suggesting a role for PKC in the regulation 
of PtdCho-PLD activity. This is supported further by the observation that 'down- 
regulation' of PKC or the use of PKC inhibitors greatly reduces or abolishes 
agonist- and phorbol ester-stimulated PtdCho hydrolysis and/or PLD activation 
(Cabot et al., 1989; Martin et al., 1989; Price et aL, 1989; Huang & Cabot, 
1990b; Liscovitch & Amsterdam, 1990). However, in neutrophils fMet-Leu-Phe- 
stimulated PLD activity is only inhibited by approximately 30% by the PKC 
inhibitor K252a even though PKC-mediated protein phosphorylation is abolished 
(Billah et al., 1989a). This suggests that there is another major path for regulation 
of PLD and in neutrophils this appears to be regulation by Ca^+. The formation of 
PtdOH or PtdEth in neutrophils can be stimulated by the sole addition of A23187 
suggesting a major role for Ca^+ in regulation of PLD; indeed, the effect of 
ionophore is more efficacious than that of PMA, giving a greater fold stimulation 
(Billah et al., 1989a). It is not clear whether this effect is mimicking 
Ins(l,4,5 )p3 -induced Ca2+ mobilization or whether it represents a Ca^+ entry 
phenomenon since depletion of extracellular Ca^+ with EGTA abolishes both 
receptor- and A23187-stimulated PLD activity.
There is evidence for regulation of PLD activity by guanine nucleotides in 
hepatocyte membranes (Bocckino et al., 1987), granulocyte homogenates (Anthes 
et al., 1989) and permeabilised endothelial cells (Martin & Michaelis, 1989). 
However, in the light of the possible role of PKC in activating PLD such an 
interpretation must depend upon the effect of the guanine nucleotide not being due 
to elevated inositol lipid hydrolysis, by interaction with Gp, and therefore activation 
of PKC.
Thus, there is certainly evidence of a role for PKC and Ca^+ in rhe
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regulation of PLD activity by agonists; in addition, preliminary studies suggest the 
possiblity of regulation by guanine nucleotide regulatory proteins and therefore 
perhaps by direct RGE interactions (e.g., Anthes et al., 1989).
1.9 The Swiss 3T3 mouse fibroblast as a model for examining early 
signals during mitogenic stimulation.
The Swiss 3T3 mouse embryo fibroblast cell is now widely used as a model 
system for studying the early signals associated with stimulation by growth factors 
(reviewed by Rozengurt, 1985; 1986). Cultures synchronised in the Gq/Gj phase 
of the cell cycle by contact inhibition of growth and serum depletion can be 
stimulated to re-enter the cell cycle by whole serum or defined mitogenic agents. 
Such an approach has allowed the identification of a variety of growth factors 
which, when added alone (complete mitogens), or in combination with other agents 
(co-mitogens), will initiate DNA synthesis in their target cells. Agonists which are 
now known to be mitogenic for the Swiss 3T3 cell line include insulin, aFGF, 
bFGF, PDGF, EGF, vasopressin, prostaglandin F2 a  bombesin and endothelin-1.
In the last five years much interest has focussed on the mechanism of action 
of bombesin as a mitogen since the discovery that bombesin-like peptides secreted 
by Small Cell Lung Carcinoma (SCLC) cells may act as autocrine growth factors in 
the genesis of this particular type of neoplasia (Cuttitta et al., 1985). Bombesin is 
a tetradecapeptide isolated from the skin of the frog Bombina bombina (Anastasi 
et al., 1971) which possesses a range of biological activities in mammalian tissues. 
It stimulates amylase secretion in exocrine glands such as pancreatic acini (Jensen 
et al., 1978), smooth muscle contraction (Minamino et al., 1984) and may also 
possess neurotransmitter activity within the brain (Gibbs etal., 1979). Bombesin 
exhibits a high degree of structural homology with the mammalian gastrin releasing 
peptide (GRP) and neuromedin B, particularly in the C-terminal eight amino acids.
In Swiss 3T3 cells, and a number of cell lines of murine and rat origin, 
bombesin is a potent mitogen when added alone as well as acting synergistically
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with insulin at nanomolar concentrations (Rozengurt & Sinnett-Smith, 1983). 
Bombesin and GRP appear to bind to the same receptor on Swiss 3T3 whole cells 
(Zachary & Rozengurt, 1985) and membranes (Sinnett-Smith et al., 1990) based 
on displacement studies using [125I-Tyt4]bombesin and [^I-Tyi^JG R P. The 
for binding is typically in the range of 0.1-5 nM and Scatchard analysis suggests 
that Swiss 3T3 cells possess a single class of high affinity receptor sites which have 
an approximate molecular weight of 75-85 kDa as determined by cross linking 
studies with [12^ I-Tyr4]GRP. The receptor has recently been purified to apparent 
homogeneity from Swiss 3T3 cell membranes (Feldman et al., 1990). Cross- 
linking studies on SDS-PAGE revealed a diffuse band of 75-100 kDa which after 
treatment with N-glycanase migrated as a sharper band of 38 kDa suggesting the 
native receptor is substantially N-glycosylated.
In recent years a number of studies have sought to identify the signal 
transduction pathways utilized by bombesin in exerting its mitogenic effect. It is 
known that bombesin stimulates the rapid hydrolysis of PtdIns(4,5)P2 to generate 
Ins(l,4,5)P3 and DG and the resulting increases in [Ca2+]j and PKC activity have 
been extensively studied (Lopez-Rivas et al., 1987; Takuwa et al., 1987a; 
Erusalimsky et al., 1988; Fischer & Schonbrunn, 1988). Furthermore this 
response is thought to be mediated via a GTP-binding protein (Gp) (Erusalimsky 
et al., 1988; Plevin et al., 1990) and consistent with this the recent cloning of the 
bombesin receptor from Swiss 3T3 cells has identified it as belonging to the family 
of seven-membrane spanning domain receptors which couple to G-proteins (Battey 
et al., 1991). The activation of PKC by bombesin is implicated in the induction of 
c-fos and c-myc mRNAs, alkalinisation of the cytosol and activation of S6 kinase 
(discussed in section 1.2). Thus, although not sufficient on its own to fully 
stimulate DNA synthesis, the inositol lipid pathway is of considerable importance in 
generating many of the early signals associated with mitogenesis (see section 1.2 & 
1.3).
Despite this there has been no thorough comparison of Ins(l,4,5)p3 and 
DG formation in bombesin-stimulated Swiss 3T3 cells. The studies by Heslop et
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al. (1986) and Nanberg & Rozengurt (1988) did not examine DG formation, 
whilst that of Takuwa et al. (1987a) looked at the formation of Ins(l,4,5)P3 and 
DG at different time points thereby precluding a direct comparison. In the light of 
recent evidence for alternative sources of DG, the Swiss 3T3 cell was chosen as a 
model system for defining the kinetics of changes in DG and Ins(l,4,5)P3 levels to 
determine what contribution to stimulated DG levels was made by hydrolysis of 
Ptdlns(4,5)p2 and, if relevant, other phospholipid classes. The Swiss 3T3 cell has 
the added advantage of being well characterised in terms of inositol phosphate 
formation (Heslop et al., 1986; Takuwa et al., 1987a; Nanberg & Rozengurt,
1988), and feedback inhibition of inositol phosphate accumulation by PKC 
activation (Brown et al., 1987), as well as being one of the best model systems in 
which to ’down-regulate' PKC by chronic phorbol ester treatment (Rodruigez-Pena 
& Rozengurt, 1984).
The majority of the work presented in this thesis has utilized bombesin as an 
RGE-type of growth factor to assess the role of inositol and choline phospholipid 
hydrolysis as sources of DG during mitogenic stimulation. Preliminary 
investigations (Chapter 3) aimed to assess the kinetics of Ins(l,4,5)P3 and InsPt 
formation in bombesin-stimulated Swiss 3T3 cells making comparisons with 
mechanistically related mitogens such as vasopressin and prostaglandin F2(X. In 
Chapter 4 bombesin-stimulated DG formation was examined and a possible role for 
activation of phospholipase D in DG formation was investigated. In Chapter 5 
evidence is presented to suggest that PtdCho is a major substrate for PLD activity in 
Swiss 3T3 cells and may play a role in the generation of DG in response to 
bombesin and mechanistically related mitogens. In addition, these studies have 
been widened to examine the effects of EGF and PDGF upon phospholipid 
metabolism and DG formation (Chapter 6). The results are discussed in terms of 
potential alternative sources of DG and the role of DG and PtdOH in cellular 
proliferation.
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Chapter 2.
Materials & methods.
2.1 Cell lines and m aterials.
2.1.1 Cell lines.
Swiss mouse 3T3 fibroblasts.
Kindly donated by Dr. Kenneth D. Brown, A.F.R.C. Institute of Animal 
Physiology, Babraham, Cambridge, CB2 4AT, U.K.
2.1.2 Materials.
The following is a list of the sources for materials used during the course of 
this research:
Aldrich Chemical Company Ltd. Gillingham. England.
2,2,4-trimethylpentane (iso-octane).
Amersham International pic. Amersham. Buckinghamshire. England.
Adenosine 5'-[y-^2P]triphosphate (specific activity 3Ci mmol"1),
[methyl-^H]Choline chloride (spec. ac. 75-85Ci mmol'1),
[2-3HJmyo-inositol (spec. ac. 10-20Ci mmol"1),
[2-3H]D-my0-inositol(l,4,5) trisphosphate (spec. ac. 20-60Ci mmol"1), 
[9,10(n)-3H]Palmitic acid (spec. ac.40-60Ci mmol"1), 
L-3-Phosphatidyl[A-mer/iy/-3H]choline, 1,2-dipalmitoyl (spec. ac.
50-60mCi mmol"1),
iPhosphoryl [mer/zy/-14C]choline, ammonium salt (spec. ac. 50-60mCi mmol'1), 
platelet derived growth factor (c-sis).
Glycerophospho[A-mef/iy/-3H]choline (GroPCho) had previously been prepared 
from [3 H]PtdCho by transacylation with monoethylamine according to the method 
of Clarke & Dawson (1981).
Avanti Polar Lipids Inc.. 5001-A. Whitling Drive. Pelham. Alabama. U.S.A. 
Cardiolipin.
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BDH Chemical Company. Poole. England.
Ammonium formate, butan-l-ol, diethyl ether, EDTA, ethanol, glycerol, Hepes, 
orthophosphoric acid, potassium hydrogen phosphate, potassium di-hydrogen 
phosphate, perchloric acid, sodium hydroxide, sodium carbonate, trichloroacetic 
acid and universal indicator.
Biogenesis Ltd. (formerly Biomedical Technologies Inc.L Bournemouth. England. 
Epidermal growth factor (receptor grade) purified from mouse submaxillary glands.
Boehringer (UK1 Ltd. Lewes. England.
ATP, dithiothreitol and Tris.
Calbiochem (Novabiochem flJ.K.) Ltd). University Boulevard. Nottingham. 
England.
n-octyl-p-D-glucopyranoside.
Cambridge Research Biomedicals. Cambridge. England.
Bombesin, [Arg^]vasopressin.
Fisons Scientific Apparatus.
Acetic acid (glacial), chloroform, ethyl acetate, hexane, methanol.'
Formachem (Research IntemationaPplc. Strathaven. Scotland.
D-glucose, sodium hydrogen carbonate
Gibco. Paisley. Scotland.
Dulbeccos modified eagles medium (DMEM, lOx), gentamycin, glutamine (lOOx), 
penicillin/streptomycin, sodium bicarbonate (7.5%).
Koch-Light Ltd. Suffolk. England.
Calcium chloride, dimethyl sulphoxide, magnesium sulphate, potassium chloride.
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Lipid Products.. Nutfield Nurseries. South Nutfield. Surrey,
Phosphatidylserine.
Lipidex Inc.. New Jersey. U.S.A.
E. coli DG kinase; crude membranes from an over expressing strain.
May and Baker. Dagenham. England.
Formic acid, hydrochloric acid and sodium tetraborate.
Riedel-DeHaenAg Seelze-Hannover. Germany.
Magnesium chloride and sodium di-hydrogen carbonate.
Roche (UK) Ltd. Welwvn Garden Citv. England.
The provision of the drug Ro-31-8220, a PKC inhibitor, by Dr. P. D. Davis is 
gratefully acknowledged.
Wellcome Research Laboratories. Beckenham. UK.
The provision of a [14C]PtdBut standard by Dr. L.G. Garland and the gift of 
[^H]butan-l-ol is gratefully acknowledged.
Whatman Ltd. Maidstone. England.
LK5DF glass backed thin layer chromatography plates, pre-laned with pre- 
adsor bent strip.
The gift of the tyrphostin, AG18, by Dr. Alexander Levitski, Department of 
Biological Chemistry, Hebrew University of Jerusalem, Jerusalem 91904, Israel is 
gratefully acknowledged.
All other chemicals including ion-exchange resins, phorbol esters and 
prostaglandins were obtained from the Sigma Chemical Company, Poole, England.
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2.2 Buffer composition.
Phosphate-buffered saline (PBS),
146mM sodium chioride, 5.4mM potassium chloride, 9.6mM di-sodium 
hydrogen orthophosphate, 1.5mM potassium di-hydrogen orthophosphate.
When freshly prepared PBS was adjusted to pH 7.2-7.4.
Sterile trypsin solution for cell passage.
Trypsin was prepared as a solution of 0.1% (w/v) trypsin, 0.025% (w/v) 
EDTA and lOmM glucose in PBS at pH 7.4 and and filtered before aliquoting 
through a sterile 0.22pm membrane (Flow pore D).
Hanks buffered saline (Hanks).
1.26mM calcium chloride, 0.5mM magnesium chloride, 0.9mM magnesium 
sulphate, 5.37 mM potassium chloride, 137mM sodium chloride, 4.2mM sodium 
hydrogen carbonate, 0.35mM sodium di-hydrogen phosphate.
When freshly prepared the pH was between 7.2 - 7.4.
Hanks buffered saline with glucose and BSA (HBGk
Buffer prepared as above containing lOmM D-glucose and 1% (w/v) BSA 
(fraction V) and pH adjusted to 7.4.
DMEM buffered with Hepes fDMBH).
Serum-free DMEM was prepared without antibiotics or glutamine 
supplement but containing 1% (w/v) bovine serum albumin. Buffering was with 
20mM Hepes and when preparing for use the buffer was adjusted to pH 7.4 using 
1M sodium hydroxide.
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2.3 Ion exchange resins.
2.3.1 Preparation of Dowex-formate.
Dowex 1x8-200 chloride form, strongly basic anion exchange resin, 8% 
cross linked with a dry mesh of 100-200 was treated as described below to obtain 
the formate form for separation of inositol phosphates. A known packed volume of 
Dowex was washed with distilled water, left to settle and the ’fines' discarded. 
This wash was repeated twice. The Dowex was transferred to a scintered glass 
funnel and washed with 20 volumes of 2M sodium hydroxide. The Dowex was 
then washed with 10 volumes of water followed by 5 volumes of 1M formic acid. 
Finally, the Dowex was washed with 50 volumes of water until the pH of the slurry 
was constant at approximately 5.5. Following each preparation of Dowex formate 
it was characterised by performing ml by ml elutions of a mixture of [^H]Ins(l)P, 
[3H]Ins(l,4)P2 and [3H]Ins(l,4,5)P3.
2.3.2 Preparation of Dowex-50W-H+.
Dowex-50W-H+ strongly acidic cation exchange resin, 8% cross linked, 
with a dry mesh of 200-400 was prepared as described below. Dowex was washed 
three times in three volumes of distilled water, allowing the resin to settle and 
discarding the 'fines' each time. The dowex was then washed three times with 
three volumes of 1M HC1 accompanied by gentle stirring with a plastic rod. 
Washings were discarded each time. Finally, the dowex was washed four or five 
times with three volumes of distilled water until the pH of the wash was constant at 
about pH 5.5.
Each newly prepared batch of dowex was characterised by performing an 
elution profile of a mixture of radiolabelled 'standards' of GroPCho, ChoP and 
Cho added to a Swiss 3T3 cell extract.
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2.4 Culture of Swiss 3T3 mouse fibroblast cells.
Swiss 3T3 cells were routinely maintained in Dulbeco's modified Eagle's 
medium (DMEM) supplemented with glutamine (2mM), penicillin/streptomycin 
(100 IU/ml.) and newborn calf serum (10%). Medium was changed every two 
days as it became acidified and depleted of serum. To prevent selection of resistant 
strains of bacteria, gentamycin was used in rotation with pen/strep. Cells were 
grown in a humidified atmosphere of 5% C 02 at 37° C. Except for experimental 
purposes cells were grown in 25 or 75 cm2 culture flasks and were passaged when 
sub-confluent. Every two or three weeks a single flask was allowed to grow to 
confluency to ensure that cells were contact inhibiting and were not exhibiting 
abberrant morphology. Cells which exhibited transformed morphology, showed 
reduced responsiveness to given agonists or reached passage numbers higher than 
40 were discarded.
2.4.1 Cell passage.
Cells were passaged at a ratio of 1 to 10 or 12 according to the following 
general protocol.
(1) Medium was aspirated and replaced with 1ml of sterile trypsin solution per 25 
cm2 flask (3ml per 75cm2 flask).
(2) Flasks were returned to the incubator for 2-3 minutes until cells were detaching 
from the flask bottom. Trypsin activity was inhibited by addition of 3ml of 
complete medium. The cells were then suspended by tituration to ensure maximum 
harvest.
(3) After transfer to a sterile tube, the cell suspension was centrifuged at lOOOrpm 
for 3 minutes and the supernatant discarded.
(4) Cells were resuspended in complete medium and and aliqouted into new sterile 
flasks containing 3ml of fresh medium. Flasks were rocked gently to ensure even 
distribution of cells across the flask bottom and returned to the incubator.
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2.4.2 Cryogenic preservation of cell lines.
Cell lines were stored in liquid nitrogen according to the following protocol.
(1) Cells were trypsinized as outlined above (cell passage 1-3)
(2) Cells were resuspended in DMEM containing 20% (v/v) donor calf serum and 
8% (v/v) DMSO at a density of approximately 10^ cells per ml of freezing 
medium and aliquoted into freezing vials.
(3) Cells were slow frozen for 24 hours at -80° C before transfer to a vat of liquid
n 2.
To bring cells up from storage, vials were removed from liquid N2 and 
thawed rapidly in a water bath at 37°C. Each aliquot of cells was plated out in 3ml 
of fresh medium and left to attach overnight. The next day the medium and 
suspended dead cells were removed and the surviving cells were fed normally.
2.5 Measurement of stimulated-inositol phosphate formation.
2.5.1 Incubation of cells with test reagents.
After plating on 24 well plates in DMEM + 10% donor calf serum for 24 
hours, Swiss 3T3 cells were grown in 1ml of inositol-free DMEM containing 1% 
dialysed donor calf serum with either lpC i ml"* (total InsPs) or 5pCi ml'* 
(individual InsP fractions) of [2-^H]myo-inositol for 48 hours, by which time the 
cells were confluent, quiescent and labelled to isotopic equilibrium. Labelling 
medium was aspirated and cells were incubated in Hanks buffered saline (pH 7.4) 
for 5 minutes at 37°C followed by incubation in HBG and lOmM LiCl (HBG.Li) 
for 20 minutes. Finally, cells were incubated with 150pl of HBG.Li containing the 
test reagent at the final concentrations and for the times indicated.
For assays of total inositol phosphates incubations were terminated by direct 
addition of 500 pi of ice cold methanol. After scraping the cell debris and removing 
to a 2ml plastic polytube each well was washed again with a further 200 p.1 of 
methanol and the two washes pooled. Phospholipids were extracted from the cell
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debris by addition of 310 |il of chloroform followed by vortexing and standing at 
on ice for 30 minutes. After addition of 500|il of ice cold distilled water samples 
were centrifuged at 14,000g for 3 minutes to split phases and 1 ml of the upper 
aqueuos/methanolic phase was transferred to a 5 ml insert vial for isolation of total 
inositol phosphates. In addition, an aliquot of the chloroform phase was removed, 
dried down in a polytube and, after addition of 1.5 ml of Optiphase Hi-safe 
scintillation fluid, the radioactivity in the total inositol lipids determined by 
scintillation counting.
For assays of individual inositol phosphate fractions incubations were 
terminated by aspiration of the test solution an d addition of 150jil of ice cold 10% 
(v/v) perchloric acid. Inositol phosphates were extracted on ice for 20 minutes 
followed by scraping and removal of the cell debris into a plastic eppendorf tube. 
The 24 well plates were washed with a further 150pl of water, pooled with the 
acidified extracts and centrifuged at 14,000g for 10 minutes at 4°C. The 
supernatants were removed to a second tube, neutralized by addition of 1.5M- 
KOH/ 60mM Hepes in the presence of Universal Indicator and the precipitated 
potassium perchloate removed by centrifugation at 14,000g for 10 minutes at 4°C. 
The supernatants were analysed by ion-exchange chromatography on Dowex 1 X8 
formate columns. Assays of individual inositol phosphates extracted using the 
neutral methanol method above gave qualitatively similar results, but quantitatively 
lower recovery of the higher phosphorylated forms of inositol (InsPg and InsP^; 
see Chapter 3). This was probably due to the reported lower solubility of these 
inositol phosphates in methanol (Wregget et al., 1987; reviewed by Palmer & 
Wakelam, 1989).
2.5.2 Preparation of samples for measurement o f Ins(l,4,5)P3  
m ass.
Swiss 3T3 cells were grown in 75cm^ culture flasks containing DMEM + 
10% donor calf serum until confluent and quiescent. Cells were then scraped in the 
growth conditioned DMEM using a rubber policeman and incubated for 45 minutes
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at 37° C with gentle shaking. After washing twice in HBG (pH 7.4) cells were 
resuspended in a volume of HBG sufficient to give a density of approximately 2 x 
107 cells/ml (an aliquot was taken for cell counting). After incubation at 37° C for a 
further 30 minutes cells were used for experiments. This incubation period has 
been shown to allow full recovery of Ins(l,4 ,5 )P3 to basal levels in Swiss 3T3 
cells after the elevation caused by the physical perturbation of scraping (S. Palmer, 
personal communication).
For experimental purposes 50|il of cell suspension in HBG was added to a 
plastic polytube containing 25pi of the test reagent at the given final concentration, 
and cells were incubated at 37° C with shaking for the required time. Incubations 
were terminated by the addition of 25jil of ice cold 10% perchloric acid followed by 
extraction on ice for 20 minutes. Samples were neutralized by addition of 1.5M 
KOH/ 60mM Hepes containing Universal Indicator and the cell debris and 
precipitated potassium perchlorate were removed by centrifugation at 14,000g for 
10 minutes at 4°C. A 25|il aliquot of the supernatant was then removed for assay 
of Ins(l,4 ,5 )p3 mass using an assay based upon a specific binding protein (Palmer 
et al., 1989) as described in appendix I.
2.5.3 Assay of total inositol phosphates.
Total inositol phosphates were assayed by accumulation in the presence of 
lOmM Li Cl essentially by the method of Berridge et al. (1982). Dowex formate 
(1x8 200-400 mesh) (300jil) was added to samples, followed by 3 ml of distilled 
water to mix. After the Dowex had settled the supernatant was aspirated. The 
removal of glycerophosphoinositides was achieved by two washes with 3 ml of 60 
mM ammonium formate/5mM sodium tetraborate followed by a further 3 ml wash 
with water. Finally total inositol phosphates (mainly InsP and InsP2 ) were eluted 
by two washes with 0.6ml of 1M ammonium formate/ 0.1M formic acid. After 
each addition, 0 .6ml of the supernatant was removed to a 2 0ml scintillation vial and 
the pooled washes for each sample were mixed with 16 ml of Optiphase Hi-safe
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scintillation fluid. The radioactivity was estimated by liquid scintillation counting.
2.5.4 Assay of individual inositol phosphate fractions.
Neutralized supernatants were diluted in 3ml of 5mM sodium tetraborate/ 
0.5mM-EDTA, pH 6.7 and applied to 1 ml columns of Dowex formate (1x8; 200- 
400 mesh) prepared in glass wool plugged pasteur pipettes. The columns were 
then washed with 12 ml of water followed by 12ml of 60 mM ammonium formate/ 
5mMsodium tetraborate to remove free inositol and glycerophosphoinositides, 
respectively. Inositol mono-, bis-, tris-, and tetrakisphosphates were eluted with 
sequential 18 ml washes of O.lM-formic acid containing 0.2M-, 0.4M-, 0.8M- and 
1.2M- ammonium formate respectively. Aliquots of each fraction (3ml) were 
mixed with Optiphase Hi-safe scintillant and the radioactivity determined by liquid 
scintillation counting.
2.6 Assay of sn-l,2-dirady!gIycerol mass.
Mass measurement of DG was essentially by the method of Preiss et al. 
(1986), with modifications developed during the course of studies. The assay 
employs a DG kinase enzyme to convert the DG from chloroform extracts of cells 
to phosphatidic acid (PtdOH) in the presence of [y-^P] ATP. Since the assay is 
linear, with a stoichiometry of one DG molecule to one ATP molecule, the amount 
of radioactivity in the PtdOH will be directly proportional to the amount of DG in 
the sample and the specific activity of the [y-^P] ATP, allowing estimation of the 
mass of s/i-l,2-DG in cell samples.
Two variations of the basic assay method were employed during the course 
of the studies presented in this thesis. The major differences were the detergent 
system used to solubilize the cellular DG samples and form mixed micelles and the 
use of glass reaction tubes rather than plastic with the Triton/PtdSer system which 
was found to increase conversion, recovery and also yielded much closer agreement
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between standard replicates (R. Plevin & A. Paterson, personal communication).
2.6.1 CardioIipin//i-octyl-p-D-gIucopyranoside detergent system.
Aliquots from the chloroform phase of chloroform/methanol/water phase 
splits or standards of l-stearoyl-2-arachidonoyl-glycerol (typically 0, 125, 250, 
500 & 1000  pmoles), were dried down in vacuo in plastic poly tubes and sonicated 
in 20jil of a detergent cocktail containing 7.5% «-octyl-p-D-glucopyranoside, 
5mM cardiolipin and ImM diethylenetriaminepentacetic acid (DETAPAC). The 
following reagents were added to each sample;
50|il of incubation buffer containing lOOmM Imidazole, lOOmM NaCl 25mM 
MgC^ and 2mM EGTA at pH 6 .6 .,
10|il of dithiothreitol to a final concentration of 2mM, 
lOjil of E. coli DG kinase enzyme,
Incubations were started by adding 1.25pCi of [y-^^P]ATP in a solution of 5mM 
ATP prepared in lOOmM Imidazole and ImM DETAPAC at pH 6.6  (ATP buffer) to 
each sample followed by vortexing. The actual volume of this ATP cocktail used 
was determined on each occasion by calculating the precise concentration of ATP 
from its absorbance at 259nm and the decay factor for the [y-^^P] ATP. Incubations 
were performed at 30° C for 30 min by which time the reaction had reached 
completion (data not shown).
Incubations were terminated by the addition o f 470pl of 
chloroform/methanol (1/2; v/v) containing 1% perchloric acid (v/v).and samples 
were extracted at room temperature for 20 minutes. Phases were resolved by 
addition of 150|il of chloroform and 1ml of 1% perchloric acid, and following 
vigorous vortexing samples were centrifuged at 14,000g for 2 minutes. The upper 
aqueous methanolic phase containing the majority of unincorpoated [y-^P]ATP 
was removed and discarded to radioactive waste and a further 1ml pechloric acid 
wash performed.
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2.6.2 Triton / PtdSer detergent system.
Samples or standards of DG were dried down in vacuo in glass vials and 
solubilised in 50pl of a detergent mix containing 6  Mol% PtdSer (0.288mM) in 
0.6% (w/v) Triton X-100 by vortexing and then sonicating at 4°C. Incubations 
were started by adding 50 pi of a mix containing:- ^
20pl of 5x incubation buffer (250mM Imidazole/HCl, pH 6 .6 ; 250mM NaCl; 
62.5mM MgCl2; 5mM EGTA), 
lOpl DG kinase (from E.coli.), 
lOpl lOx DTT (20mM),
lOpl of ATP cocktail containing 1.25pCi [y-^2 P]ATP in 5mM ATP (50 
nmoles/sample) in lOOmM Imidazole and ImM DETAPAC at pH 6 .6  (ATP buffer).
The precise volume added was determined on the day by spectrophotometric 
assay of the ATP solution and estimation of the decay factor for the [y-32P]ATP. 
Incubations were started by vortexing and proceeded at 30° C for 30min. 
Incubations were terminated by addition of 470 pi of chloroform/methanol (1/2, 
v/v) and samples were extracted for 20 min at room temperature. Phases were 
resolved by addition of 150pl of chloroform and 1ml of water and after 
centrifugation at 3000rpm for 2 min the upper aqueous-methanolic phase was 
discarded to radioactive waste. A further 1ml water wash was performed and all 
the traces of the upper aqueous phase were removed before drying down the 
chloroform layer in vacuo.
2.6.3 Resolution of DG kinase assay products.
For both assay procedures the dried chloroform phase was redissolved in 
50pl of chloroform/methanol (19/1; v/v) and 25pl spotted on to acetone washed, air 
dried silica gel 60 t.l.c. plates. The loaded plates were developed in a solvent of 
chloroform/methanol/acetic acid (65/15/5;v/v), air dried and subjected to 
autoradiography at -80°C for 12 hours to locate the reaction products. In some 
experiments the solvent system was modified to chloroform/methanol/acetic acid
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(65/15/10) to increase the mobility of the PtdOH (A. Paterson & R. Plevin, 
personal communication). The uppermost band on the tic plates was identified as 
PtdOH on the basis that it had identical chromatographic properties as the PtdOH 
obtained when pure sn- 1 -stearoyl-2 -arachidonoyl glycerol was employed in the 
assay. The PtdOH was excised from the t.l.c. plate, placed in 6ml vial with 4ml of 
Optiphase Hi-safe scintillant and the radioactivity determined by scintillation 
counting.
Standard curves of cpm in PtdOH versus pmoles of DG were plotted as 
simple straight lines and pmoles of DG in the unknown samples were calculated 
from the cpm in PtdOH and the equation of the standard curve straight line. After 
correcting for the total cell lipid extract volume DG was expressed as either pmoles/ 
10^ cells or as Mol% (nmoles of DG/lOOnmoles of lipid phosphorous).
2.7 Assay of [3 H]DG formation in [3H]paImitate labelled Swiss 3T3 
c e lls .
2.7.1 Labelling of Swiss 3T3 cells with [3 H] palmitic acid.
To establish conditions for optimum labelling of lipids, Swiss 3T3 cells 
were sub-cultured onto a 24 well plate in DMEM+10% newborn calf serum until 
approximately 70-80% confluent. They were then labelled with DMEM+1% 
newborn calf serum containing 2jiCi m T ^ H ] palmitic acid for various times up to 
49 hours using a staggered protocol. At the end of the incorporation period 
medium was aspirated, cells washed in HBG for 2 minutes and killed by addition 
of 500|il of ice cold methanol. After scraping, washing again with 200p.l of 
methanol and pooling, the cell debris was extracted into chloroform (310|il) for 60 
minutes. Phases were split by addition of 650pl of water, and the entire 
chloroform phase was dried down in vacuo and stored under N2 vapour until 
analysis.
Isolation of the major individual phospholipids was performed by one
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dimensional t.l.c. Silica gel 60 plates (20 x 20 cm) were sprayed with ImM EDTA 
and allowed to air dry, before heat activating. The samples, prepared as above, and 
various phospholipid standards were dissolved in chloroform/methanol (19/1,v/v), 
applied to the origin and air dried before developing in a solvent system of 
chloroform:methanol:acetic acid:water (75:45:3:1, v/v) until the solvent front was 
approximately 17.5cm from the origin. Following visualisation with I2 vapour, 
each lane was divided into 0.5cm slices and those sections corresponding to 
phospholipid standards were scraped into 5ml insert vials. The radioactivity 
associated with each slice and attributed to each phospholipid by co-migration with 
standards, was determined by scintillation counting after addition of 4ml of 
Optiphase Hi-safe scintillant.
2.7.2 Assay of [3 H]DG formation in [3 H]paImitate labelled Swiss 
3T3 cells.
Swiss 3T3 cells were sub-cultured into six-well culture plates and grown in 
DMEM + 10% newborn calf serum until approximately 80% confluent. The 
growth media was then replaced with 2ml of DMEM + 2% newborn calf serum 
containing 2 pCi ml"1 of [^H]palmitic acid and cells were returned to the incubator 
for a further 48 hours. For experimental purposes the labelling medium was 
removed by aspiration and cells were equilibrated in 1ml of serum-free DMEM 
containing 1% bovine serum albumin and 20mM Hepes (DMBH) (pH 7.4) at 37° 
C for 20 minutes. For kinetic studies cells were incubated in DMBH containing the 
required concentration of test reagent for the required time at 37° C. Incubations 
were terminated by aspiration of DMBH followed by the addition of 0.5ml of ice- 
cold methanol. Cell debris was scraped off the plate surface and placed in screw- 
top glass tubes together with a further 0.2ml of methanol wash. Phospholipids in 
these pooled scrapings were extracted by the addition of 0.7ml of chloroform, 
vigorous vortexing and standing at room temperature for 15 minutes. After 
addition of 0.585ml of water tubes were centrifuged for 5 minutes at 3000 rpm, the 
upper aqueous/methanolic phase discarded and the chloroform phase dried in
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vacuo. Samples were routinely analysed by thin layer chromatography 
immediately. If chromatography was delayed for 24 hours sample tubes were 
purged with oxygen-free N2 and stored at -20° C.
[^H] 1,2-DG was resolved from 1,3-DG by thin layer chromatography. 
Samples were re-dissolved in lOOjil of chloroform/methanol (19/1 ;v/v) and applied 
to Whatman LK5DF t.l.c. plates. Plates were fully developed once in a lined and 
fully equilibrated t.l.c. tank in a solvent system of hexanerdiethyl ether:acetic acid 
(60:40:1 v/v). 1,2-DG, identified by its co-migration with an authentic standard 
after I2 staining, migrated just below 1,3-DG. The plate lanes were divided into 
0.5cm strips and those corresponding to 1,2-DG were scraped off and placed in a 
scintillation vial with 4ml of Opti-phase Hi-safe scintillant fluid. Radioactivity was 
determined by scintillation counting.
2.8 Assay of PtdCho hydrolysis.
2.8.1 Incubation of cells with test reagents.
Swiss 3T3 cells were plated at a density of approximately 104 cells/ml on 
24 well plates and grown in DMEM + 10% donor calf serum for 24 hours. They 
were then grown in DMEM +1%  donor calf serum + 1.5|iCi ml-* [^H] choline 
chloride for 48 hours by which time they were confluent and quiescent. Following 
removal of the labelling medium, cells were incubated at 37° C in Hank's buffered 
saline, pH 7.4, for 5 minutes followed by two washes in HBG for 10 and 30 
minutes respectively. Finally, cells were incubated in 150jil of HBG containing the 
given concentration of test reagent for the required time.
For experiments where intracellular or cell associated choline metabolites 
were studied, incubations were terminated by aspiration of the test solution and 
addition of 500p.l of ice cold methanol. For experiments where intracellular and 
extracellular metabolites were studied incubations were terminated by addititon of 
500|il of ice cold methanol to the incubation buffer. Cell debris was scraped, 
transferredto a plastic polytube and pooled with a further 2 0 0 fil methanol wash.
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Phospholipids were extracted by addition of 310|il chloroform followed by 
vortexing. After standing at -20° C for 24 hours, 500pl of water was added and the 
phases were split by centrifuging at 14,000g for 3 minutes. A 1ml sample of the 
aqueous methanolic phase was taken for separation of the major water soluble 
metabolites of choline by cation exchange chromatography. During the initial 
characterisation of this method it was found that similar results were obtained if 
incubations were terminated with perchloric acid and neutralized either by addition 
of 1.5M KOH/60mM Hepes or Freon/tri-n-octylamine (data not shown).
To allow correction for variation in sample size an aliquot of the chloroform 
phase was dried down and mixed with 1.5 ml of Optiphase Hi-safe scintillant and 
subjected to liquid scintillation counting to estimate the activityincorporatedinto total 
choline containing lipids.
2.8.2 Separation of the major water soluble metabolites of choline.
The 1ml aqueous methanolic samples from experiments loaded on to 1ml 
Dowex-50W-H+ columns prepared in glass wool plugged pasteur pipettes. The 
flow through and a further 8 ml water wash were pooled and collected as the 
glycerophosphocholine fraction. A further wash with 20 ml of water was collected 
as the phosphocholine fraction, whilst a final wash with 20 ml of 1M HC1 eluted 
off the choline fraction. Two ml aliquots of each fraction were mixed with 
Optiphase Hi-safe scintillant and radioactivity determined by liquid scintillation 
counting.
2.8.3 Analysis of [3 H}choIine containing lipids.
[^Hjcholine labelled Swiss 3T3 cells were stimulated with mitogen or 
vehicle as described above. Following extraction in chloroform and methanol as 
described above, the aqueous methanolic phase was removed and the chloroform 
phase dried in vacuo. Choline-containing lipids were re-dissolved in 100|il of
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chloroform/methanol (19/1; v/v) and half the sample was applied to silica gel 60 
t.l.c. plates. The t.l.c. plates were developed fully in a lined, equilibrated tank in a 
solvent of chloroform:methanol:acetic acid:water (25:15:4:2, v/v) (Skipski et al., 
1964). PtdCho and sphingomyelin were identified by their Rf values and co­
migration with authentic standards. After excision the radioactivity in PtdCho and 
SphM was determined by scintillation counting using 4ml of Optiphase Hi-safe.
2.9 Measurement of Phospholipase D transferase activities in whole 
ce lls .
2.9.1 Assay of PLD phosphatidyltransferase activity in intact cells.
PLD catalysed phosphatidyltransferase activity was assayed by measuring 
the incorporation of butan-l-ol into phosphatidyl moieties by two isotopic labelling 
methods. In initial studies, unlabelled cells were incubated in the presence of the 
test reagent and carrier-free [^H] butan-l-ol essentially according to the method of 
Randall et al (1990). However because of the expense and the danger of using 
such high specific activity [^H]butan-l-ol and of disposing of such high activity 
waste most studies employed cells pre-labelled with [^H]palmitic and incubated in 
the presence of 30mM non-radioactive butan-l-ol which equilibrated more rapidly 
with the cell interior. This second method had the advantage of defining the fatty 
acid composition of at least some of the PtdBut formed by virtue of the label 
employed. Thus a combination of both methods allowed identification of PtdBut 
formation in response to defined agonists.
2.9.2 Assay of PtdBut formation in [3 H]paImitate labelled Swiss 
3T3 cells.
Swiss 3T3 cells were sub-cultured into six-well culture plates and grown in 
DMEM + 10% newborn calf serum until approximately 80% confluent. The
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growth media was then replaced with 2ml of DMEM + 1% newborn calf serum 
containing 2 pCi ml"1 of [^HJpalmitic acid and the cells were returned to the 
incubator for a further 48 hours. For experimental purposes the labelling medium 
was removed by aspiration and cells were equilibrated in 1ml of DMBH at 37° C 
for 20 minutes. For kinetic studies cells were incubated for a further 5 minutes in 
lml of DMBH containing 30 mM butan-l-ol (0.3%, v/v) at 37° C prior to addition 
of agonists. Finally cells were incubated in DMBH + 30mM butan-l-ol + the 
required concentration test reagent for the indicated time. For dose dependency 
studies there was no pre-incubation with butan-l-ol and the appropriate 
concentration of test reagent in DMBH + 30mM butan-l-ol was added directly to 
the cells for 15 or 30 minutes. Incubations were terminated by aspiration of DMBH 
followed by the addition of 0.5ml of ice-cold methanol. Cell debris was scraped 
off the plate surface and placed in screw-top glass tubes together with a further 
0.2ml of methanol wash. Phospholipids in these pooled scrapings were extracted 
by the addition of 0.7ml of chloroform, vigorous vortexing and standing at room 
temperature for 15 minutes. After addition of 0.585ml of water tubes were 
centrifuged for 5 minutes at 3000 rpm, the upper aqueous/methanolic phase 
discarded and the chloroform phase dried in vacuo. Samples were routinely 
analysed by thin layer chromatography immediately. If chromatography was 
delayed for 24 hours sample tubes were purged with oxygen-free N2 and stored for 
at -20° C. Samples were not stored in chloroform solution as PtdBut was not 
stable under these conditions.
2.9.3 Assay of PtdBut formation using [^H ]butan-l-ol as the 
phosphatidyl acceptor.
All manipulations with [^H]butan-l-ol were performed in a fume hood to 
minimize inhalation of [^H]butan-l-ol vapour. Confluent, quiescent cultures of 
Swiss 3T3 cells grown on 10cm petri dishes were incubated in 5 ml of DMBH (pH 
7.4) containing [^H]butan-l-ol (100pCi ml'*) at 37°C for 20 minutes. Test 
reagents in DMBH were added at the required concentrations and for the given
71
times with mixing and incubated at 37° C. Incubations were terminated by 
aspiration of DMBH into a radioactive waste trap and addition of 1.5ml of methanol 
previously chilled on dry ice. Following scraping of cell debris into polypropylene 
tubes, lipids were extracted by the addition of chloroform and water as described by 
Randall et al. (1990) and, after removal of the aqueous phase, chloroform layers 
were evaporated to dryness under N2 . Dry lipid extracts were re-dissolved, with 
vortexing, in lml of chloroform and washed three times with 2 ml of theoretical 
upper phase (upper phase of chloroform: methanol: 1M NaCl: water (2:2:1:1 v/v)). 
The chloroform layers were than dried down under N2 and either used directly for 
t.l.c. analysis or stored dry under N2 at -20°C for 24 hours.
2.9.4 Isolation and Identification of Phosphatidylbutanol.
Dried chloroform  extracts were re-dissolved in 100}il of 
chloroform/methanol (19/1) with vigorous vortexing and applied to Whatman 
LK5DF, 20cm x 20cm, pre-laned silica gel thin layer chromatography plates. Once 
the samples had dried, the plates were fully developed once in the organic phase of 
2,2,4-trimethylpentane:ethyl acetate:acetic acid:water (50/110/20/100, v/v) under 
non-equilibrium conditions in an un-lined chromatography tank.
After drying, plate lanes were divided into 0.5cm strips, the silica gel 
scraped into scintillation vials and radioactivity counted in 4ml of Optiphase Hi-safe 
scintillant. The band of radioactivity corresponding to PtdBut was identified by the 
following criteria:-
(a) its co-migration with an authentic [^C]PtdBut standard developed on the same 
t.l.c. plate,
(b) its unique appearance in the presence of butan-l-ol in response to a suitable 
stimulus,
(c) its dose dependent appearance with increasing butan-l-ol concentration up to 
lOOmM in response to a suitable stimulus.
In the t.l.c. solvent system used PtdBut (Rf= 0.42 ± 0.06) was resolved
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completely from all other radiolabelled bands including major phospholipids 
(PtdCho, PtdEtn, PtdSer & Ptdlns) which remained at the origin. [^H]PtdOH ran 
slightly further than the phospholipids (typical Rf value= 0.15) but was not 
completely resolved from them without a double development in the same 
dimension. Monoglyceride, di and triglycerides and free fatty acids ran closer to 
the solvent front (Pai et al., 1988); typical Revalues were 0.78 for MG and 0.9 for 
DG, TG and free fatty acid which were incompletely resolved.
2.10 Assay of lipid phosphate/phosphorus mass.
Two colorimetric methods were used to assay the mass of total phosphorus 
containing lipid in chloroform extracts from Swiss 3T3 cells during the course of 
these studies.
2.10.1 Assay of lipid phosphate.
Reagent A. ImM K2 HP04 prepared in distilled water.
Reagent B. ANS = 2.72g of Na2 S2 0 5, 0.2g of Na2 S03 and O.lg of l-amino-2- 
napthol-4 -sulphonic acid dissolved, in that order, in 100ml of distilled water and 
filtered before use. Shelf life 1 day.
Reagent C. 2.5% (w/v) ammonium molybdate.
All glassware used was either new or washed thoroughly in distilled water. 
Samples from the chloroform phase of cellular extracts were evaporated to dryness 
in a 17 mm test tube. 0 .6  ml of concentrated perchloric acid was added to the test 
tubes containing the dried sample or an appropriate standard (reagent A). Tubes 
were covered with either aluminium foil or glass marbles to minimise evaporation 
and heated at 260° C for 2 hours in a fume hood. After cooling 1.6 ml of water and 
0.5 ml of reagent B were added and mixed. 1 ml of reagent C followed by 1.3 ml 
of water was then added and samples were mixed thoroughly by vortexing. Colour 
development was at 90° C for 30 min and samples were assayed in plastic cuvettes 
by reading the absorbance at 830nm.
Standard curves of |ig of P04 versus ODg3Q were plotted and |ig of P04 in
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the unknown samples was estimated from the equation of the standard curve. The 
assay was linear over the range 0.5 to 20 jig of PO4 .
2.10.2 Assay of lipid phosphorus.
Reagent A. 10% (w/v) Mg(N0 3 )2 .6 H2 0  in methanol.
Reagent B. 4.2% (w/v) ammonium molybdate in 4.5M HC1.
Reagent C. 0.3% (w/v) malachite green (oxalate) Giirr Certistain (BDH product 
No. 34045, colour 42000) dissolved in distilled water just before use.
Reagent D. Dye-Molybdate reagent. Reagent B (1 vol) mixed with reagent C (3 
vol) and left at room temperature for 2-3 hours (or overnight). Filtered through a 
Whatman No.l filter paper. Reagent stored at room temperature; stable for 3-5 
weeks with limited precipitation. Discarded when further precipitate appears. 
Reagent E. 1% (w/v) Triton X-100 in distilled water. Refrigerated and replaced 
every 3 months.
Assay of total lipid phosphorus was essentially by the method of Duck- 
Chong (1979). All manipulations were performed in glassware which had been 
immersed for 24 hours in concentrated sulphuric acid containing 5% concentrated 
nitric acid followed by vigorous washing with distilled water. A sample of lipid 
containing approximately no more than 0.5pg of phosphorus in upto 4 ml of 
chloroform/methanol (1/2 , v/v), or a series of ’blanks’ for standards, was mixed 
with 30}il of reagent A in a 17mm test tube and evaporated to dryness at 50° C 
under a stream of N2. Lipid was digested by heating the sample for 15 sec in the 
top of a bunsen flame followed by lowering into the tip of the blue cone of the 
flame for a further 10 sec; brown fumes were driven off. After cooling to room 
temperature 1 ml of 1M HC1 was added, samples covered with glass marbles to 
minimise evaporation and heated at 95° C for 15 min before cooling to room 
temperature. Standards, KH2 PO4 in 1M HC1, were added to ’blank’, digested 
tubes.
Reagent E (30jil) was added to test solutions or standards followed by 
addition of 2ml of reagent D with immediate mixing. Colour was allowed to
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develop at room temperature for 30 min and the absorbance at 650 nm was 
determined using plastic disposable cuvettes. Standards were assayed in duplicate. 
Samples were divided and assayed in duplicate such that they fell at low and high 
points on the standard curve so as to negate any loss of linearity affecting the 
validity of the results. The assay was linear from 10 to 500ng of phosphorus.
2.11 Analysis and presentation of results.
Unless otherwise stated all experiments were performed at least three times 
and each data point represents the mean ± standard deviation (S.D.) of triplicate 
determinations. Statistical significance was estimated by a paired Students't' test 
on an Apple Macintosh Stat-Works program and significance was generally taken 
as values of p< 0.05.
EC50 and IC50 values were calculated from dose-response curves fitted to a 
logistic equation (non-linear regression analysis) as defined by DeLean et a l  
(1980). However, for presentation purposes dose-response curves were presented 
as simple line graphs from the Apple Macintosh Cricket Graph program.
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Chapter 3.
Mitogen-stimulated inositol lipid hydrolysis and 
Ins(l,4,5)P3 formation in Swiss 3T3 cells.
3.1 Introduction.
The results presented in this chapter describe some of the kinetic, 
pharmacological and mechanistic aspects of inositol phosphate generation in 
response to stimulation of Swiss 3T3 cells with defined mitogenic agents.
The mitogen-stimulated hydrolysis of PtdIns(4 ,5 )P2 to yield Ins(l,4 ,5)P3 , 
and its subsequent metabolism to higher and lower phosphorylated forms of 
inositol has been studied extensively in Swiss 3T3 fibroblasts (Brown et al., 1984; 
Heslop et al., 1986; Takuwa et al., 1987a; Brown et al., 1987; Nanberg & 
Rozengurt, 1988; Blakeley et al., 1989). These studies have demonstrated that a 
variety of neuropeptides, growth factors and other mitogenic agents stimulate the 
hydrolysis of inositol lipids at doses similar to those required to stimulate entry into 
the cell cycle and DNA synthesis (Rozengurt & Sinnett-Smith, 1983; Corps et al., 
1985).
The majority of these studies have employed cells labelled to isotopic 
equilibrium with [^H]inositol and stimulated with an appropriate agonist and the 
[^Hjinositol phosphates produced have been analysed by various ion-exchange 
techniques. The inclusion of lOmM LiCl inhibits the Ins(x)P phosphatase and thus 
results in the accumulation of total inositol monophosphates (InsPf) (Berridge et 
al., 1982). This method provides a very sensitive assay for receptor-mediated 
inositol lipid hydrolysis during prolonged stimulation, but provides little 
information on the kinetics of formation of individual inositol phosphates.
Individual inositol phosphate fractions (InsP, InsP2 & Insp3 ) can be 
resolved by anion-exchange chromatography (Downes & Michell, 1981). This 
method was used to show that InsP3 , presumed to be Ins(l,4 ,5 )P3 » was the initial 
product of inositol lipid hydrolysis and was generated fast enough to mediate Ca2+ 
mobilization and therefore fulfil a possible second messenger role (Berridge, 1983). 
The discovery of Ins(l,3 ,4 )P3 (Irvine et al., 1984), and subsequently isomers of 
InsP4 and InsP5 , has required the development of more sophisticated ion-exchange 
techniques for the separation of [^HJinositol phosphates. A number of h.p.l.c. 
methods are now widely used for this purpose.
For isotopic studies to reflect the changes in mass of inositol phosphates,
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the precursor lipids must be 'labelled' to isotopic equilibrium with the intracellular 
inositol pool. This can be achieved by prolonged preincubation of cells with 
[3 H] inositol in inositol-free culture medium. However, it has been suggested by 
some workers (Monaco, 1982), though not all (Michell et al., 1988), that distinct 
hormone sensitive and insensitive pools of inositol lipid might exist. If this is the 
case, the distribution of radioactivity between the pools must be taken into account. 
Finally, if continuous labelling is not employed, the specific activity of the 
precursor lipids may decline throughout the experiment. Clearly, isotopic studies, 
whilst useful in themselves, have their limitations.
A variety of methods have been developed to measure the mass of inositol 
phosphates in cells and this topic has been reviewed recently (Palmer & Wakelam, 
1990). Perhaps the most useful of these is the Ins(l,4,5)Pg-specific binding assay 
described by Palmer et al. (1989) in which neutralized acid extracts of unlabelled 
cells compete with a high specific activity [2 -^H]my<?-inositol(l,4 ,5 )p3 for 
binding to bovine adrenal cortex microsomes. Since this method determines 
Ins(l,4 ,5 )P3 mass directly it negates the problems of the isotopic studies.
The following results are based largely on experiments performed with cells 
labelled to isotopic equilibrium with [^Hjinositol. In the case of bombesin, 
changes in Ins(l,4 ,5 )P3 mass have also been performed for a direct comparison 
with stimulated changes in DG mass (Chapter 4). The experiments describing 
changes in Ins(l,4 ,5 )P3 mass were performed as a collaboration with Drs Susan 
Palmer & Robin Plevin, Institute of Biochemistry, University of Glasgow.
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3.2 Results.
The kinetics of inositol phosphate generation in response to stimulation with 
a maximal dose of bombesin (617nM) were determined.
The results in Figure 3.1 show the time-course (a) and dose-response curve 
(b) for bombesin-stimulated accumulation of [^H]InsPt in the presence of lOmM 
LiCl. Since incubations were performed in the presence of lOmM LiCl the major 
labelled species would be InsP. Stimulation with bombesin resulted in 
accumulation of [^H]InsPt which was significant above control at 30 seconds (p= 
0.001) and rose rapidly over the first minute of stimulation. After one minute 
[^H]InsPt continued to accumulate but at a reduced rate (results from a single 
representative experiment: 0 to 1 minute, rate = 14,087 dpm min'*; 1 to 15 minutes, 
rate = 1,787 dpm min_1).The second, slower, rate of [^H]InsPt accumulation 
continued in a near linear fashion for up to 60 minutes (data not shown). The 
increase in bombesin-stimulated [^H]InsPt accumulation, based upon a 20 minute 
incubation, was dose dependent with a concentration required to give a half 
maximal increase (EC50) of 0.58 ± 0.34 nM (n=3 determinations in triplicate).
Swiss 3T3 cells, labelled to a higher specific activity with [^HJinositol (5 
jiCiml’ 1 in inositol-free DMEM) were used to study the kinetics of formation of 
[^H]InsP, [^H]InsP2 and [^H]InsP3 in the presence of lOmM LiCl (Figure 3.2 a- 
c). Stimulation with bombesin (617nM) resulted in rapid increases in [^Pf]InsP3 
and [^H]InsP2 both of which reached a maximum (3-fold and 7-fold) after 10 and 
20 seconds of stimulation respectively, before declining again (Figure 3.2 c & b). 
[^H]InsP3 levels were significantly above control after 10 sec (p= 0.086) and 
[^H]InsP2 levels were clearly significant at 20 sec, the time of maximal elevation 
(p= <0.001). [^H]InsP3 levels returned to control values by 5 minutes whereas 
[^H]InsP2 levels declined to a half maximal value and were maintained thus for 15 
minutes. The accumulation of [^HJInsP occurred at two distinct rates (Figure 
3.2a); rapidly from 0 to 1 minute (3,817 dpm min"*) and slower from 1 to 15 
minutes (489 dpm min"*) (values from a single experiment typical of three). 
Furthermore, [^HjlnsP levels were significantly above control after 5 sec (p=
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Figure 3.1 (a & b). Timecourse and dose-response curve for 
bombesin-stimulated total [3H]inositoI phosphate formation.
(a) Swiss 3T3 cells, labelled for 48 hours with ljiCi of [^H]inositol in 1 ml 
of inositol-free DMHM containing 1% calf serum, were washed in Hanks for 5 
minutes followed by HBG.Li for 20 min at 37°C before replacing with HBG.Li 
(□ ) or HBG.Li containing 617 nM bombesin (■ ) for the times indicated. 
Following extraction in chloroform/methanol total [^H]InsPt were assayed as 
described in the Methods section. Results are expressed as radioactivity associated 
with [3 H]InsPt (d.p.m.; mean ± S.D. (n=3)) from a single experiment, 
representative of five.
(b) Swiss 3T3 cells labelled for 48 hours with lfiCi of [^HJinositol in 1 ml 
of inositol-free DMEM were washed in Hanks for 5 min followed by HBG.Li for 
20 min at 37° C before replacing with HBG.Li containing the indicated final 
concentration of bombesin. After 20 min, incubations were terminated and 
[3 H]InsPt were assayed as described in Chapter 2. Results are expressed as 
radioactivity in [^H]InsPt (d.p.m.; mean ± S.D. (n=3)) from a single experiment, 
representative of three.
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Figure 3.2 (a-c). Timecourse of bombesin-stimulated increases in 
total (a) [3 H] InsP, (b) [3 H]InsP2 and (c) [3 H]InsP3 using a neutral 
extraction procedure.
Swiss 3T3 cells, labelled for 48 hours 5|iCi m H  of [^H]inositol in inositol- 
free DMEM containing 1% dialysed calf serum, were washed for 5 minutes in 
Hanks followed by 20 min in HBG.Li at 37° C. Incubations were started by 
replacing with HBG.Li (□) or HBG.Li containing 617 nM bombesin (■ ) and 
terminated at the times indicated by aspiration and addition of ice-cold methanol. 
Individual fractions of total [^H] InsP (a), [^H]InsP2 (b) and [^H]InsP3 (c) were 
isolated by ion-exchange chromatography as described in the Methods section and 
radioactivity was determined by liquid scintillation counting. The results are 
expressed as radioactivity in[^H]inositol phosphate fraction (d.p.m.; mean ± S.D. 
(n=3)) from a single experiment, representative of three.
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0.008).
Similar experiments were performed but an acid extraction procedure was 
employed to recover a greater proportion of L1SP3. Incubations were terminated by 
addition of ice-cold 10% (v/v) HCIO4 , the samples neutralized with KOH/Hepes 
and applied to Dowex formate ion-exchange columns for isolation of the [^H]InsP, 
[^H]InsP2 and [^H]Ins? 3  fractions (Fig 3.3 a-c)
In this instance, the increase in [3 H]InsP3 was much greater (typically 9- 
fold over control at maximum) and significant (p= 0.011) and maximal 5 sec after 
stimulation with bombesin before declining towards control at 30 sec. From 30 
seconds onwards [^H]InsP3 rose slightly for the remaining 5 min (Fig3.3c). The 
radioactivity associated with the [^H]InsP2 fraction was also significantly elevated 
above control at 5 seconds (p= 0.004), but was not maximal until after 30 sec or 1 
min of stimulation (Fig 3.3b) following which the [^H]InsP2 levels declined. The 
degree of this decline was variable; in one experiment [^H]InsP2 levels returned 
almost to basal values by 5 min whilst, generally, they declined to about two thirds 
of the maximal response and were maintained at this level for up to 5 min. The 
level of H]InsP (Fig 3.3a) rose rapidly from 0 to 1 minute (typically at a rate of 
82,618 dpm m in '1) being significantly elevated above control after 5 sec (p= 
0.014), but again the rise occurred more slowly between 1 and 5 min (typically 
21,804 dpm m in'1). These two distinct rates of InsP accumulation were similar to 
those previously described (Fig 3.1a & Fig 3.2a).
These results suggest that Insp3 was the primary product of bombesin- 
stimulated inositol lipid hydrolysis. Furthermore, the production of InsP3 was 
essentially transient; it was rapidly dephosphorylated to InsP2 and thence to InsP. 
However, measuring changes in total InsP3 provides limited information about 
what is happening to the levels of Ins(l,4 ,5 )P3 . The initial transient elevation of 
InsP3 was presumably Ins(l,4 ,5 )p3 (Heslop et al., 1986 and Takuwa et al., 
1987a), but the later, sustained elevation of InsP3 could represent an alternative 
isomer of InsP3 , Ins(l,3 ,4 )P3 , which is produced upon bombesin stimulation of 
Swiss 3T3 cells (Heslop et a l , 1986; Takuwa et al., 1987a).
81
Figure 3.3 (a-c). Timecourse of bombesin-stimulated increases in 
total (a) [3 H]InsP, (b) [3 H ]InsP 2  and (c) [3 H ]InsP 3  (c) using the 
perchloric acid extraction procedure.
Swiss 3T3 cells were grown on 24 well plates and labelled for 48 hours 
with 5 fiCi of [3 H]inositol in 1 ml of inositol-free DMEM containing 1% dialysed 
calf serum. Cells were washed in HBS and then incubated in HBG.Li for 20 
minutes at 37° C. Incubations were initiated by replacing the medium with either 
HBG.Li (□) or HBG.Li containing 617 nM bombesin (■ ) and terminated at the 
times indicated by aspiration and addition of ice-cold 10% (v/v) perchloric acid. 
Following extraction on ice and neutralization, (a) total [3H] InsP, (b) [3 H]InsP2 
and (c) [3 H]InsP3 were isolated by ion-exchange chromatography and the 
radioactivity associated with each fraction determined by liquid scintillation 
counting. Results are expressed as radioactivity in each [3 H]inositol phosphate 
fraction (d.p.m.; mean ± S.D. (n=3)) from a single experiment, representative of 
three.
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Since the primary purpose of studying inositol phosphate generation was to 
assess the overall contribution made by inositol lipids to the generation of DG 
mass, it was necessary to analyse the kinetics of Ins(l,4 ,5 )P3 generation. This 
was achieved by analysis of changes in Ins(l,4 ,5 )P3 mass using the Ins(l,4 ,5)P3 
binding assay. Samples, prepared from Swiss 3T3 cells stimulated with bombesin 
were assayed for Ins(l,4 ,5 )P3 mass by Dr Susan Palmer according to the detailed 
protocol of Palmer et al.(1989) and as outlined in Appendix I.
The results (Fig 3.4) show the kinetics of changes in Ins(l,4 ,5 )P3 mass in 
bombesin-stimulated Swiss 3T3 cells over 5 and 15 min timecourses. The level of 
Ins(l,4 ,5 )P3 rose rapidly to peak at 5 seconds, the first stimulated time point 
studied, at which they were 12.52 ± 4.02- fold above controls and significantly 
elevated (p=0.003). Thereafter, Ins(l,4,5)P3 mass quickly declined to pre­
stimulated levels by 30 seconds and remained thus for up to 15 minutes with no 
further net increase. These results confirmed that, in mass terms, the bombesin- 
stimulated increase in Ins(l,4 ,5)P3 was rapid in onset and transient. The elevation 
of Ins(l,4 ,5 )P3 mass by bombesin was dose-dependent (Fig. 3.5) with half- 
maximal increases occurring at doses of 5.88 ± 3.66 nM (n=3 determinations in 
triplicate). (Normalisation of Ins(l,4 ,5 )P3 mass to mol/10^ cells revealed that 
bombesin stimulated a peak elevation of 27.52 ± 3.8 pmoles/10^ cells at 5 seconds 
from a basal of.2.33 ± 0.7 pmoles/106 cells; mean of 3 experiments).
It has been proposed that bombesin-stimulated generation of DG in Swiss 
3T3 cells leads to a protein kinase C-mediated inhibition of PtdIns(4 ,5 )P2 
hydrolysis and that this may serve to limit the response in vivo (Brown et al., 
1987). This can be mimicked in cultured cells by pre-treating with C-kinase 
activating phorbol esters, such as PM A, for 10 or 15 minutes resulting in the 
inhibition of subsequent bombesin-stimulated inositol phosphate generation. The 
effect of PMA is absent in cells which have been pre-treated with supra-maximal 
doses of PMA for 48 hours to 'down-regulate' protein kinase C (Brown et al., 
1987).
The effects of acute PMA pre-treatment upon agonist-stimulated [^H]InsPt
8 3

Figure 3.4. Tim ecourse of bom besin-stim ulated increases in 
In s(l,4 ,5 )P 3  mass.
Swiss 3T3 cells were grown to confluence and quiescence in 15cn?  flasks 
and harvested mechanically in their own conditioned medium at 37° C. Harvested 
cells were maintained in suspension at 37° C for 45 minutes to recover from 
scraping before being washed twice in HBG; cells were resuspended to a final 
density of approximately 2 x 107 cells m l'1. Incubations were started by addition 
of 50pl of cell suspension to 25pl aliquots of HBG (□ ) or HBG containing 
bombesin (■ ) at a final concentration of 617 nM. Incubations, at 37° C, were 
terminated at the indicated times by addition of 25|il of ice-cold 10% perchloric acid 
and vortexing. After extraction on ice for 20 min samples were neutralised and 
Ins(l,4,5)P3 mass was assayed using the competition binding assay of Palmer et 
a l (1989) (Appendix I). In addition an aliquot of cell suspension was taken for 
cell number determination. Results are expressed as pmoles of Ins(l,4,5)P3/10^ 
cells, mean ± S.D. (n=3) from a single experiment, representative of three.
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Figure 3.5. Dose-response curve for bombesin-stimulated increases 
in Ins(l,4,5)P3 mass.
Swiss 3T3 cells, grown to confluence and quiescence, were harvested 
mechanically and incubated in suspension in their own depleted growth medium for 
45 min at 37° C. Following two washes in HBG at 37° C cells were resuspended in 
HBG at approximately 2 x 10^ cells ml'*. Incubations were started by adding 50jil 
aliquots of cell suspension to 25}il of bombesin, giving the final concentrations 
indicated, and terminated after 5 sec by addition of 25|il of ice-cold 10% perchloric 
acid with vortexing. Following neutralisation samples were assayed for 
Ins(l,4 ,5 )P3 mass using the competition binding assay of Palmer et al. (1989) 
(Appendix I). In addition an aliquot of cell suspension was taken for a cell number 
determination. Results are expressed as pmoles of Ins(l,4 ,5 )P3 / 10^ cells, mean ± 
S.D. (n=3) from a single experiment, representative of three.
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generation were examined in an effort to define some mechanistic aspects of the 
coupling of receptors to the activation of PIC. In addition to bombesin, 
[Arg^]vasopressin ([Arg^JVp) and prostaglandin F2 a  (PGF2 a ) were employed. 
These latter two agonists are also co-mitogenic for the Swiss 3T3 cell line (Corps 
et al., 1985; MacPhee et al., 1985) and are reported to stimulate inositol lipid 
hydrolysis in a manner similar to bombesin (Nanberg & Rozengurt, 1988; Black & 
Wakelam, 1990). Since all three agents stimulate inositol phosphate generation by 
a similar mechanism the following studies employed accumulation of total inositol 
phosphates ([^H]InsPt) in the presence of lOmM LiCl as a measure of receptor- 
mediated inositol lipid hydrolysis.
Figure 3.6 (a-c) shows the dose-response curves for [^H]InsPt 
accumulation in Swiss 3T3 cells stimulated for 20 min with bombesin, [Arg^]Vp 
and PGF2 a , respectively. In the case of bombesin and [Arg^JVp, this was 
performed with or without a 15 min pre-treatment with 400nM PMA as indicated in 
the legend. Each mitogen stimulated a dose-dependent accumulation of [^H]InsPt 
with EC50  values of 0.58 ± 0.34 nM for bombesin (n=3), 0.48 ± 0.15 nM for 
[Arg^JVp (n=3) and 0.16 ± 0.14 jiM for PGF2 a  (n=4). Pre-treatment of Swiss 
3T3 cells with 400 nM PMA inhibited each agonist-stimulated response by some 
50% (Fig 3.6 a & b; Fig 3.8 c). In addition, pre-treatment with PMA resulted in a 
rightward shift of the dose-response curves to bombesin and [Arg^JVp giving new 
EC50  values of 4.4 ± 4.5nM (n=2 determinations) and 1.12 ± 0.52nM (n=2 
determinations) respectively.
The PMA mediated inhibition of agonist-stimulated [^H]InsPt accumulation 
was time- and dose-dependent. Figure 3.7 shows the time course of the effect of 
PMA pre-treatment on subsequent bombesin-stimulated [^H]InsPt accumulation. 
There was a lag of approximately 1 min before the onset of inhibition, whilst 
maximal inhibition was attained from 5 min onwards. The vehicle (0.1% DMSO) 
containing p-phorbol was without any apparent effect upon bombesin stimulated 
[^H]InsPt accumulation.
Figure 3.8 (a-c) shows the dose-response curves for PMA-mediated 
inhibition of subsequent [^H]InsPt accumulation stimulated by bombesin,
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Figure 3.6 (a & b). Dose-response curves for (a) bombesin- and (b) 
[Arg8]vasopressin-stimulated total [^H]inositol phosphate formation 
in control and PMA-pretreated(15 min) Swiss 3T3 cells.
Swiss 3T3 cells, labelled for 48 hours with lpCi of [^H]inositol in 1ml of 
inositol-free DMHM containing 1% calf serum, were washed in Hanks for 5 min 
and then HBG.Li containing 0.1% DMSO (□) or 400 nM PMA in DMSO (■) for 
15 minutes at 37° C. Incubations were started by replacing with HBG.Li 
containing the indicated concentrations of bombesin (a) or [Arg8]vasopressin (b) 
and continued at 37° C for 20 minutes. Incubations were terminated by aspiration 
and addition of ice-cold methanol and formation of [^H]InsPt was assayed as 
described in Chapter 2. Results are expressed as radioactivity in [^H]InsPt 
(d.p.m., mean ± S.D. (n=3)) from a single experiment, representative of three.
Figure 3.6 (c). Dose-response curve for prostaglandin F2 a - 
stimulated total [3H]inositol phosphate formation in Swiss 3T3 cells.
Swiss 3T3 cells, labelled with lpCi of [^H]inositol in 1 ml of inositol-free 
DMEM containing 1% serum were washed in Hanks for 5 min followed by 
HBG.Li for 15 min at 37°C. Incubations were started by replacing with HBG.Li 
containing the indicated final concentrations of PGF2 a  and continued for 2 0  
minutes before aspiration and addition of ice-cold methanol. [^H]InsPt formation 
was assayed as described in the Methods section. Results are expressed as 
radioactivity in [^H]InsPt (d.p.m., mean ± S.D. (n=3)) from a single experiment, 
representative of four.
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Figure 3.7. Tim ecourse for inhibition of bom besin-stim ulated  
[^H]InsPt formation by 400nM PMA.
Swiss 3T3 cells were labelled with ljiCi of [^Hjinositol in 1ml of inositol- 
free DMEM containing 1% calf serum for 48 hours. Following a 5 min wash in 
Hanks cells were washed in HBG.Li for the times indicated either in the presence 
of 0.1% DMSO (□) or 400nM PMA in DMSO (■). After this pre-incubation 
period bombesin was added to give a final concentration of 617nM and incubations 
were continued for a further 20 min. Incubations were terminated by aspiration and 
addition of ice-cold methanol and [^H]InsPt formation was assayed as described in 
the Methods section. Results are expressed as radioactivity in [^H]InsPt (d.p.m., 
mean ± S.D. (n=3)) from a single experiment, representative of two.
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Figure 3.8 (a-c). Dose-response curves for PMA-mediated inhibition 
of (a) bombesin, (b) [Arg8 ]Vp and (c) PGF2(X-stimuIated [^H]InsPt 
formation in Swiss 3T3 cells.
Swiss 3T3 cells were labelled with ljiCi of [^H]inositol in 1ml of inositol- 
free DMEM containing 1% calf serum for 48 hours. After washing with Hanks for 
5 min, cells were incubated in HBG.Li containing the indicated concentration of 
PMA for 15 min at 37° C. Incubations were initiated by adding mitogens to a final 
concentration of 617 nM bombesin (a), lOOnM [Arg8]Vp (b) or 2pM PGF2 a  (c) 
and incubating at 37°C for a further 20 min. After aspiration and addition of ice- 
cold methanol [^H]InsPt was assayed as described in the methods section. The 
results are expressed as radioactivity in [^H]InsPt (d.p.m., mean ± S.D. (n=3)) 
from a single experiment, representative of three in each case. The basal, 
unstimulated level of radioactivity associated with [^H]InsPt was 4997 ± 1 072  
d.p.m. for bombesin, 2566 ± 829 d.p.m. for [Arg8]Vp and 2722 ±151 d.p.m. for
p g f 2(X.
Figure 3.8 (d). Comparison of the effect of PMA and P -p h o rb o l 
upon bombesin-stimulated [^H JInsPj accumulation in Swiss 3T3 
ce lls .
Swiss 3T3 cells were labelled with ljiCi of [^H]inositol in 1ml of inositol- 
free DMEM containing 1% calf serum for 48 hours. After washing with Hanks for 
5 min, cells were washed in HBG.Li containing the indicated concentration of PMA 
(■ ) or P-phorbol (□) for 15 min at 37° C. Incubations were initiated by adding 
bombesin to a final concentration of 617 nM. After 20 min incubations were 
terminated by aspiration and addition of ice-cold methanol and [^H]InsPt was 
assayed as described in the Methods section. The results, radioactivity in 
[^H]InsPt (d.p.m., mean ± S.D. (n=3)), are expressed as percent of maximum 
response and are from a single experiment, representative of three in each case.
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[Arg8]Vp and PGF2 a , respectively. Typically a 50% inhibition of each response 
was observed with the IC5Q value for PMA being similar for each agonist 
(bombesin, 5.58 ± 3.84 nM (n=3); [Arg8 ]Vp, 2.36 ± 1.68 nM (n=3); PGF2ct, 
2.16 ± 0.52 nM (n=3)). These results suggest a common element in the 
mechanism of coupling of the receptors for bombesin, [Arg8]Vp and PGF2 a  to 
PIC. Pre-treatment of Swiss 3T3 cells with increasing doses of P-phorbol (Fig 
3.8d) did not result in a dose-dependent inhibition of bombesin-stimulated 
[^H]InsPt accumulation.
To further investigate the role of protein kinase C in phorbol ester-mediated 
inhibition of agonist-stimulated [^H]InsPt accumulation, the effects of acute pre­
treatment with PMA were compared in normal and PKC down-regulated Swiss 3T3 
cells (pre-treated with 400nM PMA for 48 hours to deplete cellular protein kinase C 
activity (Rodriguez-Pena & Rozengurt, 1984)). Figure 3.9 illustrates that PMA 
alone did not significantly elevate [^H]InsPt accumulation in the presence of lOmM 
LiCl over a 20 min incubation in either control or PKC down-regulated cells. 
Furthermore, bombesin, [Arg8]Vp and PGF2(X-stimulated [^H]InsPt accumulation 
in the control cells was not inhibited by down-regulation of PKC. To the contrary, 
the responses to all three mitogens were reproducibly enhanced in the down- 
regulated cells (the significance of enhancement of each response in the down- 
regulated compared to the 'control’cells was: bombesin, p=0.021; [Arg8 ]Vp, 
p<0.001; PGF2 a , p<0.001). The degree of enhancement of responses varied for 
each mitogen in the down-regulated cells. Thus, PGF2 a  showed the greatest 
enhancement (typically 2.5- 3.2-fold) followed by [Arg8]Vp ( 2.2- 2.5-fold 
enhancement) and, finally, bombesin (1.2- 1.5-fold enhancement). Interestingly, 
the degree of enhancement in the down-regulated cells was inversely proportional to 
the magnitude of the response in the control cells. Thus, PGF2 a , which exhibited 
the greatest enhancement in down-regulated cells gave the smallest response in 
control cells, whilst bombesin exhibited much smaller enhancement in the down- 
regulated cells but showed the biggest response in the control cells. The magnitude 
of responses in the control cells was also reflected in the degree of depletion of
9 0
Figure 3.9. Effect of chronic pre-treatment with 400nM PMA upon 
mitogen-stimulated [3 H]InsPt formation in Swiss 3T3 cells.
Swiss 3T3 cells were labelled with ljiCi of [3 H]inositol in 1ml of inositol- 
free DMEM containing 1% calf serum for 48 hours in the presence of 400nM PMA 
(hatched bars) or P-phorbol (open bars). After washing in Hanks for 5 min cells 
were incubated in HBG.Li for 15 min at 37°C before replacing with HBG.Li alone 
or containing bombesin (lOOnM), [Arg^JVp (lOOnM), PGF2 a  (2|iM) or PMA 
(lOOnM). After 20 min medium was aspirated and ice-cold methanol added to 
quench the incubations. [3 H]InsPt was assayed as described in the methods 
section. Results are expressed as radioactivity in [3 H]InsPt (d.p.m., mean ± S.D. 
(n=3)) from a single experiment, representative of three.
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Table 3.1. The effect of agonist stimulation on the radioactivity 
associated with total InsPt and inositol lipids in the presence of 
lOmM LiCl.
Swiss 3T3 cells, labelled for 48 hours with [^HJinositol, were stimulated for 
20 minutes with the indicated agonist, or control, in HBG containing lOmM LiCl. 
Following extraction and removal of total inositol phosphates in the 
aqueous/methanolic phase, the chloroform phase was dried down in vacuo. 
Radioactivity associated with total inositol phosphates was assayed as previously 
described in the Methods section. The radioactivity associated with total inositol 
lipids was determined by liquid scintillation counting after addition of 4mls of Opti 
phase Hi-safe scintillant cocktail. Results are means of radioactivity in inositol 
phosphates or inositol lipids (d.p.m.) ± S.D. (n=3) from a single experiment, 
representative of three.
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In sP t (d .p .m .).
radioactivity in 
Ins lipids (d.p.m.).
Control
bombesin (lOOnM) 
[Arg8]Vp (lOOnM) 
PGF2(X (lpM)
5,211 ±2,259 
90,142 ± 4,736 
60,246 ±812 
20,961 ± 1,924
130,714 ±8,774 
70,120 ±3,239 
107,748 ± 10,859 
136,826 ± 8,123
Figure 3.10. Effect of chronic pre-treatment with 400nM PMA on 
the ability of acute PMA treatment to inhibit mitogen-stimulated 
[3 H]InsPt accumulation in Swiss 3T3 cells.
Swiss 3T3 cells were labelled with ljiCi of [^H]inositol in 1ml of inositol- 
free DMEM containing 1% calf serum for 48 hours in the presence of 400nM PMA 
(hatched bars) or p-phorbol (open bars). Cells were then washed in Hanks for 5 
min before incubating in HBG.Li for 15min at 37°C in the presence or absence of 
400nM PMA as indicated. Incubations were started by the addition of bombesin 
(lOOnM), [Arg^JVp (lOOnM) or PGF2 a  (2|iM) and were terminated after 20 min 
by addition of ice-cold methanol. [^H]InsPt was assayed as described in the 
methods section. Results are expressed as radioactivity in [^H]InsPt (d.p.m., 
mean ± S.D. (n=3)) from a single experiment, representative of three.
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radioactivity from total inositol lipids after a 2 0  minute stimulation in the presence 
of lOmM LiCl (Table 3.1).
Finally, acute PMA pre-treatment was without effect upon mitogen- 
stimulated [^H]InsPt accumulation in PKC down-regulated cells (Figure 3.10). 
For example, in down-regulated cells pre-treated for 15 min with vehicle, InsPt 
accumulation after a 20 minute stimulation in the presence of lOmM LiCl was 
80,451 ± 2716 dpm for bombesin, 80,112 ± 3134 dpm for [Arg^JVp and 60,255 ± 
1703 dpm for PGF2 a  whilst in down-regulated cells, pre-treated with 400nM PMA 
for 15 minutes, the values were 82,619 ± 3334 dpm, 83,002 ± 2620 dpm and 
61,603 ± 4482 dpm respectively; the basal value was 9,436 ± 488 dpm (values 
from a single experiment representative of three). The loss of the acute effects of 
PMA in the down-regulated cells was consistent with the removal of an inhibitory 
or limiting component, i.e., C-kinase.
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3.3 Discussion.
The results presented in this chapter allow three major conclusions to be 
reached:
(1) The accumulation of the Ca? +-mobilizing second messenger Ins(l,4 ,5)P3 in 
bombesin-stimulated Swiss 3T3 cells is essentially transient and the response may 
be rapidly, though incompletely, desensitized.
(2) Acute pre-treatment of Swiss 3T3 cells with PMA, a potent activator of protein 
kinase C, to Swiss 3T3 cells does not stimulate the hydrolysis of inositol lipids or 
the accumulation of InsPt but, rather, inhibits these responses suggesting a 
negative, regulatory role for PKC in activation of PIC by bombesin. This effect is 
absent in PKC down-regulated cells.
(3) Bombesin, [Arg^JVp and PGF2 a  are functionally related in their ability to 
stimulate inositol lipid hydrolysis and InsPt accumulation as defined by their 
sensitivity to acute and chronic phorbol ester treatment.
3.3.1 Transient accum ulation of Ins(l,4 ,5 )P 3  in bombesin- 
stimulated Swiss 3T3 fibroblasts.
It has previously been shown that bombesin stimulates inositol lipid 
turnover in Swiss 3T3 cells by stimulating the PIC-catalysed hydrolysis of 
PtdIns(4,5)P2 to generate Ins(l,4 ,5 )P3 (Heslop et al., 1986, Takuwa et al., 
1987a). The coupling of ligand-activated receptors to the activation of PIC is 
thought to occur through the activation of a guanine nucleotide regulatory protein 
(Gp; Cockcroft, 1987). Both bombesin-stimulated Ins(l,4 ,5 )P3 and InsPt 
accumulation are greatly potentiated by GTPyS in electro-permeabilized Swiss 3T3 
cells and the onset of Ins?3  formation is much more rapid in the presence of 
GTPyS suggesting that receptor-stimulated guanine nucleotide exchange is a rate 
limiting component in the response fPlevin et al., 1990). Furthermore, events 
downstream of inositol lipid hydrolysis such as PKC-mediated phosphorylation of 
an 80 kDa protein are also modulated by guanine nucleotides (Erusalimsky et al., 
1988).
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The initial product of bombesin-stimulated inositol lipid hydrolysis was 
InsP3 when measured by radiochemical assay (Figs. 3.2c and 3.3c). Mass assay 
(Fig. 3.4) demonstrated that the initial product was indeed Ins(l,4 ,5 )P3 confirming 
the h.p.l.c. analysis performed by Heslop et al. (1986) and Takuwa et al. (1987a) 
which identified [^H]Ins(l,4 ,5 )P3 as the earliest product of bombesin-stimulated 
inositol lipid hydrolysis in [^H]inositol labelled Swiss 3T3 cells. The onset of the 
response was rapid being maximal at 5 sec (Figs. 3.3c & 3.4), the earliest time 
point tested.
Both radiochemical assays (Figs. 3.2c & 3.3c) yielded essentially the same 
kinetics of [^H]InsP3 formation; namely that [^H]InsP3 formation was maximal 
within 5 or 10 sec. However, in quantitative terms the magnitude of the response 
was quite different and this may be due to the different extraction techniques 
employed. When samples were extracted in methanol the magnitude of the 
response (typically 3-fold) was much smaller than that using the perchloric acid 
extraction technique (9-fold over control) and Ins(l,4 ,5)P3 mass (12-fold over 
control). This discrepancy may reflect the poorer extraction of higher 
phosphorylated forms of inositol in chloroform-methanol (Wregget et al., 1987; 
reviewed by Palmer & Wakelam, 1989) and may also explain the slightly slower 
onset of InsP3 formation using the methanol extraction (Fig. 3.2c) as opposed to 
the perchloric acid extraction (Fig. 3.3c & 3.4). The original reason for using a 
neutral methanol extraction was to allow [3H]InsP3 and DG mass formation to be 
assayed from the same samples; the preparation of samples for DG mass analysis 
must be performed under neutral conditions (Preiss et al., 1986). However, the 
differences in magnitude of pH]InsP3 formation indicates that increases in InsP3 
would be greatly underestimated under these conditions and the two second 
messengers were therefore assayed from separate experiments under different 
extraction conditions.
Despite these differences in magnitude, all experiments revealed a similar 
qualitative time course of Insp3 formation. Thus, the onset of InsP3 formation was 
extremely rapid but this increase was essentially transient. The rapid decline in
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[^H]InsP3 levels after 5 seconds stimulation with bombesin probably represents 
Ins(l,4 ,5 )P3 -5 'phosphatase activity. This is reflected in the rapid elevation of 
[^H]InsP2 levels which were significant above control at 5 seconds and continued 
to rise, peaking at between 30 sec and 1 min (Fig 3.2b) or 2 min (Fig 3.3b) 
stimulation. [^H]InsP2 levels declined towards 5 minutes (Fig 3.3b) to between 50 
and 75% of the peak response and were maintained at this level up to 15 minutes 
(Fig 3.2b). The rapid elevation in [^H]InsP3 and [^H]InsP2 levels was also 
reflected in [^HjlnsP levels which were significantly elevated above control after 5 
seconds stimulation with bombesin and these results are consistent with InsP being 
derived from the rapid sequential dephosphorylation of InsP3 via InsP2 . In such a 
scenario the apparent new 'steady state1 of InsP2 levels between 5 and 15 minutes 
presumably reflects the input of InsP3 de-phosphorylation and the output to InsP 
being nearly equal.
The decline in Ins(l,4 ,5)P3 levels from 5 sec may also be due, in part, to 
phosphorylation of Ins(l,4 ,5 )P3 by a specific 3' kinase to yield Ins(l,3 ,4 ,5 )P4 
(Batty et al., 1985). Consistent with this is the report of increases in 
[^H]Ins(l,3 ,4 ,5 )P4 in bombesin-stimulated, [^H]inositol labelled Swiss 3T3 cells 
(Heslop et al., 1986). In some experiments, under perchloric acid extraction 
conditions, small increases in total [^H]InsP4 were seen in response to bombesin 
though these were not reproducible (data not shown). This probably reflects the 
poor sensitivity of radiochemical assays since mass measurement of Ins( 1,3,4,5 )P4 
reveals much greater increases than [^H]Ins(l,3 ,4 ,5 )P4 in carbachol-stimulated 
bovine tracheal smooth muscle (Chilvers et al., 1990a; 1990b) and in carbachol- 
stimulated SH-SY5Y neuroblastoma cells (Lambert eta l., 1991).
There was one clear discrepancy between the time course of [^H]InsP3 and 
Ins(l,4 ,5 )P3 mass, under identical extraction conditions. Bombesin-stimulated 
increases in [^H]InsP3 declined from 5 sec but were clearly sustained 4-fold above 
control from 30 sec up to 5 min (fig 3.3c), whereas Ins(l,4,5)P3 mass declined 
from 5 sec to pre-stimulated levels at 30 sec after which there was no further net 
increase up to 15 min (Fig 3.4). Whilst the mass assay is selective for 
Ins(l,4 ,5 )P3 (Palmer et al., 1989) the [^H]InsP3 fraction from a Dowex formate
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column will contain other isomers of I11SP3 in addition to Ins(l,4 ,5 )P3 . The 
phosphorylation of Ins(l,4 ,5 )p3 by a 3'-kinase to yield Ins(l,3 ,4 ,5 )P4 followed 
by its subsequent de-phosphorylation by a 5'-phosphatase will yield Ins(l,3 ,4 )P3 
(Batty et al., 1985; Irvine et al., 1986). Such a sequence of events is likely to 
account for the slower and sustained rise in total [^H]InsP3 » w^ich is not due to 
Ins(l,4 ,5 )P3 (Fig. 3.4), and is confirmed by the observation that [^H]Ins(l,3 ,4 )P3 
levels do indeed rise in bombesin-stimulated Swiss 3T3 cells over a time course 
consistent with their contributing to the sustained elevation of total [^H]InsP3 
(Heslop et al., 1986; Takuwa et al., 1987a). In particular Takuwa et al. (1987a) 
in super-imposing the time course of bombesin-stimulated increases in 
[^H]Ins(l,4 ,5 )P3 and [^H]Ins(l,3 ,4 )P3 derive a time course which is very similar 
to that for total [^H]InsP3 in Fig. 3.3c, suggesting that the sustained elevation is 
due to the coupled activity of 3'-kinase and 5-phosphatase.
The rapid increase in [^H]InsP3 and particularly Ins(l,4 ,5 )P3 mass 
compares favourably with the time course of increases in [Ca2+]j stimulated by 
bombesin. Lopez-Rivas et al. (1987) have shown that upon addition of bombesin 
to quiescent Swiss 3T3 cells, elevations in [Ca2+]j were apparent without any 
measureable delay whilst peak values were attained 17 ± 1.1 seconds after addition. 
Similar results were obtained in bombesin-stimulated WFB rat fibroblasts 
(Hasegawa-Sasaki et al, 1988). Since elevation of Ins(l,4 ,5 )P3 would be 
required to precede increases in [Ca2+]j for it to be responsible for those increases 
the time course for increases in Ins(l,4 ,5 )P3 is consistent with its role as a Ca2+- 
mobilizing second messenger; indeed Ins(l,4 ,5 )P3 has been shown to stimulate 
Ca2+ release from permeabilized Swiss 3T3 cells (Berridge et al., 1984). These 
observations are entirely consistent with the hypothesis that Ins(l,4 ,5 )P3 is an 
intracellular messenger which stimulates the release of intracellular stores of Ca2+ 
into the cytoplasm as originally proposed by Streb et al. (1983). However, the 
elevation of [Ca2+]j by bombesin is transient and quickly declines to leave a 
smaller, more sustained elevation which is dependent on extracellular [Ca2+] 
(Lopez-Rivas et al., 1987; Hesketh et al., 1988; Hasegawa-Sasaki et al., 1988).
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The rapid decline in Ins(l,4 ,5 )P3 levels is consistent with both the transient 
bombesin-stimulated Ca2+ ’spike1 seen in Swiss 3T3 cells (Lopez-Rivas et al., 
1987) and the rapid elevation of [^lJnsP2 and [^H]InsP levels. Thus removal of 
Ins(l,4 ,5 )P3 by the 5’-phosphatase or 3'-kinase, will serve to terminate the 
physiological response (Ca2+-mobilization from intracellular stores) and will 
account for the elevation of [^H]InsP2 levels.
The 3 '-kinase pathway will also contribute to the rapid decline in 
Ins(l,4 ,5 )P3 levels and termination of Ca2+ release from intracellular stores and 
this may be enhanced by the activation of Ins(l,4 ,5)P3 3'-kinase by Ca2+ and, in 
some tissues calmodulin, as reported for the brain enzyme (Biden et al., 1987; 
Morris et al., 1987). In addition the rapid phosphorylation of Ins(l,4 ,5 )P3 to 
Ins(l,3 ,4 ,5 )P4 may result in the generation of a further biologically active second 
messenger derived from inositol lipid hydrolysis. It has been proposed that 
Ins(l,3 ,4 ,5 )P4 may play a role in the entry of Ca2+ across the plasma membrane 
accounting for the smaller, sustained elevation of [Ca2+]j seen in response to a 
variety of agonists (reviewed by Irvine, 1990).
The transient nature of bombesin-stimulated increases in [Ca2+]j would 
require that Ins(l,4 ,5 )P3 be removed rapidly, which seems to be the case (Fig 3.4), 
or that bombesin-stimulated PtdIns(4 ,5)P2 hydrolysis be desensitized. The results 
in Figure 3.1 suggest that bombesin-stimulated [^H]InsPt accumulation occurred at 
two distinct rates. The initial rate of [^H]InsPt accumulation from 0 to 1 min was 
nearly 8-fold greater than that over the period from 1 to 15 minutes, suggesting that 
the response was quickly desensitized. The results in Figure 3.2a and 3.3a show 
that, in the presence of lOmM LiCl, accumulation of [^H]InsP occurred at two 
distinct rates in all experiments performed. The initial rate of increase in [^HjlnsP 
from 0-1 minute was between 4- and 9-fold greater than the rate of accumulation 
from 1-5 (Fig3.3a) or l-15minutes (Fig 3.2a) respectively. Since Ins(l,4 ,5 )P3 has 
been identified as the initial product of bombesin-stimulated inositol lipid hydrolysis 
and LiCl allows the accumulation of InsP derived from the dephosphorylation of 
that Ins(l,4 ,5 )P3 , the rate of [^HJInsP accumulation will reflect the rate of
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PtdIns(4,5)P2 hydrolysis assuming that the rates of Ins(l,4 ,5 )P3 and Ins(l,4 )P2 
de-phosphorylation are not limiting in stimulated cells. Indeed, the rapid decline in 
peak [^HJInsPg levels and the elevation of [^HJInsP at 5 seconds suggests that 
these steps occur at a very high rate whilst the high activity of Ins( 1,4,5^ 3 -5 ’- 
phosphatase is well documented in a variety of cells (reviewed by Shears, 1989). 
If Ins(l,4 ,5 )P3 de-phosphorylation is not limiting then the change in rate of 
accumulation of [^HJInsP (and [^H]InsPt in Fig. 3.1a) may reflect some sort of 
feedback inhibition and/or desensitization of PtdIns(4,5)P2 hydrolysis. That 
PtdIns(4,5)P2 hydrolysis is indeed desensitized is supported by work from this 
laboratory showing that following removal of an initial dose of bombesin to Swiss 
3T3 cells and washing, cells are desensitized to a second dose of bombesin within 
30 seconds of the original dose (S. Palmer, R. Plevin & M.J.O. Wakelam, 
personal communication). Quite what the mechanism of this desensitization event 
is remains unclear but it continues to operate in cells in which PKC activity has 
been down regulated and is unaffected by PKC inhibitors or acute pre-treatment 
with phorbol esters suggesting that it is not mediated by PKC.
It is proposed that the initial, rapid rise in [^H]InsPt , [^H]InsP and 
[^H]InsP2 reflects the rapid formation and subsequent metabolism of Ins(l,4 ,5)P3 
upon addition of bombesin, whilst the slower rate may represent a partially 
desensitized, but continued, hydrolysis of PtdIns(4,5)P2 . No evidence is 
presented to support or discount a role for Ptdlns hydrolysis in the rapid 
accumulation of [^HJInsP in the presence of LiCl. The significant increase in both 
[3H]InsP and [^H]InsP2 at 5 seconds, also seen by Takuwa et al. (1987a), is very 
fast compared with the responses in some cells such as bradykinin-stimulated 
NG105-40IL cells (Jackson et al., 1987) and might argue in favour of hydrolysis 
of either Ptdlns or PtdlnsP. However, it seems unlikely that this rapid elevation of 
[^H]InsP and [^H]InsP2 is due to [^HJPtdlns or [^HJPtdlnsP hydrolysis in Swiss 
3T3 cells since Takuwa et al. (1987a) have shown quite clearly that there was no 
significant loss of radioactivity from Ptdlns until the loss from PtdInsP2 had 
reached maximum and PtdInsP2 levels were beginning to recover. Since levels of 
PtdlnsP remained constant throughout the time course these results suggest that
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bombesin-stimulated PIC activation leads to the hydrolysis of PtdIns(4 ,5)P2 which 
is replenished by conversion of Ptdlns to PtdlnsP and then to PtdIns(4 ,5 )P2 - 
Consequently, there seems no need to propose any other explanation for the early 
increases in [^H]InsP and [^H]InsP2 other than the rapid, sequential, 
dephosphorylation of Ins(l,4 ,5 )P3 .
In contrast the later and sustained accumulation of [^H]InsPt and [^HjlnsP, 
albeit at a reduced rate, may be due to continued PtdIns(4,5)P2 hydrolysis or the 
later initiation of Ptdlns hydrolysis (Imai & Gershengom, 1986). The observation 
that [3 H]InsP2 levels appeared to reach a new ’steady state’ between 5 and 15 
minutes supports the notion of a continued net flux from InsP3 to InsP2 and then to 
InsP in cells continually stimulated with bombesin. From 30 seconds onwards to 5 
(Fig 3.4 main) and 15 minutes (Fig 3.4 inset) there was no further net increase in 
Ins(l,4 ,5 )P3 mass above the pre-stimulated level. It is likely that this represents 
both the desensitization described above and also the possibility that 5'-phosphatase 
and 3'-kinase activity may be so high that the effective half life of newly produced 
Ins(l,4 ,5 )P3 will be negligible; if so it may not accumulate to levels sufficient to 
monitor. This continued formation of Ins(l,4 ,5 )P3 and its rapid de­
phosphorylation might account for the continued, though slower, accumulation of 
[^HJInsP and [^H ]InsPt from 1 minute onwards (Fig. 3.1a, 3.2a & 3.3a). 
Alternatively, Imai & Gershengorn (1986) have provided evidence for TRH- 
stimulated Ptdlns hydrolysis in GH3 pituitary cells which occurs after the transient 
hydrolysis of PtdIns(4 ,5)P2 is complete, and is sustained for at least 30 min. Thus 
it is possible that the sustained accumulation of [3H]InsP may represent either a 
desensitized rate of Ptdlns(4 ,5 )p2 or Ptdlns hydrolysis and future studies should 
aim to assess which is the major source.
The dose-response curve for bombesin-stimulated increases in Ins(l,4 ,5 )P3 
mass (Fig 3.5) generated an EC5g of 5.88 ± 3.66 nM (n=3); this value is slightly 
greater than that for accumulation of [^H]InsPt (EC5 q= 0.58 ± 0.34 nM). The 
anomaly between these two values may simply reflect the errors associated with 
performing a dose-response curve for a 5 sec stimulus (Ins(l,4 ,5 )P3 mass) as 
compared with a 20 min stimulus for [^H]InsPt . Furthermore, Ins(l,4 ,5 )P3 levels
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at 5 seconds will be a composite of formation and breakdown rates whilst 
[^H]InsPt levels will be a much more sensitive assay by virtue of the inhibition of 
InsP phosphatases by LiCl allowing accumulation of all inositol moieties produced 
upon stimulation of PtdIns(4 ,5 )P2 hydrolysis. In the former case even a small 
error will be greatly amplified by minute variations in start-stop times. Despite this 
the EC50 value quoted for Ins(l,4 ,5 )P3 mass elevation agrees well with various 
parameters previously described for Swiss 3T3 cells including the IC5q for 
bombesin-stimulated inhibition of specific ^ I -G R P  binding to cell membranes 
(1.5 nM, Sinnett-Smith et al., 1990), bombesin-stimulated Ca2+ mobilization (1-2 
nM, Lopez-Rivas et al., 1987) and bombesin-stimulated phosphorylation of an 
80kDa protein kinase C substrate (4 nM, Erusalimsky et al., 1988).
3.3.2 Activation of protein kinase C, by administration of PMA, 
inhibits bombesin-stimulated inositol lipid hydrolysis.
A number of studies have reported sustained elevations of DG in response 
to a variety of agonists (rerviewed by Billah & Anthes, 1990). Typical of these, 
Griendling et al. (1986) reported sustained elevation of [^H]DG in response to 
angiotensin II in VSMC labelled with [^HJarachidonic acid. Since the sustained 
phase of DG elevation was kinetically downstream of InsP3 formation and was 
accompanied by a sustained depletion of [^HJPtdlns they suggested that Ptdlns was 
the source of sustained DG elevation. They proposed that DG produced from the 
primary PtdIns(4 ,5 )P2 hydrolysis would act, via PKC, to switch from 
PtdIns(4,5)P2 to Ptdlns hydrolysis and showed that addition of PMA to mimic DG 
resulted in the inhibition of InsP3 formation without inhibiting the sustained phase 
of DG elevation. The logical extension of such a model is that addition of PMA to 
cells would result in the elevation of DG and InsP by stimulating Ptdlns hydrolysis. 
However there is no evidence to date, in any eukaryotic system, that activation of 
PKC by addition of PMA or DG analogues actually stimulates inositol lipid 
hydrolysis. In contrast there is evidence from a number of sources to suggest that
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addition of PMA or DG analogues to cells does result in an increase in cellular DG 
content (Takuwa et al., 1987b; Agwu et al., 1989; Huang & Cabot, 1990a). To 
address this anomaly the effect of PMA upon inositol lipid hydrolysis required 
thorough characterization.
The effect of PMA upon bombesin-stimulated InsPt accumulation in Swiss 
3T3 cells was assessed using accumulation of [^H]InsPt in the presence of lOmM 
LiCl as an assay of receptor-mediated inositol lipid hydrolysis. Pre-treating Swiss 
3T3 cells with 400nM PMA for 15 minutes inhibited bombesin-stimulated 
[^H]InsPt accumulation by approximately 50% (Figure 3.6a) and shifted both the 
dose-curve and the EC50 to the right
These results confirm those of Brown et al. (1987) who showed that acute 
pre-treatment of Swiss 3T3 cells with the C-kinase activating phorbol ester PMA 
results in marked inhibition of subsequent bombesin-stimulated inositol phosphate 
accumulation. The shift in EC50  for bombesin in the PMA-treated cells is 
consistent with the coupling between the activated receptor and PIC being impaired 
in some way as described by Brown et al. (1987) and Plevin et al. (1990). 
Indeed, Plevin et al. (1990) in studying the role of guanine nucleotides in the 
regulation of bombesin-stimulated inositol phosphate formation in electro- 
permeabilized Swiss 3T3 cells have shown that PMA will inhibit bombesin- 
stimulated [^H]InsPt accumulation and the synergy between bombesin and GTPyS 
but not the response to GTPyS alone. This suggests that PMA in some way 
impairs the linkage between the bombesin receptor and the G-protein, Gp. There 
seems to be no consensus as to where PMA exerts its effect. In DDTjMF2 
smooth-muscle cells PMA-stimulated phosphorylation of (Xj adrenoceptors 
decreases agonist-receptor binding (Leeb-Lundberg et al., 1985), though this is 
clearly not the case for the bombesin receptor in Swiss 3T3 cells (Browner a/., 
1987). In HL60 cells PMA inhibits both GTPyS- and Ca^+-stimulated inositol 
phosphate accumulation suggesting that both coupling between the G-protein and 
PIC aswell as the PIC itself may be impaired in a PMA-dependent manner (Geny 
etal., 1989).
The effect of PMA upon bombesin-stimulated [^H]InsPt accumulation was
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time-dependent. Figure 3.7 shows that there was a 30 sec to 1 min lag before the 
onset of PMA-mediated inhibition of bombesin-stimulated [^H]InsPt accumulation. 
This lag may represent the time taken for the phorbol ester to cross the plasma 
membrane and enter its receptor site.
It is well known that addition of PMA to Swiss 3T3 cells results in 
activation of PKC as assessed by phosphorylation of a candidate marker substrate, 
an 80 kDa acidic phoshoprotein (Eruslalimsky et al., 1988). That this is due to 
activation of PKC is supported by the ability of cell permeant DG analogues and 
growth factors which stimulate inositol lipid hydrolysis to mimic the effect of PMA 
(Erusalimsky et al., 1988; Kazlauskas & Cooper, 1988). Phosphorylation of the 
80 kDa protein is lost in cells which have been pre-treated with high doses of 
phorbol ester to down regulate PKC.
That the effect of PMA upon bombesin-stimulated [^H]InsPt formation 
described in Fig 3.6a was mediated by protein kinase C was supported by a number 
of lines of evidence. First, the ability of PMA to inhibit bombesin-stimulated 
[^H]InsPt accumulation was not shared by P-phorbol (Fig 3.8d), a phorbol ester 
which is not able to activate PKC (Castagna et al., 1982). Second, the IC50  for 
PMA-mediated inhibition of bombesin-stimulated [^H]InsPt accumulation 
(approximately 5 nM) was essentially the same as that value previously reported by 
Brown et al. (1987) and is the same as the EC5Q for PMA-stimulated PKC activity 
(Castagna et al., 1982). The anomaly between the IC5Q reported here and that 
described by Plevin et al. (1990) of 50-100nM PMA is probably due to the latter 
study being in cells which were electro-permeabilized after treatment with PMA. 
Such a treatment would result in loss of PMA and perhaps other cellular 
components required for a phosphorylation event from the cytosol, or might 
activate phosphatases, resulting in a shift in effective dose of the phorbol ester.
Treatment of Swiss 3T3 cells for 48 hours with 400nM PMA down- 
regulates protein kinase C (Collins & Rozengurt, 1984; Rodriguez-Pena & 
Rozengurt, 1984; Brown et al., 1990). In this laboratory it has been shown that 
such a treatment results in the loss of [^HJPDBu binding to Swiss 3T3 cells (S. 
Currie & M.J.O. Wakelam, personal communication). In Swiss 3T3 cells pre­
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treated with 400nM PMA for 48 hours the ability of bombesin to stimulate the 
accumulation of [^H]InsPt was reproducibly enhanced as compared to the control 
cells treated with p-phorbol (Fig 3.9), consistent with the removal of a limiting 
component, presumably PKC. Furthermore, in the PKC down-regulated cells 
acute pre-treatment with PMA was no longer effective at inhibiting bombesin 
stimulated [^H]InsPt accumulation (Fig 3.10) supporting the proposal that the 
inhibitory effects of PMA were exerted through protein kinase C.
Finally, addition of PMA to quiescent, [^H] inositol labelled Swiss 3T3 cells 
did not result in any statistically significant accumulation of [^H]InsPt over 20 
minutes in the presence of lOmM LiCl (Fig 3.9) under the same conditions in 
which bombesin elicited a near 10-fold response. These results clearly suggest that 
activation of protein kinase C, by addition of PMA or by the generation of DG from 
PtdIns(4 ,5 )P2 hydrolysis, does not stimulate inositol lipid hydrolysis but may 
actually serve to limit bombesin-stimulated PtdIns(4 ,5 )P2 hydrolysis as suggested 
by Brown et al. (1987).
Such evidence clearly argues against the original prediction of Griendling et 
al. (1986), that PKC acti vates Ptdlns hydrolysis which is responsible for 
sustained elevation of DG, being pertinent to Swiss 3T3 cells. Nevertheless, in 
Swiss 3T3 cells (Takuwa et al., 1987b), as well as a number of other cell types, 
administration of PMA is clearly able to increase the cellular DG content Since this 
is accompanied by the inhibition of inositol lipid hydrolysis it strongly suggests that 
PMA-stimulated DG formation must be derived from a source other than inositol 
lipids.
3.3.3 Bombesin, [Arg8 ]Vp and PGF2 a  stim ulate inositol lipid 
hydrolysis by a similar mechanism.
The neuropeptide [Arg8] vasopressin ([Arg8 ]Vp) and the eicosanoid 
prostaglandin F2a  (PGF2 a ) are also potent co-mitogens for the Swiss 3T3 cell line 
(Corps et al., 1985; MacPhee et al., 1984). Both mitogens stimulate the
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hydrolysis of PtdIns(4 ,5 )P2 and the rapid generation of Ins(l,4 ,5 )P3 (Nanberg & 
Rozengurt, 1988; Black & Wakelam, 1990) and these responses are modulated by 
guanine nucleotides and their analogues (Erusalimsky & Rozengurt, 1989; Plevin 
et al., 1990) in much the same way as the bombesin response. Because of these 
similarities experiments were performed to compare the effects of PMA treatment 
upon [Arg^] Vp- and PGF2 a -stimulated [^HJInsPt accumulation.
Figure 3.6 (b & c) showed that both agents did indeed stimulate the 
accumulation of [^H]InsPt with EC50 values which agreed well with their potency 
in stimulating [^H]thymidine incorporation as previously cited (Corps et al., 
1985). Furthermore, in the case of [Arg^JVp, pre-treatment of cells with 400nM 
PMA inhibited [^H]InsPt accumulation and shifted the EC50 to the right, as was the 
case for bombesin, suggesting that PMA impaired the coupling between the Vj 
vasopressin receptor and PIC. Pre-treatment of Swiss 3T3 cells with increasing 
doses of PMA revealed that the inhibitory effect of PMA was dose-dependent 
(Figure 3.8b & c) with maximal inhibition occurring at 30-100 nM PMA and IC5q 
values of the same order as that for bombesin (2-6 nM).
When Swiss 3T3 cells were treated for 48 hours with 400nM PMA to 
down-regulate PKC, the ability of both [Arg^]Vp and PGF2 a  to stimulate 
[^H]InsPt accumulation was enhanced (Fig 3.9). Furthermore, under these 
conditions acute pre-treatment with PMA no longer inhibited the responses to either 
mitogen (Fig 3.10). These results are similar to those for bombesin and the 
similarity in IC5 Q values for PMA-mediated inhibition of mitogen-stimulated 
[^H]InsPt accumulation with that for activation of PKC (Castagna et al., 1982) 
suggests a common mechanism of action which probably involves PKC.
The degree of enhancement of InsPt accumulation in down-regulated cells 
was different for each of the three agonists. The greatest enhancement was always 
observed with PGF2 a  (2.5- 3.2-fold) > [Arg^jVp (2.2- 2.5-fold) > bombesin 
(1.2- 1.4-fold). A similar trend has recently been reported by Brown et al. (1990) 
and may represent subtle differences in the role of PKC in regulating coupling of 
the receptors to PIC or different sites for intervention between receptor, Gp and 
effector by PKC. However, a simpler interpretation may lie in the fact that, in
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control cells, PGF2 a  gives the smallest accumulation of [^H ]InsPt and, 
consequently, the smallest depletion of [^H] inositol lipids over a 2 0  minute 
stimulation in the presence of lOmM LiCl (Table 3.1). Removal of a C-kinase- 
mediated inhibition by down-regulation of PKC would then allow large potentiation 
of the response. Such a mechanism would apply for [Arg^JVp and bombesin, but 
since they give successively greater responses in control cells and much greater 
depletion of [^H]inositol lipids (Table 3.1), potentiation of [^H]InsPt accumulation 
in down-regulated cells may be limited by the amount of [^H]inositol lipids 
available as substrate for PIC.
There was a clear rank order in the magnitude of InsPt accumulation in 
response to the three mitogens; bombesin > [Arg^JVp > PGF2 a . This agrees 
broadly with the rank order of bombesin > [Arg^]Vp > PGF2 a  for the magnitude 
of mitogen-stimulated [^H]thymidine incorporation seen in Swiss 3T3 cells (Corps 
et al, 1985). Whilst this proportionality between mitogenic potentcy and inositol 
lipid hydrolysis suggests an important role for the latter in mitogenic signal 
transduction, this is clearly not the case in all systems. For example, Black & 
Wakelam (1990) reported that PGF2 a  stimulates similar inositol phosphate 
generation in two distinct clones of NIH3T3 cells but is only mitogenic in one of 
the cell lines. Furthermore a number of growth factors, for example EGF in Swiss 
3T3 cells (Hesketh et al., 1988) and CSF-1 in human monocytes (Imamura et al., 
1990), are mitogens despite being unable to stimulate measureable inositol lipid 
hydrolysis. Clearly, whilst inositol lipid hydrolysis may be an important early 
event in response to some mitogens, it is not in itself sufficient, or necessary for, 
mitogenesis in response to all growth factors (Whitman & Cantley, 1988).
Thus, the three mitogens, bombesin, [Arg^]Vp and PGF2 a , exhibit marked 
similarities in the mechanism by which they stimulate hydrolysis of inositol lipids. 
The generation of Ins(l,4 ,5 )P3 was rapid in onset and essentially transient (Fig 
3.4; Nanberg & Rozengurt, 1988; Black & Wakelam, 1990), the responses are 
modulated by guanine nucleotides in a manner consistent with a general model for 
receptor - G-protein interactions (Plevin et al, 1990; Erusalimsky & Rozengurt,
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1989) and they display similar sensitivity to acute pre-treament with phorbol esters 
(Fig 3.8, 3.9 & 3.10), a response which is most likely to be mediated by protein 
kinase C. These charcteristics are typical of agonists which couple to inositol lipid 
hydrolysis in a classical RGE type manner.
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Chapter 4.
Multiple sources of sn-l,2-diradylg!ycerol in bombesin- 
stimulated Swiss 3T3 cells; evidence for activation of 
phospholipase D.
4.1 Introduction.
In Chapter 3, the ability of bombesin and other mitogenic agents to 
stimulate inositol lipid hydrolysis in Swiss 3T3 cells was characterised in terms 
of kinetics, dose-dependency and sensitivity to acute- and long term- phorbol 
ester pre-treatment. In this chapter experiments are described which investigate 
the ability of bombesin to stimulate increases in the cellular content of sn- 1,2 - 
diglyceride and these changes are compared with the generation of Ins(l,4 ,5 )P3 
mass. Furthermore, evidence is presented to suggest that bombesin and phorbol 
esters may contribute to increases in cellular diglyceride content by hydrolysing a 
non-inositide phospholipid by a phospholipase D catalysed reaction.
Mitogen-stimulated increases in sn-l,2-DG have been less extensively 
studied in Swiss 3T3 cells than increases in inositol phosphates, with many 
reports making no attempt to assess stimulated increases in DG (Brown et al., 
1984; Heslop et al., 1986). Historically, this probably represents the 
inadequacies of the assay methods available. Until recently the commonest 
method employed was labelling of cellular glycerophospholipids with either 
[3 H] glycerol or a [3 H]fatty acid to isotopic equilibrium followed by monitoring 
changes in the radioactivity associated with 1,2-DG upon stimulation; 
radiolabelled diglyceride was usually resolved by thin layer chromatography. 
The major criticism of these methods is that they cannot distinguish between sn-
1,2-DG and sn-2,3-DG, an important consideration since it is only the sn- 1,2- 
forms of DG that are able to activate protein kinase C (Rando & Young, 1984; 
Nomura et al., 1986). The use of a radioactive fatty acid to label cellular 
phospholipids provides both advantages and disadvantages. The major 
advantage of such an approach is that, to some extent, it allows one to investigate 
which phospholipid species may be contributing to increases in DG since some 
phospholipids are enriched in particular fatty acids. Thus the inositol lipids, 
particularly PtdIns(4)P and PtdIns(4,5)P2» are characterised by generally 
possessing stearic acid at position 1 and arachidonic acid at position 2  (reviewed 
by Downes & Michell, 1985; Pessin & Raben, 1989). In contrast, PtdCho, 
whilst containing a considerable portion of arachidonate also contains large
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amounts of oleic acid, linoleic acid, palmitic, stearic or myristic acid. However, 
this potential specificity of labelling can also be a disadvantage since it excludes 
those species of diglyceride which do not contain the particular fatty acid used in 
the labelling, thereby leading to an under-estimation of both basal and stimulated 
amounts of DG.
The development of a radioenzymatic assay for total sn-\,2-DG mass by 
Preiss et al. (1986) has allowed for much more accurate determinations of 
cellular diglyceride content. The assay employs DG kinase (from an over 
producing strain of E.coli) to phosphorylate the DG in cellular lipid samples in 
the presence of [y-^P]ATP. The conversion of DG to [^PjPtdOH can be 
monitored by constructing a standard curve, allowing quantitation of cellular DG 
mass. This method has been applied successfully by Wright et al. (1988) to 
show that a-thrombin stimulates a biphasic increase in sn-l,2-DG  in IIC9 
fibroblasts. A criticism of this method is that it gives no indication of the fatty 
acyl structure of the DG; however it is absolutely specific for .s/i-l,2-DGs since 
they are the only diglyceride substrates for DG kinase (Bishop et al., 1986).
The use of chemical derivitizations for sn-1,2-diglycerides has meant that 
the mass amounts of individual species of DG can now be analysed with great 
accuracy. DG derivatives can be separated by h.p.l.c. or g.l.c. whilst 'on-line* 
mass spectrometry allows mass analysis of individual diglyceride species (e.g., 
Pessin & Raben, 1989). These techniques have been used to great effect in 
showing that agonist-stimulated increases in DG are derived largely from non­
inositol lipid sources from 30 seconds onwards in a-thrombin-stimulated IIC9 
fibroblasts (Pessin & Raben, 1989); in fact, the profile of different DG species at 
later timepoints was consistent with them being derived from PtdCho. A role for 
the hydrolysis of non-inositide phospholipids in generating DG in stimulated 
cells is now increasingly accepted (reviewed by Billah & Anthes, 1990).
The major question which must be addressed when considering the role 
of other phospholipids in generating DG is the route of hydrolysis since both 
PLC- and PLD-catalysed pathways have been variously proposed (reviewed by 
Billah & Anthes, 1990). PLC-catalysed hydrolysis of PtdCho yields DG and
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phosphocholine (ChoP) whereas the activation of PLD yields phosphatidic acid 
(PtdOH) and free choline (Cho); PtdOH may then be dephosphorylated by 
phosphatidate phosphohydrolase (PPH) to yield DG. This latter route of DG 
formation, referred to as a coupled PLD/PPH pathway, is certainly more complex 
since it involves what is effectively the reversal of the DG kinase reaction by 
PtdOH phosphohydrolase. Using two definitive assays in cells labelled with 1- 
0-[^H]alkyl-2-lyso-glycero-3-[^^P]phosphocholine Pai et al. (1988a & b) and 
Billah et al. (1989a &b) have shown quite clearly that in HL-60 granulocytes 
and human neutrophils, both phorbol esters and the chemotactic peptide fMet- 
Leu-Phe rapidly activate a PLD/PPH pathway which serves to elevate DG levels. 
The formation of ^^P-labelled PtdOH under these conditions rather than ^2p_ 
labelled ChoP allows definitive identification of PLD rather than PLC activity; 
32p labelled PtdOH cannot have been formed from DG since the cellular ATP 
pool is not labelled in this system. The formation of phosphatidylalcohols by the 
transferase reaction also serves as a useful marker for PLD activity in whole 
cells.
To date, the majority of reports describing generation of DG from a non­
inositol lipid source have reported activation of a PLD/PPH pathway though a 
limited number of reports have suggested the involvement of a PLC (reviewed by 
Billah & Anthes, 1990). This is an important distinction since the former 
pathway produces another phospholipid with a potential messenger function, 
PtdOH (Putney et al., 1980; Moolenaar et al., 1986).
In this chapter, evidence is presented to show that bombesin stimulates a 
biphasic increase in DG mass. The first phase correlates with Ins(l,4 ,5 )P3 
generation in terms of kinetics whilst the second phase is sustained and divorced 
from a further increase in Ins(l,4 ,5 )P3 mass and can be mimicked by addition of 
PKC-activating phorbol esters. The sustained formation of DG is associated 
with the activation of PLD which may, in part, be mediated by the activation of 
PKC. The results are discussed in terms of a possible functional link between 
PtdIns(4 ,5 )P2 hydrolysis and PLD.
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4.2 Results.
4.2.1 Bombesin- and phorbol ester-stimulated DG formation in 
Swiss 3T3 cells.
Preliminary experiments examined the changes in DG mass upon 
stimulation of quiescent Swiss 3T3 cells with a maximal dose (617nM) of 
bombesin. Fig. 4.1a shows the timecourse for changes in DG mass in response 
to bombesin. DG levels rose rapidly upon stimulation to give a pronounced peak 
after 5 sec before declining towards control at 30 sec. However, in contrast to 
Ins(l,4,5)P3 (Fig. 3.4), DG levels did not return to basal but rose again in a 
second phase from between 30 sec or 1 min onwards. This second phase was 
maintained for up to 30 min (Fig. 4.1b) and, in some experiments, DG mass 
remained significantly above control at 60 min (data not shown). This sustained 
increase in diglyceride is in agreement with the work of Takuwa et al. (1989) 
who reported that bombesin-stimulated DG elevation persisted for up to 4 hours 
in Swiss 3T3 cells. In some experiments the initial peak of DG formation was 
seen as a less pronounced shoulder on a greater sustained second phase of the 
response (for example see Fig. 4.2). The time course shown in Fig. 4.2 is 
actually from the same experimental samples as Fig. 3.2, allowing direct 
comparison of f^H]InsP3 and DG mass from the same experiment.
The basal level of DG in unstimulated Swiss 3T3 cells was 210 ± 61 
pmoles/10^ cells (mean ± S.D. of 21 determinations conducted throughout the 
course of these studies). This is similar to that recently reported for Swiss 3T3 
cells by Staddon ef al. (1990). A comparison of the net increase in Ins(l,4 ,5 )P3 
and DG mass indicated that after 5 sec stimulation with bombesin the net increase 
in DG mass (179 ± 64 pmoles/106 cells, n=6  determinations) exceeded that of 
Ins(l,4 ,5 )P3 (25.2 ± 3.8 pmoles/10^ cells) by 7.2 ± 2.6 fold. The net increase 
in DG at 5 or 15 min (the second phase) was 606 ± 387 pmoles/10^ cells (mean 
± S.D., n= 6  experiments in triplicate). Because of the variation in basal DG level 
during the course of these studies, fold increases were calculated against the 
corresponding experimental basal and then averaged rather than calculating the
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Figure 4.1 (a & b) Time course of increases in s/i-l,2-D G  mass in 
bombesin-stimulated Swiss 3T3 cells.
Confluent monolayers of quiescent Swiss 3T3 cells were incubated at 37° C 
for 60 min in HBG before replacing with HBG containing 617nM bombesin (■) or 
HBG alone (□) for the times indicated. Incubations were terminated by aspiration 
and the addition of ice-cold methanol and, after harvesting, the cell debris was 
extracted in chloroform by the method described in Chapter 2. An aliquot of the 
chloroform phase was dried down, solubilised in a cardiolipin/w-octyl-P-D- 
glucopyranoside mixed micelle detergent preparation and assayed for sn-l,2-DG 
mass as described in the Methods section. Samples were taken for analysis of total 
lipid phosphorous and for cell number determination. The results are expressed as 
mass of DG (pmoles of DG/10^ cells, mean ± S.D., n= 3) from a single, 
representative experiment. Fig. 4.1 (a & b) show the time course up to 5 and 30 
min respectively.
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Figure 4.2 Time course of increases in sn -l,2 -D G  m ass in 
bombesin-stimulated Swiss 3T3 cells.
Confluent monolayers of quiescent Swiss 3T3 cells were washed in HBG at 
37°C for 60 min before replacing with HBG containing 617nM bombesin (■) or 
HBG alone (□) for the indicated times. Incubations were terminated by aspiration 
and addition of ice-cold methanol and, after harvesting, the cell debris was extracted 
in chloroform as described in the methods section. An aliquot of the chloroform 
phase was dried down, solubilised in a cardiolipin/rc-octyl-P-D-glucopyranoside 
mixed micelle detergent preparation and assayed for sn- 1,2-DG mass as described 
in the Methods section. Samples were taken for analysis of total lipid phosphorous 
and for cell number determination. The results are expressed as mass of DG 
(pmoles of DG/10^ cells, mean ± S.D., n= 3) from a single, representative 
experiment.
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increase over the mean basal. The fold increases in DG over the corresponding 
experimental control in response to bombesin were 1.98 ± 0.36 at 5 sec (the first 
phase) and 3.07 ± 0.92 at 5 or 15 min (the second phase). A number of recent 
studies (Takuwa et al., 1987 a & b; Wright et al., 1988; 1990) have expressed 
DG mass as nmoles/1 OOnmoles of lipid phosphorous (mol %). To allow 
comparisons between these studies samples were assayed for total lipid 
phosphorous as described in the Methods section. Using two different assay 
methods during the course of these studies there were found to be 70 ± 19 
nmoles of lipid phosphorous/10^ Swiss 3T3 cells (mean ± S.D., of three 
determinations where n=3-9); this value is of a similar order to that described by 
Wright et al. (1988) in IIC9 fibroblasts. In unstimulated cells DG mass levels 
were 0.3 ± 0.09 mol %. In cells stimulated with bombesin for 5 sec the net 
increase in DG was equivalent to an increase of 0.25 mol %, whilst the second 
phase of DG formation was equivalent to a net increase of 0.87 mol %. The 
precise details of the timecourse varied between experiments; for example, in 
some cases, the second phase of the response was of equivalent or slightly 
smaller magnitude than the first (Fig. 4.1b) whereas, in other experiments, the 
second phase was the greater (e.g., Fig. 4.2). It is thus evident that the 
accumulation of DG in response to bombesin was sustained at times when the 
levels of Ins(l,4 ,5 )P3 had declined to pre-stimulated levels (30 sec, Fig. 3.4).
To assess whether both phases of the response were occurring over the 
same dose range of bombesin and presumably, therefore, being mediated by the 
activation of a single population of receptors, dose-response experiments were 
performed at both 5 sec and 5 or 15 min stimulation times. The results in Fig.
4.3 (a & b) show that, at both phases of the response, bombesin stimulated a 
dose-dependent increase in DG mass with EC5Q values of 2.04 ± 1.68 nM at 5 
sec and 0.42 ± 0.15 nM at 5 or 15 min (mean ± S.D., n=3 experiments in each 
case). These results aie similar to the EC5Q values for bombesin stimulated 
Ins(l,4 ,5 )P3 generation and accumulation of [^H]InsPt reported in Chapter 3.
Further experiments measuring DG mass examined the effects of adding
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Figure 4.3 (a & b) Dose response curves for increases in DG in 
Swiss 3T3 cells stimulated with bombesin for (a) 5 sec or (b) 15 
min.
Confluent monolayers of quiescent Swiss 3T3 cells were washed in DMBH 
for 60 min at 37° C before replacing with buffer containing the indicated 
concentration of bombesin for (a) 5 sec or (b) 15 min. Incubations were terminated 
by aspiration and addition of ice-cold methanol and, after harvesting, the cell debris 
was extracted in chloroform as described in the methods section. An aliquot of the 
chloroform phase was dried down, solubilised in either (a) a cardiolipin/w-octyl-P- 
D-glucopyranoside detergent preparation or (b) a Triton X-100/PtdSer detergent 
mix and assayed for 5« -l,2 -DG mass as described in the Methods section. 
Samples were taken for analysis of total lipid-containing phosphorous and for cell 
number determination. The results are expressed as mass of DG (pmoles of 
DG/106 cells, mean ± S.D., n= 3) from a single, representative experiment.
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phorbol esters to quiescent Swiss 3T3 cells since their reported effects upon 
inositol lipid hydrolysis and DG generation seemed, at first sight, anomalous. It 
is well characterised in a variety of systems, including Swiss 3T3 cells, that 
phorbol esters do not stimulate inositol lipid hydrolysis but rather inhibit inositol 
phosphate accumulation stimulated by subsequent agonist challenge, (see Brown 
et al., 1987 and Chapter 3 of this thesis). Despite this, a number of groups have 
reported that addition of phorbol esters to cells results in an increase in DG 
content. In the Swiss 3T3 cell, Takuwa et al. (1987b) showed that PM A 
stimulated an increase in DG mass after a lag of about 2 min. This response was 
sustained for up to 30 min, and occured at doses at which PMA is mitogenic, but 
was not accompanied by the accumulation of inositol phosphates. To confirm 
and advance these observations, the effect of PMA upon cellular DG content was 
investigated using the DG mass assay and in cells labelled with [^H]palmitic 
acid.
First, addition of PMA to quiescent Swiss 3T3 cells resulted in a time 
dependent increase in DG mass (Fig 4.4a) which was apparent, though not 
significant, after 1 min. DG mass was significantly elevated after 2 min (p= 
0.003); the rate of accumulation from 5 min onwards was somewhat reduced but 
the elevation of DG was sustained above control for up to 30 min (Fig. 4.4a) and 
60 min (data not shown). PMA stimulated increases in DG mass were dose- 
dependent (Fig. 4.4b); the concentration of PMA giving half-maximal 
accumulation of DG mass was 2.6 ± 0.59 nM (mean ± S.D. of 2 experiments). 
The net increase in DG stimulated by PMA was 435 ±113 pmoles/10^ cells 
(mean ± S.D., n= 6  experiments in triplicate) equivalent to an increase of 0.62 
mol % and representing a fold increase over the corresponding basal of 2.78 ± 
0.65. The lag time of approximately 1 min before the onset of the response was 
probably due to the time taken for the phorbol ester to cross the plasma 
membrane and enter its receptor site. Thus, the time course of PMA-stimulated 
increase in DG was similar to the second phase of bombesin-stimulated DG 
accumulation. Furthermore, both the PMA response and the second phase of the 
bombesin response were divorced from stimulated inositol lipid hydrolysis and
11 7
Figure 4.4 (a & b) Increases in s/i-l,2-D G  mass in PMA-stimuIated 
Swiss 3T3 cells.
Confluent monolayers of quiescent Swiss 3T3 cells were incubated at 37° C 
for 60 min in DMBH before replacing with DMBH containing lOOnM PMA (■) or 
p-phorbol (□) for (a) the times indicated; dose response curves (b) were performed 
at the concentration indicated for 10 min. Incubations were terminated by aspiration 
of the medium and addition of ice-cold methanol. After harvesting, the cell debris 
was extracted in chloroform by the method described in Chapter 2. An aliquot of 
the chloroform phase was dried down, solubilised in a Triton X-100/PtdSer mixed 
micelle detergent preparation and assayed for sn-l,2-DG mass as described in the 
Methods section. Samples were taken for analysis of total lipid-containing 
phosphorous and for cell number determination. The results are expressed as mass 
of DG (pmoles of DG/10^ cells, mean ± S.D., n= 3) from a single, representative 
experiment.
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further net Ins(l,4 ,5 )P3 generation respectively. This suggested that PMA might 
mimic the second phase of bombesin-stimulated DG accumulation.
Since PMA can stimulate accumulation of DG without increasing inositol 
lipid hydrolysis, the DG may be derived by hydrolysis of an alternative 
phospholipid or increased de novo synthesis. However, since the effects of 
PMA were apparent within 1 or 2 min, it seemed unlikely to be due to the latter 
possibility. In those systems where enhanced de novo synthesis is thought to 
play a role in agonist-induced elevation of DG, the effects are thought to be more 
important over longer stimulation times e.g., tens of minutes (discussed in 
section 1.6). For this reason the source of the second phase of DG elevation 
stimulated in bombesin- and PMA-stimulated Swiss 3T3 cells was investigated.
In recent years it has become apparent that, in a variety of stimulus- 
response sytems, both PtdCho (reviewed by Exton, 1990; Billah & Anthes,
1990) and, to a lesser extent, PtdEtn (Kiss & Anderson, 1989) are significantly 
hydrolysed within minutes of addition of phorbol esters and receptor agonists. 
To investigate the possibility of DG being derived from one of these sources, an 
isotopic labelling protocol was chosen which would preferentially label all the 
major phospholipid classes other than the inositol lipids. Since the inositol lipids 
are particularly characterised by a l-stearoyl-2 -archidonoyl acyl composition 
(reviewed by Downes & Michell, 1985; Pessin & Raben, 1989), [^Hjpalmitic 
acid was chosen as a means of selectively labelling the diglyceride moiety of non­
inositol-containing phospholipids.
Fig. 4.5 shows the timecourse for incorporation of [^H]palmitic acid into 
the major phospholipid species in Swiss 3T3 cells. The results indicate that 
equilibrium labelling of all the major phospholipids was achieved over a 49 hour 
period. The rapid incorporation of HJpalmitate into PtdCho, PtdOH and 
PtdSer suggested that these lipids were rapidly turning over in control cells. Of 
the other major phospholipids, PtdEtn incorporated label more slowly whilst 
Ptdlns incorporated very little at 4 hours and showed no significant increase over 
the remaining labelling period. The amount of [^HJpalmitate incoiporated into 
the different phospholipid classes after 49 hours varied quite markedly (Table
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Figure 4.5 Time course of incorporation of [^HJpalmitic acid into 
the major phospholipid classes in Swiss 3T3 cells.
Swiss 3T3 cells were plated on to 24 well plates and grown in normal 
medium for 24 hours until judged to be approximately 80% confluent. The medium 
was then replaced with DMEM containing 1% calf serum and cells were returned to 
the incubator. At staggered intervals, medium was replaced with lml of DMEM 
containing 1% calf serum and 2pCi of [^Hjpalmitic acid so that cells were 
incubated in the presence of isotope for the times indicated. After 49 hours, 
medium was aspirated and incubations were terminated by the addition of ice-cold 
methanol. Chloroform extracts, prepared as described in the Methods section, were 
loaded on to silica gel 60 t.l.c. plates and developed in the solvent system described 
in Chapter 2. PtdCho (■), PtdSer (A), PtdEtn ( • ) ,  Ptdlns (O) and PtdOH (□), 
identified by their co-migration with authentic standards after visualising with I2 
vapour, were excised from the silica gel and the associated radioactivity determined 
by scintillation counting. Results are expressed as radioactivity in phospholipids 
(d.p.m., mean ± S.D., n= 3) from a single experiment.
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Table 4.1 D istribution of H jpalm itic acid in the major 
phospholipid classes in Swiss 3T3 cells.
Swiss 3T3 cells were seeded on to 24 well plates and grown in normal 
medium for 24 hours until judged to be approximately 80% confluent. The medium 
was then replaced with DMEM containing 1% calf serum and cells were returned to 
the incubator. At staggered intervals, medium was replaced with 1ml of DMEM 
containing 1% calf serum and 2|iCi of [^Hjpalmitic acid so that cells were 
incubated in the presence of isotope for the times indicated. After 49 hours, 
medium was aspirated and incubations were terminated by the addition of ice-cold 
methanol. Chloroform extracts, prepared as described in the Methods section, were 
loaded on to silica gel 60 t.l.c. plates and developed in the solvent system described 
in Chapter 2. PtdCho, PtdSer, PtdEtn, PtdOh, Ptdlns and SphM were identified 
by their co-migration with authentic standards after visualising with I2 vapour. The 
corresponding regions of the silica gel were excised the associated radioactivity 
determined by scintillation counting. Results are expressed as radioactivity in 
phospholipids (d.p.m., mean ± S.D., n=3) from a single experiment and as 
percentage of total radioactivity incorporated into total phospholipids after 49 hours.
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D istrib u tio n  o f [^H ]p a lm itic  acid  
in m ajor phospholipid classes.
L ip id . R adioactiv ity
(d.p.m.)
% of radioactivity in 
total phospholipids.
PtdCho 122,416 ± 7,256 50.3
PtdSer 48,049 ±7,144 19.8
PtdSer 43,976 ±1,807 18.1
PtdOH 23,651 ±7,132 9.7
Ptdlns 5,032 ± 629 2.1
SphM 109,330 ± 13,189 Not applicable.
4.1). Clearly the majority of [^HJpalmitate was incorporated into PtdCho (50% 
of total radioactivity incorporated into total phospholipids) with sphingomyelin, 
PtdSer and PtdEtn labelled to a lesser extent. Only 2% of the total label 
incorporated into the major phospholipids was found into Ptdlns. Therefore, 
under these conditions PtdCho and other major phospholipids were labelled 
preferentially to inositol lipids.
Stimulation of [^Hjpalmitate labelled Swiss 3T3 cells with lOOnM PMA 
resulted in a time-dependent increase in radioactivity associated with total 
[^H]1,2-DG. PMA-stimulated increases in [^H]1,2-DG were apparent after 1 
min but were never significantly elevated until 2 min (p=0.009) (Fig. 4.6). 
Increases in [^H]1,2-DG exhibited similar kinetics to those for PMA-stimulated 
increases in DG mass but were of a smaller magnitude. PMA-stimulated 
increases in [^HjPtdOH were difficult to observe since there was an 
unexpectedly high amount of radioactivity in PtdOH even in the absence of a 
stimulus. Since it is known that PtdOH is a minor phospholipid component of 
Swiss 3T3 cells by mass (Takuwa et al., 1987b), this may suggest that palmitate 
containing PtdOH makes a significant contribution to the total mass of PtdOH. 
PMA-stimulated increases in [^HjPtdOH were sometimes seen after 1 min rising 
to a maximal elevation at 2-5 min, after which the increased level was maintained 
for up to 15 min (data not shown). However, it was not clear if the basal levels 
were accurate or elevated due to contamination with other lipid species. 
Nevertheless , [^HjPtdOH was resolved by three different t.l.c. systems in these 
experiments.
4.2.2 Bombesin and phorbol ester stimulate phospholipase D 
transferase activity in [^HJpalmitate-labelled Swiss 3T3 cells.
Bombesin- and PMA-stimulated activation of PLD was investigated by 
assessing the formation of phosphatidylalcohols. This method has the added 
advantage of acting as a definitive cellular marker for PLD since the
1 2 2
Figure 4.6 Time course of increases in [3 H]1,2-DG in PMA- 
stimulated, [^H]palmitate-labelled Swiss 3T3 cells.
Swiss 3T3 cells, grown on 6 well plates until judged to be 80% confluent, 
were grown for a further 48 hours in 2 ml of DMEM containing 1% calf serum and 
a total of 4}iCi of [^Hjpalmitic acid. Monolayer cultures were then washed in 
DMBH for 60 min at 37° C before incubating in DMBH containing lOOnM PMA 
(■ ) or p-phorbol (□ ) for the times indicated. Incubations were terminated by 
aspiration of the medium and addition of ice-cold methanol: chloroform extracts 
were prepared as described in Chapter 2. Samples were resolved on Whatman 
LK5DF t.l.c. plates using the solvent system described the Methods section. 1,2- 
DG, resolved from 1,3-DG and identified by its co-migration with an authentic sn-
1,2-DG standard visualised by I2 vapour, was excised from the t.l.c. plate in 0.5 
cm slices and associated radioactivity determined by scintillation counting. Results 
are expressed as radioactivity (d.p.m., mean ± S.D., n=3) from a single experiment 
typical of three.
1 2 3
radioactivity  in 1,2-DG (d.p.m.)
phosphatidylalcohols are not formed by other pathways in whole cells (Pai et 
al.y 1988a). In contrast, the normal product of PLD, PtdOH, can be formed de 
novo, or by the action of 1X5 kinase and is, therefore, not a definitive marker for 
PLD activity in whole cells.
Phosphatidylalcohols are formed by the phosphatidyltransferase activity 
of PLD in the presence of a suitable primary short chain alcohol. For the 
experiments described herein butan-l-ol was chosen since Bonser et al.{ 1989) 
had previously shown that in neutrophils PtdBut was formed at lower 
concentrations of the alcohol than were required for ethanol in forming PtdEth. 
Furthermore, on the t.l.c. system chosen PtdBut migrated further than PtdEth by 
virtue of the longer chain alcohol group, making for complete resolution of 
PtdBut from other species. Finally, the provision of a [*4C]PtdBut 'standard' by 
Dr. R Randall, The Wellcome Laboratories, Beckenham, Kent, allowed 
identification of PtdBut.
Preliminary experiments aimed to assess whether H]palmitate-labelled 
Swiss 3T3 cells could form PtdBut under appropriate conditions and to 
rigorously identify this product as PtdBut. Fig. 4.7a shows the distribution of 
radioactivity along two lanes of a t.l.c. plate after development of samples from 
control and PMA-stimulated, Hjpalmitate-labelled Swiss 3T3 cells as described 
in the methods section. The appearance of a peak of radioactivity with an Rf of 
0.40 ± 0.06 can be seen in response to PMA-stimulation. The identity of this 
peak was confirmed as PtdBut by a number of criteria. Firstly, it co-migrated 
upon t.l.c. with an authentic [^CJPtdBut standard which had been prepared by 
incubating [^C]arachidonoyl-PtdCho with butan-l-ol and cabbage PLD. In 
addition, it co-migrated with a 'dual-labelled' [^C/^H]PtdBut standard prepared 
as above using [^H]butan-l-ol. Secondly, when quiescent, unlabelled Swiss 
3T3 cells were incubated with carrier-free [^H]butan-l-ol and either bombesin, 
PMA or DMSO, the formation of a [^H] labelled product with identical Rf as the 
PtdBut standards and the [^H]PtdBut formed in H]palmitate-labelled cells was 
observed only in response to PMA (Fig. 4.7b) and bombesin (data not shown).
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Figure 4.7 (a & b) Resolution and identification of [3 H]PtdBut in 
PMA-stimuIated Swiss 3T3 cells.
(a) Swiss 3T3 cells, grown on 6  well plates until judged to be 80% 
confluent, were cultured for a further 48 hours in 2 ml of DMEM containing 1% 
calf serum and a total of 4|iCi of [^Hjpalmitic acid. Monolayer cultures were then 
washed in DMBH for 60 min at 37° C before incubating in DMBH containing 
lOOnM PMA ( • )  or p-phorbol (O) for 30 min. Incubations were terminated by 
aspiration of the medium and addition of ice-cold methanol: chloroform extracts 
were resolved on Whatman LK5DF t.l.c. plates in parallel with a [*4 C]PtdBut 
standard (□) using the solvent system described in Chapter 2. Each lane of the 
t.l.c. plate was divided into 0.5 cm slices which were excised and the associated 
radioactivity determined by scintillation counting. The results are expressed as 
radioactivity per 0.5 cm slice (d.p.m.) and are from a single experiment, 
representative of nine.
(b) Confluent monolayer cultures of Swiss 3T3 cells were incubated in 
DMBH for 30 min at 37° C before replacing with DMBH containing 500{iCi of 
carrier free [^Hjbutan-l-ol and either 500nM PMA ( • )  or 0.1% (v/v) DMSO as a 
vehicle control (O) for a further 30 min at 37°C. Incubations were terminated by 
aspiration of the medium and addition of ice-cold methanol. Chloroform extracts, 
prepared by the method described by Randall et al. (1990), were washed three 
times in theoretical upper phase before applying to Whatman LK5DF t.l.c. plates 
together with a dual labelled [^C /^H ]PtdB ut standard (□). Samples were 
developed in the solvent system described in Chapter 2. Each lane was divided into 
0.5 cm strips, which were excised from the plate and the associated radioactivity 
determined by scintillation counting. Results are expressed as radioactivity in 
PtdBut (d.p.m.) from a single experiment representative of three.
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Figure 4.8 The effect o f butan-l-ol concentration on agonist- 
stimulated [3 H]PtdBut formation in [3 H]paImitate-labelled Swiss 
3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4(iCi of [^H]palmitic acid and the cells cultured for a further 48 hours. 
The medium was then replaced with DMBH for 30 min at 37° C and finally DMBH 
containing the indicated concentration of butan-l-ol and either 617 nM bombesin 
(□) or lOOnM PMA (■); incubations were continued for 20 min before aspiration 
and addition of ice-cold mathanol. Chloroform extracts, prepared as described in 
the Methods section, were loaded on to Whatman LK5DF tl.c. plates and resolved 
using the solvent system described in Chapter 2. [^HjPtdBut, identified by its co­
migration with a [14C]PtdBut standard, was excised in 0.5 cm slices from each lane 
and its radioactivity determined. The results, expressed as radioactivity in 
[^HJPtdBut (d.p.m., mean ± S.D., n=2) are from a single experiment 
representative of two.
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Finally, the ability of bombesin and PMA to stimulate an increase in radioactivity 
co-migrating with the PtdBut standard was absolutely dependent on the presence 
and concentration of butan-l-ol (Fig. 4.8). Bombesin- and PMA-stimulated 
[3H]PtdBut formation were essentially maximal at 30mM butan-l-ol (0.3%, v/v); 
concentrations of butan-l-ol higher than lOOmM gave a reduction in PMA-and 
bombesin-stimulated [^HjPtdBut formation resulting in a bell-shaped dose 
response curve. The EC50 values for butan-l-ol-dependent, agonist-stimulated 
[^HJPtdBut formation were 8.95 ± 1.11 mM for PMA and 3.75 ± 0.33 mM for 
bombesin. Microscopic examination of cells exposed to buffer containing 0.9% 
(v/v, 100 mM) butan-l-ol for 20 min revealed that many cells became detached 
from the culture plate, whilst those remaining exhibited morphological changes 
and some lysis. For further studies, 30mM butan-l-ol was chosen as a 
concentration which supported near-maximal [^H]PtdBut formation without 
compromising cellular responsiveness or viability over short term exposure. 
Having optimised the conditions for formation and identification of [^H]PtdBut, 
further studies concentrated upon characterizing the responses of Swiss 3T3 cells 
to stimulation with bombesin and PMA.
Addition of lOOnM PMA to quiescent, H]palmitate-labelled Swiss 3T3 
cells resulted in a time- and dose-dependent increase in the levels of [^H]PtdBut 
(Fig. 4.9 a & b). Statistically significant formation of [^H]PtdBut in response to 
PMA occurred after 1 min (p=0.004) and continued in a near linear fashion, 
without any apparent desensitization, for up to 30 min. There was no significant 
elevation over the zero time control seen in response to vehicle (0.01% DMSO 
containing p-phorbol). The concentration of PMA required to elicit half-maximal 
accumulation of [^H]PtdBut was 2.80 ± 1.02 nM (mean ± S.D., n=3 
determinations in triplicate) (Fig. 4.9b).
Addition of a maximal dose (617nM) of bombesin to quiescent, 
[^H]palmitate-labelled Swiss 3T3 cells in the presence of 30mM butan-l-ol 
resulted in the time- and dose-dependent formation of [^H]PtdBut (Fig. 4.10 a & 
b). Formation of [^H]PtdBut was apparent and significantly above control
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Figure 4.9 (a & b) Time course (a) and dose-response curve (b) for 
PMA-stimuIated [3H]PtdBut formation in Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4pCi of [3 H]palmitic acid and the cells maintained for a further 48 
hours. The medium was then replaced with DMBH for 30 min at 37°C.
(a) For time course studies medium was replaced with DMBH containing 
0.3% (v/v) butan-l-ol for 5 min and incubations started by replacing with DMBH 
containing 0.3% (v/v) butan-l-ol and either lOOnM PMA (■) or p-phorbol (□). 
At the indicated times, medium was aspirated and the incubations were terminated 
by addition of ice-cold methanol.
(b) For dose response studies medium was replaced with DMBH containing 
0.3% (v/v) butan-l-ol and the indicated final concentration of PMA (■ ). 
Incubations were for 20 min before terminating by aspiration of the medium and 
addition of ice-cold methanol.
In both cases, chloroform extracts were prepared and resolved on Whatman 
LK5DF t.l.c. plates as described in the Methods section. [3 H]PtdBut was 
identified by its co-migration with a [^4C]PtdBut standard and excised from the 
silica gel in 0.5 cm slices. The associated radioactivity was determined: results are 
expressed as radioactivity in [3 H]PtdBut (d.p.m., mean ± S.D., n=3) from a single 
experiment, representataive of three.
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Figure 4.10 (a & b) Time course (a) and dose-dependence (b) for 
bombesin-stimulated [^H]PtdBut formation in Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4jiCi of [^H]palmitic acid and the cells maintained for a further 48 
hours. The medium was then replaced with DMBH for 30 min at 37° C.
(a) For time course studies medium was replaced with DMBH containing 
0.3% (v/v) butan-l-ol for 5 min and incubations started by replacing with DMBH 
containing 0.3% (v/v) butan-l-ol and either 617nM bombesin (■) or DMBH alone 
(□). At the indicated times, the medium was aspirated and incubations terminated 
by addition of ice-cold methanol.
(b) For dose-response studies medium was replaced with DMBH containing 
0.3% (v/v) butan-l-ol and the indicated final concentration of bombesin (■ ). 
Incubations were for 20 min before terminating by aspiration of the medium and 
addition of ice-cold methanol.
In both cases, chloroform extracts were prepared and resolved on Whatman 
LK5DF t.l.c. plates as described in the Methods section. [^HJPtdBut was 
identified by its co-migration with a [14C]PtdBut standard and excised from the 
t.l.c. plates in 0.5 cm slices. The associated radioactivity was determined: results 
are radioactivity in [^HJPtdBut (d.p.m., mean ± S.D., n=3) from a single 
experiment, representataive of three.
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(p=0.009) after a 30 sec stimulation with bombesin though, in some cases, 
significant elevation was observed after 15 sec (p<0.001, Fig 4.15). [^HJPtdBut 
levels rose up to 2  min after which time, the rate of accumulation was reduced up 
to 5 and 15 min. This apparent desensitization of the response was not always 
complete since the increase in [^H]PtdBut from 5 min to 15 min was in some 
instances statistically significant (p=0.026) suggesting that accumulation of 
[3H]PtdBut continued, albeit at a reduced rate. The basal, unstimulated level of 
[^H]PtdBut did not vary significantly from the zero time control over 15 min. 
[^HJPtdBut formation appeared to be slower than bombesin stimulated increases 
in [^HjlnsPg and Ins(l,4 ,5 )P3 mass and the initial phase of DG elevation all of 
which were maximal after 5 sec, suggesting that it occurred later than 
PtdIns(4 ,5 )P2 hydrolysis. Interestingly, the increase in PtdBut actually seemed 
to precede the second phase of the DG response which was not apparent until 
after 30 sec or 1 minute. The ability of bombesin to stimulate accumulation of 
PtdBut was dose-dependent (Fig. 4.10b), the EC50 being 1.3 ± 0.31nM (mean ± 
S.D., n=3 determinations in triplicate). These results indicated that both 
bombesin and PMA were able to activate phospholipase D; furthermore, under 
these labelling conditions, it was unlikely that inositol lipids were substrates for 
this PLD activity.
4.2.3 What role does the PLD/PPH pathway play in bombesin- and 
PMA-stimuIated DG formation ?
Since both bombesin and PMA appeared to stimulate PLD activity in a 
manner consistent with it contributing to sustained increases in DG formation, 
experiments were performed to confirm that this pathway did indeed operate.
To assess the role of the PLD/PPH pathway in bombesin- and PMA- 
stimulated DG formation, the ability of butan-l-ol to inhibit DG formation was 
examined since it has been shown in neutrophils that butan-l-ol effectively 
'traps' phosphatidyl moieties as PtdBut thereby interupting the PLD/PPH 
pathway of DG formation (Bonser et al., 1989). Metz & Dunlop (1991) have
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Figure 4.11 The effect of 0.3% (v/v) butan-l-ol upon bombesin- and 
PMA-stimulated s/i-l,2-DG mass formation in Swiss 3T3 cells.
Confluent monolayers of quiescent Swiss 3T3 cells were incubated at 37° C 
for 60 min in DMBH before replacing with DMBH with (hatched bars) or without 
(open bars) 0.3% (v/v) butan-l-ol for 5 min. Incubations were started by replacing 
with DMBH alone, or with lOOnM PMA or lOOnM bombesin in the presence 
(hatched bars) or absence (open bars) of 0.3% (v/v) butan-l-ol. Incubations were 
terminated by aspiration of the medium and the addition of ice-cold methanol; after 
harvesting, the cell debris was extracted in chloroform as described in Chapter 2. 
An aliquot of the chloroform phase was dried down, solubilised in a Triton X- 
100/PtdSer mixed micelle detergent preparation and assayed for srt-l,2-DG mass 
as described in the Methods section. Samples were taken for analysis of total lipid 
phosphorous and for cell number determination. The results are expressed as mass 
of DG (pmoles of DG/106 cells, mean ± S.D., n=3) from a single experiment, 
representative of three.
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recently shown that the metabolic half-life of phosphatidylethanol in pancreatic 
islets is greater than two hours whereas that for PtdOH is only 15 min. The 
results in figure 4.11 show that whilst PMA-stimulated increases in DG mass 
were inhibited by 74 ± 14 % (n=3 determinations in triplicate) by the inclusion of 
butan-l-ol, bombesin-stimulated increases were only inhibited by some 30 ± 5 % 
(n=3) at the same concentration of the alcohol (30mM). These results suggest 
marked differences in the role of the PLD/PPH pathway in DG formation for a 
receptor-linked mitogen (bombesin) and the tumour-promoting phorbol esters.
4.2.4 The mechanism of activation of phospholipase D by 
bombesin and phorbol esters.
Because the formation of PtdBut appeared to occur after Ins(l,4 ,5 )P3 
elevation and before the second, sustained phase of DG accumulation, it seemed 
possible that PLD activation might be involved in the sustained elevation of DG 
as has been shown in other systems (Bonser et al., 1989; Huang & Cabot, 
1990a). The results in figure 4.11 suggested that this was the case for PMA and 
to a lesser extent for bombesin. Such a model would require a functional link 
between the bombesin receptor and PLD. Whilst this could be achieved by PLD 
being directly coupled to the receptor in a manner analagous to PIC, two 
observations suggested that this might not be the case. Firstly, the appearance of 
PtdBut seemed to occur more slowly than Ins(l,4 ,5 )P3 suggesting that PLD 
activation was kinetically downstream of PIC activation. Secondly, PMA, a 
potent activator of protein kinase C, could mimic the sustained accumulation of 
DG, though not to the same magnitude as bombesin (see Fig 4.4 and particularly 
Fig. 4.11), and activate PLD (Figs. 4.7, 4.8 & 4.9). Since activation of PKC is 
an early consequence of bombesin-stimulated PtdIns(4 ,5 )P2 hydrolysis, this 
suggested that PKC might represent a functional link between PtdIns(4,5)P2 
hydrolysis and activation of PLD. Furthermore, [Arg^JVp and PGF2 a , agonists 
which were able to stimulate inositol lipid hydrolysis in a similar manner to 
bombesin, were also able to stimulate PLD-transferase activity in the presence of
1 3 2
Figure 4.12 [Arg8 ]Vp and PGF2 a activate PLD transferase activity 
in Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4pCi of [^H]palmitic acid and the cells cultured for a further 48 hours. 
The medium was then replaced with DMBH for 30 min at 37°C. Incubations were 
started by replacing with DMBH alone or DMBH containing lOOnM bombesin , 
lOOnM [Arg^lVp or 2{iM PGF2 a  in the presence (hatched bars) or absence (open 
bars) of 0.3% (v/v) butan-l-ol as indicated. Incubations were continued for 15 min 
before terminating by apiration of the medium and addition of ice-cold methanol. 
Chloroform extracts were prepared and resolved on Whatman LK5DF t.l.c. plates 
as described in the Methods section. [^H]PtdBut was identified by its co-migration 
with a [14C]PtdBut standard and excised from the t.l.c. plate in 0.5 cm slices. The 
associated radioactivity was determined: results are radioactivity in [^HJPtdBut 
(d.p.m., mean ± S.D., n=3) from a single experiment, representative of two.
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butan-l-ol (Fig. 4.12). This suggested that activation of PLD might be a 
common consequence of inositol lipid hydrolysis and, therefore, activation of 
PKC or increases in [Ca2+]i. Thus, experiments were performed to investigate 
the requirement for PKC activity in the activation of PLD.
Treatment of Swiss 3T3 cells with 400nM PMA for 48 hours results in 
the depletion of cellular PKC as measured by loss of [^HJPDBu binding (Collins 
& Rozengurt, 1984), loss of susbstrate phosphorylation (Rodriguez-Pena & 
Rozengurt, 1984) and loss of the protein itself as determined by western blotting 
(Brown et al., 1990). Under these conditions, the ability of both bombesin and 
PMA to stimulate the accumulation of [^H]PtdBut was completely abolished 
compared to cells pre-treated with a DMSO vehicle containing p-phorbol (Fig. 
4.13). These results suggested that both bombesin and PMA absolutely required 
the presence of functional PKC to be able to activate PLD.
To further confirm this, a recently described analogue of staurosporine, 
Ro-31-8220, was used as a PKC inhibitor (Davis et al., 1989). Whilst acting at 
the catalytic domain of PK C, Ro-31-8220, is much more selective for PKC than 
PKA or Ca2+-calmodulin dependent protein kinase and is half-maximally 
effective at sub-micromolar concentrations. Pre-incubation of Swiss 3T3 cells 
with Ro-31-8220 for 5 min resulted in a dose-dependent inhibition of bombesin- 
and PMA-stimulated [^HJPtdBut formation (Fig. 4.14 a & b). In the case of 
PMA, Ro-31-8220 resulted in 92 ± 7% (n=4 experiments) inhibition of 
[3H]PtdBut formation at 10|iM whilst half-maximal inhibition ( IC ^ q) occurred at 
a concentration of 0.87 ± 0.43pM. The almost complete inhibition of PMA- 
stimulated [^HJPtdBut formation by Ro-31-8220 was consistent with PMA 
exerting its effects via activation of protein kinase C, agreeing with the result 
obtained in PKC-down-regulated Swiss 3T3 cells (Fig. 4.13). In contrast 
bombesin-stimulated [^H]PtdBut formation was only inhibited by 45 ± 5% (n=3) 
at 10|iM Ro-31-8220 with an apparent IC5Q value of 1.12 ± 0.47 pM.
To assess whether Ro-31-8220 might be exerting different effects at 
various stages during the response the effects of the drug were compared at
1 3 4
Figure 4.13 The effect of a 48 hour pre-treatment with 400nM PMA 
upon bombesin- and PMA-stimulated [^HJPtdBut formation in Swiss 
3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent. They were then cultured for a further 48 hours in DMEM containing 1% 
calf serum, 4pCi of [^Hjpalmitic acid and either 400nM PMA (hatched bars) or p- 
phorbol (open bars). After 48 hours the medium was replaced with DMBH for 30 
min before starting incubations by addition of DMBH containing 0.3% (v/v) butan- 
l-ol alone or with lOOnM bombesin or lOOnM PMA as indicated. Incubations 
were terminated after 2 0  min by aspiration of the medium and addition of ice-cold 
methanol; [^HjPtdBut formation was assayed as previously described after 
resolution by t.l.c. Radioactivity in [^HjPtdBut was normalised to the degree of 
labelling in total HJphospholipids which was enhanced some four-fold by the 
PMA pre-treatment. The results are expressed as radioactivity in [^HJPtdBut 
(d.p.m., mean ± S.D., n=3) from a single experiment, representative of two which 
gave qualitatively identical results.
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Figure 4.14 The effect of Ro-31-8220 concentration upon (a) PMA- 
and (b) bombesin-stimulated [^H]PtdBut formation in Swiss 3T3 
c e lls .
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4|iCi of [^HJpalmitic acid and the cells maintained for a further 48 
hours. The medium was then replaced with DMBH for 30 min at 37° C and then 
DMBH containing 0.3% (v/v) butan-l-ol and the indicated concentration of Ro-31- 
8220 for 5 min. Finally, incubations were started by addition of agonist to give 
final concentrations of lOOnM PMA (a) or lOOnM bombesin (b). After 15 min, 
incubations were terminated by aspiration of the medium and addition of ice-cold 
methanol. [^HJPtdBut formation was assayed as described in the Methods section 
after resolution by t.l.c. The results are mean radioactivity in [^HJPtdBut (d.p.m., 
mean ± S.D., n=3) from a single experiment, representative of (a) four and (b) 
three. In both cases ■  = the effect of Ro-31-8220 upon (a) PMA- and (b) 
bombesin-stimulated [^H]PtdBut formation and □  = the effect of a 0.3% DMSO 
vehicle control in the absence of agonist.
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different time points in bombesin-stimulated cells. However the results in Fig. 
4.15 indicate that Ro-31-8220 inhibited [^H]PtdBut formation by approximately 
50% at all time points tested from 15 sec to 15 min.
The inability of Ro-31-8220 to completely inhibit bombesin stimulated 
[^HJPtdBut formation suggested that this response, unlike that of PMA, might 
not be entirely mediated by PKC. Another early signal elicited by bombesin is 
the increase in [Ca2+] j , initially from an intracellular store and later by entry of 
Ca2+ into the cell (Lopez-Rivas et al., 1987; Hesketh et al., 1988). To assess 
if entry of Ca2+ was playing any part in the activation of PLD by bombesin, the 
extracellular medium concentration of Ca2+ was lowered by chelation with 
EGTA. Using a computer programme (IONS, Microsoft Basic on Apple 
Macintosh), based upon the concentration of Mg2+, Ca2+, ATP and glutamate in 
DMEM, it was calculated that inclusion of 2.5mM EGTA would result in a free 
Ca2+ concentration of 150nM. Pre-treatment of Swiss 3T3 cells with 
DMBH/EGTA for 15 min had no effect upon control [^H]PtdBut levels (Fig.
4.16). The ability of PMA to stimulate [^H]PtdBut formation was unaffected by 
the inclusion of EGTA in the incubation medium suggesting that entry of Ca2+ 
was not required for phorbol ester-stimulated PLD activity (Fig. 4.16). 
However, the ability of bombesin to stimulate H]PtdBut formation was 
inhibited by 57 ± 5 % (n=3) by the inclusion of EGTA in the incubation medium 
(Fig. 4.16).
Since increases in Ca2+ synergise with DG in activating PKC, the effect 
of Ca2+ chelation might not have been directly upon PLD but rather upon PKC 
activity. To address this, the effect of both EGTA and Ro-31-8220 upon 
bombesin-stimulated PLD activity was examined by pre-treating cells with EGTA 
in the presence or absence of the PKC inhibitor. As previously shown, pre­
treatment with Ro-31-8220 for 5 min resulted in a 45 ± 12 % inhibition of 
bombesin stimulated [^H]PtdBut formation. However, when a combination of 
Ro-31-8220 and EGTA was used, the inhibition of bombesin-stimulated 
[^HJPtdBut formation (70 ± 9 %, n=3) was not fully additive (Fig. 4.16).
Finally, to further investigate the role of Ca2+ in activation of PLD, the
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Figure 4.15 The effect of Ro-31-8220 upon the time course of 
bombesin-stimulated [^H]PtdBut formation in Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4pCi of HJpalmitic acid and the cells maintained for a further 48 
hours. The medium was replaced with DMBH for 30 min at 37°C and then DMBH 
containing 0.3% (v/v) butan-l-ol alone (■) or with 10pM Ro-31-8220 (□) for 5 
min. Incubations were started by replacing the medium with DMBH containing 
0.3% (v/v) butan-l-ol and lOOnM bombesin alone (■) or with 10|iM Ro-31-8220 
(□) and were terminated at the indicated times by aspiration of the medium and 
addition of ice-cold methanol. [^H]PtdBut formation was assayed as described in 
the Methods section. The results are expressed as radioactivity in [^HJPtdBut 
(d.p.m., mean ± S.D., n=3) from a single experiment, representative of two.
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Figure 4.16 The effect of EGTA and Ro-31-8220, alone and in 
com bination, upon PMA- and bom besin-stim ulated [^HjPtdBut 
formation in Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4pCi of [^Hjpalmitic acid and the cells maintained for a further 48 
hours. The medium was then replaced with DMBH for 15 min at 37°C and then 
DMBH containing 0.3% (v/v) butan-l-ol alone (open bars) or with 2.5mM EGTA 
(hatched bars) for 15 min. In some experiments, as indicated, lOjiM Ro-31-8220 
was included in the last 5 min of pre-incubation. Incubations were started by 
replacing with DMBH alone (open bars) or with EGTA (hatched bars) in the 
presence or absence of Ro-31-8220 and containing lOOnM PMA or lOOnM 
bombesin as indicated. Incubations were continued for 20 min and were terminated 
by aspiration of the medium and addition of ice-cold methanol. [^H]PtdBut 
formation was assayed as described previously. The results are expressed 
radioactivity in [^H]PtdBut (d.p.m., mean ± S.D., n=3) from a single experiment, 
representative of three.
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Figure 4.17 The effect of EGTA and Ro-31-8220, alone and in 
combination, on A23187-stimulated [3 H]PtdBut formation in Swiss 
3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent when the medium was replaced with 2ml of DMEM containing 1% calf 
serum and 4}iCi of [^Hjpalmitic acid and the cells maintained for a further 48 
hours. The medium was replaced with DMBH for 15 min at 37°C and then DMBH 
containing 0.3% (v/v) butan-l-ol alone (open bars) or with 2.5mM EGTA (hatched 
bars) for 15 min. Where indicated, IOjiM Ro-31-8220 was included in the last 5 
min of pre-incubation. Incubations were started by replacing the medium with 
DMBH alone (open bars) or with EGTA (hatched bars) in the presence or absence 
of Ro-31-8220 and 5|iM A23187 as indicated. Incubations were continued for 20 
min and terminated by aspiration of the mediumand addition of ice-cold methanol. 
[^HjPtdBut formation was assayed as described previously. The results are 
expressed as radioactivity in [^HjPtdBut (d.p.m., mean ± S.D., n=3) from a single 
experiment representative of two.
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ability of the calcium ionophore A23187 to stimulate [^H]PtdBut formation was 
examined. Addition of A23187 to [^HJpalmitate-labelled Swiss 3T3 cells in the 
presence of butan-l-ol resulted in the formation of [^H]PtdBut over a 15 minute 
incubation (Fig. 4.17) indicating that an increase in intracellular [Ca2+] was able 
to activate PLD. However, the previous results in Swiss 3T3 cells pre-treated 
with high doses of PMA (Fig 4.13) or Ro-31-8220 (Fig. 4.14) had indicated a 
role for PKC in the activation of PLD. Since Ca2+ is involved in the activation 
of PKC, it was necessary to investigate if the increase in PLD activity stimulated 
by A23187 might simply represent Ca2+-mediated activation of PKC rather than 
a direct effect upon the PLD. To address this issue HJpalmitate-labelled Swiss 
3T3 cells were pre-treated with lOjiM Ro-31-8220 for 5 min in the presence of 
0.3% (v/v) butan-l-ol before addition of A23187. Such a treatment resulted in a 
58 ± 14 % (n=2) inhibition of A23187 stimulated [^HjPtdBut formation (Fig.
4.17) suggesting that at least half of the A23187 response was due to Ca2+ 
induced PKC activation of PLD. Suprisingly, the chelation of extracellular Ca2+ 
did not entirely inhibit the response to A23187; 55 ± 20 % (n=2) of the response 
was inhibited by the inclusion of EGTA. However, combination of both EGTA 
and Ro-31-8220 resulted in the majority of the response to A23187 (82 ± 18 %, 
n=2) being inhibited (Fig. 4.17).
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4.3 D iscu ssion .
The results presented in this chapter allow three major conclusions to be 
reached:
(1) Bombesin stimulates a biphasic increase in DG; the sustained phase is 
partially mimicked by phorbol esters.
(2) Both bombesin and PMA stimulate phospholipase D activity. The kinetics of 
PLD activation are consistent with a role in the sustained phase of DG elevation, 
but there are marked differences between bombesin and PMA in the contribution 
made by a PLD/PPH pathway to DG formation.
(3) Activation of phospholipase D appears to be largely dependent upon protein 
kinase C activity which may therefore represent a major link between 
PtdIns(4 ,5 )P2 hydrolysis and PLD activation.
4.3.1 Bombesin stimulates a biphasic increase in DG mass in 
Swiss 3T3 cells.
In Chapter 3, results were presented to indicate that bombesin-stimulated 
increases in Ins(l,4 ,5 )P3 mass were transient and returned to pre-stimulated 
levels within 30 sec (Fig. 3.4). However, a number of the early mitogenic 
signals associated with the inositol lipid pathway are sustained for some time 
after Ins(l,4 ,5 )P3 levels and the initial rapid increase in [Ca2+]j have declined, 
including phosphorylation of an 80 kDa PKC substrate (Isacke et al.y 1986; 
Erusalimsky et al.y 1988) and increases in pHj (Bierman et al.y 1990), whereas 
others occur tens of minutes later e.g., increases in c-fos and c-myc mRNA 
(Sinnett-Smith & Rozengurt, 1987). Since many of these events are particularly 
associated with the DG/PKC arm of the signal pathway, the kinetics of increases 
in DG mass were compared with those of Ins(l,4 ,5 )P3 mass.
Fig.4.1 shows that there were two kinetically distinct phases of DG mass 
accumulation in response to bombesin stimulation. The initial increase, peaking 
at 5 to 10 sec before declining at 30 sec, mirrored the transient increase in 
Ins(l,4 ,5 )P3 mass, presumably because they are both derived from PIC-
1 4 2
catalysed hydrolysis of PtdIns(4 ,5 )P2 . However, the mass of DG generated in 
this early phase exceeded, by at least four-fold, the mass of Ins(l,4 ,5 )P3 
formed. This might represent evidence for receptor-stimulated Ptdlns hydrolysis 
which would generate DG without a concomitant increase in Ins(l,4 ,5 )P3 . 
Alternatively, it may simply be that the removal of Ins(l,4 ,5 )P3 by the 5'- 
phosphatase and 3-kinase is so rapid that the effective half life of Ins(l,4 ,5 )P3 is 
much shorter than that for DG resulting in an under-estimation of mass increases. 
The equally rapid drop in DG mass from 5 sec to 30 sec or 1 minute is consistent 
with its rapid removal by DG kinase and/or lipase. In particular, since the DG 
from PtdIns(4 ,5 )P2 hydrolysis is likely to be l-stearoyl-2-arachidonoyl (Pessin 
& Raben, 1989), this rapid removal of DG may reflect the high activity of a 
membrane-associated DG kinase selective for arachidonoyl-containing DG as 
reported in Swiss 3T3 cells by MacDonald et al. (1988). Equally the rapid 
increase in free arachidonic acid in Swiss 3T3 cells in response to bombesin may 
represent rapid, coupled activation of DG lipase and MG lipase or direct 
activation of PLA2 (S. Currie & M.J.O. Wakelam, unpublished results).
The transient nature of the first phase of DG formation was consistent 
with the transient increase in Ins(l,4 ,5)P3 and PtdIns(4 ,5 )P2 hydrolysis and yet 
from between 30sec and 1 min onwards DG levels rose again in response to 
continued bombesin stimulation. This second phase was sustained for at least 30 
min (Fig 4.1b) and in some cases 60 min (data not shown) whilst a recent report 
from Takuwa et al. (1989) has shown that bombesin-stimulated increases in DG 
mass in Swiss 3T3 cells are sustained above control for at least 4 hours. Whilst 
the pronounced initial 'spike' of DG formation was not always as clearly 
resolved from the second phase (Fig 4.2), DG levels were reproducibly 
maintained above control long after Ins(l,4 ,5 )P3 levels had declined. The 
magnitude of the second phase was variable but was generally greater than that of 
the first and this is perhaps consistent with the second phase being derived from a 
potentially larger lipid pool than PtdIns(4 ,5 )P2 ; candidates for this pool might be 
Ptdlns or other phospholipids such as PtdCho.
There are two potential reasons for the sustained increase in DG mass:
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either that the DG derived from PtdIns(4 ,5 )P2 hydrolysis was not removed as 
rapidly as Ins(l,4 ,5 )P3 or that DG was being generated from another source. 
Since in most experiments there was a distinct initial peak of DG formation which 
declined before rising again in a second phase of DG accumulation argues against 
the former possibility as does the observation of a high DG kinase activity in 
Swiss 3T3 membranes (MacDonald et al., 1988). Thus it would seem that the 
second phase of DG formation, which is sustained, divorced from net formation 
of Ins(l,4 ,5 )P3 » and occurs at a time at which PtdIns(4 ,5 )P2 hydrolysis is 
apparently desensitized, is derived from an alternative source. These results are 
not without precedent, either within the Swiss 3T3 cell line or in other cell lines. 
Takuwa et al. (1987a) have previously shown that bombesin stimulated a 
sustained increase in DG levels in Swiss 3T3 cells; however, the earliest 
timepoint which they examined was 15 sec by which time DG levels are declining 
(Fig 4.1a), explaining why they were unable to detect biphasic kinetics. In 
addition, Wright et al. (1988) have demonstrated pronounced biphasic kinetics 
of DG formation in response to a-thrombin stimulation of IIC9 fibroblasts. In 
this case the two phases of DG formation exhibited quite different dose- 
dependency; thus, with 500ng/ml a-thrombin Wright et al. (1988) observed a 
clear biphasic response whilst using lOOpg/ml they were only able to detect the 
second sustained phase of DG formation. Furthermore, at the lower 
concentrations a-thrombin did not stimulate increases in [^l|lnsP3 or arachidonic 
acid. This raises the intruiging possibility that the two phases of DG formation 
may be associated with activation of different receptor subtypes with different 
affinities for the same ligand. Whether this is the case in Swiss 3T3 cells 
stimulated with bombesin is not clear since the dose-dependency for the two- 
phases of bombesin-stimulated DG formation whilst not identical were not as 
strikingly different as that for a-thrombin (Fig. 4.3). The BC5q for bombesin- 
stimulated DG formation at 5 sec (2.04 ± 1.68 nM) was of a similar order to that 
for Ins(l,4 ,5 )P3 formation (5.88 ± 3.66 nM), again suggesting that the two were 
derived from the same source. The EC5Q for DG formation after a 5 or 15 min 
exposure to bombesin (0.48 ±0.15 nM) was not significantly different from that
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at 5 sec but was clearly sub-nanomolar. This may warrant further examination 
by performing timecourses at different concentrations of bombesin as described 
for a-thrombin (Wright et al., 1988). Alternatively, if PKC is involved in the 
initiation of the second phase of DG elevation the lower EC^q may be due to the 
amplification of the response by PKC resulting in a lower effective concentration 
required to give the same response.
The observation that addition of PMA to Swiss 3T3 cells stimulated an 
increase in DG mass, with kinetics very similar to the sustained phase of the 
bombesin response (Fig. 4.4), confirms the initial observation of Takuwa et 
a/.(1987b) and is of great interest in the context of its mitogenic effects. PMA 
circumvents receptor activation and inositol lipid hydrolysis by entering the cell 
and, acting as a DG analogue, binding to and activating PKC (Castagna et al.y 
1982). The observed increase in DG in response to PMA was not accompanied 
by accumulation of inositol phosphates (Chapter 3, Fig. 3.9) suggesting that the 
DG was derived from a non-inositide source. Indeed, the timecourse of 
increases in DG formation in response to PMA was similar to the timecourse for 
inhibition of bombesin-stimulated InsPt accumulation (Chapter 3, Fig. 3.7) 
suggesting that the two events were related, presumably through the action of 
PKC. This is supported further by the fact that the EC50  for PMA-stimulated 
increases in DG mass (Fig 4.4b 2.6 ± 0.59 nM) is essentially the same as the 
IC50  for PMA mediated inhibition of bombesin-stimulated inositol phosphate 
accumulation (Brown et al.y 1987; Chapter 3 of this thesis).
Since the sustained elevation of DG in response to bombesin and PMA 
was clearly not associated with the accumulation of Ins(l,4 ,5)P3 or [^H]Inst 
respectively, further experiments sought to define the kinetics of DG formation in 
Swiss 3T3 cells isotopically labelled so as to largely exclude the inositol lipids as 
a possible source. Since the inositol lipids, and particularly the 
polyphosphoinositides, are defined by a l-stearoyl-2 -arachidonoyl composition, 
[^HJpalmitic acid was chosen to label PtdCho, PtdEtn & PtdSer preferentially 
over Ptdlns. The results in Fig. 4.5 show that after a 49 hour incubation with
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[^Hjpalmitic acid all the major phospholipids had been labelled to a constant 
specific activity. Furthermore, they show that the label was initially incorporated 
into PtdCho suggesting that PtdCho was a metabolically active pool of palmitate- 
containing phospholipid. The rapid increase in labelling of PtdCho was followed 
by a slower incorporation into the other phospholipid classes which may serve to 
distribute fatty acids to other lipids. Table 4.1 shows that after 49 hours the 
majority of [^Hjpalmitic acid incorporated into total phospholipids was in 
PtdCho (50%) with only 3% of the label in Ptdlns. Whilst incorporation into the 
polyphosphoinositides was not analysed it is likely to be negligible since they are 
minor components of total cellular inositol lipids which themseleves make up less 
than 10% of the total cell phospholipid and are characterised by a l-stearoyl-2 - 
arachidonoyl fatty acid composition. Clearly, this protocol allowed preferential 
labelling of PtdCho, PtdEtn and PtdSer and was therefore used to determine if 
phorbol esters could stimulate an increase in [^H]DG under these conditions.
The formation of [^H]DG in response to PMA exhibited very similar 
kinetics to the increases in DG mass (Fig. 4.6) but were of smaller magnitude. 
Taken together with the lack of inositol phosphate accumulation this result 
confirms that phorbol esters are able to increase DG levels in cells from a non- 
inositide source since under these conditions Ptdlns was poorly labelled.
Since bombesin-stimulated inositol lipid hydrolysis and DG formation 
will necessarily result in activation of PKC, which will also result from PMA 
stimulation, it seems likely that a consequence of PKC activation will be to 
stimulate the hydrolysis of a non-inositide lipid which may serve as the source 
for the second phase of DG formation. In addition to the observation that PMA 
does not stimulate inositol lipid hydrolysis, evidence in support of the sustained 
phase of DG formation being derived from an alternative phospholipid source has 
been provided most conclusively from the work of Pessin & Raben (1989). By 
analysing the molecular species of DG in a-thrombin-stimulated IIC9 fibroblasts 
by gas chromatography they have shown that the fatty acid composition of DG 
was similar to that of Ptdlns in the first 15 sec of stimulation whereas DG 
produced at 5 and 60 min stimulation was derived from PtdCho. In addition,
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Muir & Murray, (1987) and Takuwa et al.(1987) have shown that stimulation of 
Swiss 3T3 cells with bombesin or PMA results in the formation of DG which is 
associated with the increased metabolic turnover of PtdCho.
4.3.2 Bombesin and PMA stim ulate phospholipase D activity in 
Swiss 3T3 cells.
Since the elevation in DG levels could conceivably be due to the action of 
phospholipases C or D the ability of PMA or bombesin to stimulate increases in 
[^H]PtdBut was examined as an assay of PLD activity. The formation of 
[3 H] PtdOH was not used since it was not a definitive assay for PLD activity and 
the high basal counts associated with [^H]PtdOH meant that only small increases 
were apparent making this is a relatively insensitive assay. Whether the high 
degree of labelling of [^HjPtdOH indicates that palmitate is a major constituent of 
PtdOH or that there are hormone-sensitive pools of phospholipid which are 
poorly enriched with palmitate is not clear. Other groups have used the same 
t.l.c. methodology described here to resolve PtdOH from cells labelled with 
H]oleic or [^Hjmyristic acid with much lower associated radioactivity (Huang 
& Cabot, 1990 a & b; Liscovitch & Amsterdam, 1989). This again suggests that 
there may be a distinct pool of phospholipid, made up of certain fatty acids, 
which is sensitive to hormone stimulation as has been suggested by Pessin et al. 
(1990). To more clearly define the kinetics of PtdOH formation it seems likely 
that either a convenient and reliable mass assay must be developed or some form 
of isotopic labelling and t.l.c. separation protocol analagous to that described by 
Billah et al. (1989b) but suitable for all cell types. Since some small increases in 
[3 H] PtdOH were seen in response to PMA which exhibited similar kinetics to DG 
formation the possibility of activation of PLD was examined.
To investigate if stimulation by PMA or bombesin resulted in activation of 
PLD the ability of Swiss 3T3 cells to form phosphatidylalcohols was assessed. 
As previously described PLD can catalyse the formation of phosphatidylalcohols 
by its phosphatidyltransferase activity in the presence of low, non-cytotoxic,
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concentrations of primary alcohols such as ethanol and butan-l-ol. Whilst this is 
probably of little physiological relevance it serves as a useful marker for PLD 
activity in whole cells since it is not formed by any other pathway in cells 
including base-exchange (Kanfer, 1980), a putative alcohol kinase/CDP-alcohol 
transferase pathway (Pai et al., 1988a), or by transfer of alcohols on to CMP- 
PtdOH (Pai et al., 1988a).
Preliminary experiments confirmed that stimulation of [^H]palmitate- 
labelled Swiss 3T3 cells with bombesin or PMA in the presence of non-cytotoxic 
concentrations of butan-l-ol resulted in the formation of a [^H]PtdBut as 
confirmed by its co-migration with various authentic PtdBut 'standards' (Fig 4.7, 
a & b) and by the absolute dependency upon butan-l-ol concentration (Fig 4.8). 
These experiments allowed the unequivocal identification of [^H]PtdBut 
formation, and therefore PLD activity, in response to bombesin and PMA in 
Swiss 3T3 cells and optimised the conditions for maximal cellular responsiveness 
without adverse effects by butan-l-ol.
Stimulation of Hjpalmitate-labelled Swiss 3T3 cells with PMA resulted 
in increases in [^H]PtdBut (Fig. 4.9) which were significantly above control 
after 1 min and continued in a near linear fashion for up to 30 min suggesting that 
the response was not desensitized since phosphatidylalcohols are poor substrates 
for PPH (Billah et al., 1989b; Bonser et al., 1989; Metz & Dunlop, 1991). 
Over the same time course the small increase in [^H] PtdOH levels increased at 1 
and 2 min but then reached a plateau, suggesting that PMA-stimulated 
[3 H] PtdOH produced by PLD activity is then removed, presumably by PPH. 
Additional evidence for [^HJPtdOH produced by PLD activity being the 
precursor of DG comes from the observation that formation of [^H]PtdBut 
clearly precedes [^H]DG formation; the former being significantly elevated at 
lmin whilst the latter was increased between 1 and 2 min. Since the kinetics of 
PLD activation preceded the onset of PMA-stimulated [^H]DG formation the 
normal product of PLD, PtdOH, could be a precursor for [^H]DG (Martin, 1988; 
Billah et al., 1989b); this may also explain why increases in PtdOH were so
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hard to detect since in this case the molecule would be rapidly de-phosphorylated 
by PPH. Furthermore, the EC50 for PMA-stimulated [^HjPtdBut formation was 
virtually identical to that for PMA-stimulated DG formation suggesting that both 
arose from the phorbol ester interacting at a common site.
Stimulation [^HJpalmitate-labelled Swiss 3T3 cells with bombesin 
resulted in the time- and dose-dependent formation of [^H]PtdBut (Fig. 4.10, a 
& b). Bombesin-stimulated increases in [3H]PtdBut were apparent as early as 15 
sec (Fig 4.15) after addition of bombesin and rose rapidly from 30 sec to 2 min 
after which the rate of increase was greatly reduced but sustained in some cases 
up to 15 min (Fig. 4.10a). The drop in the rate of [^H]tdBut formation after 2 
min may reflect desensitization. However, the observation that the levels of 
[^HJPtdBut continued to rise from 2 to 15 min in some experiments, albeit at a 
reduced rate, questions whether this desensitization was complete. The levels of 
[^HJPtdBut remained unchanged in the absence of bombesin indicating that PLD 
activity was largely ligand-dependent, occurring at a very slow rate in 
unstimulated cells.
The EC50  for bombesin stimulated [^HJPtdBut formation (Fig 4.10b) 
was of a very similar order to that for previously described parameters such as 
Ins(l,4,5)P3 and DG formation, as well as [3 H]InsPt accumulation, suggesting 
that all these events were perhaps mediated through the same population of 
receptors.
In the case of bombesin, using [^H]PtdBut formation as an indicator of 
PLD activation, there was a clear temporal dissociation of PLD activation from 
Ins(l,4,5)P3 formation and the second phase of bombesin-stimulated DG 
formation. Thus, bombesin-stimulated [^HjPtdBut formation was apparent after 
15 sec at which time Ins(l,4,5)P3 mass formation and the first phase of DG 
formation were declining from their peak values. Despite this, [^HJPtdBut 
formation preceded the onset of the second phase of bombesin-stimulated DG 
formation, again arguing that PLD activation and therefore PtdOH formation, 
occurred prior to, rather than as a consequence of, the sustained elevation of DG. 
This together with the fact that the EC5 Q values for bombesin-stimulated
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Ins(l,4 ,5 )P3 » DG mass and [^HJPtdBut formation were essentially the same 
suggested that the activation of PLD might occur via the same receptor as that 
stimulating inositol lipid hydrolysis, but downstream of this event. As such the 
PtdOH normally produced by PLD activity might serve as the precursor of the 
second phase of DG formation. In such a scenario a link between the two 
phospholipases would be required and since PMA can stimulate both PLD and a 
sustained increase in cellular DG content in the absence of inositol lipid 
hydrolysis this would suggest that protein kinase C may represent such a link 
between transient, PtdIns(4 ,5)P2 -derived and sustained, PLD/PPH-derived DG 
formation.
4.3.3 The PLD/PPH pathway makes different contributions to 
bombesin- and PMA-stimulated DG formation.
The use of ethanol or butan-l-ol to inhibit DG formation has been 
demonstrated by a number of groups in various cells types (e.g., Bonser et al., 
1989; Huang & Cabot, 1990a). Since the phosphatidylalcohol formed by the 
transferase reaction of PLD is a poor substrate for PPH (Billah et al.y 1989b; 
Bonser et al.y 1989; Metz & Dunlop, 1991) the inclusion of butan-l-ol 
effectively interrupts the PLD/PPH pathway of DG formation. Perhaps the most 
significant observations have been by Bonser et al. (1989) who showed that 
butan-l-ol caused a dose-dependent inhibition of f-Met-Leu-Phe-stimulated DG 
formation in the human neutrophil which correlated with a loss of PtdOH 
formation and the appearance PtdBut. Furthermore, over the same dose range, 
butan-l-ol inhibited f-Met-Leu-Phe-stimulated 0 2'  generation indicating that the 
PLD/PPH pathway of DG formation was required for the physiological 
response, the oxidative burst.
Since the kinetics of PLD activation in response to both PMA and 
bombesin suggested that the PLD/PPH pathway could make a contribution to 
sustained DG elevation, the ability of butan-l-ol to inhibit DG formation by both
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agonists was examined. The results in Fig. 4.11 indicate striking differences 
between PMA and bombesin in the role of the PLD/PPH pathway of DG 
formation. The presence of butan-l-ol at 0.3% (v/v), a concentration giving 
maximal [^HJPtdBut formation, resulted in inhibition of 76 ± 14% of PMA- 
stimulated DG formation suggesting that the major pathway was that of 
PLD/PPH. In contrast, at the same concentration of butan-l-ol, only 30 ± 5% of 
bombesin-stimulated DG formation was inhibited suggesting that the PLD/PPH 
pathway was of less quantitative importance for bombesin-stimulated diglyceride 
generation.
These results are of interest for a number of reasons. Firstly, they 
suggest that the PMA-stimulated increase in [^HjPtdBut does indeed reflect PLD 
activity and that the normal product, PtdOH, would usually be dephosphorylated 
to DG. As such this would confirm the reports in a wide variety of cell types that 
phorbol esters do activate PLD (Huang & Cabot, 1990a; Martin et al., 1990; 
reviewed by Billah & Anthes, 1990). However, it seems likely that not in all 
cases will the PtdOH produced by PLD activity serve as the precursor of DG by 
the PPH reaction. Huang & Cabot (1990a) showed that PMA is able to activate 
PLD in a variety of cell lines including MDCK epithelial cells, bovine pulmonary 
endothelial cells and two smooth muscle cell lines. However, in the smooth 
muscle cell lines they were unable to demonstrate inhibition of PMA-stimulated 
DG formation by ethanol suggesting that in these cell lines the purpose of PLD 
activation is not to form DG by the PLD/PPH pathway. The demonstration that 
30% of the bombesin-stimulated DG formation is inhibited by butan-l-ol 
indicates that some of the sustained DG formation is occurring via the PLD/PPH 
pathway; however, in comparison with PMA this is clearly a minor pathway. 
This may reflect the observation that bombesin-stimulated PLD activity is 
essentially transient (Fig. 4.10); [^HJPtdBut formation was rapid in onset up to 2 
min but was then greatly reduced from 2 min onwards. The effect of butan-l-ol 
upon bombesin-stimulated DG formation was assessed at 15 min when PLD 
activity was desensitised; it will be of interest to examine the effect of butan-l-ol 
upon DG formation at earlier points in the bombesin time course when PLD
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activity is still maximal (e.g., 1-1.5 min).
Since the assay for [^H]PtdOH formation was not of adequate sensitivity 
it was not possible to determine if the differences between bombesin and PMA 
were due to butan-l-ol not completely inhibiting bombesin-stimulated PtdOH 
formation. Such an explanation seems unlikely since 0.3% butan-l-ol resulted in 
maximal [^HJPtdBut formation for both agents suggesting that butan-l-ol was 
competing with water to the same extent in both bombesin- and PMA-stimulated 
PLD reactions. For this reason these results must be considered preliminary and 
should be confirmed by studying the inhibition of PtdOH formation by butan-l- 
ol as well as the effect of proposed inhibitors of PPH. However, with these 
caveats in mind, the results suggest that in comparison with PMA the PLD/PPH 
route is a relatively minor pathway of bombesin-stimulated DG formation 
indicating that the action of PMA is not simply to mimic the second phase of 
bombesin-stimulated DG formation, some of which may be formed by an 
additional pathway. The studies of Huang & Cabot (1990) suggest that an 
alternative pathway may be a PtdCho-PLC acting in parallel with the PLD activity 
described above. In addition there remains the observation that accumulation of 
[^H]InsPt in response to bombesin continued for up to 30 min (Fig. 3.1a) and 1 
hour (data not shown) and this may also contribute to sustained bombesin- 
stimulated DG accumulation after PLD activity is largely desensitised.
4.3.4 A role for PKC in activation of phospholipase D ?
Evidence for a role for PKC in the activation of phospholipase D is 
widespread having been reported in neutrophils (Billah et a/., 1989a), HeLa 
cells (Hii et al., 1989), pulmonary endothelial cells (Martin et al.y 1990), 
NIH3T3 cells (Ben-Avi & Liscovitch, 1989) and NG108-15 cells (Liscovitch, 
1988). Studies have typically involved the use of phorbol esters and cell 
permeant DG analogues, PKC inhibitors such as staurosporine and H7 (Huang 
& Cabot, 1990b; Liscovitch & Amsterdam, 1989) and also the use of chronic 
treatment with high doses of phorbol ester to down-regulate PKC (e.g.,
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Liscovitch & Amsterdam, 1989). Addition of both bombesin and PMA to Swiss 
3T3 cells results in the rapid activation of PKC as assayed by phosphorylation of 
an 80kDa phosphoprotein (Kazlauskas & Cooper, 1988; Erusalimsky et al.,
1988). Since both [Arg^JVp and PGF2 a  were able to activate PLD (Fig 4.12) 
and appeared to stimulate inositol lipid hydrolysis by similar mechanisms it 
seemed possible that activation of PLD might occur through a common pathway 
via activation of PKC.
To address the question of whether PKC was involved in the activation of 
PLD by bombesin and PMA, Swiss 3T3 cells were pre-treated for 48 hours with 
400nM PMA to down-regulate PKC. The fact that under these conditions the 
ability of both mitogens to stimulate [^H]PtdBut formation was completely 
abolished (Fig. 4.13), suggests an absolute requirement for PKC in the activation 
of PLD. A simple working hypothesis to fit this observation might be that 
activation of PKC resulting from the first phase of bombesin-stimulated DG 
formation might lead to the phosphorylation of PLD resulting in its activation. 
To confirm such an idea use was made of a recently described PKC inhibitor, 
Ro-31-8220 (Davis et al., 1989). The observation that pre-treatment of Swiss 
3T3 cells with Ro-31-8220 for 5 min resulted in the dose-dependent, near total, 
inhibition of PMA-stimulated [^HJPtdBut formation (Fig 4.14a) is consistent 
with the result in down-regulated cells suggesting that PMA exerts its effect upon 
PLD by activation of PKC. This is supported by the IC50 value for inhibition of 
the PMA response (0.87 ± 0.43 pM) which was similar to the value for 
inhibition of PKC by Ro-31-8220 in an in vivo assay (Davis et al., 1989). 
However, in the same series of experiments, using the same stock preparation of 
the inhibitor, bombesin-stimulated [^HJPtdBut formation was only inhibited by 
approximately 50% (Fig 4.14b), with the same IC^q value (1.12 ± 0.47 pM), 
and yet, like PMA, the response to bombesin was completely abolished in down- 
regulated cells. This 50% inhibition of bombesin-stimulated [^H]PtdBut 
formation was observed at all stimulated time points tested, from 15 sec (Fig 
4.15) to 15 min (Fig 4.14), ruling out the possibility of a PKC-independent PLD 
activity which was only observed at early times in the time course. These results
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cannot easily be reconciled with a simple model in which activation of PKC as a 
consequence of PtdIns(4 ,5 )P2 hydrolysis is solely responsible for the activation 
of PLD and, therefore, the sustained generation of DG.
There may be a number of possible explanations for the apparently 
anomalous results obtained using both PKC 'down-regulation' and PKC 
inhibitors as approaches in defining PKC-dependent PLD activity. Perhaps one 
potential model lies in the idea that PMA may not exert all its effects via activation 
of PKC; this has also been suggested by Billah and co-workers (Billah & 
Anthes, 1990) and is supported by the discovery of novel non-PKC type phorbol 
ester receptors (Ahmed et al., 1990). If PMA is able to bind to PLD and activate 
it in a manner analagous to its activation of PKC then PLD might also be 'down- 
regulated' and this could explain the loss of PLD activity stimulated by both 
bombesin and PMA. Again, however, this model does not account for the total 
inhibition of PMA-stimulated PLD activity by the PKC inhibitor Ro-31-8220 
which suggests that the effects of PMA can be accounted for solely by activation 
of PKC.
The fact that Ro-31-8220 inhibition of bombesin-stimulated PLD activity 
was only ever approximately 50% of the total maximum response implies that at 
least some of the response might be activated by a PKC-independent pathway. 
Alternatively the observation that PKC is now known to constitute a large family 
of isozymes with different properties may point to bombesin-stimulated PLD 
activity being mediated by an isozyme which is sensitive to down-regulation but 
relatively less sensitive to Ro-31-8220. To examine whether some of the 
bombesin-stimulated PLD activity could be accounted for by PKC-independent 
mecahnisms its dependency upon extracellular Ca2+ concentration, and therefore 
Ca2+ entry, was examined.
The 57 ± 5 % inhibition of bombesin-stimulated PLD activity by the 
buffering of extracellular Ca2+ to approximately 140 nM (Fig 4.16) suggests that 
increases in intracellular Ca2+ play some role in regulation of PLD activity per  
se. The major problem in interpreting such results is that it is not clear whether
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the inhibition of PLD activity is due to loss of Ca2+ entry , loss of Ca2 + 
mobilization from intracellular stores due to their depletion during the EGTA 
treatment period, or depletion of intracellular Ca2+ which is required as a co- 
factor for PLD but does not, alone, activate or stimulate the enzyme.
Although A23187-stimulated increases in [Ca2+]j stimulated [^H]PtdBut 
formation this does not mean that PLD is simply activated by Ca2+ which could 
exert its effects at some other site. For example, it is known that increases in 
[Ca2+]j are involved in activation of PKC which has already been shown to play 
a role in activation of PLD (Figs. 4.13 and 4.14). The ability of A23187 to 
activate PLD alone (Fig. 4.17) indicates that increasing [Ca2+]j will activate PLD; 
however the 58 ± 14 % inhibition of A23187-stimulated PLD activity by pre­
treating cells with Ro-31-8220 suggests that at least half of this response may be 
due to Ca2+-induced activation of PKC which is then responsible for activating 
PLD. This is supported further by the fact that the inhibition of bombesin- 
stimulated PLD activity by EGTA or Ro-31-8220 is not greatly enhanced by 
combination of the two treatments suggesting that they are acting at the same site; 
in the presence of EGTA and Ro-31-8220 30 ± 9 % of the bombesin response 
remained intact (Fig. 4.16). A simple model to explain this might suggest that 
bombesin-stimulated increases in DG and Ca2+ entry due to bombesin-stimulated 
PtdIns(4 ,5)P2 hydrolysis cooperate to stimulate PKC which is then responsible 
for activation of PLD. However, the results in Fig. 4.16 suggest that this cannot 
be a full explanation since there is still residual bombesin-stimulated PLD activity 
in the presence of Ro-31-8220 and EGTA whilst some A23187-stimulated PLD 
activity remains in the presence of Ro-31-8220 (Fig. 4.17). Thus it seems 
possible that some of the effects of increased [Ca2+]j upon PLD activity may be 
independent of PKC and represent effects upon PLD itself.
In some experiments the ability of A23187 to stimulate [^H]PtdBut 
formation was not completely inhibited by the chelation of extracellular Ca2+ 
with EGTA. At first site this is an unusual result since the role of A23187 is to 
transport Ca2+ into the cell and so chelation of Ca2+ would be expected to inhibit 
its effects completely. There may be two possible explanations for this. Firstly,
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there was no access to a Ca2+ electrode to confirm the final concentration of 
Ca2+ in DMBH/EGTA and thus there may have been a higher than calculated 
[Ca2+]0 allowing sufficient to be taken into the cell for activation of PLD, by 
whatever means. Secondly, A23187 acts by carrying Ca2+ ions across 
membranes; it is possible that some of the ionophore entered the cell and actually 
carried Ca2+ out of intracellular stores into the cytosol thereby overcoming the 
depletion of extracellular Ca2+.
It seems likely that a definition of the roles played by Ca2+ entry and 
Ca2+ mobilization will require the use of specific drugs which inhibit plasma 
membrane Ca2+ channels as well as the use of thapsigargin, a potent inhibitor of 
the endoplasmic reticulum Ca2+-ATPase, which will allow depletion of the 
Ins(l,4,5 )P3 -sensitive Ca2+ store. Treatment of cells with thapsigargin results 
in a small increase in [Ca2+]j but results in the inhibition of subsequent 
Ins (1,4,5)P3-stimulated Ca2+ mobilisation (Thastrup et a l,  1990). In addition 
agents such as BAPTA may be used which will allow buffering of changes in 
[Ca2+]j and so prevent any input from release of intracellular stored Ca2+. Such 
approaches should allow future definition of the relative importance of Ca2+ 
mobilization from intracellular stores and Ca2+ entry on activation of PLD. What 
is clear is that there may be marked differences in the role of Ca2+ in activation of 
PLD in different cell types. For example in neutrophils (Agwu eta l., 1989) and 
in human erythroleukaemia cells (Halenda et al., 1990) A23187 seems to be 
even more effective at activating PLD than PMA. In Swiss 3T3 fibroblasts the 
role of Ca2+ seems to be subordinate to that of the DG/PMA-PKC signal. Quite 
how these differences in activation of PLD correlate with the physiological 
responses of these cell to the various agonists is not clear.
In addition to the possible role of Ca2+ entry in PLD regulation, there 
remains the observation that bombesin-stimulated PLD activity is still apparent in 
the presence of both EGTA and Ro-31-8220. Whether this points to a possible 
direct coupling of receptor to PLD independently of inositol lipid hydrolysis, 
activation of PLD by Ca2+ mobilised from Ins( 1,4,5)P3-sensitive intracellular
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stores or a role for DG or arachidonic acid in activating PLD is not clear and 
future studies should aim to address these points.
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Chapter 5.
Hydrolysis of phosphatidylcholine by phospholipase D is a 
common response to mitogens which stimulate inositol 
lipid hydrolysis in Swiss 3T3 cells.
5.1 Introduction.
In the previous chapters results have been presented to show that bombesin 
stimulates a biphasic increase in cellular DG content; the first corresponds to the 
transient elevation of Ins(l,4 ,5 )P3 mass whilst the second phase is sustained and 
divorced from any elevation of Ins(l,4 ,5 )P3 . The sustained phase is mimicked by 
addition of phorbol esters but this occurs in the absence of inositol lipid hydrolysis; 
indeed PMA inhibits bombesin-stimulated inositol lipid hydrolysis. Kinetic and 
functional studies suggest that some part of this sustained phase of DG formation 
may occur via a PLD/PPH pathway which is mediated in part by prior activation of 
PKC. Furthermore, it seems likely that the substrate for this mitogen stimulated 
PLD is a non-inositide phospholipid.
Since the sustained elevation of DG stimulated by bombesin and phorbol 
ester is essentially divorced from inositol lipid hydrolysis it is important to identify 
the phospholipid source. In theory any glycerophospholipid may serve as a source 
of DG either directly by PLC-catalysed hydrolysis or via the PLD/PPH pathway. A 
number of recent studies have reported that phosphatidylcholine (PtdCho) 
hydrolysis and synthesis are increased in response to a variety of stimuli (Billah & 
Anthes, 1990). Consequently studies were undertaken to see if PtdCho hydrolysis 
was enhanced by mitogenic stimuli in Swiss 3T3 cells.
Evidence for stimulated PtdCho metabolism playing a role in signal 
transduction events dates back to the late 1970s and early 1980s. Some of these 
observations have remained unsubstantiated, for example the suggestion that 
activation of PtdEtn methyltransferase played a role signal transduction in mast cells 
(reviewed by Axelrod & Hirata, 1982), whilst the significance of others is only 
now being realised. One of the earliest studies of relevance to increased cellular DG 
content was the work of Grove & Schimmel (1982) who showed that addition of 
PMA to cultured chick embryo myoblasts resulted in an elevation of 1,2-DG levels 
and stimulated the synthesis of PtdOH and PtdCho. A number of studies have 
demonstrated that addition of phorbol esters, serum, and a variety of receptor 
agonists to various cell types results in the synthesis of PtdCho as measured by the 
incorporation of [^H] choline or [^2P]Pi into PtdCho.
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In Swiss 3T3 cells there is a rapid 2-3 fold increase in choline kinase 
activity following stimulation with either whole serum or phorbol esters (Warden & 
Friedkin, 1984 &1985) and this is reflected in an increase in levels of 
phosphocholine. There is also evidence that the half-life of phosphocholine is 
altered in response to serum and phorbol esters and that this is likely to be due to 
the translocation and activation of CTP:phosphocholine cytidylyltransferase (Lim 
et al., 1983; reviewed by Pelech & Vance, 1984), a rate limiting step in the 
synthesis of PtdCho.
Despite extensive studies on agonist-stimulated PtdCho synthesis a primary 
hydrolytic event must be identified if considering a role for PtdCho as a source of 
DG. Mufson et al. (1981) were one of the first groups to report stimulated PtdCho 
hydrolysis when they showed that addition of PMA to C3H10T1/2 mouse embryo 
fibroblasts resulted in the release of [^Hjcholine (Cho) and [^Hjphosphocholine 
(ChoP) and similar effects of PMA have now been reported in a variety of cell types 
including Swiss 3T3 fibroblasts (Muir & Murray, 1987; Price et al, 1989), 
NG108-15 cells (Liscovitch et al, 1987) and endothelial cells (Martin et al., 
1990).
Evidence for receptor-coupled PtdCho hydrolysis was a little slower in 
appearing and was probably first observed in fMet-Leu-Phe-stimulated neutrophils 
by Cockcroft (1984) though at the time it was attributed to Ptdlns hydrolysis by 
phospholipase D. The list of agonists now known to stimulate the hydrolysis of 
PtdCho is quite wide ranging and this topic has recently been reviewed extensively 
(Pelech & Vance, 1988; Loffelholz,1989; Exton, 1990; Billah and Anthes, 1990). 
The best characterised systems remain the fMet-Leu-Phe-stimulated human 
neutrophil and HL-60 cell (Pai et al., 1988a & b; Billah et al., 1989a & b) but 
other agonists known to stimulate PtdCho hydrolysis include bombesin, 
vasopressin & PDGF in Swiss 3T3 cells (Muir & Murray, 1987; Price et al.,
1989), bradykinin and purinergic agonists in endothelial cells (Martin & Michaelis, 
1988 & 1989b), carbachol in 132INI astrocytoma cells (Martinson et al., 1989), 
gonadotrophin-releasing hormone in ovarian glomerulosa cells (Liscovitch & 
Amsterdam, 1989) and also in spermatozoa stimulated to undergo the acrosome
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reaction by a fucose sulphate glycoconjugate (Domino et al, 1989).
Hydrolysis of PtdCho to generate DG may proceed by either activation of a 
PtdCho-PLC to generate DG and phosphocholine (ChoP) or by activation of a 
PtdCho-PLD to generate PtdOH and choline (Cho) followed by de-phosphorylation 
of PtdOH to DG by PtdOH phosphohydrolase (PPH). There are a number of 
difficulties in unequivocally identifying which is the primaiy hydrolytic event For 
example, the elevation of ChoP (a PLC product) can be achieved by the rapid 
phosphorylation of Cho (a PLD product) by choline kinase (Warden & Friedkin, 
1985) though the reverse reaction, ChoP phosphatase, seems unlikely to function 
(Cabot et al., 1988). Equally, the generation of [^2P]PtdOH in [^2P]Pi-labelled 
cells can also be achieved by phosphorylation of DG (a PLC product) by DG 
kinase, a reaction occurring rapidly following stimulation of inositol lipid 
hydrolysis.
Definitive assays for PLD activity are now available and the use of 1-0- 
alkyl-2 -acyl-5«-glycerol[^2P]phosphate ([^2P]PtdOH) in neutrophils and the 
formation of phosphatidylalcohols in the presence of short chain primary alcohols 
have already been described (Chapters 1 & 4 of this thesis).
Having identified PLD activity in mitogen-stimulated Swiss 3T3 cells it was 
necessary to confirm that this activity was utilizing PtdCho as a substrate. One 
obvious way to approach this is to label cells with [^Hjcholine and examine the 
release of the water soluble head groups Cho or ChoP. Not only will this confirm 
or refute PtdCho as a substrate, but by examining the kinetics of formation of either 
Cho or ChoP one should be able to confirm a PLD or PLC activity previously 
characterized. Many early studies in this field made no attempt to separate 
individual metabolites and simply attributed any increase in 'total water soluble 
metabolites' as evidence for PtdCho-PLC activity (e.g., Muir & Murray, 1987; 
Monaco et al., 1988; Welsh et al., 1988).
The following results describe the development of a simple ion-exchange 
chromatography procedure to separate the major water soluble metabolites of 
endogenous [^HjPtdCho hydrolysis in Swiss 3T3 cells. This method has been 
used to study the effects of defined mitogenic agents upon PtdCho hydrolysis. The
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results confirm that activation of PtdCho hydrolysis by PLD is a common response 
to mitogens which stimulate hydrolysis of inositol lipids in Swiss 3T3 cells.
5.2 Results.
5.2.1 Analysis of the water soluble products of PtdCho hydrolysis 
by ion-exchange chromatography.
The separation of choline metabolites has been most commonly reported by 
the method of Yavin (1976) which involves thin layer chromatography. However, 
preliminary work suggested that this method, as well as being time-consuming and 
laborious, did not adequately resolve the major water soluble metabolites of PtdCho 
hydrolysis; a fundamental drawback since in many cells phosphocholine levels 
exceed those of choline by up to six-fold making even minor cross-contamination a 
serious problem. The modifications of Kolesnick & Paley (1987) go some way to 
overcoming these problems but it was decided that better resolution might be 
obtained by an ion-exchange system which would also be quicker and easier to use. 
The use of Dowex-50W-H+ cation exchange resin was originally suggested by the 
work of Dowdall et al. (1972) who used it to isolate phosphocholine from neutral 
extracts of guinea pig cerebral cortex after the intraventricular injection of [N- 
methyl-^ H] choline.
From the structures of choline, phosphocholine and glycerophosphocholine 
it was decided that the strongly cationic quartemary amino group on the choline 
moiety provided the best oppurtunity for binding to an acidic cation exchange resin. 
A sample of [^H] choline chloride diluted to 1ml with water was loaded onto a 1ml 
column prepared in a glass wool plugged pasteur pipette. Washing with 1ml 
fractions of water did not elute any radioactivity from the column. Using 1M HC1 
as a competing cation, 20  x 1ml washes eluted a single peak of radioactivity which 
corresponded to 100  % recovery of the load and was found to be completely 
reproducible (Figure 5.1c).
161
Figure 5.1 (a-c). Elution of (a) [3 H]GroPCho, (b) [14C]ChoP and
(c) [3 H]Cho from 1 ml Dowex-50-WH+ columns.
Samples of each 'standard' were diluted with water to 1 ml and loaded on to 
separate 1 ml columns of Dowex-50-WH+ in plugged pasteur pipettes. Elutions 
were performed with either water or 1M HC1 as indicated in a ml by ml manner and 
each sample was collected and the associated radioactivity (d.p.m.) determined by 
liquid scintillation counting. The results shown are from a single experiment 
performed in singlicate but representative of 8 other similar elutions.
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On the basis that the phosphate group on phosphocholine would to some 
extent counteract the strong positive charge of choline resulting in weaker binding, 
a sample of [14C] phosphocholine was loaded on to a 1ml Dowex-50W-H+ column 
in 1ml of water. Washing with 15 x 1ml fractions of water eluted off a single peak 
of activity after an initial lag of 9ml (Figure 5.1b). Recovery of the loaded [14C] 
phosphocholine was 96%. When a sample of [methyl-^ H] glycerophosphocholine 
was loaded in 1ml of water and washed with 1ml fractions of water it was found to 
elute as a single peak of activity in the first 10 ml of water with a recovery of 95% 
of the loaded activity (Figure 5.1a). Further characterisations using Hanks buffered 
saline as a 'synthetic cell extract' to which was added a mixture of the three 
standards yielded similar results (Figure 5.2a).
All other chracterisations were performed by adding a mixture of the 
standards to a Swiss 3T3 cell extract prepared either by chloroform/methanol 
extraction or 10% perchloric acid extraction so as to mimic experimental conditions. 
Fractions were counted on a [^H]/[14C] dual label programme allowing estimation 
of recoveries and crossovers. Batch elutions were found to yield the same results 
as ml by ml elution profiles. In addition this method was routinely employed to 
characterise each newly prepared sample of Dowex-50W-H+ throughout the series 
of experiments described herein (Fig 5.2b). The average percent recoveries of 
'standards' as well as the average percentage cross-overs between different 
fractions are shown in Table 5.1.
When this procedure was applied to an aqueous methanolic extract from 
cells which had been labelled with l|iCi/ml of [methyl-^ HJcholine chloride for 48 
hours three peaks of radioactivity were eluted with identical mobility to the 
standards previously characterised. Furthermore, after elution of [^H]GroPCho 
and [^HJChoP the competing cation concentration was increased in four 10 x 1ml 
steps from 0.25M-, 0.5M-, 0.75M- to 1M HC1 to see if any other peaks of activity 
were eluted off before [^H]Cho. Such stepwise elutions did not reveal any peaks 
of activity until [^H]Cho which came off as a broad band between 0.5- and 0.75M 
HC1 (Fig 5.3).
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Figure 5.2 (a & b). Elution profile of a mixture of [3 H]GroPCho, 
[14C]ChoP and [3 H]Cho loaded in either (a) a synthetic cell extract 
(HBG) or (b) in a Swiss 3T3 cell extract.
A mixture of standards was diluted to 1 ml with either Hanks buffered 
saline solution as a synthetic cell extract (a) or with a cell extract prepared from 
unlabelled Swiss 3T3 cells by chloroform/methanol extraction (b). Each mix was 
then applied to separate 1ml Dowex-50-WH+ columns in plugged pasteur pipettes 
and ml by ml elutions were performed with water followed by 1M HC1 as 
indicated. Each 1 ml fraction was collected and counted on a [^4 C] ( • )  and [^H] 
(O) dual label programme. The profiles shown represent radioactivity in each 
fraction (d.p.m.), and are typical of seven other similar experiments.
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Figure 5.3. The elution of [3 H]Cho by stepwise increases of HCI 
reveals no further [^HJcholine labelled bands in Swiss 3T3 cells.
One 25 cm2 flask of Swiss 3T3 cells was labelled with lpC i ml"1 for 48 
hours before harvesting and preparation of an aqueous methanolic extract as 
described in the Methods section. The sample, final volume 1 ml, was applied to a 
lml Dowex-50-WH+ column and [^HjGroPCho and [^HjChoP eluted with 9 and 
15 ml of water respectively. The concentration of the competing cation, HCI (—), 
was increased by four stepwise 10 x 1 ml elutions with 0.25, 0.5, 0.75 and 1M 
HCI. All fractions were collected and the radioactivity determined by liquid 
scintillation counting. Results are radioactivity in fraction (d.p.m.), ( • ) ;  similar 
results were obtained in two experiments
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Table 5.1. Analysis of recoveries of, and cross-contamination  
between, [^H] or [* 4C]choline-labelIed metabolites separated on 
D ow ex-50-W H +.
Standard samples of [^H]GroPCho, [^H ]C hoP and [^H]Cho were 
separated on Dowex-50-WH+ columns in the presence of an aqueous methanolic 
extract prepared from Swiss 3T3 cells. Recoveries and cross-overs were 
determined by dual-label liquid scintillation counting. The results are means ± 
S.D. calculated from eight separate experiments. Other details are as in the 
Methods section.
N. A. = not applicable; N.D. = not detectable.
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Recovery (%) % contamination with:
F raction  Cho ChoP GroPCho
Cho 94.8 ± 8.4 N.A. 2.51 ± 4 N.D.
ChoP 92.6 ±9.1  2.5 ± 4  N.A. 2.9 ±2.8
GroPCho 91.5 ± 7 .5  N.D. 6.1 ±2.8 N.A.
Finally, to assay the integrity of the separation of GroPCho and ChoP 
batch wise elutions of a [methyl-^ HJcholine chloride labelled cell extract were 
freeze dried, redissolved in ethanol/water (50/50; v/v), spotted on to heat activated 
silica gel 60 thin layer chromatography plates and developed by the method of 
Kolesnick and Paley (1987). By comparing mobility with known standards it was 
found that GroPCho and ChoP were resolved well with a cross contamination of 
only about 8 % of each fraction, agreeing well with the values from dual labelling 
studies.
Analysis of a labelled cell extract by this t.l.c. method revealed that 
GroPCho, ChoP and Cho were the only major labelled products; betaine, an 
oxidative metabolite of choline, was found to be a very minor component of 
labelled cells representing only 1% of the total activity of an aqueous cell extract, 
and seemed to remain unchanged when cells were stimulated with either bombesin 
or PMA. Similar low levels of betaine have been reported previously in Swiss 3T3 
cells (Warden & Friedkin, 1984), NG108-15 cells (Liscovitch et aU 1987) and 
brain cells (Yavin, 1976). Isolation of CDP.choline by t.l.c. also revealed it to be a 
minor component of Swiss 3T3 cells under the labelling conditions employed.
On the basis of these experiments it was concluded that the method of 
separation devised gave both good resolution and recovery of GroPCho, ChoP and 
Cho and was suitable for analysing their relative levels in control and stimulated 
cells. This method has subsequently and successfully been applied to the analysis 
of choline metabolites in Rat-1 fibroblasts stimulated with Endothelin-1 
(MacNulty er fl/, 1990).
Vi
5.2.2 The effect of defined growth factors upon PtdCho hydrolysis 
in Swiss 3T3 cells.
Swiss 3T3 cells were grown to approximately 80-90% confluence in 24- 
well culture plates and incubated for a further 48 hours, or part thereof, with 
DMEM containing 1% newborn calf serum and lfiCi ml" ^ [^H]choline. At given 
times the medium was aspirated, cells harvested and lipid extracts prepared as
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described in the Methods section. Following phase resolution the entire chloroform 
phase was dried down in vacuo and the radioactivity in total choline containing 
lipids was determined by liquid scintillation counting. The results indicated that 
equilibrium labelling of the choline containing lipids was essentially reached after 
30 hours (data not shown). However, all experiments were performed on cells 
which had been labelled for at least 48 hours in low serum containing medium to 
ensure quiescence.
Of the three major choline-containing lipids in Swiss 3T3 cells [^Hjcholine 
was preferentially incorporated into PtdCho (85%) with the remainder in 
sphingomyelin (13-14%). Negligible label was found to be associated with lyso- 
PtdCho. Upon stimulation of [^Hjcholine-labelled Swiss 3T3 cells with bombesin 
or PMA there was a loss of radioactivity from the PtdCho pool with little change in 
the radioactivity associated with sphingomyelin (Table 5.2). The amount of label 
lost from PtdCho was small representing only about 5% of the total associated 
radioactivity. This is in agreement with the finding of Liscovitch et a/.(1987) in 
PMA-stimulated NG108-15 cells and probably represents the relatively small 
generation of Cho seen (Fig 5.5a) as compared with the large size of the cellular 
PtdCho pool.
Since the loss of label presumably represented a hydrolytic event, the effect 
of both bombesin and PMA upon Cho, ChoP and GroPCho levels was examined 
as an indication of which pathway of hydrolysis was being activated. Figure 5.4 
shows the elution profile of a cell samples from [^Hjcholine labelled Swiss 3T3 
cells incubated for 5 minutes with either a control buffer or 617nM bombesin. The 
results indicated that both Cho and ChoP levels increased upon stimulation with 
bombesin whilst GroPCho appeared to remain unchanged. Further studies sought 
to define the kinetics of these changes in choline metabolites.
Figure 5.5 (a-c) shows the time course of effects of stimulating [^Hjcholine 
labelled Swiss 3T3 cells with 617nM bombesin upon [^HjCho, [^HjChoP and 
[^HjGroPCho levels. Bombesin stimulated a rapid increase in [^HjCho levels 
which was apparent at 10 sec, significant between 30 sec and 1 min (p=0.002) and 
was maximally above control (2-2.5 -fold) after 2 min (Fig 5.5a). The rate of
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Table 5.2. Effect of bombesin- and PM A-stimulation on the level of 
PtdCho and sphingomyelin in [^H]choline labelled Swiss 3T3 cells.
Following stimulation of [^H]choline labelled Swiss 3T3 cells with 
bombesin (617nM), PMA (lOOnM) or appropriate vehicle (0.1% DMSO) organic 
extracts were spotted on to heat-activated silica gel 60 t.l.c. plates and developed 
according to the method of Skipski et al. (1964) as described in Chapter 2. 
PtdCho and sphingomyelin (SphM) were visualised by I2 staining alongside 
authentic standards. Radioactivity associated with phosphatidylcholine (PtdCho) 
and SphM was determined by scintillation counting following excision of the 
appropriate spots from the silica gel. The results are mean radioactivity in PtdCho 
or SphM (d.p.m.) ± S.D. of triplicate determinations from a single experiment 
typical of three.
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Incubation. radioactivity in PtdCho radioactivity in SphM 
(d.p.m.) (d.p.m.)
Control, 2 min. 
Bombesin, 2 min 
Vehicle, 5 min 
PMA, 5 min
76,961 ± 5,195 
66,205 ±1,176 
80,802 ±363 
75,735 ± 1,926
7,247 ± 158 
8,644 ± 549 
8,003 ± 138 
8,983 ± 194
Figure 5.4 Elution profile from control and bombesin-stimulated, 
[3 H]choline labelled Swiss 3T3 cells.
Swiss 3T3 cells were labelled with [3 H]choline, 1.5|iCi ml"* in 1 ml of 
DMEM containing 2% calf serum, for 48 hours by which time they were confluent 
and quiescent. After washing and incubating at 37°C for 5 min in HBG (O ) or 
HBG containing 617 nM bombesin ( • )  aqueous methanolic extracts were prepared 
as described in the Methods section. Samples were applied to 1 ml Dowex-50- 
WH+ columns in plugged pasteur pipettes and GroPCho, ChoP and Cho eluted in a 
ml by ml manner. The radioactivity associated with each fraction (d.p.m.) was 
determined by liquid scintillation counting.
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Figure 5.5. Bombesin-stimulated changes in (a) total [3 H]Cho, (b) 
total [3 H]ChoP, (c) total [3 H]GroPCho and (d) cell associated  
[3 H]Cho in [3 H]choIine labelled Swiss 3T3 cells.
Swiss 3T3 cells grown on 24-well plates were labelled for 48 hours with 
1.5}iCi ml'* [3 H]choline in 1 ml of DMEM containing 2% calf serum by which 
time they were confluent and quiescent. Cells were washed with HBG at 37° C as 
described in the Methods section before incubating with either HBG (□) or HBG 
containing 617 nM bombesin (■ ) for the times indicated. Incubations were 
terminated by direct addition of ice-cold methanol (a-c) or by aspiration prior to 
addition of methanol so that total or intracellular choline metabolites were included 
in the assay. After preparation of aqueous methanolic extracts (a & d) [3 H]Cho, 
(b) [3 H]ChoP and (c) [3 H]GroPCho were resolved by batch elution from Dowex- 
50-WH+ columns and the associated radioactivity determined by liquid scintillation 
counting. Results are mean radioactivity in Cho, ChoP or GroPCho (d.p.m.) ± 
S.D. (n=3) from a single experiment typical of four.
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pHjCho generation was reduced between 2 and 5 minutes after which it paralleled 
the increase in basal up to 15 and 30 minutes (data not shown). The precise details 
of the time course varied between experiments and in one case pH]Cho levels were 
significantly elevated after 10 seconds. Increases in pH]ChoP levels in response 
to bombesin were generally smaller in fold terms, varying in magnitude from 2 0  to 
58% above basal and were generally not significantly elevated above control until 
between 5 (Fig 5.4) and 15 minutes of stimulation (p<0.001) (Fig 5.5b) though in 
some experiments non-significant increases were apparent at 2 min. No significant 
increase in the radioactivity in the pH]GroPCho fraction over basal was observed 
in response to bombesin stimulation for up to 15 and 30 minutes in any experiment 
(Fig 5.5c).
These experiments represented total intracellular and extracellular choline 
since incubations were terminated by the direct addition of ice-cold methanol to the 
incubation medium. By aspirating the incubation medium prior to addition of ice- 
cold methanol, experiments were performed to see if increases in pH]Cho occurred 
within the cell or represented leakage from the cell. Figure 5.5d shows the time 
course for increases in cell-associated pH]Cho upon stimulation with bombesin. 
Intracellular pH]Cho levels mirrored the rise in total pH]Cho described in Fig 
5.5a up to 2 min after which the levels declined slightly, reaching a new apparent 
’steady state’ which was maintained for at least 10 min; basal intracellular pH]Cho 
levels remained unchanged over this time course (data not shown).
The increase in total pH]Cho levels in response to a 5 min stimulation with 
bombesin was clearly dose-dependent (Fig 5.6); the EC5Q for bombesin was 1.44 
± 1.02 nM (mean ± S.D. of four separate experiments performed in triplicate).
In contrast to bombesin there was a lag of 1 min before any increase in 
pH]Cho was observed (Fig 5.7a) when pH]choline labelled Swiss 3T3 cells were 
stimulated with lOOnM PMA. Details varied between experiments but generally 
pH]Cho levels rose above control in a sustained manner from 1 min up to 30 min 
(Figure 5.7a) and continued to rise in a near linear fashion above control for at least 
60 min (data not shown). pH]Cho elevation was sometimes apparent, though not
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Figure 5.6. Bombesin stim ulates a dose-dependent increase in 
[3 H ]C ho.
L HJCholine labelled Swiss 3T3 cells were washed in HBG and stimulated 
with the indicated final concentration of bombesin in HBG (■ ) for 5 min. 
Incubations were terminated by the direct addition of ice-cold methanol and aqueous 
methanolic extracts were prepared as described previously. pH]Cho was resolved 
by batch elution from Dowex-50-WH+ columns after the prior elution of 
pH]GroPCho and pH]ChoP. Radioactivity was determined by liquid scintillation 
counting. The results are mean radioactivity in Cho (d.p.m.) ± S.D. (n=3) from a 
single experiment representative of three.
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Figure 5.7. PMA-stimuIated changes in (a) total [3 H]Cho, (b) total 
[3 H]ChoP, (c) total [3H]GroPCho and (d) cell associated [3 H]Cho in 
[3 H]choline-labelIed Swiss 3T3 cells.
Swiss 3T3 cells were labelled with 1.5|iCi m H  of [3 H]choline in 1 ml of 
DMEM containing 2% (v/v) calf serum for 48 hours by which time they were 
confluent and quiescent. Cell were washed with HBG at 37° C before incubating 
with HBG containing either 0.1% DMSO (□) or lOOnM PMA in DMSO (■) at 
37° C for the indicated times. Incubations were terminated by the direct addition of 
ice-cold methanol (a-c) or by aspiration prior to addition of methanol (d) and 
aqueous methanolic extracts were prepared and resolved on Dowex-50-WH+ 
columns as described in the Methods section. Radioactivity associated with each 
fraction was determined by liquid scintillation counting. The results are mean 
radioactivity in Cho, ChoP or GroPCho (d.p.m.) ± S.D. (n=3) from a single 
experiment representative of four.
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significant, at 1 min but was significantly above control from 2  min onwards 
(p=0.004). PMA-stimulated elevation of pH]ChoP, as observed for bombesin, 
was generally much slower than pH ] Cho and was not significantly above control 
until 15 or 30 minutes (p= 0.093) after addition of the phorbol ester (Figure 5.7b). 
The levels of [3 H]GroPCho remained unchanged by addition of PMA over the time 
course examined, up to 60 minutes (Figure 5.7c).
When the effect of PMA upon intracellular pH ] Cho levels was examined it 
was found that, like bombesin, a significant increase in pH]Cho was occurring 
within or associated with the cells. Figure 5.7d shows that stimulation with PMA 
resulted in an increase in cell associated pH ] Cho, the onset of which exhibited 
virtually identical kinetics to that previously described (Fig 5.7c). However, from 
10 min onwards PMA-stimulated increases in pH]Cho reached a plateau and were 
maintained at this level for at least 30 min. Cell associated [3 H]ChoP and 
pH]GroPCho levels did not change significantly. The effect of PMA upon 
pH]Cho levels was dose-dependent (shown in Figure 5.8) with half-maximal 
elevation occurring at doses of 4.95 ± 3.63 nM (mean ± S.D. of n=4 experiments).
Since both [Arg^]Vp and PGF2 a  appeared to stimulate inositol lipid 
hydrolysis by a similar mechanism to bombesin (Chapter 3) experiments were 
performed to determine if these mitogens were also able to stimulate the hydrolysis 
of PtdCho in pH]choline labelled Swiss 3T3 cells. Figure 5.9a shows the time 
course for increases in pH]Cho levels in Swiss 3T3 cells stimulated with lOOnM 
[Arg8 ]Vp. The kinetics of the response were essentially similar to that for 
bombesin; elevation of pH]Cho levels was clearly significant at the first time-point 
tested (1 minute, p= 0.015) and maximally above control (2-fold) at 5 minutes after 
which these levels were maintained above basal for up to 15 minutes. No 
significant increases in the radioactivity associated with [3 H]ChoP or 
pHJGroPCho was observed in response to [Arg^]Vp. Furthermore, whilst no 
thorough kinetic analysis was performed, it was also observed that stimulation with 
ljiM PGF2 a  also resulted in a significant elevation of pH]Cho levels though this 
was not of the magnitude of the responses to bombesin or [Arg^]Vp, being
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Figure 5.8. PMA-stimuIates a dose-dependent increase in [3 H ]C ho.
[3 H]Choline labelled Swiss 3T3 cells were washed with HBG before 
incubating at 37° C with HBG containing the given concentration of PM A (■) for 
10 min. Incubations were terminated by the direct addition of ice-cold methanol 
and aqueous methanolic extracts were prepared as described in the Methods section. 
Aqueous methanolic extracts were loaded on to Dowex-50-WH+ columns and 
[3 H]Cho eluted with 1M HC1 after prior elution of [3 H]GroPCho and [3 H]ChoP. 
Radioactivity in [3 H]Cho fraction was determined by liquid scintillation counting. 
Results are mean radioactivity in Cho (d.p.m.) ± S.D. (n=3) of triplicate 
determinations from a single experiment representative of four.
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typically 1.5-fold above basal after 5 minutes. No significant elevation of 
pH]ChoP or pH]GroPCho levels was observed upon stimulation with PGF2 a . 
The dose response curves for elevation of pH ]Cho levels by [Arg^]Vp and 
PGF2 a  are shown in Figure 5.9b. The concentrations of each mitogen required to 
give half-maximal elevation of pH]Cho levels were 0.92 ± 0.57 nM for [Arg^]Vp 
and 0.51 ± 0.32 pM for PGF2oc.
Since activation of phospholipase D appeared to be dependent upon 
functional PKC activity and the stimulated release of pH]Cho exhibited identical 
kinetics to pH]PtdBut formation for both bombesin and PMA, experiments were 
performed to see if the release of pH]Cho from PtdCho had the same dependency 
upon PKC activity.
Firstly, in the case of PMA, the ability of P-phorbol to stimulate increases in 
cellular pH]Cho content was compared with that of PMA. p-phorbol, a phorbol 
ester analogue which does not activate PKC (Castagna et al., 1982), was 
ineffective in elevating pH]Cho levels above control, based on a 15 minute 
stimulation in which the identical final concentration of PMA was quite clearly 
effective. The radioactivity associated with pH]Cho was for control (15 min, 
0.1% DMSO) 2,851±196 dpm, p-phorbol (15 min, lOOnM) 3,2201164 dpm and 
PMA (15 min, lOOnM) 6,1511476 dpm; results from a single typical experiment, 
n=3).
Secondly, when pH]choline labelled Swiss 3T3 cells were pre-incubated 
for 15 minutes with ljiM  staurosporine (a proposed PKC inhibitor) prior to 
stimulation with bombesin or PMA, the elevation of pH ]Cho levels by each 
mitogen was inhibited by 30-40% (Table 5.3).
Furthermore, chronic treatment of Swiss 3T3 cells with PMA results in the 
loss of cellular PKC (Collins & Rozengurt, 1984; Rodriguez-Pena & Rozengurt, 
1984; Brown et al., 1990). When Swiss 3T3 cells were labelled with pH]choline 
for 48 hours in the presence of 400nM PMA there was a 1.7- 2-fold increase in 
pH]choline incorporation into both lipid and aqueous pools, probably reflecting the 
reported stimulation of PtdCho synthesis by PMA (e.g., Muir & Murray, 1987). 
To allow a real comparison between down-regulated and control cells, pH]Cho
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Figure 5.9
(a) [Arg8 ] Vasopressin stimulates the release of [3 H]Cho from  
[3 H]choIine labelled Swiss 3T3 cells.
pHJCholine labelled Swiss 3T3 cells were washed with HBG before 
incubating with HBG (□) or HBG containing lOOnM [Arg8]Vp (■ ) at 37°C for 
the indicated times. Incubations were terminated by the direct addition of ice-cold 
methanol and aqueous methanolic extracts were assayed for pH ]C ho after 
resolution on Dowex-50-WH+ columns. Results are mean radioactivity in Cho 
(d.p.m.) ± S.D. (n=3) from a single experiment representative of four.
(b) [Arg8 ]vasopressin and prostaglandin F2 a  both stimulate the 
dose-dependent accumulation of p H ] Cho.
pH]Choline labelled Swiss 3T3 cells were washed with HBG and 
incubated at 37° C with HBG containing the given concentration of either [Arg8]Vp 
(■ ) or PGF2(X (□) for 5 min. Incubations were terminated by direct addition of 
ice-cold methanol and aqueous methanolic extracts were assayed for pH]Cho after 
resolution on Dowex-50-WH+ columns. Results are normalised to % of control to 
include both sets of data on a single graph; the basal dpm values were 3290 ±151 
for [Arg8]Vp and 5992 ± 368 for PGF2 a . Results are mean radioactivity in Cho 
(d.p.m.) ± S.D. (n=3) from a single experiment representative of three in each 
case.
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Table 5.3. The effect of acute pre-treatment with staurosporine upon 
bombesin- and PMA-stimulated [3H]Cho elevation.
[3 H]choline labelled Swiss 3T3 cells were incubated for 15 min with l(iM 
staurosporine or vehicle (0.1% DMSO) as indicated prior to addition of agonist. 
Cells were then incubated with bombesin (617nM, 2 min) or PMA (100 nM, 15 
min) and radioactivity associated with [3H]Cho determined as before. Results are 
mean radioactivity in Cho fraction (d.p.m.) ± S.D. of triplicate determinations from 
a single experiment typical of three.
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Radioactivity in Cho (d.p.m.).
Incubation. Control + Staurosporine
Control, 2 min. 3,439 ± 540 3,692 ± 706.
Bombesin, 2 min. 5,029 ± 394 4,358 ± 209.
DMSO (0.1%), 15 min. 4,217 ± 624 4,481 ± 937.
PMA, 15 min. 6,739 ± 751 5,416 ± 247.
Figure 5.10 Effect of 48 hour pre-treatment with 400nM PMA upon 
agonist stimulated [3H]Cho accumulation.
Swiss 3T3 cells were labelled for 48 hours with 1.5p.Ci ml' 1 of [3 H] choline 
in 1 ml of DMEM containing 2% (v/v) calf serum and either 400nM p-phorbol 
(open bars) or 400nM PMA (hatched bars). Cells were then washed in HBG and 
incubated for 10 min with PMA (lOOnM), bombesin (lOOnM), [Arg^]Vp (lOOnM) 
or PGF2 a  (2jiM), at 37°C. Incubations were terminated by the direct addition of 
ice-cold methanol and aqueous-methanolic extracts were assayed for [3 H]Cho 
following resolution on Dowex-50-WH+ columns. Results were normalised to the 
amount of label incorporated into total choline containing lipids. Each data set is the 
radioactivity associated with [3 H]Cho (d.p.m.) ± S.D. (n=3) from a single 
experiment representative of six (PMA and bombesin) or three ([Arg^jVp and 
PGF2 a ).
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levels were normalised by equating the radioactivity in total choline containing 
lipids in down-regulated cells with a mean value for radioactivity associated with 
choline containing lipids in control cells. The results, shown in Figure 5.10, show 
that the ability of PMA, bombesin, [Arg8]Vp and PGF2(X to stimulate increases in 
cellular [^HJCho content was completely abolished in cells which had been treated 
with PMA for 48 hours whilst in cells treated with the vehicle control containing p- 
phorbol the responses remained intact.
The ability of bombesin, [Arg8]Vp and PGF2 a  to increase levels of 
[^H]Cho exhibited the same rank order as that for [3H]InsPt accumulation, i.e. 
bombesin> [Arg8 ]Vp> PGF2 a  (Figure 5.10 and compare Figs 5.6b and 5.9b). 
Thus, fold increases in [^H]Cho were typically 2- 2.5-fold for bombesin, 1.8- 2- 
fold for [Arg8]Vp and 1.2- 1.5-fold for PGF2(X.
Finally, if bombesin, [Arg8]Vp and PGF2(X were activating PtdCho 
hydrolysis by a common mechanism involving PKC then one would expect that 
combination of two of these agonists at sub-maximal doses would not synergise to 
stimulate [^HjCho accumulation. Consistent with this, combination of sub- 
maximal doses of [Arg8]Vp and bombesin resulted in accumulation of [^H]Cho 
which was only additive compared to the two responses alone. For example, the 
net increase in radioactivity in [^H]Cho in response to a 5 min stimulation with 
O.lnM bombesin was 1,530 ± 179 d.p.m.; 5 min, with 0.1 nM[Arg8 ]Vp= 882 ± 
42; 5 min with 0.1 nM each of bombesin and [Arg8 ]Vp= 2,334 ± 147 (the 
radioactivity in [^HJCho in control cells was 7,214 ± 424 d.p.m.; results from a 
single experiment representative of two).
181
5.3 Discussion.
5.3.1. Analysis of the water soluble products of PtdCho hydrolysis 
by cation exchange chromatography.
The analysis of the water soluble metabolites of PtdCho hydrolysis has been 
hampered by the lack of a suitable assay method. Much of the work in the literature 
has used variations of the t.l.c. separation method of Yavin (1976) which is time- 
consuming and in these studies often proved unreliable. Many studies (e.g. Muir & 
Murray, 1987; Welsh et al., 1988) simply measured the radioactivity associated 
with the total water-soluble metabolites without identifying the primary product and 
therefore the route of lipid hydrolysis; an important point if PtdCho is being viewed 
as a potential source of DG. Recently an ion-exchange separation of Cho 
metabolites was described by Liscovitch et a l  (1987) but this procedure involved 
the use of h.p.l.c. The method described in this chapter is quick, reproducible and 
yields quantitative separation and recovery of Cho, ChoP and GroPCho. It is not 
clear if the method will also separate betaine, but in the cell system examined here 
this metabolite was such a minor, and seemingly inert, component that it did not 
interfere with the analysis. Similar extremely low levels of betaine have been 
reported before in Swiss 3T3 cells (Warden & Friedkin, 1984) aswell as NG108- 
15 cells (Liscovitch et al., 1987) and brain cells (Yavin, 1976). Furthermore, the 
total radioactivity associated with CDP-choline when isolated from a [^H]choline 
labelled Swiss 3T3 cell extract was also so low as to not interfere with analysis of 
levels of [^HCho, [^HJChoP and [^HjGroPCho. It therefore seems likely that this 
method should prove applicable to a wide range of cell types following suitable, 
thorough characterization.
Recently methods have also been described for assay of mass amounts of 
both Cho and ChoP respectively (Murray et al., 1990; Truett et al., 1989b). 
Whilst these will be very useful along side mass assays for Ins(l,4,5)P3 and DG in 
determining the contributions made by PtdIns(4,5)P2 and PtdCho to DG they are 
relatively time-consuming.
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5.3.2 Bombesin and PMA stimulate the hydrolysis of PtdCho by a 
phospholipase D catalysed pathway.
Having defined a mitogen-stimulated PLD activity in Swiss 3T3 cells 
(Chapter 4) it remained to identify the major substrate(s) for that PLD. Stimulation 
of P Hjcholine-labelled Swiss 3T3 cells with bombesin or PMA resulted in the loss 
of radioactivity from pH]PtdCho with only small and variable changes in 
sphingomyelin, the other major Cho-containing lipid in Swiss 3T3 cells (Table 
5.2). The amount of label lost was very small representing only about 5% of total 
radioactivity associated with PtdCho. This is in agreement with the result of 
Liscovitch et al. (1987) in PMA-treated NG108-15 cells and is probably due to the 
relatively small generation of pH]Cho and pH]ChoP (Figure 5.4) as compared to 
the large size of the cellular PtdCho pool. Since the loss of label fom pH]PtdCho 
was accompanied by increases in pH]Cho and pH]ChoP (Figure 5.4) it clearly 
suggests that PtdCho is a substrate for a mitogen-stimulated PtdCho hydrolytic 
activity.
The initial product of PtdCho hydrolysis generated in response to bombesin 
was pH]Cho with an increase in pH]ChoP only being observed at later time 
points (Figure 5.5a & b). Thus, in agreement with the results in Chapter 4, it 
appears that the primary hydrolytic activity is that of a phospholipase D. In essence 
the time course for pH]Cho generation was identical to that previously described 
for bombesin-stimulated pH]PtdBut formation in the presence of 0.3% butan-l-ol 
(Chapter 4) and the two results confirm that a PLD, acting upon PtdCho, is 
activated in bombesin-stimulated Swiss 3T3 cells.
The slower increase in pH]ChoP in response to bombesin stimulation may 
represent activation of a PtdCho-specific phospholipase C enzyme. However, the 
increase in pH]ChoP could also be due to phosphorylation of liberated pH]Cho 
by choline kinase. The ratio of pH ]Cho to pH]ChoP in equilibrium-labelled 
Swiss 3T3 cells is of the order of 1:5 or 1:6 (see Figure 5.5a & b and Price et al, 
1989) and phosphorylation by choline kinase following a rapid increase in pH]Cho 
levels as seen in Figure 5.5a might simply reflect the activation of a PtdCho 
synthetic pathway to replenish the parent lipid. In support of this Muir & Murray
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(1987) noted that bombesin stimulated PtdCho synthesis in Swiss 3T3 cells, as 
measured by the incoiporation of ^ P i  into PtdCho, after a lag of approximately 10 
minutes; this is similar to the lag time before increases in pH]ChoP were observed 
in response to bombesin. Furthermore, Warden & Friedkin (1984; 1985) have 
demonstrated a 2- 3-fold increase in choline kinase activity and PtdCho 
biosynthesis in Swiss 3T3 cells following stimulation with either PMA or whole 
serum; these agents have in common with bombesin the ability to stimulate PtdCho 
hydrolysis and activate PKC. It is not possible to predict which of these two 
sources of pH]ChoP (PtdCho-PLC or choline kinase) is the more likely due to the 
lack of selective inhibitors of choline kinase and the difficulties in comparing the 
inter-relationships between the Cho and ChoP pools in a stimulated cell system. In 
this respect the magnitude of increases in radioactivity associated with pH]ChoP 
was variable and it was therefore difficult to determine if this could be explained in 
terms of the increase in radioactivity in pH]Cho followed by its phosphorylation. 
Such questions will require mass analysis of changes in Cho and ChoP to be 
adequately addressed.
The metabolic fate of liberated pH]Cho is further complicated by the exit 
from the cell. Figure 5.5d shows that the bombesin-stimulated increases in 
pH]Cho actually occurred within the cells rather than simply reflecting a 
bombesin-stimulated leakage of Cho. Cell associated pH]Cho reached a plateau 
after 2 minutes beyond which its levels were maintained for up to 30 minutes. Over 
the same time course total pH]Cho continued to rise in parallel with the control. 
Since elevated intracellular Cho levels were maintained from 2 minutes when 
pH ] Cho was being lost from the cells and choline kinase activity was likely to be 
high (Warden & Friedkin, 1984), this implies that bombesin-stimulated PtdCho 
hydrolysis and generation of pHjCho was sustained. This is supported by the 
observation that significant increases in PtdBut continue, albeit at a reduced rate, for 
at least 15 minutes (Chapter 4 of this thesis). The HCjq for bombesin-stimulated 
increases in pH]Cho (1-2 nM) was essentially the same as that for its effects upon 
pH]PtdBut accumulation suggesting that the two responses were related or linked, 
presumably because they reflect the same PtdCho-PLD activity. Furthermore, the
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EC50 value was similar to that for pH]InsPt accumulation, Ins(l,4 ,5 )P3 formation 
and DG formation suggesting that all these events might be mediated through the 
same receptor.
The second, sustained phase of bombesin-stimulated DG formation can be 
mimicked by addition of PMA which can also stimulate increases in pHjpalmitate- 
labelled DG from a non-inositide source (Chapter 4 of this thesis). Further, the 
kinetics of this PMA-stimulated DG formation are similar to the onset of PMA 
stimulated PLD activity as measured by the formation of pH]PtdBut. The ability 
of PMA to stimulate increases in pH]Cho levels following a lag of approximately 1 
minute (shown in Figure 5.7a) agrees very well with the time course of increases in 
pH]PtdBut confirming that PMA-stimulated PLD activity utilises PtdCho as a 
major substrate. Like bombesin, the primary product of PtdCho hydrolysis was 
pHJCho with increases in pH]ChoP occurring over much longer time points 
confirming activation of a PtdCho-PLD. The increase in pH]ChoP may reflect 
either activation of a phospholipase C or choline kinase activity as previously 
discussed. The continued rise of both total and cell associated pH]Cho for up to 
60 minutes following stimulation clearly indicated that PMA addition resulted in the 
sustained activation of phospholipase D confirming the result obtained for 
pH]PtdBut formation which continued, unabated, for at least 30 minutes (Chapter 
4 of this thesis). The EC5q for PMA-stimulated increases in pHJCho (4-5 nM) 
was in close agreement with the value for pH]PtdBut formation and that for 
activation of protein kinase C previously described (Castagna et al., 1982).
5.3.3 A role for PKC in activating PtdCho hydrolysis
Both PMA and bombesin can activate PKC and since both mitogens were 
able to activate PLD with the same dose dependency as their effects upon PKC, it 
seemed possible that both exerted their effects through the activation of PKC. In 
the case of bombesin this was supported by the fact that the onset of both pHJCho 
generation and pHJPtdBut formation were kinetically downstream of Ins(l,4 ,5 )P3 
formation and the first phase of DG formation; Ins(l,4 ,5 )P3 levels peaked at 5
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seconds and were declining at 15 sec when pHJCho was elevated above control 
and had fully declined by 30 seconds when pH]PtdBut formation was significantly 
above control. Therefore, it seemed possible that activation of PKC in response to 
the first phase of bombesin-stimulated DG formation might in some way serve to 
'switch on' PtdCho hydrolysis as seemed to be the case for PLD activity assayed 
by pH]PtdBut formation (Chapter 4 of this thesis).
The results in this chapter (Table 5.3 and Fig 5.10) support such a role for 
PKC in the activation of PtdCho hydrolysis in response to both PMA and 
bombesin. Firstly, PMA was able to activate pH ]Cho generation whereas (3- 
phorbol, a phorbol ester which cannot activate PKC (Castagna et al., 1982), was 
unable to elevate pH]Cho levels above the vehicle control. Second, pre-treatment 
of Swiss 3T3 cells with staurosporine, a proposed PKC inhibitor, resulted in the 
partial inhibition of both bombesin- and PMA-stimulated pHJCho generation 
(Table 5.3). It should be stressed that staurosporine is not a selective inhibitor of 
PKC since it competes with ATP at the catalytic domain and therefore will have 
effects upon a variety of protein kinases. Indeed, this non-selectivity may explain 
the poorer inhibition of mitogen-stimulated PtdCho hydrolysis compared with the 
effects of Ro-31-8220 which abolished 90% of PMA-stimulated and 50% of 
bombesin-stimulated pH]PtdBut formation (Chapter 4). Ro-31-8220, whilst 
based upon the staurosporine structure, has been shown to be at least two orders of 
magnitude more selective for PKC than for PKA or Ca^+-CaM kinase (Davis et 
al., 1989). Nevertheless the fact that a kinase inhibitor did inhibit both bombesin- 
and, particularly, PMA-stimulated pH]Cho generation argues in favour of a role 
for PKC in the activation of PtdCho hydrolysis when considered together with the 
results in Fig 5.10 which show that 'down-regulation' of PKC, resulted in the 
complete abolition of both bombesin- and PMA-stimulated pH]Cho elevation.
Taken together the results in Chapters 4 and 5 suggest that upon stimulation 
of Swiss 3T3 cells with bombesin, phospholipase D catalysed PtdCho hydrolysis is 
stimulated within at least 15 seconds and that this activation is at least partially 
dependent upon activation of protein kinase C. As such PKC may represent a 
major functional link between bombesin-stimulated inositol lipid hydrolysis and
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activation of PtdCho-PLD. In such a model PMA would exert its effects by 
mimicking the action of DG derived from PtdIns(4,5)P2 hydrolysis in activating 
PKC and 'switching on' PLD; however the possibility that PMA may exert effects 
upon PLD independently of PKC, as mentioned in Chapter 4, must not be ignored. 
There remains the intruiging anomaly that PMA- and bombesin-stimulated increases 
in pH]Cho and pH]PtdBut levels are completely abolished by down-regulation of 
PKC and yet Ro-31-8220 will abolish essentially all PMA-stimulated pH]PtdBut 
formation but only 50% of the bombesin-stimulated response.
One model which might go some way to explain this assumes that as well as 
the PKC-mediated effects, PMA may be able to bind to, and activate, PLD in a 
manner analagous to its activation of PKC at the DG binding site. In such a 
scenario PLD would be predicted to have a DG/PMA binding site and therefore 
might also be 'down-regulated' in response to chronic PMA treatment. However 
this model would not explain the total loss of PMA-stimulated PLD activity by Ro- 
31-8220 since PMA would be predicted to exert some effects independently of 
PKC. It is possible that PLD possesses both PKC-dependent (presumably 
phosphorylation) and -independent (DG-binding) regulatory sites which may 
exhibit cooperative and non-cooperative interactions to achieve activation in 
response to diverse stimuli. PMA and DG (derived from PtdIns(4 ,5 )P2 
hydrolysis) may also exert different effects on PLD activity. In this respect there 
are a number of reports suggesting that PMA and DG do exert different effects 
upon phospholipid metabolism. In particular Kolesnick & Paley (1987) 
demonstrated that the effects of diCg and PMA upon PtdCho hydrolysis were 
additive at maximal concentrations whilst diCg, but not PMA, was able to stimulate 
the release of water soluble [3 H]choline metabolites from PKC down regulated 
GH3 pituitary cells. These results are consistent with PMA and diCg being able to 
exert separate and distinct effects. In addition, Muir & Murray (1988) have shown 
that diCg but not PMA will stimulate PtdCho synthesis in platelets.
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5.3.4 Bombesin, [Arg8 ]Vp and PGF2 a  activate PtdCho hydrolysis 
by a common mechanism involving protein kinase C.
Bombesin, [Arg8]Vp and PGF2 a  possess the common property of 
stimulating the rapid hydrolysis of PtdIns(4 ,5 )P2 to generate Ins(l,4 ,5 )P3 and DG. 
Furthermore there are a number of similarities between the three mitogens in the 
mechanism by which their receptors are coupled to the activation of PIC. The 
generation of inositol phosphates stimulated by each mitogen is modulated by a G- 
protein (Erusalimsky & Rozengurt, 1989; Plevin et al., 1990) and is also subject to 
PKC-mediated negative feedback inhibition (Brown et al., 1987; Chapter 3 of this 
thesis). Since these three mitogens exhibited marked similarities in their ability to 
stimulate pH]InsPt accumulation (Chapter 3) experiments sought to determine if 
[Arg8]Vp and PGF2 a  would also be able to stimulate PtdCho hydrolysis.
The observation that both [Arg8]Vp and PGF2 a  were able to stimulate the 
generation of pH ] Cho from Swiss 3T3 cells at concentrations at which both are 
mitogenic (MacPhee et al., 1984; Corps et al., 1985) and at which both stimulate 
InsPt accumulation suggests that, by analogy with bombesin, PtdCho hydrolysis 
by a PLD might be a common response to mitogens which stimulate the rapid 
hydrolysis of inositol lipids. In the case of [Arg8]Vp and PGF2 a  formation of 
pH]Cho does represent PLD activity since both these agonists stimulated the 
formation of pH]PtdBut in pH]palmitate labelled Swiss 3T3 cells in the presence 
of butan-l-ol. The time course for [Arg8 ]Vp-stimulated pH]Cho generation was 
similar to that for bombesin, not reaching maximal elevation above basal until 
between 1 and 5 minutes. Since this was kinetically downstream of [Arg8 ]Vp- 
stimulated increases in Ins(l,4 ,5 )P3 (Nanberg & Rozengurt, 1988) it seemed 
possible that, like bombesin, [Arg8 ]Vp-stimulated PtdCho hydrolysis might be 
dependent upon prior activation of PKC via inositol lipid hdrolysis. Since both 
[Arg8]Vp- and PGF2 a -stimulated pH]Cho generation was completely abolished in 
cells which had been treated with 400nM PMA for 48 hours to down-regulate 
protein kinase C this would suggest that, like bombesin, PKC activity is required 
for activation of PtdCho-PLD.
The fact that bombesin, [Arg8]Vp and PGF2 a  exhibited broadly the same
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rank order of increases in pH]InsPt (Chapter 3) and pH]Cho accumulation was 
consistent with the degree of PtdCho hydrolysis being dependent upon the 
magnitude of prior inositol lipid hydrolysis and, therefore, activation of PKC. 
Finally, the observation that sub-maximal concentations of bombesin and [Arg8]Vp 
were additive rather than synergistic in stimulating pH jC ho accumulation in 
combination is also consistent with the the two agonists stimulating PtdCho 
hydrolysis through a common pathway.
Thus, it seems that for RGE-type mitogens which couple to inositol lipid 
hydrolysis via a G-protein, a common consequence of mitogen-stimulated inositol 
lipid hydrolysis will be the activation of PtdCho-PLD. The kinetics of bombesin- 
stimulated PtdCho hydrolysis and formation of pH]Cho and pH]PtdBut are fully 
consistent with PtdCho-PLD contributing to the second phase of bombesin- 
stimulated DG elevation and this has been shown to be the case by using butan-l-ol 
to block DG formation (Chapter 4 of this thesis). By analogy with bombesin, it 
would seem likely that PLD activation will contribute to the formation of DG by 
vasopressin and PGF2 a ; consistent with this, Huang & Cabot (1990b) have 
recently shown that vasopressin does indeed stimulate a PLD activity which may 
perform just this function in REF52 fibroblasts.
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Chapter 6.
Growth factor receptors with tyrosine kinase activity can 
couple to DG formation and activation of PtdCho- 
phospholipase D.
6.1 Introduction.
In bombesin-stimulated Swiss 3T3 cells neither the kinetics or mass 
increase in Ins(l,4 ,5 )P3 can completely account for the observed increases in DG 
(Chapters 3 and 4). Furthermore, the sustained increase in DG levels can be 
dissociated from inositol lipid hydrolysis by the phorbol ester PMA. It seems that 
phospholipase D-catalysed hydrolysis of PtdCho contributes to the sustained phase 
of DG production and this may require prior activation of protein kinase C resulting 
from initial PtdIns(4,5)P2 hydrolysis. Furthermore, it would seem that activation 
of a PtdCho-PLD may be a common early response to those mitogens which 
activate PtdIns(4,5)P2 hydrolysis via a 'classical' receptor- Gp- PIC (RGE) 
mechanism. These results suggest that PtdCho hydrolysis by PLD might be a 
widespread signal transduction pathway involved in mitogenic signalling events. 
Using the Swiss 3T3 cell as a model system experiments were performed to 
determine if this pathway of stimulated PtdCho hydrolysis was activated by growth 
factors of the 'receptor tyrosine kinase’ (RTK) family. These studies concentrated 
upon epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) 
whose receptors possess ligand activated tyrosine kinase activity. EGF and PDGF 
serve as particularly useful comparisons to bombesin since PDGF is able to 
stimulate Ins(l,4,5)P3 formation, albeit by a fundamentally different mechanism 
(Blakeley et al., 1989), whilst EGF is reported not to stimulate inositol lipid 
hydrolysis in Swiss 3T3 cells (Hesketh et al., 1988).
In this chapter the ability of EGF and PDGF to stimulate inositol lipid 
hydrolysis, PLD activity and, in the case of EGF, DG formation is compared with 
bombesin and phorbol ester. The results suggest that in addition to regulation by 
PKC, PLD activity may be regulated by other pathways including growth factor 
receptor tyrosine kinases. The results are discussed in the context of possible 
multiple pathways of PLD regulation and DG formation in response to mitogenic 
stimuli.
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6.2 Results.
6.2.1 EGF stimulates an increase in DG mass in the absence of 
significant inositol lipid hydrolysis.
The ability of EGF to activate PKC in Swiss 3T3 cells is subject to some 
debate (Isacke et al., 1986; Rodruigez-Pena & Rozengurt, 1986; Kazlauskas & 
Cooper, 1988). Those reports describing the inablility of EGF to activate PKC in 
Swiss 3T3 cells are supported by the observation that EGF does not stimulate 
inositol lipid hydrolysis in this cell line (Hesketh et al., 1988). Because of the 
anomalous reports concerning the ability of EGF to activate PKC in Swiss 3T3 
cells and the recent reports of agonist-stimulated DG formation from PtdCho (Billah 
& Anthes, 1990), the effect of EGF upon DG levels was examined by mass assay. 
Figure 6.1a shows the timecourse of EGF-stimulated increases in DG mass. 
Unlike the response to bombesin there was no rapid increase at 5 sec. Increases 
above control were only apparent from 30 sec onwards, but were statistically 
significant from 1 (p= 0 .0 2 1 ) or 2  min and were maintained at this maximum level 
for 30 min before declining. At 60 min DG levels had declined, but were still 
above the corresponding control time point (Fig. 6.1b). The ability of EGF to 
increase DG levels in Swiss 3T3 cells was dose-dependent (Fig.6.2) with maximal 
elevation occurring at approximately InM and an EC50  value of 0.07 ± 0.02 nM. 
In general the magnitude of EGF-stimulated increases in DG mass was much 
smaller than that observed for bombesin or PMA; this is particularly apparent in Fig. 
6.6  where the three agonists were used in parallel in the same experiment allowing a 
direct comparison. EGF stimulated a net increase of 150 ± 41 pmoles of DG/10^ 
cells (mean ± S.D. of n= 5 determinations) representing a 1.81 ± 0.48 fold increase 
over unstimulated levels (mean ± S.D. from n= 9 determinations). This smaller 
response, compared with the sustained phase of bombesin-stimulated DG 
formation, is similar to that seen by Wright et al. (1988; 1990a) in EGF-stimulated 
DC9 cells in comparison to that stimulated by a-thrombin.
Despite this increase in cellular diglyceride content, EGF was unable to 
stimulate a reproducible increase in [^Hjinositol phosphate accumulation over
1 9 1
Figure 6.1 (a & b). Time course of EGF-stimulated increases in DG 
mass in Swiss 3T3 cells.
Confluent, quiescent Swiss 3T3 cells were washed in serum-free DMBH 
for 60 min at 37°C before replacing with DMBH alone (□) or containing lOOnM 
EGF (■ ) for the indicated times up to 15 (a) or 60 (b) min. Incubations were 
terminated by aspiration and addition of ice-cold methanol and chloroform extracts 
were assayed for DG mass by incubating with DG kinase and [y-^PjA TP as 
outlined in Chapter 2. The results are expressed as mass of DG (pmoles/10^ cells) 
and each point represents the mean ± S.D. of triplicate determinations from a single 
experiment representative of three.
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Figure 6.2. D ose-response curve for EG F-stim ulated DG 
accumulation in Swiss 3T3 cells.
Confluent, quiescent Swiss 3T3 cells were washed in serum-free DMBH 
for 60 min at 37° C before replacing with DMBH containing the indicated final 
concentration of EGF (■) for a further 10 min. Following aspiration and addition 
of ice-cold methanol, chloroform extracts were prepared and an aliquot assayed for 
DG mass by the method outlined in Chapter 2. The results are expressed as mass 
of DG (pmoles/106 cells) and each point represents the mean ± S.D. of triplicate 
determinations from a single experiment representative of three.
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Figure 6.3 (a & b). The effect of EGF upon [^H]InsPt accumulation 
in Swiss 3T3 cells; a comparison with bombesin.
Swiss 3T3 cells were grown in 24 well plates until judged to be 80 % 
confluent and were then grown for a further 48 hours in inositol-free DMEM 
containing 1% dialysed calf serum and either 0.75|iCi ml'* (bombesin in (b)) or 
ljiCi ml"1 ((a) and EGF in (b)) [^H]inositol. After washing in HBG for 5 min 
cells were incubated in HBG containing lOmM LiCl (HBG.Li) for a further 15 min 
before replacing with HBG.Li containing the indicated final concentrations of (a) 
EGF (■) and (b) EGF (■) or bombesin (□). Incubations were terminated after 20 
min by aspiration and addition of ice-cold methanol and aqueous methanolic 
extracts were prepared as described in the Methods section. H]InsPt were 
resolved as described in Chapter 2 and the associated radioactivity was determined 
by liquid scintillation counting. The results are expressed as (a) radioactivity in 
[3H]InsPt (d.p.m.) or (b) percentage of control, to allow comparison of the two 
agonists. Each point represents the mean ± S.D. of triplicate determinations from 
single experiments representative of three. In the case of (b) the basal radioactivity 
associated with [^H]InsPt was 2716 ± 93 dpm for bombesin and 5665 ± 948 dpm 
for EGF.
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controls even in the presence of lOmM LiCl. Figure 6.3a shows the dose response 
curve for EGF-stimulated changes [^H]InsPt accumulation; a small elevation was 
sometimes observed at the highest dose (lOOnM, Fig. 6.3b), but was not 
reproducible and was clearly at least two orders of magnitude to the right of the 
dose response curve for DG accumulation (Fig. 6.2.). Figure 6.3b compares the 
dose-response curves for EGF- and bombesin-stimulated increases in [^H]InsPt 
accumulation. The accumulation of [^H]InsPt in response to EGF was negligible 
in comparison to that stimulated by bombesin, suggesting that at mitogenically 
relevant doses the activated EGF receptor did not couple to inositol lipid hydrolysis. 
Furthermore EGF did not stimulate any apparent increase in Ins(l,4 ,5 )P3 mass up 
to 5 min when assayed by the competitive binding assay (S. Palmer, personal 
communication).
6.2.2 EGF stim ulates PtdCho-PLD activity but this does not serve 
as a pathway for DG formation.
Since a number of reports (Wright et al., 1990a; Billah & Anthes, 1990) 
and results from Chapter 4 have suggested a role for phospholipase C- & D- 
catalysed PtdCho hydrolysis as an alternative source of DG, experiments were 
performed to investigate if EGF did stimulate PtdCho hydrolysis and whether this 
played a role in DG formation.
Figure 6.4a shows the kinetics of EGF-stimulated increases in [^H]PtdBut 
in [^H]palmitate-labelled Swiss 3T3 cells stimulated in the presence of butan-l-ol. 
Following addition of EGF increases in [^H]PtdBut were apparent and significant 
after 30 sec (p= 0.006) and increased rapidly until 2 min. In most experiments 
[^HJPtdBut levels continued to rise from 2 min up to 15 min. However, the rate of 
[^HJPtdBut formation from 2 min onwards was much lower than that in the first 2 
min (0-2 min + EGF 854 dpm min"1, 2-15 min + EGF 65 dpm m in'1, control no 
added EGF, 12 dpm m in'1; results from a single representative experiment). This 
slower increase in [^H]PtdBut was variable; in some cases the 15 min stimulated 
point was significantly higher than the 5 min stimulated point (p= 0.032, Fig. 6.4a)
1 9 5
Figure 6.4 (a & b). EG F-stim ulated [3 H ]PtdBut form ation in Swiss 
3T3 cells.
Swiss 3T3 cells were grown in 6  well plates until judged to be 80% 
confluent. They were then grown for a further 48 hours in 2ml DMEM containing 
1% calf serum and a total of 4|iCi of [^HJpalmitic acid.
(a) After washing in DMBH for 30 min at 37° C cells were incubated for a 
further 5 min in DMBH containing 0.3% (v/v) butan-l-ol before replacing with 
DMBH containing 0.3% (v/v) butan-l-ol alone (□) or with lOOnM EGF (■) for 
the indicated times.
(b) After washing in DMBH for 30 min at 37° C cells were incubated in 
DMBH containing 0.3% (v/v) butan-l-ol and the indicated concentration of EGF 
(■) for 15 min.
In both cases incubations were terminated by aspiration and addition of ice- 
cold methanol and chloroform extracts were prepared and [^HjPtdBut resolved on 
LK5DF t.l.c. plates as described in the Methods section. [^H]PtdBut was excised 
from the silica gel and the radioactivity determined by scintillation counting. The 
results are mean radioactivity in PtdBut (d.p.m.) ± S.D. of triplicate determinations 
from a single experiment representative of three.
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Figure 6.5 (a & b). EG F-stim ulated increases in [3 H ]Cho and 
[3 H]ChoP in Swiss 3T3 cells.
Swiss 3T3 cells were grown in 24 well plates until judged to be 80% 
confluent after which they were grown for a further 48 hours in 1ml of DMEM 
containing 1% calf serum and 1.5}iCi of [3 H]choline chloride. Cells were then 
washed in Hanks and HBG for a total of 45 min as described in the Methods 
section before replacing with HBG alone (□) or containing lOOnM EGF (■) for 
the indicated times. Incubations were terminated by addition of ice-cold methanol 
and aqueous methanolic extracts were loaded onto Dowex-50W-H+ columns for 
resolution of (a) [3 H]Cho and (b) [3 H]ChoP. The radioactivity associated with an 
aliquot of each fraction was determined by scintillation counting. The results are 
mean radioactivity in each fraction (d.p.m.) ± S.D. of triplicate determinations from 
a single experiment representative of three.
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whilst in other experiments the continued rise in [^H]PtdBut was not statistically 
significant. Fig. 6.4 (b) shows the dose-response curve for EGF-stimulated 
increases in [^H]PtdBut levels in Swiss 3T3 cells; the EC5Q value was 1.14 ± 0.54 
nM (mean ± S.D., n=3 experiments). These results clearly demonstrated that EGF 
stimulates PLD activity.
To confirm that this PLD activity was utilizing PtdCho as a major substrate 
the effect of EGF upon [^HjCho, [^HjChoP and [^HjGroPCho levels was 
examined in Swiss 3T3 cells labelled to isotopic equilibrium with [^H]choline 
chloride. Figure 6.5 (a & b) shows the time course of changes in the radioactivity 
associated with [^H]Cho and [^HjChoP in EGF-stimulated Swiss 3T3 cells; there 
was no significant increase in [^HJGroPCho in any experiment performed (data not 
shown). Following addition of EGF, [^HJCho levels were elevated within 30 sec 
and were significantly above control at 1 minute (Fig. 6.5a) (p= 0.025). Maximal 
elevation was observed at 2  min after which the rate of increase slowed but 
[^H]Cho levels were maintained above control for at least 30 and, in some cases, 
60 min (data not shown). No significant increases in the radioactivity associated 
with [^HjChoP were observed in response to EGF until much later timepoints 
(typically 30 min, Fig.6.5b).
Incubation in the presence of primary alcohols allows a preliminary 
assessment of what role a coupled PLD/PPH pathway plays in DG formation since 
it traps phosphatidyl moieties as the relativeley non-reactive phosphatidylalcohol 
(Bonser et al., 1989; Metz &Dunlop, 1991; Chapter 4). To determine what 
contribution, if any, the PLD/PPH pathway made to EGF-stimulated DG formation 
the effect of butan-l-ol upon EGF-stimulated DG levels was examined. Pre­
incubation of Swiss 3T3 cells with 0.3% (v/v) butan-l-ol for 5 min resulted in 
inhibiton of PMA- and, to a lesser extent, bombesin-stimulated DG formation (Fig.
6 .6 ). Under the same conditions EGF-stimulated increases in DG formation were 
unaffected by the presence of butan-l-ol prior to and during the stimulation (Fig.
6 .6 ), suggesting that DG formation did not occur via a PLD/PPH coupled pathway 
in response to EGF.
1 9 8
Figure 6.6. The effect of butan-l-ol upon EGF-stimulated DG 
formation.
Swiss 3T3 cells were grown to confluence and quiescence and were washed 
for 60 min in serum-free DMBH at 37°C. Cells were then washed for a further 5 
min in DMBH containing 0.3% (v/v) butan-l-ol before replacing with DMBH 
containing butan-l-ol and either EGF (lOOnM), bombesin (lOOnM) or PMA 
(lOOnM) for 15 min. Incubations were terminated by aspiration and addition of 
ice-cold methanol and chloroform extracts were prepared as described in chapter 2 . 
DG mass in these extracts was assayed as described in the Methods section. 
Results are expressed as mass of DG (pmoles/106 cells) and each data set is the 
mean ± S.D. of triplicate determinations from a single experiment representative of 
three.
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6.2.3 Regulation of PLD by ligand-activated EGF receptors.
These results suggested that the EGF receptor was able to activate a 
PtdCho-PLD activity, though this apparently did not serve as a pathway for DG 
formation. In Chapter 4 evidence was presented to suggest that bombesin- 
stimulated PtdIns(4 ,5 )P2 hydroysis might couple to activation of PLD via increases 
in PKC activity. Since EGF was able to increase DG levels and activate PLD 
without PtdIns(4,5)P2 hydrolysis this suggested that the EGF receptor might 
couple directly to PLD independently of PKC activity. To investigate this, the 
effect of the PKC inhibitor Ro-31-8220 on EGF-stimulated [^H]PtdBut formation 
was determined and compared with that of PMA and bombesin. The results are 
shown in Figure 6.7 (a & b). In Fig.6.7a, [^HJpalmitate labelled Swiss 3T3 cells 
were pre-treated for 5 min with increasing concentrations of Ro-31-8220 followed 
by addition of a maximal dose of EGF (20 nM). The figure shows that even at the 
highest concentration of the PKC inhibitor EGF-stimulated [^H] PtdBut formation 
was not significantly inhibited. When the results were normalised to 'percent of 
maximum' and compared with that for PMA and bombesin (Fig. 6.7b) the 
contrasting effect upon the EGF response was clearly seen. PMA-stimulated 
[3 H] PtdBut formation was inhibited by approximately 90% whilst bombesin- 
stimulated PLD activity was inhibited by about 50% as described in Chapter 5. In 
contrast EGF-stimulated [^H]PtdBut activity was not inhibited and in some cases 
there was a clear enhancement at 3|iM Ro-31-8220 which was statistically 
significant (p= 0.007) at 10|iM Ro-31-8220 (Fig. 6.7b).
The cytosolic domain of the EGF receptor includes a tyrosine kinase 
catalytic region which is activated after ligand induced receptor autophosphoiylation 
and dimerisation. It has been proposed that, once activated, this catalytic domain is 
responsible for interacting with and phosphorylating various key substrates such as 
effector systems (reviewed by Ullrich & Schlessinger, 1990). In A431 cells and 
NIH3T3 cells over-expressing the human EGF receptor one of these substrates is 
PLC-yl (Meisenhelder et a/., 1989; Margolis et a/., 1989) However, in Swiss 
3T3 cells possessing their 'native' receptor complement EGF does not stimulate 
inositol lipid hydrolysis (Hesketh et al., 1985; Fig 6.3) or phosphorylation of
2 0  0
Figure 6.7 (a & b). Comparison of the effect of Ro-31-8220 upon 
EGF-, PMA- and bombesin-stimulated [3 H]PtdBut formation in 
Swiss 3T3 cells.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent whereupon they were grown for a further 48 hours in 2 ml of DMEM 
containing 1% calf serum and 4fiCi of [3 H]palmitic acid. After washing in DMBH 
for 30 min at 37° C cells were incubated for 5 min in 0.9 ml of DMBH containing 
0.3% (v/v) butan-l-ol and the indicated concentration of Ro-31-8220. Incubations 
were started by addition of 0.1 ml of agonist solutions to give final concentrations 
of 30nM for EGF and lOOnM each for PMA and bombesin. After 15 min 
incubations were terminated by aspiration and addition of ice-cold methanol and 
chloroform extracts were prepared as described in the Methods section. 
[3H]PtdBut was resolved by t.l.c. and the associated radioactivity determined by 
scintillation counting after excision from the plate. The results are expressed as (a) 
mean radioactivity in [3 H]PtdBut (d.p.m.) ± S.D.(n=3) from a single experiment 
typical of four or (b) are normalised to percentage of maximal response to allow 
comparison with bombesin and PMA. In the case of bombesin the unstimulated 
d.p.m. in [3 H]PtdBut was 1894 ± 57 and the maximaum response was 12033 ± 
1185 d.p.m., whilst for PMA the unstimulated radioactivity in [3HPtdBut was 
1306 ±218 d.p.m. and the maximal response was 32289 ± 1704 d.p.m.
In (a), ■  = EGF and □  = the vehicle control, DMSO, with no EGF 
stimulus. In (b), □  = EGF, A = bombesin and ■  = PMA.
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PLC-yl (Meisenhelder et al., 1989). To investigate whether the EGF receptor 
tyrosine kinase activity was required for activation of PLD by EGF the effect of 
pre-treating Swiss 3T3 cells with the tyrosine kinase inhibitor AG 18 (Levitski, 
1990a) was examined. AG 18 exemplifies a group of compounds called 
Tyrphostins, hydroxylated benzylidene malonitrile compounds, which inhibit 
receptor tyrosine kinase activities by competing with the substrate rather than 
inhibiting at the ATP binding site. However, the Kj against the EGF receptor is at 
least two orders of magnitude lower than that against the insulin receptor and as 
such it can be used as a reasonably selective inhibitor of the EGF receptor tyrosine 
kinase (Lyall et al., 1989; Levitski, 1990a).
When [3 HJpalmitate labelled Swiss 3T3 cells were pre-treated with 
increasing concentrations of AG 18 for 18 hours there was a dose-dependent 
inhibition of EGF-stimulated [^HjPtdBut formation as shown in Fig. 6 .8 a. In 
addition, the results were normalised to ’percent of maximum' to allow comparison 
with bombesin which gave a larger response. Maximal inhibition of EGF- 
stimulated H]PtdBut formation was observed at lOOpM AG18 with an apparent 
IC50 of about 30jiM; an accurate IC5Q could not be estimated since the inhibition 
was not complete. At IOOjiM AG 18 the response to EGF was inhibited by 
approximately 85-90%. In the same experiments in which 100|iM AG18 inhibited 
90% of EGF-stimulated [^HjPtdBut formation the response to bombesin was 
completely unaffected (Fig. 6 .8b).
Finally, the role of Ca^+ in regulating EGF-stimulated PLD activity was 
assessed by buffering extracellular [Ca2+]j to approximately 150nM with EGTA. 
In Swiss 3T3 cells the ability of EGF to stimulate an increase in [Ca^+]j is a subject 
of some debate (Hesketh et al., 1985; 1988; Olsen et al.t 1988). However in 
those cells where EGF does stimulate an increase in [Ca^+]j it is wholly dependent 
upon the presence of extracellular Ca^+ (Hesketh et al., 1985; 1988), so by 
buffering extracellular Ca^+ with EGTA experiments were performed to see if Ca^+ 
entry played any role in EGF-stimulated PLD activity. The results shown in Fig. 
6.9 are preliminary and await the confirmation that EGF does indeed stimulate an
2 0  2
Figure 6.8 (a & b) A comparison of the effect of AG 18 upon EGF- 
and bombesin-stimulated [3H]PtdBut formation.
Swiss 3T3 cells were grown on 6  well plates until judged to be 80% 
confluent whereupon they were grown for a further 48 hours in 2 ml of DMEM 
containing 1% calf serum and 4pCi of [^Hjpalmitic acid. For the last 18 hours AG 
18 was added to the cells at the indicated final concentration such that the 
concentration of the vehicle, DMSO, was never greater than 0.1% (v/v). After 48 
hours cells were washed at 37° C in DMBH for 15 min followed by a further wash 
in 0.9 ml of DMBH containing the same concentrations of AG 18 and 0.3% (v/v) 
butan-l-ol for 15 min; incubations were started by the addition of 0.1 ml of agonist 
to give final concentrations of 30nM for EGF and lOOnM for bombesin. After 15 
min incubations were terminated by aspiration and addition of ice-cold methanol 
and chloroform extracts were prepared as described in the Methods section. 
[^HjPtdBut was resolved by tl.c ., excised from the plate and the associated 
radioactivity determined by scintillation counting. The results are expressed as (a) 
radioactivity in [^HjPtdBut (d.p.m.) ± S.D. (n=3) from a single experiment typical 
of three or (b) as percentage of response in the absence of inhibitor to allow a 
comparison with bombesin. In the case of (b) the unstimulated radioactivity in 
[■^HjPtdBut was 1461 ± 230 d.p.m. and the maximum response in the absence of 
AG 18 was 3905 ± 332 d.p.m. for EGF and 11557 ±115 d.p.m. for bombesin.
In (a) ■  = EGF and □  = the vehicle control, DMSO, in the absence of 
stimulus. In (b) ■  = EGF and □  = bombesin.
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Figure 6.9. The effect of EGTA upon EGF-stimulated [^H jPtdBut 
formation in Swiss 3T3 cells.
Swiss 3T3 cells, grown until judged to be 80% confluent, were grown for a 
further 48 hours in 2 ml of DMEM containing 1% calf serum and 4jiCi of 
H]palmitic acid. Cells were washed at 37°C with DMBH for 15 min followed by 
DMBH containing 0.3% (v/v) butan-l-ol in the presence (hatched bars) or absence 
(open bars) of 2.5mM EGTA and incubations were started by replacing with 
DMBH containing 0.3% (v/v) butan-l-ol ± 2.5mM EGTA and 50nM EGF. After 
15 min incubations were terminated by aspiration and addition of ice-cold methanol 
and chloroform extracts were prepared as described in the Methods section. 
[^HjPtdBut was resolved by t.l.c., excised from the plate and the associated 
radioactivity was determined by scintillation counting. The results are expressed as 
mean radioactivity in [^H]PtdBut (d.p.m.) ± S.D. (n=3) from a single experiment; 
essentially identical results were obtained in a second experiment.
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increase in [Ca^+]j in this clone of Swiss 3T3 cells but buffering of extracellular 
Ca^+ resulted in an inhibition of EGF-stimulated PLD activity suggesting that 
EGF-stimulated PLD activity required the entry of extracellular Ca^+ or was Ca2+- 
dependent in some way.
6.2.4 PDGF stimulates a PtdCho-PLD activity in Swiss 3T3 cells.
Since stimulated PLD activity appears to be a common response to diverse 
mitogenic growth factors, studies were undertaken to determine if activation of PLD 
occurred in response to PDGF whose receptor also possesses a ligand activated 
tyrosine kinase activity. These experiments employed the c-sis protein as a BB 
homodimer of PDGF. Since it is able to interact with both the PDGF a  and p type 
receptor it allowed investigation of the effects of PDGF even though it was not 
known which receptor sub-type was present in the Swiss 3T3 cell line. 
Furthermore c-sis has been used successfully by other workers studying the 
effects of PDGF in Swiss 3T3 cells (Blakeley et al., 1989).
Swiss 3T3 cells labelled for 48 hours with H]palmitate were incubated 
with buffer containing butan-l-ol and PDGF (c-sis, 30ng ml"*) for the times 
indicated. The results in Fig. 6.10a show that PDGF was able to activate two 
distinct phases of [^HjPtdBut formation. Increases in [^HJ PtdBut were apparent 
and statistically significant after a 30 sec stimulation (Fig. 6 .10 a & b; p= 0.082 & 
0.077 respectively) at which point they were 1.5- 2-fold over control values. 
Elevated [^H] PtdBut was generally maintained thus for up to 2 min. However, 
from between 2 and 5 min [^H]PtdBut levels increased again in a second distinct 
phase which was maintained, and continued to rise for up to 15 min (Fig. 6 .10, a & 
b). The initial phase of PDGF-stimulated [^H] PtdBut formation was similar to the 
response to EGF in both magnitude and kinetics of onset as shown in Fig. 6 .10b 
where the two responses are compared; thus it appears that the initial phase of PLD 
activation was common to both growth factors whilst the later sustained activation 
was unique to PDGF.
PDGF was also able to stimulate the hydrolysis of H] PtdCho and release
2 0 5
Figure 6.10 (a & b). A comparison of the time course of PDGF- and 
EGF-stimulated [^HjPtdBut formation in [^HJpalmitate labelled  
Swiss 3T3 cells.
Swiss 3T3 cells, judged to be 80% confluent, were grown for a further 48 
hours in 2 ml of DMEM containing 1% calf serum and 4pCi of Hjpalmitic acid. 
Cells were washed at 37° C for 30 min in DMBH followed by a 5 min wash in 
DMBH containing 0.3% butan-l-ol (v/v). Incubations were started by replacing 
with DMBH containing 0.3% butan-l-ol ± 30ng ml'* PDGF (c-sis) and were 
terminated after the indicated time by aspiration and addition of ice-cold methanol. 
Chloroform extracts prepared as described in the methods section were applied to 
LK5DF plates and [^HjPtdBut was resolved by t.l.c. and the associated 
radioactivity was determined by scintillation counting. The results are mean 
radioactivity in [^HjPtdBut (d.p.m.) ± S.D. (n=3) from a single representative 
experiment. In (b) a time course for EGF-stimulated H]PtdBut formation is 
included for comparison.
In (a) □  = control and ■  = PDGF. In (b) □  = control, ■  = PDGF and •  
= EGF.
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of [^H]choline metabolites (Fig. 6.11, a & b). Addition of PDGF (c-sis, 10 ng 
ml-1) resulted in a small increase in [^HjCho at 20 and 30 sec (Fig. 6 .11 a) which 
whilst not always statistically significant was similar to the early increase in 
[3H]PtdBut (Fig.6.10). From 1 min stimulation with PDGF resulted in a sustained 
increase in [^H]Cho which was maintained above control for at least 15 min. 
Whilst the small initial phase of [^H]Cho elevation may be due to the limits of 
detection of a simple isotopic labelling assay the sustained phase was clearly 
reproducible. PDGF-stimulated increases in cell associated [^HjCho were also 
observed (Fig.6.11b) indicating that Ptdho hydrolysis was ocurring within the cells 
and the increase in [^HjCho was not due to leakage from the cells into the medium. 
In this case the response was again apparent as early as 30 sec after addition of 
PDGF. Since the early response could be detected as PLD transferase activity 
which is a more sensitive, cumulative assay, it seems that PDGF is able to activate a 
PtdCho-PLD activity within 30 sec of addition in Swiss 3T3 cells.
PDGF-stimulated increases in ChoP were smaller in fold magnitude, 
occurred at later timepoints and were less reproducible (data not shown). 
However, as discussed in the previous chapter this may be due to an underestimate 
of increases in ChoP due to a relatively high basal associated radioactivity.
Unlike EGF, PDGF-stimulated PtdCho PLD activity was not dissociated 
from inositol lipid hydrolysis since PDGF was able to stimulate a dose-dependent 
increase in [^H]InsPt (Fig. 6.12). The EC5Q value for this response was 8.64 ± 
0.77 ng ml"*; similar to that previously described by Blakely et al. (1989). 
However, the mechanism of PDGF-stimulated [^H]InsPt accumulation was quite 
different to that of bombesin, [Arg^JVp or PGF2 a . Firstly, acute pre-treatment for 
15 min with lOOnm PMA did not inhibit the response to PDGF (Fig. 6.12, open 
symbols). Furthermore, chronic pre-treatment with 400nM PMA for 48 hours to 
down-regulate PKC did not result in potentiation of the response as described for 
bombesin, [Arg^]Vp and PGF2 a  (data not shown; Blakeley et al., 1989); rather 
there was a small inhibition (approximately 10%) of the response as described by 
Blakeley et al. (1989).
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Figure 6.11 (a & b). Time course of PDGF-stimulated increases in 
[3 H]Cho in Swiss 3T3 cells.
Swiss 3T3 cells, grown on 24 well plates until judged to be 80% confluent, 
were grown for a further 48 hours in 1 ml of DMEM containing 1% calf serum and 
1.5fiCi of [3 H]choline. Cells were washed for 45 min in Hanks and HBG as 
described in the Methods section before incubating for the indicated times with 
HBG alone (□ ) or containing PDGF (30ng m l'1) (■ ). In (a) total Cho was 
assayed whereas in (b) intracellular Cho was assayed. Incubations were terminated 
by addition of ice-cold methanol either (a) directly or (b) after aspirating the medium 
and aqueous methanolic extracts were loaded on to Dowex-50WH+ columns. 
[3 H]Cho was eluted as described in the Methods section. The associated 
radioactivity was determined by liquid scintillation counting. The results are 
expressed as mean radioactivity in [3 H]Cho fraction (d.p.m.) ± S.D. (n=3) from a 
single experiment representative of three.
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Figure 6.12. Dose-response curve for PDGF-stimulated [3 H]InsPt 
accumulation in Swiss 3T3 cells.
Swiss 3T3 cells, grown on 24 well plates until judged to be 80% confluent, 
were grown for a further 48 hours in 1 ml of DMEM containing 1% dialysed calf 
serum and ljiCi of [3 H] inositol. Cells were washed at 37°C in HBG for 5 min 
followed by HBG containing lOmM LiCl (HBG.Li) with 300nM PMA (□) or 
0.1% DMSO containing P-phorbol (■) for 15 min before incubating in HBG.Li 
containing the indicated final concentration of PDGF for 20 min. Incubations were 
terminated by aspiration and addition of ice-cold methanol and aqueous methanolic 
extracts were assayed for [3 H]InsPt as described in the methods section. Results 
are expressed as mean radioactivity in [3 H]InsPt (d.p.m.) ± S.D.(n=3) from a 
single experiment respresentative of two.
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Finally the ability of PDGF to stimulate PLD activity, as measured by 
[3 H]Cho release (Fig.6.13a) or [^HJPtdBut formation (Fig.6.13b), was attenuated 
in cells which had been pre-treated with 400nM PMA for 48 hours to 'down- 
regulate' PKC (Fig. 6.13). In addition, 'down-regulation* of PKC exerted a 
somewhat variable effect upon the ability of EGF to stimulate PtdCho hydrolysis. 
In some experiments EGF-stimulated [^HjCho release was apparently unaffected 
by the 48 hour pre-treatment with PMA (e.g., dpm in [^H]Cho fraction; control 
cells, unstimulated = 6740 ± 424 dpm, lOOnM EGF = 9713 ± 1106 dpm; PMA- 
treated cells, unstimulated = 6850 ± 466 dpm, lOOnM EGF, 10080 ± 933 dpm). 
These results were consistent with the lack of inhibitory effect of Ro-31-8220 upon 
EGF-stimulated [^HJPtdBut formation. In contrast, other experiments yielded 
results suggesting that EGF-stimulated PtdCho hydrolysis was abolished in cells 
treated with 400nM PMA for 48 hours (e.g., dpm in [^H]Cho fraction; control 
cells, unstimulated = 6518 ± 155 dpm, lOOnM EGF = 12454 ± 1329 dpm; PMA- 
treated cells, unstimulated = 6292 ± 450 dpm, lOOnM EGF = 6767 ± 841 dpm).
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Figure 6.13 (a & b). The effect of 48 hour pre-treatment with 
400nM PMA upon PDGF-stimulated PtdCho-PLD activity in Swiss 
3T3 cells.
(a) Swiss 3T3 cells, grown on 24 well plates until judged to be 80% 
confluent, were grown for a further 48 hours in 1 ml of DMEM containing 1% calf 
serum, 1.5jiCi of [^H] choline and either 400nM PMA (hatched bars) or p-phorbol 
(open bars). Cells were washed for 45 min in Hanks and HBG as described in the 
Methods section before incubating for the indicated times with HBG alone or 
containing bombesin (lOOnM), PMA (lOOnM) or PDGF (30ng mT^) as indicated. 
Total [^H]Cho was isolated as described in the methods section and the associated 
radioactivity was determined by liquid scintillation counting. The results are 
expressed as mean radioactivity in [^H]Cho fraction (d.p.m.) ± S.D. (n=3) from a 
single experiment representative of three.
(b) Swiss 3T3 cells, grown on 6  well plates until 80% confluent, were 
grown for a further 48 hours in 2 ml of DMEM containing 1% calf serum, 4jiCi of 
[^Hjpalmitic acid and either 400nM PMA (hatched bars) or P-phorbol (open bars). 
Cells were washed at 37° C for 30 min in DMBH followed by a 5 min wash in 
DMBH containing 0.3% butan-l-ol (v/v). Incubations were started by replacing 
with DMBH containing 0.3% butan-l-ol alone or with bombesin (lOOnM), PMA 
(lOOnM) or PDGF (30ng ml-1) as indicated, and were terminated after 20 min by 
aspiration and addition of ice-cold methanol. Chloroform extracts prepared as 
described in the Methods section were applied to LK5DF plates and [^HjPtdBut 
was resolved by t.l.c. and the associated radioactivity was determined by 
scintillation counting. The results are mean radioactivity in [^HJPtdBut (d.p.m.) ± 
S.D. (n=3) from a single representative experiment.
A 48 hour pre-treatment with PMA resulted in a 2-fold increase in 
radioactivity in total [^HJcholine labelled lipids and a 3.5- 4-fold increase in the 
total radioactivity in [^HJpalmitate labelled lipids. Consequently the radioactivity in 
either [^H]Cho or [^HJPtdBut was normalised to the labelling in the lipids.
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6.3 Discussion.
6.3.1 EGF-stimulated DG formation in the absence of inositol lipid 
hydrolysis.
The ability of EGF to stimulate inositol lipid hydrolysis, and indeed cell 
growth, appears to vary with cell lineage. In a number of quiescent fibroblast cell 
lines including Swiss 3T3 cells (Otto et al., 1981; Hesketh et al., 1985; 1988), 
NIH3T3 fibroblasts (Meisenhelder et al., 1989), Balb/c 3T3 cells (Besterman et 
al., 1986) and IIC9 cells (Wright et al., 1990a) EGF is mitogenic with EC50 
values in the 0.1-1 nM range, but does not significantly stimulate the accumulation 
of inositol phosphates, Ins(l,4 ,5 )P3 or phosphorylation of PLC-yl. In Swiss 3T3 
cells EGF is reported to be a complete mitogen as it can stimulate DNA synthesis in 
the absence of other growth factors though it is not as efficacious as serum (Otto et 
al., 1981). EGF is also able to synergise with insulin and PGF2 a  in stimulating 
DNA synthesis. In Swiss 3T3 cells EGF elevates [Ca^+]j and pHj and stimulates 
DNA synthesis and cell proliferation in the absence of inositol lipid hydrolysis (Otto 
et al., 1981; Hesketh et al., 1985; 1988), though the precise mechanism is in 
some doubt since in another clone of Swiss 3T3 cells EGF was only able to 
stimulate increases in [Ca^+]j after priming with [Arg^JVp or PGF2 a  (Olsen et 
al., 1988).
In contrast a number of cells do respond to EGF by tyrosine 
phosphorylation of PLC-yl and stimulation of inositol lipid hydrolysis, but it is not 
clear that these are physiologically relevant models of mitogenesis. For example, 
the A431 human epidermoid carcinoma cell line over-expresses EGF receptors to 
the order of 1.5-2 x 10^ per cell and addition of EGF to these cells has variously 
been reported to result in the primary generation of Ins(l,4 ,5 )P3 or Ins(l,3 ,4 )P3 
(Hepler et al., 1987; Tilly et al., 1988) but actually inhibits growth (Kamata et 
al., 1986; Iwashita et al., 1990) whilst the EC5 0  for inositol phosphate generation 
is much higher than its reported mitogenic effects in other cells being in the range of 
10-lOOnM (Hepler et al., 1987). The results of Tilly et al. (1988) are of interest 
since these authors were able to detect an increase in Ins(l,3 ,4 )P3 in response to
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EGF but not Ins(l,4 ,5)P3 ; these results are in contrast to those of Hepler et al. 
(1987) and to date it is not clear what the source of this Ins(l,3 ,4 )P3 is. EGF can 
also stimulate Ins(l,4 ,5 )P3 formation in a number of 'engineered' cell lines such as 
the murine NIH3T3 cell over-expressing the human EGF receptor (the HER14 cell, 
Margolis et al., 1989). It is interesting to note that Levitski (1990a) speculates that 
the EGF receptor/PLC-yl interaction may be confined to those cells over- 
expressing the EGF receptor. Thus, phosphorylation, and presumably activation, 
of PLC-yl may not be an event associated with EGF stimulation of normal cells but 
it may be of great importance in the unrestrained growth of cells which either over­
express, or possess mutant EGF receptors. Such speculation raises the important 
question of whether receptor/effector coupling specificity is compromised when 
receptors are over-expressed or mutated. For example, the CSF-1 receptor is 
unable to couple to inositol lipid hydrolysis (Imamura et al., 1990) whereas its 
constitutively active counterpart, the fm s  oncogene product, is able to couple to 
inositol lipid hydrolysis (Jackowski et al., 1986). Furthermore, over-expression 
of the a-2 C-10 adrenergic receptor in Rat-1 fibroblasts results in the expression of 
an agonist-dependent PLD activity which is only present in the cells expressing 2-3 
fmoles mg"* of membrane protein; not in clones with lower receptor density 
(Milligan et al., 1991). Whilst such cell lines provide novel approaches to 
adressing certain questions of structure-function relationship their use in 
extrapolation to the 'normal' situation is difficult and perhaps questionable.
Since in most cell lines where EGF is mitogenic there is no evidence for 
EGF-stimulated PKC activity the inability of EGF to stimulate inositol lipid 
hydrolysis would seem to fit the available facts and few studies have determined if 
DG levels rise upon EGF stimulation. However, even in different clones of a 
single cell line, Swiss 3T3, there appears to be no consensus and the ability of EGF 
to activate PKC in Swiss 3T3 cells is the subject of conflicting reports. Isacke et 
al. (1986) and Rodruigez-Pena & Rozengurt (1986) reported that EGF was unable 
to stimulate the phosphorylation of an 80 kDa phosphoprotein, which is reported to 
serve as a marker for PKC activation in Swiss 3T3 cells. This result was deemed
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to be consistent with the inability of EGF to activate inositol lipid hydrolysis or 
inositol phosphate accumulation in Swiss 3T3 cells (Hesketh et al., 1985; 1988). 
However in the same cell line Kaslauskas & Cooper (1988) were able to 
demonstrate EGF-stimulated phosphorylation of an 80 kDa protein which was of 
the same magnitude as that for PDGF and PMA. Since, the response was 
abolished following the down-regulation of PKC it suggested that EGF was 
stimulating PKC-mediated 80 kDa protein phosphorylation. Furthermore, in Swiss 
3T3 cells Susa et al. (1989) have demonstrated that the kinetics of EGF-stimulated 
S6  kinase activity are biphasic and that the second phase is inhibited by chronic pre- 
treament with phorbol ester suggesting a role for activation of PKC. A possible 
explanation for this anomaly has come from the recent report that EGF can elevate 
DG levels in IIC9 fibroblasts in the absence of inositol lipid hydrolysis; the 
hydrolysis of PtdCho is implicated as the source (Pessin et al., 1990; Wright et 
al., 1990a) and the DG produced may then activate PKC in the absence of 
Ins(l,4 ,5 )P3 formation.
In the light of the results obtained in the previous chapters the ability of 
EGF to stimulate the formation of DG, the endogenous activator of PKC, was 
tested directly using the DG mass assay. The results in Fig. 6 .1 confirm that DG 
formation occurs within 30 sec of addition of lOOnM EGF to Swiss 3T3 cells. 
Furthermore, the response is sustained above control levels for at least 1 hour 
indicating that sustained elevation of DG appears to be an early signal associated 
with EGF stimulation. The response was clearly of smaller magnitude than that for 
bombesin or PMA; whether this reflects the lack of input from inositol lipid 
hydrolysis is not clear but, in agreement with other reports, EGF did not stimulate a 
reproducible elevation of [^H ]InsPt in Swiss 3T3 cells (Fig. 6.3). In some 
experiments there was a very small increase in [^H]InsPt accumulation in the 
presence of lOmM LiCl, but this was observed rarely and then only at the highest 
concentrations of EGF (lOOnM). This indicated that EGF-stimulated DG formation 
was not due to even this small stimulation of inositol lipid hydrolysis since the 
concentration required was at least two orders of magnitude to the right of the EC50 
for EGF-stimulated DG formation. Furthermore, EGF was unable to stimulate an
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increase in Ins(l,4,5)P3 mass using the competitive binding assay (S. Palmer, 
personal communication). Thus, EGF-stimulated DG formation occurred over 
mitogenically relevant doses at which inositol phosphate accumulation was 
unaffected.
The ability of EGF to stimulate DG formation, albeit modestly, is in contrast 
to the recent report of Bierman et al. (1990) who were able to demonstrate biphasic 
bombesin-stimulated DG formation but no EGF-stimulated DG formation in Swiss 
3T3 cells. Apart from the possibility that this represents clonal differences between 
different Swiss 3T3 cell lines, differences in sample preparation for the DG mass 
assay may explain these conflicting results. After stimulating cells with agonist, 
incubations were terminated by aspiration and addition of 10% trichloroacetic acid 
(Bierman et al., 1990); however, Preiss et al. (1986) report that exposure of sn- 
1,2-DGs to even mild acid or alkali results in acyl group migration and loss of the 
sn-1,2- specificity of the assay leading to an underestimation of increases in DG 
mass. The increase in DG mass seen with EGF is clearly much smaller than that 
seen with bombesin or PMA and might not be observed if samples had been 
prepared under acid conditions.
The ability of EGF to stimulate increases in DG in the absence of inositol 
lipid hydrolysis is not unprecedented. Wright et al. (1988; 1990a & b) have 
demonstrated an increase in DG of similar magnitude and duration in EGF- 
stimulated nC9 fibroblasts whilst Baldassare et al. (1990) have made similar 
observations in human dermal fibroblasts; in both cases there was no evidence for 
EGF-stimulated inositol lipid hydrolysis.
6.3.2 EGF stimulates the PLD-catalysed hydrolysis of PtdCho but 
this does not serve as a pathway for DG formation.
Despite its inability to stimulate the hydrolysis of inositol lipids, EGF 
clearly stimulated phospholipase D activity as measured by the formation of 
[^HJPtdBut by the transferase pathway. The kinetics of EGF-stimulated 
[^HJPtdBut formation (Fig. 6.4a) were very similar to those for increases in DG
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(Fig. 6.1). The slowing in rate of PtdBut formation suggested that activation of 
PLD was rapidly desensitised though this desensitization did not always appear to 
be complete since [^H] PtdBut formation was in some cases maintained though the 
rate from 2 min onwards was greatly reduced. The kinetics of [^HJPtdBut 
formation suggested that a PLD/PPH pathway might be a more likely candidate 
pathway for DG formation than inositol lipid hydrolysis and this was supported by 
the dose-dependency studies (Fig. 6.4 b). The EC50  o^r EGF-stimulated 
[3H]PtdBut formation (1.14 ± 0.54 nM) was closer to that for DG formation than 
the small increase in [^H]InsPt accumulation.
The rapid increase in [^H]Cho in response to EGF indicated that a major 
substrate for the activated PLD was PtdCho. Indeed, the kinetics of [^HJCho 
elevation were similar to both EGF-stimulated DG and PtdBut formation. 
Statistically significant increases in [^H]ChoP were not observed until after 20 or 
30 min stimulation though in some instances non-significant increases were 
apparent at 5 min. As discussed previously (Chapter 5) this may represent 
phosphorylation of the [^H]Cho liberated in the PLD reaction by choline kinase as 
part of a PtdCho cycle to replenish the parent lipid. Alternatively, the increases in 
[^H]ChoP may represent PLC activity. Both Wright et al. (1990b) and Baldassare 
et al. (1990) have described EGF-stimulated DG formation which was associated 
with the release of both [^H]Cho and [^HjChoP suggesting activation of both 
PtdCho-PLD and PLC.
Despite the close agreement in the kinetics and dose-dependency of EGF- 
stimulated DG fomjation and PLD activation the results in Fig. 6 .6  suggest that 
EGF-stimulated DG formation did not proceed by a PLD/PPH pathway since the 
inclusion of 0.3% (v/v) butan-l-ol to 'trap' phosphatidyl moieties as PtdBut did not 
affect EGF-stimulated DG formation. These experiments should be repeated with 
inhibitors of PPH such as sphingosine or propranolol to confirm that this pathway 
does not play a role in DG formation. In addition a thorough time course of the 
effects of butan-l-ol upon EGF-stimulated DG formation should be performed. 
The onset of PLD activity was 30 sec after addition of EGF but the effect of butan-
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l-ol upon DG formation was assessed at a single 15 min time point at which the 
rate of [^H]PtdBut formation was greatly desensitised and increases in [^HJChoP 
were apparent. If PLD activity is transient, as is perhaps suggested by the drop in 
rate of [^HJPtdBut formation (Fig. 6.4a), then it may make a contribution to DG 
formation at early time points which would be missed by assessing the effects of 
butan-l-ol at 15 min when a potential PtdCho-PLC pathway might be more 
important. Similar results have recently been described by both Wright et al. 
(1990b) and Baldassare et al. (1990) suggesting that whilst EGF does indeed 
stimulate a PLD activity the PtdOH so produced does not serve as a precursor of 
DG. In both studies the authors propose that both PtdCho-PLD and PLC are 
activated by EGF but it is the latter reaction which is responsible for DG formation. 
If this is the case it is reasonable to ask what purpose activation of PLD serves if 
not as a pathway for DG formation; this issue is considered in Chapter 7. A 
possible role for PtdCho-PLC in DG formation should be addressed more fully and 
assessing ChoP mass formation may allow clearer definition of this issue. It is 
unlikely that the small and non-reproducible increase in inositol lipid hydrolysis 
contributes to DG formation since this only occurred at lOOnM EGF whereas the 
EC50 for DG formation was approximately 0.1 nM.
The ability of EGF to stimulate PtdCho hydrolysis is not entirely without 
precedent in the Swiss 3T3 cell line. Until recently many studies of stimulated 
PtdCho hydrolysis only measured the re-synthesis of PtdCho by incorporation of 
32pi into PtdCho (for example Muir & Murray, 1987). In this respect EGF- 
stimulated PtdCho, but not Ptdlns, synthesis was observed in Swiss 3T3 cells by 
MacPhee et al. (1984). In hindsight these results are consistent with the re­
synthesis of PtdCho following its stimulated hydrolysis as shown in this thesis.
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6.3.3 R egulation of phospholipase D by EG F; evidence of a 
requirem ent for the receptor tyrosine kinase activity.
Despite the finding that PLD did not seem to be the pathway for EGF- 
stimulated DG formation the observation that PLD is activated by diverse mitogenic 
stimuli suggested that it might play some additional role in mitogenic signal 
transduction. Therefore studies were undertaken to define the regulation of EGF- 
stimulated PLD activity in whole cells using bombesin and PMA as comparisons.
By analogy with bombesin, the observation that EGF stimulated an increase 
in DG without stimulating inositol lipid hydrolysis suggested that EGF-stimulated 
PLD activity might be independent of protein kinase C. To test this hypothesis the 
effect of the PKC inhibitor Ro-31-8220 upon PLD activity was assessed. In the 
same experiments in which PMA-stimulated PLD activity was inhibited by 90% and 
the response to bombesin by 40-50%, EGF-stimulated PLD activity was never 
significantly inhibited by Ro-31-8220. This was consistent with the observation 
that EGF did not stimulate inositol lipid hydrolysis and suggests that activation of 
PLD is not downstream of prior PKC activation. However, in two out of four 
experiments the response was significantly enhanced at 10 |iM Ro-31-8220 (Fig. 
6.7 b). It is well known that the EGF receptor is subject to a PKC-mediated 
phosphorylation of Thr 654 (Davis & Czech, 1985; Hunter et al., 1984) which 
results in a shift to a lower affinity binding form of the receptor (Livneh et al., 
1987) and an inhibition of signalling capacity (Cochet et al., 1984). This is known 
as receptor ’transmodulation' and not 'down-regulation' since the number of 
receptors stays the same (Brown et al., 1979), and can be mimicked in whole cells 
by addition of PMA, bombesin, PDGF and other agents which activate PKC 
(Brown et al., 1979; 1984; reviewed by Rozengurt, 1985). Thus inhibition of 
PKC by Ro-31-8220 might explain the significant potentiation of the EGF response 
in some instances since this would prevent receptor ’transmodulation' allowing the 
response to continue for longer at the initial maximal rate. This would require that 
the DG derived from EGF-stimulated PtdCho hydrolysis would normally activate 
PKC resulting in receptor transmodulation and so such speculation must await 
confirmation of whether EGF-stimulated PKC activity does indeed occur in this
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clone of Swiss 3T3 cells.
The use of tyrphostins to inhibit EGF, PDGF and insulin-stimulated events 
is now well documented (reviewed by Levitski, 1990a). These drugs have been 
used to inhibit EGF-stimulated cell proliferation in fibroblasts over-expressing the 
human EGF receptor (Lyall et al., 1989) and EGF-stimulated phosphorylation of 
PLC-yl and elevation of [Ca2+]j (Margolis et al., 1989) and inositol lipid 
hydrolysis (Posner et al., 1989).
The ability of lOOpM AG 18 to inhibit up to 90% of EGF-stimulated PLD 
activity (Fig. 6 .8a) clearly indicates that this response requires a tyrosine 
phosphorylation event. No higher concentrations were examined since they were 
deemed to be potentially harmful to the cell; even at IOOjiM there was some concern 
that any inhibition observed might be due to non-specific cytotoxic effects of 
AG 18. To address this question the effect of 100|iM AG 18 upon both EGF- and 
bombesin-stimulated PtdBut formation was compared since the bombesin receptor 
couples to PIC via a G-protein rather than via tyrosine kinase activity (Plevin et al., 
1990). The observation that even at lOOpM AG 18 there was no effect upon 
bombesin-stimulated PLD activity (Fig.6 .8b) indicates that the drug was exerting a 
selective effect upon tyrosine kinase activity rather than a non-selective or cytotoxic 
effect. Microscopic examination of the cells after 18 hours treatment with the 
tyrphostin did not reveal any marked morphological changes (data not shown).
It has recently been shown that a number of proteins implicated as effectors 
in mitogenic signal transduction pathways are phosphorylated upon tyrosine 
residues after stimulation with EGF, PDGF and CSF-1. These proteins, which 
include p2 lras GAP (Molloy et al., 1989; Ellis et al., 1990), Raf-1 (Morrison et 
al., 1989), PLC-yl (Meisenhelder et al., 1989) and Ptdlns 3'-kinase (Kaplan et 
al., 1987; Varticovski et al., 1989), appear to physically associate with the growth 
factor receptors perhaps through interactions with SH2 (&rc homology) domains 
within these molecules. In the light of these results it is tempting to speculate that 
the inhibition of EGF-stimulated PLD activity by AG 18 may be due to inhibition of 
EGF receptor-mediated phosphorylation of PLD as has been shown for PLC-yl 
(Margolis et al., 1989). Such speculation must await the demonstration of PLD
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activity in EGF-receptor immune precipitates or the co-immuno precipitation of 
EGF receptors and PLD once suitable anti-sera are available.
The ability of A23187 to activate PLD, even in the presence of Ro-31-8220 
(Chapter 4, Fig 4.17) indicated that an alternative mechanism for regulation of PLD 
activity might be EGF-stimulated Ca2+ entry. The ability of EGF to stimulate 
increases in [Ca2+]j in Swiss 3T3 cells is also the subject of conflicting reports 
which may represent variations between different clones of Swiss 3T3 cells. Thus, 
Hesketh etal. (1985; 1988) were able to demonstrate EGF-stimulated increases in 
[Ca2+]j which were completely dependent upon [Ca2 + ]0 indicating that EGF was 
able to stimulate Ca2+ entry. In contrast Olsen et al. (1988) were only able to 
demonstrate EGF-stimulated increases in [Ca2+]j when EGF was added after 
PGF2 a  or [Arg^jVp. The results in Fig 6.9 indicate that buffering extracellular 
Ca2+ to 150 nM, the resting [Ca2+]j in Swiss 3T3 cells, resulted in an inhibition of 
EGF-stimulated PLD activity. The simplest conclusion from this is that EGF- 
stimulated increases in [Ca2+]j, as a result of Ca2+ entry, are responsible for 
activating PLD but to date it is not known if this clone of Swiss 3T3 cells is one 
which exhibits an EGF-stimulated Ca2+ entry response. An alternative explanation 
for these results is that Ca2+ represents a vital co-factor for PLD activity, rather 
than actually stimulating its activity directly, and that during the buffering of 
[Ca2+]0 there is depletion of intracellular Ca2+ so that PLD activity is 
compromised. Since the regulation of PLD activity by EGF is apparently different 
from that described for bombesin and PMA (Figs 6.7 & 6.8  and Chapter 4) it may 
be possible that EGF stimulates a distinct isoform of PLD which has a different 
Ca2+ sensitivity to that regulated by bombesin or PMA. Another possibility is that 
EGTA inhibits EGF binding to its receptor but this is unlikely since binding of the 
related growth factor PDGF to its cognate receptor was not affected by omission of 
extracellular Ca2+ (Bowen-Pope & Ross, 1982). Thus it remains to be clearly 
defined at what site the buffering of extracellular Ca2+ exerts its effect. In this 
context quite how EGF does stimulate Ca2+ entry (Hesketh et al., 1985; 1988) is 
unclear. In those instances where EGF stimulates Ins(l,4,5)P3 formation the entry
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of Ca2+ may be by a similar mechanism to that described for agonists such as 
bombesin though this mechanism is also far from resolved (Irvine, 1990). 
Speculation as to whether the activated EGF receptor is able to phosphorylate and 
thereby activate a Ca2+ channel awaits a thorough pharmacological assessment of 
Ca2+ entry to determine the nature of the channel using defined channel blockers.
6.3.4 PDGF can stimulate PtdCho-PLD activity in Swiss 3T3 cells.
Studying the signal transduction pathways of PDGF is particularly 
important since PDGF is capable of stimulating DNA synthesis and cell division in 
a variety of cell types including, Swiss 3T3 cells and IIC9 fibroblasts, without the 
requirement for a co-mitogen such as insulin.
Recent studies have demonstrated the existence of two distinct receptor sub- 
types which display different ligand binding affinities for the various divalent forms 
of PDGF; -AA, -AB & BB (Heldin et al., 1988). Thus, the a-type receptor binds 
all three isoforms with high affinity whereas the P-type receptor binds PDGF-BB 
with high affinity, PDGF-AB with lower affinity and does not bind PDGF-AA. 
cDNAs for both receptor types have been cloned (Yarden et al., 1986; Matsui et 
al., 1989) and the predicted proteins exhibit similar structural organization 
including Ig-like ligand-binding domains, a hydrophobic transmembrane segment 
and an intracellular protein tyrosine kinase domain. This catalytic domain is divided 
in two by the so-called ’kinase insert sequence' which includes Tyr 751, a major 
site of in vivo receptor autophosphorylation; mutation of this Tyr to Phe or Gly, or 
mutation of the catalytic domain to abolish kinase activity, blocks association of the 
PDGF receptor with Ptdlns 3’-kinase as well as other cellular proteins. 
Furthermore, deletion of 82 of the 104 amino acids in this insert region abolishes 
PDGF-induced mitogenesis without affecting ligand induced receptor auto- 
phosphorylation or inositol phosphate accumulation (Escobedo & Williams, 1988). 
Kazlauskas & Cooper (1989) propose that autophosphorylation in this insert 
sequence regulates interactions with cell proteins. The nature of some of these 
proteins has been described previously in the Introduction (Chapter 1) and only the
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modulation of lipid signalling pathways will be considered.
Within 30 sec of stimulation of Swiss 3T3 (Meisenhelder et al, 1989), 
Balb/c3T3 (Wahl et al, 1989) or NIH3T3 cells (Meisenhelder et al, 1989) with 
PDGF, PLC-yl associates with and is phosphorylated on tyrosine residues by the 
PDGF receptor in a ligand-dependent manner. This may well be the mechanism by 
which PLC-yl is activated resulting in the formation of Ins(l,4,5)P3 and DG since 
these responses are certainly not modulated by guanine nucleotides (Cattaneo & 
Vicentini, 1989) as is the case for bombesin (Plevin et al, 1990). In fact EGF- 
stimulated phosphorylation of PLC-yl upon tyrosine residues has recently been 
shown to increase the catalytic activity of the enzyme (Nishibe et al., 1990) as well 
as resulting in its translocation to the plasma membrane (Todderud et al, 1990).
Stimulation of many cells with c-sis and/or PDGF-BB, acting at either the 
a- or P-type receptors, results in the formation of both Ins(l,4,5)P3 and DG, but it 
has recently been shown that stimulation with the AA form of PDGF, acting at the 
a-type receptor may result in the formation of DG and activation of PKC in the 
absence of inositol phosphate formation (Block et al., 1989; Sachinidis et al., 
1990). Furthermore, PDGF can stimulate the formation of DG in the absence of 
InsP accumulation in IIC9 fibroblasts and the molecular species analysis of this DG 
reveals that it is most likely derived from PtdCho (Pessin et al., 1990). Thus it 
appears that production of DG and activation of PKC are a common response to 
PDGF and can, in some circumstances, be dissociated from inositol lipid 
hydrolysis at the receptor level. This would suggest that in terms of mitogenicity, 
DG formation is more important than Ins(l,4,5)P3 and this is supported by the fact 
that micro-injection of DG into Balb/c 3T3 cells stimulates proliferation whereas 
Ins(l,4,5)P3 is ineffective (Suzuki-Sekimori et al., 1989).
The finding that PDGF was able to activate PtdCho-PLD activity as 
measured by H]Cho release (Fig.6.11) and [^H]PtdBut formation (Fig. 6.10) 
indicates that this may be a common response to both RGE- and RTK-type 
mitogens, irrespective of their ability to couple to inositol lipid hydrolysis. The 
identification of this PDGF-stimulated PtdCho-PLD activity is in contrast to a recent 
report by Larrodera et al. (1990) who suggested that PDGF actually stimulated
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hydrolysis of PtdCho via PLC. However, the earliest stimulation time in their 
study was 2 hours at which point increases in [^H]ChoP might be due to activation 
of choline kinase (Warden & Friedkin, 1984; 1985). In the same study the authors 
were unable to demonstrate PDGF-stimulated [2 H]Cho generation; this is in 
contrast to the studies reported in this thesis since increases in [^H]Cho was the 
earliest and most reproducible manifestation of PtdCho hydrolysis (Fig 6.11). In 
addition the generation of [^HJChoP is not a definitive assay for PtdCho-PLC 
activity (see Billah & Anthes, 1990; Chapter 5 of this thesis) whereas the formation 
of [^H]PtdBut (Fig 6.10) is definitive for PLD. PDGF-stimulated [^H]Cho 
formation has also been observed by Price et al. (1989) again implicating PLD 
catalysed PtdCho hydrolysis.
The kinetics of PtdCho-PLD activation are of particular interest since, 
although PDGF does indeed stimulate inositol lipid hydrolysis in Swiss 3T3 cells 
the mechanism by which this occurs is clearly different from agonists such as 
bombesin (Nanberg & Rozengurt, 1988; Blakeley et al., 1989). These two studies 
have suggested that the onset of the response to PDGF, in terms of generation of 
[^H] InsP3 or [2 H]Ins(l,4,5)P3 , is much slower than that for bombesin being not 
apparent until after 1.5-2 min stimulation. In the light of the results shown in Fig 
6.10 (a & b) this would suggest that PtdCho-PLD activation was actually upstream 
of inositol lipid hydrolysis. However, recent results from this laboratory (R. 
Plevin, S. Palmer & M.J.O. Wakelam, personal communication) using the 
sensitive mass assay for Ins(l,4,5)P3 as well as h.p.l.c resolution of 
[^H]Ins(l,4,5)P3, from cultures labelled with [^Hjinositol to a high specific 
activity, show that Ins(l,4,5)P3 levels increase 30 sec after addition of PDGF 
though the magnitude of this response is clearly smaller than that for bombesin (Fig 
3.4). Thus, it would seem that the two responses, activation of PLC-yl and PLD, 
are initiated commensurate with each other rather than PLD being kinetically 
downstream of PIC activation as seems to be the case for bombesin (Chapter 4 of 
this thesis). Furthermore, mass analysis of the increase in DG and Ins(l,4,5)P3 in 
response to PDGF stimulation reveals that the mass of DG formed exceeds that of 
Ins(l,4,5)P3 even more so than that for bombesin (R. Plevin, S. Palmer &
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M.J.O.Wakelam, personal communication; Chapter 4) suggesting that the majority 
of DG is derived from another source. The demonstration of PDGF-stimulated 
PtdCho hydrolysis and PLD activity suggest that this is PtdCho and future 
experiments should aim to assess the role of this PLD activity in PDGF-stimulated 
DG formation using butan-l-ol and a selection of PPH inhibitors.
The observation that PDGF-stimulated PtdCho hydrolysis and DG 
formation are dissociated from inositol lipid hydrolysis in IIC9 cells (Pessin et al., 
1990) and that DG formation and PKC activation occur in the absence of InsP 
formation in response to the the PDGF-AA homodimer (Block et al., 1989; 
Sachidinis et al., 1990) suggests that the a -  and P-type receptors may couple 
selectively to PtdCho-PLD and PLC-yl respectively. In such a case PDGF would 
be able to activate PtdCho-PLD by two distinct mechanisms; directly, via an a-type 
receptor (a situation perhaps analagous to the activation of PLD by the EGF 
reeceptor) or indirectly, via p-type receptor activation of PLC-yl leading to 
activation of PKC and thence PLD. The c-sis used in these experiments is a BB 
homodimer and can therefore interact with both a- and p-type receptors (Heldin et 
al., 1988). The ability of PDGF to stimulate inositol phosphate accumulation 
(EC50  approximately 8 ng ml-*) exhibited similar dose-dependency to PDGF- 
stimulated pH jC ho release (EC50  2.02 ± 0.33 ng ml"1; R. Plevin, personal 
communication) suggesting that c-sis is either activating one class of p-type 
receptors or is interacting with two classes of receptor with similar affinities. The 
latter scenario may explain the commensurate initiation of PLD and PLC-yl activity 
whilst the larger sustained activation of PLD may represent the downstream, PKC- 
mediated component of PLD activation by PDGF which is absent in the EGF 
response since EGF cannot stimulate inositol lipid hydrolysis (Fig. 6.3). Certainly, 
the ability of PDGF to activate PKC in Swiss 3T3 cells is in no doubt (Kazlauskas 
& Cooper, 1988) and the stimulated accumulation of inositol phosphates is 
sustained and non-desensitising in this cell line (Blakeley et al., 1989) and is not 
subject to a PKC-mediated feedback inhibition (Fig. 6.12). Thus the sustained 
activation of PKC and increases in [Ca2+]j resulting from PDGF-stimulated inositol
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lipid hydrolysis may account for the slower but sustained activation of PLD.
An observation which is to some extent consistent with this model is that 
down-regulation of PKC results in the loss of PDGF-stimulated PLD activity. This 
is not likely to be due to loss of PDGF-stimulated inositol lipid hydrolysis since 
down-regulation of PKC resulted in only a very small inhibition of PDGF- 
stimulated pH]InsPt (B lak e ley ^  a l,  1989). Like the results with bombesin- 
stimulated [2 H]Cho release and [3H]PtdBut formation, the simplest explanation is 
that both phases of PDGF-stimulated PLD activity require activation of PKC and 
yet the model described above would predict that the small initial phase of PLD 
activity might be receptor-mediated and therefore PKC-independent.
One possible explanation for this returns to an issue raised in Chapters 4 
and 5; namely the possibility that PLD is down-regulated by prolonged PMA- 
treatment. The observation that EGF does not significantly stimulate inositol lipid 
hydrolysis argues against a role for PKC in mediating EGF-stimulated PLD 
activity. This is confirmed by the lack of inhibition of EGF-stimulated [3 H]PtdBut 
formation by the PKC inhibitor Ro-31-8220. Despite this in some experiments, 
under PKC down-regulating conditions, there was some inhibition of EGF- 
stimulated [3H]Cho release though this was not reproducible (section 6.2.4). If 
PLD is also down-regulated by prolonged PMA treatment this might imply that the 
loss of PLD activity is not simply due to loss of PKC but is to some extent 
artefactual; thus, any study of the role of PKC in a given response should not rely 
solely upon the use of PKC down-regulation but should also use PKC inhibitors to 
confirm the results. This matter clearly warrants further and fuller consideration 
and a starting point would be to assess the effect of the PKC inhibitor Ro-31-8220 
upon PDGF-stimulated PLD activity. Other approaches are considered in the 
discussion, Chapter 7.
Thus, the results in this chapter indicate that growth factors of the tyrosine 
kinase family are also able to increase DG levels in their target cells and activate 
PtdCho hydrolysis by a PLD pathway. In the case of EGF the activation of PLD 
and formation of DG are divorced from inositol lipid hydrolysis and activation of 
PLD requires the receptor tyrosine kinase activity and appears to be dependent upon
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Ca2+ entry. In the case of PDGF the activation of PtdCho-PLD occurs at least as 
fast as the formation of Ins(l,4,5)P3, but is suceptible to chronic pre-treatment with 
high doses of PMA. EGF-stimulated DG formation was not inhibited by butan-l- 
ol suggesting that it does not proceed by a PLD/PPH pathway. Thus it would seem 
that activation of PLD and/or formation of DG are also common events following 
stimulation of Swiss 3T3 cells with growth factors which couple to receptor 
tyrosine kinases, raising the possibility of multiple pathways for regulation of PLD 
activity.
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Chapter 7.
Conclusions and perspectives.
7.1 Evidence for multiple sources of DG in mitogen-stimulated 
Swiss 3T3 fibroblasts.
The results presented in this thesis indicate that the increases in DG mass in 
bombesin- and EGF-stimulated Swiss 3T3 cells cannot be explained solely in terms 
of inositol lipid hydrolysis. Moreover, the hydrolysis of PtdCho and generation of 
[^H]Cho and [^HjChoP by these mitogens suggests that PtdCho may contribute to 
DG formation.
The kinetics and mass of bombesin-stimulated Ins(l,4,5)P3 formation 
could not account for the observed increase in DG mass which was biphasic 
(Chapter 4). The first phase of DG formation accompanied the transient generation 
of Ins(l,4,5)P3 (Chapter 3) but exceeded it in mass terms whilst the second phase, 
from 30 sec onwards for up to 30 min and 4 hours (Takuwa et al., 1989), was 
divorced from any further elevation of Ins(l,4,5)P3. These studies have confirmed 
and advanced those of Takuwa et al. (1987a) by making a more thorough 
comparison of the kinetics of Ins(l,4,5)P3 and DG formation. Furthermore, recent 
reports of similar biphasic DG formation in a-thrombin-stimulated IIC9 fibroblasts 
(Wright et al., 1988), CCK-stimulated pancreatic acini (Matozaki et al., 1990), 
PGF2  ^ stim ulated NIH3T3 cells (Fukami & Takenawa, 1989) and vasopressin- 
stimulated REF52 fibroblasts (Huang & Cabot, 1990b) indicate that this might be a 
more general response to agonists which can couple to the hydrolysis of 
PtdIns(4,5)P2- In the majority of these studies PtdCho has been implicated as the 
source of the sustained DG formation by observations of stimulated release of Cho 
or ChoP. Additionally, molecular species analysis of the sustained phase of DG 
formation in a-thrombin-stimulated IIC9 cells confirms that it is derived from 
PtdCho (Pessin & Raben, 1989). In the case of bombesin-stimulated Swiss 3T3 
cells the onset of [^H]Cho release (Chapter 5) was consistent with PtdCho 
hydrolysis contributing to sustained DG formation since it occurred after the initial 
phase of DG but prior to the second phase. A notable exception to these studies is 
the markedly transient and monophasic formation of DG in thrombin-stimulated 
platelets (Bishop et al., 90). Interestingly, this in turn correlates with the poor 
ability of thrombin to stimulate PtdCho-PLD activity in these cells (Randall et al.,
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1990) again suggesting that sustained DG formation is derived from PtdCho 
hydrolysis.
PMA-stimulated DG formation (Chapter 4) occurred in the absence of 
inositol lipid hydrolysis (Chapter 3) confirming the previous report of Takuwa et 
al. (1987b) and was sustained for at least 1 hour. Furthermore, it occurred over 
the same dose range at which the phorbol ester inhibited bombesin-stimulated InsPt 
formation. Since bombesin, like PMA, can activate PKC this suggests that in vivo 
bombesin-stimulated PKC activation may serve to both inhibit PtdIns(4,5)P2 
hydrolysis (Brown et al., 1987) and stimulate a second phase of DG formation. 
The observation that PMA-stimulated [3h]1,2-DG formation in Swiss 3T3 cells 
labelled with [3H]palmitic acid and also stimulated the release of [3H]Cho and 
[^HJChoP suggests that accelerated PtdCho hydrolysis is a candidate source for 
phorbol ester-stimulated DG formation. These results, subsequently confirmed by 
Price et al. (1989) who have also demonstrated bombesin and PMA-stimulated 
[2H]Cho release in Swiss 3T3 cells, advance our understanding of phorbol ester- 
stimulated PtdCho hydrolysis considerably from the studies of Muir and Murray 
(1987) and Takuwa et al. (1987b) which measured PtdCho resynthesis and made 
no thorough kinetic analysis of Cho and ChoP release.
EGF-stimulated DG formation (Chapter 6) was of much smaller magnitude 
than that for bombesin and PMA but was maximal at doses of 0.1 nM in the absence 
of significant inositol phosphate accumulation which was poorly stimulated and 
only apparent at 100 nM EGF. EGF-stimulated DG formation was accompanied by 
the release of [^HJCho implicating PtdCho as a possible source. Thus, these 
results agree with those of Wright et al. (1988; 1990a & b) who showed that EGF 
stimulates a small, but sustained, increase in DG mass in IIC9 cells which is 
associated with PtdCho hydrolysis and not the hydrolysis of inositol lipids. 
Furthermore, the results are consistent with those of Pessin et al. (1990) who 
demonstrated that the molecular species of the DG produced by EGF was similar to 
PtdCho rather than Ptdlns.
Taken together with the results of Raben and co-workers (Wright et al., 
1988; 1990 a & b; Pessin & Raben, 1989; Pessin et al. 1990), Price et al. (1989),
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Takuwa et al., (1987 a & b; 1989) and Huang & Cabot (1990b) these results 
indicate that in cultured fibroblasts PtdCho represents a metabolically active pool of 
phospholipid which can be hydrolysed within seconds of addition of growth factors 
to contribute towards sustained DG elevation. It seems likely that PtdCho serves a 
similar function in a variety of other cell types stimulated by appropriate ligands 
(reviewed by Billah & Anthes, 1990; Exton, 1990). As such it now seems that the 
generation of DG within cells can no longer be considered solely in terms of the 
hydrolysis of the inositol lipids and the stimulated, cyclical hydrolysis of PtdCho 
(Fig. 7.1) must now be considered as a widespread and important signal 
transduction pathway.
7.1.1 By which pathway is PtdCho hydrolysed, PLD or PLC ?
In Swiss 3T3 cells stimulated with either bombesin, PMA or EGF the 
earliest apparent manifestation of PtdCho hydrolysis is the release of [^HjCho. 
This would suggest that PtdCho is hydrolysed initially by a PLD-like activity (Fig. 
7.1) since it seems unlikely that such an increase in Cho would be due to the 
stimulated dephosphorylation of ChoP (Cabot et al., 1988). The demonstration 
that all three agonists stimulated the formation of [^H]PtdBut in the presence of 
butan-l-ol with identical kinetics to the stimulated release of [^H]Cho confirms that 
the initial pathway of PtdCho hydrolysis was indeed that of PLD.
The observation that bombesin also stimulated the release of HjChoP 
which was significantly elevated after 15 min suggests that PtdCho may also be 
hydrolysed to DG by the direct PLC pathway (Fig 7.1), although the possibility of 
this being due to Cho kinase activity (Warden & Friedkin, 1984 & 1985) cannot be 
ruled out because of the apparent temporal dissociation of increases in [^HJCho and 
[^HjChoP. PMA-stimulated [^HJCho formation was slower in onset than the 
bombesin response and this is reflected in the slower rise in [3 H] ChoP. In the case 
of EGF this temporal dissociation is even more apparent. It seems likely that the 
question of whether PtdCho-PLC is activated can only be adequately addressed by 
sensitive assays for Cho and ChoP mass (e.g., Murray e ta l., 1990) and definitive
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Figure 7.1 Major elements of a hormone-sensitive PtdCho cycle.
The major elements of a hormone-sensitive PtdCho cycle are shown. 
Pathways directly involved in the regulation of DG levels are indicated by thick 
arrows; other pathways are in thin arrows including PLA2 which may serve as a 
source of arachidonic acid from PtdCho. The enzymes are: (1) Phospholipase C;
(2) DG kinase; (3) Phospholipase D; (4) Phosphatidate phosphohydrolase; (5) 
CTP:phosphocholine cytidylyltransferase; (6) CDP choline: 1,2-DG 
phosphocholinetransferase; (7) Choline kinase; (8) Phospholipase A2 ; (9) 
Lysophospholipase; (10) GroPCho phosphodiesterase; (11) GroPCho 
cholinephosphodiesterase.
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identification of PtdCho-PLC activity such as the formation of [^2P]ChoP under 
conditions where the ATP pool is not labelled (e.g., Billah et al., 1989b).
7.1.2 The role of PtdCho-PLD in sustained DG formation.
The use of butan-l-ol to 'trap' phosphatidyl moieties liberated during PLD- 
catalysed head group release allows intervention in a PLD/PPH pathway of DG 
formation (Bonser et al., 1989; Metz & Dunlop et al., 1991). There were marked 
differences between PMA and bombesin in terms of the contribution made by a 
PLD/PPH pathway to DG formation. The inhibition of approximately 70% of 
PMA-stimulated DG mass formation by butan-l-ol suggests that the majority of 
PMA-stimulated DG formation arises by a PLD/PPH coupled pathway. Since DG 
levels are maintained, despite removal via DGK or DGL, this would require 
sustained activation of PLD which is demonstrated by the linear, non-desensitising 
accumulation of [^HJPtdBut in response to PMA. Furthermore, the inability of 
cells to metabolize PMA would ensure that PLD activity was sustained. However, 
in the case of bombesin, the inclusion of butan-l-ol inhibited only 30% of 
bombesin-stimulated DG formation at 15 min suggesting a relatively minor role for 
a PLD/PPH pathway in bombesin-stimulated DG formation. This seems to 
correlate with the rapid drop in the rate of [^HJPtdBut accumulation after 2 min 
stimulation with bombesin suggesting a rapid desensitisation. This raises a number 
of questions concerning the role of PtdCho hydrolysis in DG generation.
First, if only 30% of the sustained phase of bombesin-stimulated DG 
formation is due to PLD activity, where is the remaining 70% derived from ? If the 
slower increase in [^HjChoP seen in bombesin-stimulated Swiss 3T3 cells does 
indeed represent PtdCho-PLC activity this may contribute to long term bombesin- 
stimulated DG generation. If both PLD and PLC are being activated do both 
pathways make the same contribution to DG formation at the onset of the second 
phase (e.g., 30 sec-1 min) as they do at later times (e.g, 15 min) ? It may be 
possible to assess this question by examining the effect of butan-l-ol on DG
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formation at different points in the bombesin timecourse. In addition, the sustained 
accumulation of [^H]InsPt and [^HjlnsP in bombesin-stimulated Swiss 3T3 cells 
(Chapter 3, Fig 3.1-3.3 inclusive) indicates sustained hydrolysis of either 
PtdIns(4,5)P2 or Ptdlns (Imai & Gershengom, 1986), though at a reduced rate, 
which will necessarily result in DG formation. This may explain why, in parallel 
incubations, bombesin-stimulated DG formation was greater than the PMA- 
stimulated response (Chapter 4, Fig. 4.11); whilst both agents can activate PtdCho- 
PLD, and perhaps PtdCho-PLC, PMA cannot utilize inositol lipids as a source of 
DG (Chapter 3, Fig. 3.9).
Second, a major requirement for any hydrolytic event which contributes to 
the long term generation of DG is that it should be sustained. The generation of 
[^H]PtdBut in response to bombesin, whilst rapid in onset up to 2 min, was 
quickly reduced in rate by nearly 10-fold (Chapter 4). This suggests that 
bombesin-stimulated PLD activity is quickly desensitised and, therefore, might only 
contribute to the early part of sustained DG formation. In contrast, bombesin- 
stimulated increases in cell associated or intracellular [^H]Cho were equally rapid in 
onset up to 1-2 min but then appeared to reach an apparent new 'steady state' where 
removal of [^H]Cho, by choline kinase or exit from the cell, was apparently in 
equilibrium with its continued formation (Chapter 5). This would suggest that 
PtdCho-PLD activity was sustained.
This anomaly could perhaps be explained by the invasive nature of the 
transphosphatidylation assay for PLD as opposed to assaying Cho or PtdOH 
formation. If PKC is a major link between transient PtdIns(4,5)P2 hydrolysis and 
activation of PLD, as is suggested by the results in Chapter 4, then one can 
envisage a positive feedback loop (outlined schematically in Fig 7.2), as suggested 
by Exton (1990). Activation of PKC, consequent with PtdIns(4,5)P2 hydrolysis 
and DG formation, would lead to activation of PLD which, coupled to PPH, would 
provide further DG for activation of PKC, and so on. Such a model would account 
for sustained increases in both [^HjCho and DG. By including butan-l-ol one 
immediately interrupts such a positive feedback loop since PtdBut cannot provide 
DG for activation of PKC and so activation of PLD cannot be sustained. Thus, the
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Figure 7.2 The pathway for activation of PtdCho-PLD in bombesin- 
stimulated Swiss 3T3 cells.
The major pathway for activation of PLD appears to be via activation of 
PKC; a possible role for Ca2+ is not shown for simplicity and because these studies 
are only preliminary. Reactions which are known to take place are shown in thick 
arrows; reactions which are speculative are shown in thin arrows. The activated 
bombesin receptor couples to PIC via a G-protein (Plevin et al., 1990) resulting in 
the generation of Ins(l,4,5)P3 and DG (Chapters 3 & 4). Activation of PKC 
results in an inhibition of inositol lipid hydrolysis (Brown et al., 1987; Chapter 3). 
Activation of PLD is kinetically downstream of PIC activation, can be mimicked by 
phorbol esters and is inhibited by PKC down-regulation or selective kinase 
inhibitors (Chapters 4 & 5), consistent with a sequential PIC-PKC-PLD pathway. 
A potential positive feedback loop for DG formation, involving a coupled 
PLD/PPH pathway, is shown; intervention in this pathway using butan-l-ol is 
shown by the inability of PtdBut to be de-phosphorylated to DG (see text for 
discussion).
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rapid onset of [^H]PtdBut formation in response to bombesin may represent the 
initiation of the positive feedback loop by DG derived from PtdIns(4,5)P2, whereas 
the drop in the rate of [^HJPtdBut formation may be due to interruption, by butan- 
l-ol, of the positive feedback loop required to sustain PLD activity when 
PtdIns(4,5)P2 hydrolysis has subsided. In such a scenario the slower, sustained 
accumulation of [^HJPtdBut seen in some experiments from 2 to 15 min may be 
due to the incomplete competition between butan-l-ol and water for accepting the 
released phosphatidyl moiety, providing some PtdOH as a source of DG, or the DG 
derived from sustained inositol lipid hydrolysis serving to maintain a lower level of 
PKC-mediated PLD activity. An alternative model is that activation of PLD is 
dependent upon prior bombesin-stimulated inositol lipid hydrolysis but the rapid 
desensitisation of this response (Chapter 3, Fig. 3.1-3.4 inclusive; S. Palmer, R. 
Plevin & M.J.O. Wakelam, personal communication) is reflected in a 
desensitisation of PLD.
If a positive feedback loop does operate a prediction from such a model is 
that addition of butan-l-ol to bombesin-stimulated Swiss 3T3 cells should result in 
a gradual drop in stimulated H]Cho elevation as the positive feedback loop 
gradually 'runs down1. An alternative approach would be to stimulate Swiss 3T3 
cells with bombesin for 2-5 min and then add a bolus of butan-l-ol to the required 
final concentration. If [^H]PtdBut is formed as normal over the next 2 min and 
then slows this would suggest that butan-l-ol is indeed interrupting a feedback 
loop; alternatively if [^H]PtdBut is not formed this would imply that the response is 
largely desensitised. Recent work from this laboratory using the latter approach has 
shown that pre-incubation of Swiss 3T3 cells with bombesin followed by addition 
of butan-l-ol prevents stimulated formation of [^H]PtdBut suggesting that 
bombesin-stimulated PLD activity is largely desensitised after 5 min (R. Plevin & 
M.J.O. Wakelam, personal communication). This suggests that PLD activity 
remains dependent upon receptor-stimulated inositol lipid hydrolysis, declining as 
this initial response desensitises, and is not maintained by a self-sustaining PKC 
loop. Thus, a PLD/PPH pathway may only make a contribution to DG formation 
over the first 2-5 min of the bombesin response and future experiments should
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address where the sustained elevation of DG is derived from.
The apparent anomaly that EGF clearly stimulates a PLD activity, as 
measured by the release of [^H]Cho and formation of PtdBut, which seems to play 
no role in EGF-stimulated DG formation, which is not inhibited by butan-l-ol, is 
not easily explained. The effect of butan-l-ol was only assessed at a single 15 min 
time point whereas PLD activity appeared to be largely desensitised after 2 min. In 
this case there was no significant increase in [^H]ChoP until 20 min after addition 
of EGF. Whether these smaller and later increases in [^HJChoP are underestimates 
due to the poor sensitivity of isotopic labelling measurements and a high basal level 
of [^HJChoP is not clear but mass analysis of ChoP may help to address this. This 
should allow an assessment of whether PtdCho-PLC activity may contribute to 
EGF-stimulated DG formation as has been suggested by Wright et al. (1990 a & b) 
and Baldassare et al. (1990).
These results should be considered in the light of the recent work by Huang 
& Cabot (1990a) who have assessed the role of the PLD/PPH pathway in phorbol 
ester-stimulated DG formation in MDCK epithelial cells, bovine pulmonary 
endothelial cells and two smooth muscle cell lines. These authors show that whilst 
activation of PLD is a common response to stimulation by PMA, only in the MDCK 
and endothelial cells does the PLD/PPH pathway operate in DG formation. In the 
two smooth muscle cell lines PtdEth and PtdOH were formed but the latter did not 
serve as the precursor of DG. This indicates that there may be marked differences 
between different cell types in their ability or necessity to utilise a PLD/PPH 
coupled pathway of DG formation even when PLD is clearly activated. Whether 
these differences are also reflected for different agonists within the same cell 
remains to be seen.
The results in this thesis concerning the role of a PLD/PPH pathway are 
preliminary since they rely upon the use of butan-l-ol to trap phosphatidyl moieties. 
Whilst this appears to be a valid approach in neutrophils (Bonser et al., 1989) it is 
not clear as yet whether this method will be universally applicable with the same 
degree of success. Furthermore, the method relies upon butan-l-ol (30 mM)
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competing with water as the nucleophile attacking a Ptd-Enz intermediate. Since the 
effective concentration of water within the cell is very high adequate controls will be 
required to ensure that PtdOH formation is completely abolished in favour of 
PtdBut.
It appears that PtdCho hydrolysis does occur by a PLD-catalysed pathway 
and indeed this may be the initial hydrolytic route. This pathway is involved in DG 
formation by PMA and, to a lesser extent bombesin, but a clearer assessment of 
how much it contributes to DG formation requires comparison of the effects of 
butan-l-ol with proposed PPH inhibitors such as sphingosine and propranolol. In 
addition to PLD/PPH, other pathways may make a significant contribution to 
bombesin-stimulated DG formation even when PLD is activated (Huang & Cabot, 
1990a). The identity of these other pathways remains unclear but the direct 
formation of DG via PtdCho-PLC activity or the slower, sustained hydrolysis of 
inositol lipids are both candidates.
7.1.3 The implications of PLD/PPH and/or PLC as pathways for DG 
formation.
The hydrolysis of PtdIns(4,5)P2 to form Ins(l,4,5)P3 and DG followed by 
the recycling of the inositol and diglyceride moieties is an energetic process 
requiring 4 molecules of ATP and 1 of CTP for each turn of the cycle (including 
Ins(l,4,5)P3 3'-kinase but not Ptdlns 3'-kinase, see Fig 1.2). In the context of 
mitogenic signalling it appears that DG/PKC mediated signals may be more 
important in the long term than the transient Ins(l,4,5)P3-mediated mobilisation of 
intracellular stores of Ca^+ (e.g., Suzuki-Sekimori et al.> 1989). Thus, a switch 
to an energetically cheaper source of DG, such as PtdCho, might be advantageous 
once the requirement for large increases in [Ca^+]j and therefore Ins(l,4,5)P3 has 
passed. The cyclical turnover of PtdCho, initiated by a PLD pathway, consumes 1 
molecule of ATP (the choline kinase reaction) and 1 of CTP (the 
cytidylyltransferase reaction) per turn of the cycle (Fig. 7.1) whilst the PtdCho- 
PLC pathway, which may contribute to sustained DG formation in response to
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prolonged bombesin stimulation, consumes only 1 molecule of CTP (the 
cytidylyltransferase reaction). Thus, the sequential activation of PIC, PLD and 
perhaps PLC could allow sustained DG formation accompanied by the transient 
formation of Ins(l,4,5)P3 and PtdOH whilst making progressively smaller 
demands upon cellular nucleotide triphosphate pools.
The rapid hydrolysis of a significant portion of cellular PtdIns(4,5)P2 is 
energetically expensive and may perturb the integrity of the inner plasma membrane 
if continued for any length of time. Few definitive studies have been made, but in 
fMet-Leu-Phe-stimulated neutrophils it seems that 3-5% of total PtdCho is 
hydrolysed (Billah et al., 1989b). Isotopic measurements in other cells indicate 
that, in general, no more than 10% of labelled PtdCho is hydrolysed in response to 
a variety of mitogenic and non-mitogenic stimuli (Chapter 5). Since PtdCho 
accounts for approximately 50% of total cellular phospholipid its hydrolysis may 
provide large, sustained, quantities of PtdOH and DG without exerting great 
influences on localised plasma membrane fluidity and permeability.
The generation of second messengers, by definition, must ultimately be 
terminated to ensure adequate regulation of responses. The sustained elevation of 
DG levels presents the cell with another regulatory problem if, as seems to be the 
case in Swiss 3T3 cells, PKC plays a role in activating PtdCho hydrolysis. Whilst 
there is no clear evidence as to how sustained DG elevation is terminated, the 
answer may lie in the regulation of CTP:phosphocholine cytidylyltransferase 
activity which is known to be a rate limiting step in the resynthesis of PtdCho (Lim 
et al., 1983; Pelech & Vance, 1984). Like PPH and DGK this enzyme is 
apparently translocated to particulate fractions upon stimulation of cells (Pelech & 
Vance, 1984; Besterman et al., 1986b; Maroney & Macara, 1989). In addition it is 
activated by PtdOH and DG (Liscovitch et al., 1986; Kolesnick, 1987; Kolesnick 
& Paley, 1987). Billah & Anthes (1990) speculate that PtdOH and DG, both 
products of PtdCho hydrolysis, will activate the cytidylyltransferase so that 
sustained DG formation will ensure its own conversion to PtdCho thereby leading 
to an eventual termination of the signal.
The rapid formation of DG by, for example, bombesin-stimulated PIC
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activity constitutes a potent mitogenic signal which must be rapidly removed; the 
'classical' pathways for this are via DG kinase or DG lipase. However, in the light 
of the potential roles for PtdOH and arachidonic acid as second messengers can the 
DGK and DGL pathways simply be considered as routes for signal termination ? 
Tsai etal. (1988; 1990) report that l-stearoyl-2-arachidonoyl PtdOH is the most 
potent inhibitor of ras GAP and stimulator of ras GIP (discussed below) whilst 
arachidonic acid also exerts considerable effects upon the activities of GAP and GIP 
as well as activating certain PKC isoforms (reviewed by Kikkawa et al., 1989), 
stimulating DG formation in Swiss 3T3 cells (Takuwa et al., 1988) and 
synergising with [Arg^]vasopressin to stimulate DNA synthesis in Swiss 3T3 
cells (Millar & Rozengurt, 1990). Thus, in this context both DGK and DGL can be 
considered as routes for prolonging and diversifying the signal initiated by DG 
formation. By the same token, removal of PtdOH by PPH or a putative PLA2 
pathway (Billah et al., 1981) can also be considered as routes for prolonging and 
diversifying a given signal, namely activation of PLD.
Therefore, which pathways within cellular phospholipid metabolism might 
fulfil a signal termination role without generating other second messenger-like 
molecules ? One possible candidate is phosphatidate cytidylyltransferase (or CMP 
PtdOH synthetase) which catalyses the formation of CMP PtdOH from PtdOH and 
CTP, though little is known about this enzyme in terms of regulation of its activity. 
CTP:phosphocholine cytidylyltransferase might be considered to fulfil a similar role 
since it converts DG to PtdCho thereby terminating a signal and generating a 
molecule with no second messenger activity. Such speculation must await 
confirmation of any messenger functions for PtdOH and arachidonic acid. If 
however PtdOH and arachidonic acid do turn out to be second messengers this will 
perhaps necessitate a reconsideration of the roles of DGK and DGL as not simply 
signal terminators but under certain circumstances also signal generating pathways.
Finally, for those agonists which stimulate PtdIns(4,5)P2 hydrolysis a 
major pathway of DG removal appears to be DGK (Bishop et al., 1986; reviewed 
by Kanoh et al., 1990). If such agonists are also capable of activating a PLD/PPH 
pathway of DG formation the cell is faced with considerable regulatory problems in
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balancing the removal of DG by DGK and the formation of DG from PtdOH by 
PPH. If the two events are clearly temporally divorced, does the cell 'switch' from 
DGK to PPH activity and if so what is the biochemical/molecular basis of this 
switch ? Alternatively, the two pathways may operate in distinct compartments of 
the cell allowing independent regulation of the two enzymes due to spatial 
separation. Indeed, it is not clear, whether there is any communication between the 
two pathways for example in terms of DG from PtdIns(4,5)P2 hydrolysis serving 
as a substrate for the CDP:phosphocholine cytidylyltransferase or PtdOH from 
PtdCho-PLD serving as a precursor for CMP.PtdOH. On the latter point 
MacDonald et al. (1989) suggest that the DGK selective for arachidonoyl- 
containing DG in Swiss 3T3 membranes may play a role in specifically enriching 
inositol lipids with arachidonic acid at the sn-2 position. This is only a preliminary 
study, but suggests that the DG derived from PtdIns(4,5)P2 hydrolysis may stay 
within the inositol lipid cycle; studies of the metabolic fate of l-stearoyl-2- 
arachidonoyl glycerol in broken cell preparations may help to address the question 
of communication between the two phospholipid cycles.
These issues are important since without adequate regulation of DGK and 
PPH activities, there exists the possibility of futile cycling of diglyceride moieties 
and wastage of ATP. PtdCho hydrolysis may serve distinct functions in signal 
transduction, be it DG formation or the generation of other messenger molecules 
(discussed below), which it can perform with less energetic expenditure than the 
hydrolysis of PtdIns(4,5)P2 . However it also places significant regulatory 
constraints upon the cell in which it operates.
7.2. DG formation and PtdCho hydrolysis; common elements in 
mitogenic lipid signalling pathways ?
By comparing the results presented in this thesis with those of related model 
systems of mitogenic signalling a picture begins to emerge of which growth factors 
employ which pathways of lipid signalling.
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One correlation which is immediately apparent is that those mitogens of the 
RGE type which are able to stimulate the rapid generation of Ins(l,4 ,5 )P3 and DG 
are also able to activate a PtdCho-PLD and elicit sustained DG elevation. This 
appears to be the case for a variety of mitogens and co-mitogens of this class 
including a-thrombin (Wright et al., 1988; Pessin & Raben, 1989), PGF2 a  
(Fukami & Takenawa, 1989) and vasopressin (Huang & Cabot, 1990b) and in 
many ways the responses resemble those for bombesin described herein. Since all 
these agonists are able to activate PKC which dissociates PtdIns(4,5)P2 and 
PtdCho hydrolysis (Brown et al., 1987; Chapters 3 and 5) it would appear that 
PtdCho hydrolysis and presumably sustained DG formation are common events 
following inositol lipid hydrolysis and PKC activation. A major exception to this 
apparent consensus may be the generation of DG by a-thrombin in IIC9 cells. This 
response is clearly biphasic, but it is possible to distinguish between the two phases 
on a pharmacological basis. Lowering the a-thrombin concentration from 500ng 
ml'* to lOOpg ml"* results in a loss of InsP3 formation and the first phase of DG 
formation, but the second phase of DG formation is still observed, if reduced in 
magnitude (Wright et al., 1988). This suggests that whilst a PKC regulated 
pathway may contribute to the second phase of DG, some of it may be coupled to 
activation of a distinct receptor subtype. It is of interest to note that a-thrombin is 
mitogenic for IIC9 cells at both of these concentrations, suggesting that 
Ins(l,4 ,5 )P3 formation can be lost without compromising mitogenic potency. As 
mentioned in Chapter 4 it is not clear whether this is also the case for bombesin for 
two main reasons; whilst the second phase of bombesin-stimulated DG formation 
exhibits a slightly lower BC50 than the first phase this might be due to amplification 
of the response by PKC resulting in a lower effective concentration of bombesin 
required for DG elevation. In addition there is a precedent for two distinct receptor 
sub-types for a-thrombin since the inhibition of adenylyl cyclase occurs at much 
lower doses than does the stimulation of Ins(l,4 ,5 )P3 formation (Pouyss6gur, 
1990). Whilst the bombesin receptor has recently been purified (Feldman et al., 
1990) and cloned (Battey et al., 1991) there is no evidence to suggest the existence 
of any receptor sub-types on Swiss 3T3 cells other than the single class of high
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affinity sites with a in the range 0 . 1 - 1  nM (Feldman et al., 1990; Sinnett- 
Smith et al., 1990).
For the RTK group of mitogens and co-mitogens such as PDGF and EGF it 
is more difficult to reach a consensus since their ability to stimulate lipid signalling 
pathways seems to depend upon the cell type studied (discussed in Chapter 6). In 
those cells where RTK growth factors do stimulate inositol lipid hydrolysis it seems 
likely that as a consequence of the resulting PKC activation PtdCho hydrolysis will 
be initiated. EGF does not stimulate inositol lipid hydrolysis in Swiss 3T3 cells 
(Hesketh et al., 1988), Balb/c 3T3 cells (Besterman et al., 1986a), CCL39 cells 
(Paris et al., 1988) or IIC9 cells (Pessin et al., 1990) whilst PDGF is unable to 
couple to inositol lipid hydrolysis in IIC9 cells (Pessin et al., 1990) or CCL39 
fibroblasts (Paris et al., 1988). Despite this, evidence to date indicates that PDGF, 
EGF and FGF are able to stimulate increases in DG levels and/or PtdCho 
hydrolysis irrespective of their ability to couple to activation of PIC in Swiss 3T3 
cells (Price et al., 1989; Larrodera et al., 1990; Nanberg et al., 1990; Chapter 6), 
IIC9 cells (Pessin et al., 1990) and CCL39 cells (Paris et al., 1990). In those 
instances where activation of PLD and generation of DG is dissociated from inositol 
lipid hydrolysis, future studies should aim to assess the mechanism of coupling of 
the receptor tyrosine kinase catalytic domain to these responses.
The colony stimulating factor 1 (CSF-l) receptor is identical to the c-fms 
proto-oncogene product and undergoes agonist-dependent autophosphorylation. 
Immamura et al. (1990) have shown that in human monocytes CSF-1 activates 
PKC and increases cellular DG content but does not stimulate the hydrolysis of 
PtdIns(4,5)P2- However, CSF-1 does stimulate the hydrolysis of PtdCho and the 
generation of ChoP (Immamura et al., 1990). Also, Rossof et al. (1988) have 
shown that interleukin-1 is apparently able to stimulate an increase in DG and ChoP 
in T lymphocytes though they were unable to demonstrate measureable binding of 
EL-1 to the T-cells used in their study.
Thus, the ability to raise DG levels and activate PtdCho hydrolysis may be 
common responses to stimulation by diverse mitogens and co-mitogens. In many 
cases this is accompanied by the hydrolysis of the polyphosphoinositides and
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generation of Ins(l,4,5)P3, though even in these cases the quantitative contribution 
made by inositol lipid hydrolysis may be minor and PtdCho may be a more 
significant source. However there are clearly a number of examples, such as EGF, 
PDGF and CSF-1, where DG elevation proceeds in the absence of inositol lipid 
hydrolysis and apparently derives from the stimulated hydrolysis of PtdCho. By 
virtue of this fact there is a case for arguing that PtdCho hydrolysis and DG 
formation may be common denominators amongst mitogen-stimulated lipid 
signalling pathways.
A number of reports have shown that growth factors and other hormones 
and neurotransmitters appear to activate PKC in various target cells but are unable 
to stimulate inositol lipid hydrolysis These include embryonal carcinoma-derived 
growth factor (Mahadevan et al., 1987), FGF in a distinct clone of Swiss 3T3 cells 
(Nanberg et al., 1990) and interleukin-3 in the multipotent stem cell line FDCP- 
Mixl (Whetton et al., 1988). In hindsight it will be of interest to examine whether 
these agonists are able to activate PLD- or PLC-catalysed hydrolysis of PtdCho and 
generation of DG.
The contention that PtdCho hydrolysis and DG formation are common lipid 
signalling responses to proliferative stimuli does not, and should not, imply that 
they represent the vital, overriding mitogenic signals. Indeed such speculation of a 
single ’master' signal ignores the enormous evidence indicating that growth factors 
can employ multiple early and later signal pathways to mediate the transition 
through Gj to 'commitment' to the cell cycle (reviewed by Rozengurt, 1985; 1986; 
Pouyssegur, 1990; Cantley et al., 1991). Some growth factors are able to elicit 
different signals in target cells at different stages in the cell cycle. For example, 
insulin-like growth factor-I stimulates increases in Ca^+ entry and DG content in 
'primed-competent' Balb/c 3T3 cells but does not in quiesecent cells (Kojima et 
al., 1990).
If the stimulated transition from quiescence into the cell cycle, culminating 
in cell division is considered as a 'stimulus-response' system in much the same way 
as, for example, C>2 - generation in f-Met-Leu-Phe-stimulated neutrophils, the sheer
2 4 2
complexity of events required for completion of the cell cycle is staggering in 
comparison. To then try and attribute all these events to a single signal transduction 
pathway or second messenger is to greatly over simplify the whole process.
Micro-injection of DG, but not Ins(l,4,5)P3» into Balb/c 3T3 cells (Suzuki- 
Sekimori et al., 1989) and exogenous addition of cell permeant DG analogues to 
Swiss 3T3 cells (Rozengurt eta l., 1984) both synergise with insulin in stimulating 
DNA synthesis. In addition, overexpression of PKC results in accelerated growth 
rates and morphological transformation (Housey et al., 1988; Persons et al., 
1988). These observations suggest that increases in DG and/or PKC activity lie on 
a mitogenic signal pathway. However, down-regulation of PKC does not inhibit 
the mitogenic effects of all growth factors indicating that other parallel, PKC- 
independent pathways exist such as receptor and non-receptor tyrosine kinases. 
The discovery of so called 'switch kinases' (e.g., Raf-1 and MAP II), serine- and 
threonine-directed kinases activated by tyrosine and/or threonine phosphorylation 
indicates that cross-talk will occur between serine/threonine kinase pathways (PKC) 
and tyrosine kinase pathways (EGF-R, PDGF-R and src). The role of cAMP- 
dependent PKA in stimulating or inhibiting mitogenesis, depending on the system 
under investigation, must be considered along side these other pathways.
Consequently we cannot consider a single pathway in isolation and hope to 
understand mitotic regulation. However, with these caveats in mind one can 
speculate as to the role of sustained DG formation and PLD activation in the pre- 
replicative phase of mitogenesis.
7.2.1 The role of sustained DG elevation in mitogenesis.
The simplest and most obvious role for sustained DG elevation is the 
prolonging of PKC activation. This would seem reasonable since many PKC- 
mediated events occur either kinetically downstream, or in the absence of, elevated 
Ins(l,4,5)P3 levels. Thus phosphorylation of an acidic 80 kDa protein by PKC in 
Swiss 3T3 cells continues after Ins(l,4,5)P3 levels and [Ca^+]j have declined in 
bombesin-stimulated Swiss 3T3 cells (Isacke etal., 1986). Transcription of the c­
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fo s  and c-myc proto-oncogenes, which encode transcription factor elements, is 
downstream of the initial growth factor stimulus by 30 to 60 min and in the case of 
bombesin is greatly reduced following ’down-regulation' of PKC (Rozengurt & 
Sinnett-Smith, 1987). Likewise, in bombesin-stimulated Swiss 3T3 cells increases 
in pHj by a PKC-activated Na+/H+ antiporter are biphasic, mirroring the biphasic 
increase in DG mass; the second phase of alkalinisation correlates with the 
sustained phase of DG mass formation (Bierman et al., 1990).
Despite this recent studies by Leach et al. (1991) question the role of 
sustained DG formation in activating PKC. The authors have isolated total PtdCho 
from BC9 cells, treated it with PLC and demonstrated that the DG so derived is able 
to activate PKC in vitro in a mixed micelle assay using IIC9 cytosol as a source of 
PKC. However, in whole cells PKC activation and translocation in response to a- 
thrombin is only associated with the first phase of DG activation as assessed by 
phosphorylation of an 80kDa PKC substrate. At low concentrations of a-thrombin 
(lOOpg/ml) there is no phosphorylation of the 80kDa protein associated with the 
second sustained phase of DG elevation. These results suggest that the DG derived 
from PtdCho hydrolysis does not activate PKC in vivo. In contrast, Block et al. 
(1989) were able to demonstrate activation of PKC by both PDGF A A and BB in 
vascular smooth muscle cells despite the fact that the same authors showed that 
PDGF AA is able to elevate DG levels in the absence of InsP3 accumulation 
(Sachidinis et al., 1990).
PKC is a family of enzyme isoforms with distinct activation requirements 
(reviewed by Kikkawa et al., 1989; Parker et al., 1990) and possibly distinct 
substrate specificities (Schaap & Parker, 1990) and tissue/cell distribution (Bacher 
et al., 1991). DG derived from PtdCho hydrolysis, having a different fatty acid 
complement to that from PtdIns(4,5)P2 and being produced in the absence of 
elevated [Ca^+]j, may activate different isoforms of PKC which may not utilise the 
classical marker substrates such as the 80kDa protein. Alternatively, these isoforms 
may make an important qualitative rather than quantitative contribution to mitogen- 
stimulated protein phosphorylation and the cell and tissue distribution of these 
isoforms may dictate whether PKC activation is associated with PtdCho hydrolysis
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\(Block et al., 1989) or not (Leach et al., 1991). Certainly there is evidence for 
distinct tissue-specific distribution even among the Ca2+-independent isoforms 
such as PKC-e which is found in neural tissue (Ono et al., 1988) and the highly 
homologous PKC-L which is absent from brain but is found in lung, skin and heart 
(Bacher etal., 1991).
Such speculation also calls into question the validity of assessing PKC 
activation solely in terms of phosphorylation of the 80kDa protein. The 80kDa 
phosphoprotein is an acidic, cytosolic protein of unknown identity or function; this 
very fact might make it a poor candidate for use as a marker for PKC activity. At 
least two 80kDa proteins exist (Morris & Rozengurt, 1988; Patel & Kligman, 1987; 
Hirai & Shimizu, 1990); in the studies by Hirai & Shimizu (1990) '80K-L' was 
phosphorylated to a greater extent than '80K-H1 by purified PKC but the two 
exhibited completely different 2-D phosphopeptide maps after digestion with 
TPCK-treated trypsin. Furthermore, significant phosphorylation of ’80K-H' 
occurred in the presence of EGTA upon four major tryptic peptides, but was 
reduced by the addition of Ca2+, whilst four novel phosphopeptides were apparent 
in the presence of Ca2+, PtdSer and PMA. The two forms of 80kDa protein were 
also phosphorylated to quite different extents by different isoforms of PKC. Thus 
whilst phosphorylation of 80kDa protein will strongly suggest activation of PKC, 
lack of phosphorylation need not rule out activation of distinct isoforms of the 
kinase.
In addition to PKC there exist a number of serine- and threonine-kinases in 
cells which may be potential candidates for activation by DG. Protease-activated 
kinase (PAK II) activity is stimulated by phospholipid and DG, inhibited by the 
inclusion of Ca2+ and is resolved from PKC upon ADP-agarose chromatography 
(Gonzatti-Haces & Traugh, 1986), but gives similar 2-D tryptic phosphopeptide 
maps of Histone-1 and S6 ribosomal proteins. Krebs and co-workers (Ahn & 
Krebs, 1990; Ahn et al., 1990) have recently identified six separate EGF- 
stimulated serine and threonine kinases in Swiss 3T3 cells; at least two of these 
appear to be novel kinases which may therefore be potential candidiates for 
regulation by the products of stimulated phospholipid metabolism. The Raf-1
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protein also possesses cysteine-rich sequences homologous to the highly conserved 
motifs in the regulatory domain of PKC (Ohno et al., 1988) though to date no 
effects of phospholipid or DG upon Raf-1 activity have been shown. Certainly 
PKC and Raf-1 share similar mechanisms of regulation; in both cases the regulatory 
domain exerts an inhibitory effect upon the catalytic domain which can be overcome 
by DG/PMA binding (PKC) or by N-terminal truncation (PKC or Raf-1). Such 
truncation leads to irreversible activation of the kinase activity which in the case of 
Raf-1 is oncogenic when injected into cells (Rapp et al., 1987 a & b). There are 
conserved cysteine rich motifs within the Cl regulatory domain of PKC which are 
shared by a number of proteins in addition to Raf-1. These include DG kinase 
(Sakane et al., 1990), the human glucocorticoid receptor (Green et al., 1988) and 
n-chimaerin, a novel high affinity phorbol ester receptor in brain (Ahmed et al., 
1990). By producing degenerate oligonucleotides to conserved motifs in the 
regulatory domain of PKC it may be possible to clone cDNAs for novel DG- 
activated proteins by low stringency hybridization. Such an approach would be 
likely to produce a lot of false positives (i.e. clones of PKC itself) and would 
require a second round of screening to select against such clones, but this could 
provide a powerful approach to determining novel targets for DG. Similar 
strategies have recently been successful in isolating PKC-L from a human 
keratinocyte cDNA library (Bacher et al., 1991) as well as novel receptor-like 
tyrosine phosphatases from a fibroblast cDNA library using conserved sequences 
from the catalytic domain of the leukocyte common antigen CD45 as a probe 
(Kaplan et al., 1990).
In addition to kinases there is some evidence that DG may exert effects upon 
other proteins involved with mitogenic signal transduction. DG activates a partially 
purified PLA2 preparation from Swiss 3T3 cells which exhibits no DG-activated 
PKC activity (Burch, 1988); DG appears to exert its effect at the level of PLA2 
itself. The highest stimulation of PLA2 activity was by SAG which is produced 
rapidly upon mitogenic stimulation of Swiss 3T3 cells. In these experiments PLA2 
was stimulated by as little as 0.3 Mol% DG which is of similar magnitude to the 
increase in DG observed upon stimulation of Swiss 3T3 cells with bombesin
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(Takuwa et al., 1987a; Chapter 4). Furthermore, in bombesin-stimulated Swiss 
3T3 cells activation of PLA2 is independent of PKC activity (S. Currie & M.J.O. 
Wakelam, personal communication) Thus, production of DG by mitogens may 
serve to activate PLA2 as part of a signal transduction pathway. The product of 
PLA2, arachidonic acid, may also activate distinct isoforms of PKC as well as 
serving as the precursor of prostanoids, leukotrienes and epoxides (reviewed by 
Smith, 1989)
Tsai et al. (1990) have recently partially purified a p 2 \ras GTPase 
inhibiting protein (ras GIP) which is stimulated in vitro by DG. The result of 
activating GIP would be to inhibit the GTPase activity of p2\ras thereby increasing 
the amount of active, GTP-bound, p 2 lras. Since p21rfl5.GTP represents a potent 
mitogenic signal and constitutively active p21ras.GTP a transforming signal, these 
observations raise the intruiging possibility that DG may act as a second messenger 
regulating the activation of p2\ras.
7.2.2 A role for PLD and PtdOH in mitogenic signal transduction.
Activation of PLD appears to be a common response to a variety of 
mitogenic and non-mitogenic stimuli, but may not always function as a pathway for 
DG formation (Huang & Cabot, 1990b; Chapters 4 and 6) suggesting that PtdOH 
may serve other distinct functions. For example the studies presented in this thesis 
indicate that PLD activity may account for less than half of the sustained phase of 
bombesin-stimulated DG formation whereas the small increase in DG stimulated by 
EGF seems not to be produced by a PLD/PPH pathway even though PLD is clearly 
activated. What then is the purpose of PLD activation in these circumstances and 
what, if any, might be the role of PtdOH ?
Various possible roles have been proposed for PtdOH. Reports of a Ca2+- 
ionophore function (Putney et al., 1980) have remained unsubstantiated but in 
neutrophils the kinetics of PtdOH formation, produced largely by a PLD pathway 
(Cockcroft, 1984; Billah et al., 1989b), correlate with enzyme secretion 
(Cockcroft, 1984) suggesting a role for PtdOH in membrane fusion and secretion
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events. Certainly the membrane fusogenic properties of PtdOH and DG are well 
documented (reviewed by Wakelam, 1988).
The exogenous addition of PtdOH and particularly its lyso- derivative, lyso- 
PtdOH, to fibroblast and non-fibroblast cells results in the hydrolysis of 
polyphosphoinositides, activation of PKC, inhibition of adenylyl cyclase and 
stimulation of DNA synthesis (Moolenaar et al., 1986; Van Corven et al., 1989; 
Murayama & Ui, 1987) suggesting that the two agents may act as growth factors. 
It seems likely that lyso-PtdOH is more potent than PtdOH and that some of the 
reported effects of PtdOH may be due to contamination of commercial preparations 
with lyso-PtdOH (Jalink et al., 1990). Whether PtdOH and lyso-PtdOH produced 
by intracellular signal pathways actually leave the cell membrane and act as auto- 
and para-crine mitogens remains unclear; such speculation will await the 
identification of receptors for these molecules.
In the context of mitogenic messenger properties PtdOH and arachidonic 
acid are both able to inhibit p21rayGTPase activating protein (ras GAP) (Tsai et 
al., 1989) and stimulate ras GIP (Tsai et al., 1990) in vitro. As described 
previously, the net effect of both of these events, should they occur in vivo, would 
be to greatly increase the amount of p 2 lras in its active, GTP-bound state. Both 
PDGF and EGF have been shown to activate ras by increasing the ratio of 
p21rflJGTP/GDP (Satoh et al., 1990, a & b). Since EGF and PDGF are also able 
to activate PLD it is tempting to speculate that the PtdOH/DG produced may be 
involved in the activation of ras by virtue of their effects upon GAP and GIP. 
However, it seems likely that the ability of EGF and PDGF to phoshorylate GAP 
upon tyrosine residues (Molloy et al., 1989; Kaplan et al., 1989; Ellis et al., 
1990) will also play a major role though what effect this phosphorylation has upon 
GAP function is not known.
Finally there are some recent reports that PtdOH may actually activate 
kinases in a manner analagous to DG. Epand & Stanford (1990) have shown that 
PtdOH will support a PKC activity which is inhibited by Ca2+ in a dose-dependent 
manner. In addition a preliminary report from Bocckino et al. (1990) suggests that
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PtdOH can stimulate a distinct pattern of protein phosphorylation from that induced 
by DG in an in vitro assay using rat liver cytosol as a source of kinase activity. 
Thus, it seems likely that PtdOH may serve a role as a second messenger in its own 
right with perhaps diverse intracellular and extracellular targets, as well as a 
precursor of DG, and further research into its possible funtions is clearly 
warranted.
7.3 Suggestions for further work arising from the studies presented 
in this thesis.
In this chapter a number of ideas have been presented for further work 
arising out of some of the observations made in this study. These have mostly been 
speculative, concerning the possible roles of PtdCho-derived DG and PtdOH in 
mitogenic signal transduction. However, there still remain a number of points 
raised by this thesis concerning pathways of DG and PtdOH formation which 
should be addressed and will hopefully yield much information.
Analysis of PtdOH formation in mitogen-stimulated Swiss 3T3 cells.
The formation of [^H]PtdBut serves as a definitive assay for PLD activity 
since [^H]PtdOH formed in cells labelled with [^HJpalmitic acid could also be due 
to the action of DG kinase. However, in the light of the possible roles for PtdOH 
as a second messenger a thorough characterisation of the kinetics and mass of 
PtdOH formation is clearly required. This is particularly important because the 
transferase assay may give a false indication of the duration of PLD activity since it 
is not a substrate for PPH. Mass analysis :>f PtdOH should be possible by assaying 
for phosphorus, using malachite green, after the PtdOH has been resolved by t.l.c. 
or h.p.I.c. and digested, or some variation of g.I.c. mass spectrometry should 
allow assessment of mass changes in the level of PtdOH as well as molecular 
species analysis. Alternatively, Huang & Cabot (1990b) have recently shown that 
labelling of REF52 fibroblasts with l-(9-[^H]hexadecyl-2-lyso-Jw-glycero-3-
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phosphocholine can be employed to specifically label the cellular PtdCho pool and 
have demonstrated vasopressin-stimulated PLD activity in cells labelled in this 
manner. This may prove a better method of detecting increases in isotopically- 
labelled PtdOH. Finally, the formation of [32p]PtdOH in cells labelled with ^2Pi 
may not just represent DG kinase acting on the DG derived from PtdIns(4,5)P2 
hydrolysis. It now seems likely in a number of sytems that at least some of this 
may be due to PLD catalysed PtdCho hydrolysis. Formation of [^2P]PtdOH may 
prove a useful assay for PLD since the use of butan-l-ol should allow assessment 
of how much [^2P]PtdOH is derived by the DG kinase pathway and how much by 
PLD.
Mass analysis of Cho and ChoP formation and assessment of PtdCho-PLC activity.
The observation that in bombesin-stimulated Swiss 3T3 cells a PLD/PPH 
pathway apparently accounts for only 30% of the sustained phase of DG formation 
must be addressed. Mass analysis of Cho and ChoP formation should provide two 
pieces of information. First, it will allow a comparison with the mass of of DG and 
Ins(l,4,5)P3 formed, to address which is quantitatively the major pathway for DG 
formation. Second, it should provide a more sensitive assay for ChoP and allow an 
assessment of whether increases in ChoP mass can be accounted for solely by 
choline kinase activity or whether PtdCho-PLC activity is taking place. PtdCho- 
PLC activity can be identified by developing a labelling protocol similar to that of 
Billah et al. (1989b) to label PtdCho with 32p without labelling the ATP pool. The 
studies of Huang & Cabot (1990b) suggest that this should be possible in 
fibroblasts and formation of [32p]ChoP under these conditions will serve as a 
definitive assay for PtdCho-PLC just as the formation of [32p]PtdOH does for 
PLD.
The possibility that either PtdIns(4,5)P2 or Ptdlns hydrolysis contributes to 
the sustained phase of DG formation should be addressed. The continued 
accumulation of [3H]InsPt in the presence of LiCl suggests that inositol lipid 
hydrolysis is continuing by some route, albeit at a reduced rate. Furthermore the 
observation that in parallel incubations bombesin-stimulated DG formation was
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always greater than PMA suggests that bombesin can draw upon a source of DG 
which PMA is unable to utilise. The inability of PMA to stimulate accumulation of 
inositol phophates suggests that this source may be an inositol lipid.
Regulation of PLD activity in Swiss 3T3 cells.
The results presented in this thesis on the role of [Ca2+]0 and Ca2+ entry in 
regulating PLD are preliminary since they do not address the role of intracellular 
stored Ca2+. They do however point the way to further studies since they indicate 
a role for Ca2+ in PLD activity. It must not be assumed that this role will be an 
active, stimulatory, role but may rather, in vivo, be a role as an essential co-factor 
supporting PLD activity; in vitro it may well prove possible to stimulate PLD 
activity with, for example, millimolar concentrations of Ca2+ but this will provide 
little information concerning the in vivo regulation of PLD by Ca2+. A thorough 
assessment of the role of Ca2+ is clearly warranted and will require the use of 
BAPTA or thapsigargin and the development of a cell-free or membrane system.
The speculation that DG may activate PLD at the level of the enzyme itself is 
warranted by a number of investigations reviewed by Billah & Anthes (1990). In 
addition some of the apparently artefactual results obtained with chronic pre­
treatment of Swiss 3T3 cells with PMA (Chapter 6) suggest that PLD might also be 
down-regulated by PMA pre-treatment. A role for DG/phorbol ester in activating 
PLD directly can only satisfactorily be resolved by studying PLD activity in 
membranes or partially pure enzyme preparations which exhibit no PKC activity or 
under conditions which do not support PKC activity (e.g. no ATP). An alternative 
will be to compare the time course for down-regulation of PKC activity with that of 
PLD activity in response to treatment with PMA. If the loss of PLD activity simply 
parallels the loss of PKC activity then this would suggest that PLD activity requires 
functional PKC activity. Alternatively, if PLD is down-regulated before PKC this 
might point towards the two enzymes being independently modulated by PMA.
Purification, cloning and expression of mammalian PLD and PPH.
With the increasing evidence of a role for PtdCho-PLD in signal
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transduction the purification of the enzyme from a mammalian source is of great 
importance. Once purified and sequenced the cloning of PLD may well reveal a 
family of enzymes analagous to the diverse forms of PIC. Once the enzyme is 
cloned over-expression studies should allow assessment of whether base exchange 
and PLD activities reside in the same enzyme and indeed whether the hydrolytic and 
transferase activities of PLD are solely attributable to the same protein.
Furthermore, since there is evidence of a role for a PLD/PPH pathway in 
DG formation a thorough charcterization of PPH is clearly required; ideally this will 
involve the purification of the enzyme and ultimately its cloning. This will be of 
particular interest in terms of the regulation of DG levels since it catalyses the 
reverse reaction to DG kinase and is therefore a likely point of control for either 
removal or formation of DG. As such the interplay between these two activities 
may be crucial in regulating second messenger supply (DG or PtdOH). PPH has 
largely been studied in liver (Martin et al., 1987) where it is of importance in the 
synthesis of triglycerides (Brindley, 1984); the results in this thesis, taken together 
with those of a number of other groups working in similar systems (reviewed by 
Billah & Anthes, 1990) suggest that both PLD and PPH should now be considered 
as important enzymes in signal transduction.
Generation of specific neutralizing anti-sera to PLD and PPH may allow 
micro-injection studies to assess their role in mitogenic signalling in much the same 
way that the Y 13-259 antibody has been used to identify the requirement for 
p2 l ras in serum-stimulated DNA synthesis (Mulcahy et al., 1985). Such 
approaches may lead to a better understanding of the role of stimulated 
phospholipid metabolism and DG formation in the transition from quiescence into 
the cell cycle.
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Appendix I.
Protocol for assay of Ins(l,4,5)P3 mass.
Samples prepared as described in the Methods section (Chapter 2, 2.5.2) 
were assayed for Ins(l,4,5)P3 mass by the competitive binding assay of Palmer et 
al. (1989). The assay employs a bovine adrenocortical microsomal preparation 
which possesses a single population of specific high affinity binding sites for 
Ins(l,4,5)P3.
Aliquots of adrenal cortex preparation (0.5-1 mg of protein) were incubated 
with an aliquot of Swiss 3T3 cell extract or Ins(l,4,5)P3 standard in 25mM Tris 
(pH 9), ImM EDTA, 5mM NaHC03, 0.25mM dithiothreitol and lmg ml"1 BSA 
(Fraction V). Incubations were performed on ice in a final volume of lOOjil with 
[^H]Ins(l,4,5)P3 (approx. 3000 c.p.m. = 52 fmoles = 0.52 nM). Non-specific 
binding was determined in the presence of 940nM Ins(l,4,5)P3. Incubations were 
terminated by centrifugation at 12000 r.p.m. in a bench top centrifuge for 3 min at 
4°C and the supernatant was removed by aspiration. The radioactivity bound to the 
pellet was determined by liquid scintillation counting after solubilisation in Hi-Safe 
scintillant cocktail. The use of a standard curve of displacement of 
[^H]Ins(l,4,5)P3 by unlabelled Ins(l,4,5)P3 with each assay allowed estimation 
of Ins(l,4,5)P3 mass in cell extracts.
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Appendix II.
Publications arising from the work presented in this thesis.
[1] Analysis of the water soluble metabolites of phosphatidylcholine breakdown by 
ion-exchange chromatography; bombesin and TP A (12-0-tetradecanoylphorbol-
13-acetate) stimulate choline generation in Swiss 3T3 cells by a common mechanism . 
Simon J. Cook & Michael J.O. Wakelam. (1989) Biochem. J. 263, 581-587.
[2] Mass measurement of inositol-1,4,5-trisphosphate and sn- 1,2-diacyl glycerol 
in bombesin-stimulated Swiss 3T3 mouse fibroblasts.
Simon J. Cook, Susan Palmer, Robin Plevin & Michael J.O. Wakelam. (1990) 
Biochem. J. 265, 617-620.
[3] Bombesin and platelet-derived growth factor stimulate phosphatidylcholine 
breakdown by a common mechanism.
Simon J. Cook, Robin Plevin, Susan Palmer & Michael J. O Wakelam. (1990) 
Biochem. Soc. Trans. 18, 484-485.
[4] Epidermal growth factor stimulates phospholipase D activity in the absence of 
inositol lipid hydrolysis in Swiss 3T3 cells.
Simon J. Cook & Michael J.O. Wakelam. (1991) Biochem. Soc. Trans. 19, 
108S.
[5] Hydrolysis of phosphatidylcholine by phospholipase D is a common response 
to mitogens which stimulate inositol lipid hydrolysis in Swiss 3T3 cells.
Simon J. Cook & Michael J.O. Wakelam (1991) Biochim. Biophys. Acta, in 
press.
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